data_2n56_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n56 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.65 119.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 mp -77.03 -67.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.445 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -146.64 142.01 27.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.825 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.31 137.47 52.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.002 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.95 108.41 21.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.82 175.85 5.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.348 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.19 108.38 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.252 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.64 134.18 13.6 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.67 0.748 . . . . 0.0 112.778 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.47 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.42 114.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -76.94 171.06 15.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.181 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.59 129.78 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.143 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.8 89.11 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.219 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.72 -171.15 3.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 20' ' ' ALA . 5.4 tm0? -141.48 157.13 45.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 19' ' ' GLN . . . -117.74 138.95 51.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.784 0.326 . . . . 0.0 110.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 27.0 p -125.38 104.55 8.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.324 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -124.4 117.55 24.69 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.429 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -144.54 150.03 36.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 33.3 t -132.75 98.86 4.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.964 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.3 m -79.92 114.72 19.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -105.64 -167.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.838 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -112.87 -2.27 14.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.66 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -145.09 143.31 30.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.277 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.0 137.0 33.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.909 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 20.5 t -114.01 133.92 22.25 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.611 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.5 Cg_exo -61.51 -142.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.816 1.011 . . . . 0.0 109.978 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.0 t -121.45 110.13 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.43 -45.0 0.71 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.84 -12.89 59.73 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.31 132.67 52.08 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -127.52 118.95 24.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.623 ' CE2' ' CD1' ' A' ' 77' ' ' PHE . 75.4 m95 -118.52 106.32 12.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -151.05 149.2 29.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.594 0.711 . . . . 0.0 111.749 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.12 122.85 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -61.02 126.68 28.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.596 1.089 . . . . 0.0 110.341 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 -4.93 24.44 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.18 94.2 0.24 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.307 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.63 132.56 45.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.3 m -85.25 106.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.245 0.545 . . . . 0.0 111.193 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -80.78 156.4 72.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -47.99 -26.72 7.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.264 1.31 . . . . 0.0 110.54 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -107.22 27.25 9.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -57.66 132.06 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.09 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.3 p -90.66 -43.28 10.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.057 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.85 -40.1 63.51 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -106.68 152.79 23.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.188 0.518 . . . . 0.0 110.699 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.8 m -132.12 132.59 43.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.89 138.1 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 110.301 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -146.1 158.81 43.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.135 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.96 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.368 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -129.57 102.95 6.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.973 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.84 -134.22 23.54 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -91.73 20.04 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.456 0.169 . . . . 0.0 111.445 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -123.61 124.32 42.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.62 0.248 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -112.21 119.36 38.08 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.71 131.03 56.33 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.416 0.626 . . . . 0.0 111.339 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.35 131.85 28.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.943 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.65 -174.61 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.301 1.048 . . . . 0.0 111.643 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 65' ' ' ARG . 8.0 tp -142.21 119.64 11.63 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 113.007 -1.906 . . . . 0.0 107.351 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.9 mtt180 -61.65 -138.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 p -69.57 112.93 6.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.97 137.89 57.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 70' ' ' HIS . 83.6 mm-40 -129.54 143.14 47.75 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.622 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.44 83.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.09 1.193 . . . . 0.0 111.145 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 68' ' ' GLN . 86.1 t60 174.85 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.887 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -76.38 -1.75 28.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.67 144.27 43.89 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.993 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.94 179.66 40.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -87.29 157.6 19.26 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.687 -0.302 . . . . 0.0 110.351 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.31 116.81 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.675 0.274 . . . . 0.0 110.558 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -131.38 133.96 45.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 12.5 t80 -141.23 142.47 33.95 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.527 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.28 145.52 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -156.67 -153.09 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.379 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -55.08 87.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.846 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 55.11 13.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.03 90.36 6.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.404 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -87.91 136.58 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 164.17 35.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.155 0.503 . . . . 0.0 111.212 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.3 p -159.95 178.64 9.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.646 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 175.49 179.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.259 0.552 . . . . 0.0 111.364 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -133.42 110.34 9.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.396 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -102.29 128.69 48.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 147.28 33.15 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.7 132.46 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.986 0.422 . . . . 0.0 110.811 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.631 0.253 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.56 119.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.19 -68.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.753 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.29 140.93 30.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.425 0.631 . . . . 0.0 112.164 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 1.4 pt? -130.1 134.12 47.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.623 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.0 tp -101.7 116.99 33.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.12 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -129.75 -170.25 2.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.5 t30 61.4 108.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.496 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.62 133.86 13.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.018 0.913 . . . . 0.0 113.216 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.34 133.89 54.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.2 112.39 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.754 0.788 . . . . 0.0 112.163 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ALA . 56.2 ttm-85 -84.68 147.22 27.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.937 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ARG . . . -34.75 121.83 0.52 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.377 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 14.1 61.34 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.0 150.74 28.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.749 0.309 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -101.69 172.19 7.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.096 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.95 138.39 48.31 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.845 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -128.48 112.28 14.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.345 0.593 . . . . 0.0 111.843 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -124.22 116.73 23.17 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -138.49 141.37 39.4 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.793 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -127.01 96.2 4.54 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.9 m -73.78 107.23 5.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.528 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' SER . 98.3 mt -100.24 -171.85 2.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 t -112.12 -11.2 13.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.605 ' H ' HH21 ' A' ' 80' ' ' ARG . 47.7 tp10 -138.75 145.58 40.39 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.161 0.505 . . . . 0.0 110.952 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.21 139.27 39.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.942 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 31' ' ' PRO . 8.7 t -112.9 128.53 25.49 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.78 -145.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 120.074 1.062 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.56 110.67 27.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.26 -29.5 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.52 -17.82 29.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.79 141.98 43.4 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -130.81 132.53 45.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.651 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.563 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 94.9 m95 -130.27 110.42 11.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 85.7 m-85 -158.98 154.35 25.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.201 0.524 . . . . 0.0 111.476 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.33 122.77 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.04 124.41 20.73 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.682 1.128 . . . . 0.0 110.346 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.43 2.39 31.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 100.17 0.79 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.91 136.09 50.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.89 100.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASP . 43.7 mt-30 -87.42 151.17 50.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.73 -22.42 13.36 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.335 1.357 . . . . 0.0 110.644 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.91 14.75 12.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.929 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' GLN . 25.9 p30 -42.8 112.22 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.207 0.527 . . . . 0.0 111.435 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 t -84.7 -46.58 11.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.917 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -85.14 -25.44 27.46 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -113.44 147.56 37.58 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.5 m -126.65 130.04 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.4 130.46 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 p -144.6 153.99 42.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.904 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.21 103.72 6.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.432 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 35.9 p-10 -114.43 110.78 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.176 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.91 -133.71 52.61 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.54 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 24.4 m -95.41 38.87 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 110.42 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.54 ' ND1' ' O ' ' A' ' 58' ' ' SER . 12.9 m-70 -141.04 141.28 34.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.07 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -129.29 137.27 50.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.74 131.03 47.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.231 0.539 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -124.02 131.6 53.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.399 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.67 165.66 12.79 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.507 1.146 . . . . 0.0 113.711 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 24.9 tp -141.68 113.67 7.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 111.835 -2.439 . . . . 0.0 106.152 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' LEU . 61.8 ttt180 -64.08 -126.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -80.87 109.59 15.58 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.662 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.93 136.05 55.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -133.81 144.57 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.928 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -51.49 94.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.366 1.377 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER 160.82 -21.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.462 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.71 -6.75 55.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.485 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 150.21 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.48 39.21 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.255 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -98.41 151.57 20.42 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.46 115.04 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.6 m -122.36 132.94 54.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 111.568 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 4.2 t80 -144.66 135.38 24.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.977 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ASP . 28.6 p -153.76 -134.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.805 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.605 HH21 ' H ' ' A' ' 28' ' ' GLU . 47.0 mtm180 -52.56 82.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' CYS . 97.3 m-20 45.12 10.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.826 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -97.62 91.38 5.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.2 126.4 39.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.35 133.19 13.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -152.26 133.0 14.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.24 -159.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.769 0.795 . . . . 0.0 111.458 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -142.7 117.25 9.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.852 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.9 tp -107.64 133.02 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 t -136.51 148.66 47.76 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.6 t -111.91 125.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.2 mp . . . . . 0 N--CA 1.462 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.091 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.61 97.79 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.82 -54.2 42.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.051 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -138.4 132.38 31.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.775 0.322 . . . . 0.0 110.258 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.55 147.3 43.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mp -121.48 123.0 41.0 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' H ' ' HE3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.23 -165.64 2.27 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.56 108.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 144.67 3.8 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.89 0.852 . . . . 0.0 113.033 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.09 135.91 51.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.796 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.1 113.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -76.39 170.02 17.15 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.42 109.72 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.168 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.36 -1.23 50.14 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.45 152.12 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.091 0.445 . . . . 0.0 110.136 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.94 154.22 21.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.863 0.363 . . . . 0.0 111.809 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.74 142.11 51.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.711 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -130.67 123.54 29.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 0.0 111.529 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -133.12 123.25 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.558 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.0 t -147.62 154.22 40.37 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.326 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.01 99.93 3.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 109.968 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -81.05 120.68 25.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.084 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.2 -174.79 2.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.44 1.99 14.53 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -138.9 143.93 38.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.135 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -75.84 138.99 41.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.402 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.44 136.81 19.88 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.56 -148.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.319 1.15 . . . . 0.0 110.501 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -121.99 124.66 71.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.1 -35.59 4.3 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -70.93 -42.06 70.37 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 140.67 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -148.06 116.25 6.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.866 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.549 ' NE1' ' CE1' ' A' ' 77' ' ' PHE . 48.6 m95 -109.68 125.14 52.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.442 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 91.3 m-85 -156.86 152.26 26.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 111.517 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.09 119.52 60.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -58.69 116.84 3.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.05 -3.11 9.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.9 107.05 0.13 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.39 132.21 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.072 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.78 104.61 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.197 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -89.14 154.65 49.46 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.44 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -53.07 -25.79 30.17 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.462 1.441 . . . . 0.0 110.057 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -91.31 11.96 21.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.149 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 39.3 p-10 -37.69 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -73.11 -45.8 54.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.484 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.0 -29.08 17.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -102.34 147.06 27.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.187 0.518 . . . . 0.0 111.015 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.1 m -122.15 126.12 47.63 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.91 128.18 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.1 p -142.82 151.76 41.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.056 0.455 . . . . 0.0 111.151 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.14 103.84 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.867 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -104.91 109.12 20.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.715 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.85 -119.17 16.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -105.31 47.43 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.662 0.267 . . . . 0.0 110.449 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.558 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 9.3 t-160 -145.82 138.88 25.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.422 ' O ' ' OG1' ' A' ' 23' ' ' THR . 78.3 m80 -127.05 138.49 53.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.67 109.1 4.33 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tt -112.67 127.13 56.03 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.396 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.38 143.24 39.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 tp -101.83 128.4 48.21 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -71.59 -108.58 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.209 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.9 p -79.91 96.21 6.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 111.234 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.39 142.29 55.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.739 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 70' ' ' HIS . 17.0 mm100 -130.97 144.15 52.36 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.63 84.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.402 1.401 . . . . 0.0 111.378 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' GLN . 78.6 t60 176.25 -28.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -81.77 -6.14 58.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 148.49 9.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.88 -164.91 38.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -104.06 153.71 20.56 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.64 115.9 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.106 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -133.01 133.24 42.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.013 0.435 . . . . 0.0 110.965 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.549 ' CE1' ' NE1' ' A' ' 37' ' ' TRP . 56.0 t80 -127.66 133.99 49.62 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 142.89 50.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.878 0.371 . . . . 0.0 110.678 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 81' ' ' ASP . 17.7 p -154.36 -156.83 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.363 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.597 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.4 ptp180 -50.7 84.67 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.096 0.474 . . . . 0.0 111.6 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' CYS . 99.1 m-20 51.93 0.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -92.82 94.14 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.91 146.99 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.73 165.19 27.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.0 p -151.67 169.85 21.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 177.96 172.1 0.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.836 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -137.55 136.08 37.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -118.55 126.2 51.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.881 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.9 t -144.09 154.18 42.94 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.722 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -115.0 122.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.368 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.787 -179.474 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 6' ' ' LEU . 80.2 mm-40 . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 5' ' ' ILE . 1.1 pt -41.78 70.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' GLU . 42.2 mt -81.54 -28.99 33.66 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -107.28 118.83 37.75 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.82 2.1 . . . . 0.0 112.625 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.42 127.96 32.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -90.4 114.93 27.16 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 11' ' ' ASN . 3.2 mmpt? -121.68 -168.1 1.64 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 10' ' ' LYS . 27.1 m120 53.79 103.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.61 121.2 35.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.698 0.761 . . . . 0.0 113.002 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.37 126.16 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.6 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 28.1 m -137.74 121.23 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -76.35 -166.72 0.66 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.71 124.42 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.22 65.96 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.231 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.71 143.91 44.71 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -92.79 163.34 13.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 148.01 27.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -130.49 123.99 30.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.12 116.53 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.479 ' HG1' ' N ' ' A' ' 24' ' ' CYS . 1.8 t -143.69 150.36 38.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.153 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.479 ' N ' ' HG1' ' A' ' 23' ' ' THR . 3.9 m -122.08 94.12 4.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.663 0.268 . . . . 0.0 110.712 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -71.51 109.9 5.76 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.238 0.542 . . . . 0.0 110.206 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 mt -99.48 -178.57 3.94 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.24 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.86 -3.84 13.39 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 1.1 pm0 -137.45 146.38 44.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.094 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.27 139.24 37.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.421 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' PRO . 21.8 t -107.11 133.24 20.39 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -58.23 -154.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 120.809 1.006 . . . . 0.0 110.187 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -115.53 102.54 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.71 -46.35 0.65 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.76 -43.31 89.29 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.155 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.0 139.97 38.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -140.97 144.37 35.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.714 0.292 . . . . 0.0 110.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 82.9 m95 -140.42 121.79 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.615 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -156.54 152.18 26.99 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.613 0.72 . . . . 0.0 112.127 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.36 114.12 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.01 112.06 3.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.013 1.279 . . . . 0.0 107.616 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.5 -15.67 9.85 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.65 89.38 1.17 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.386 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.33 140.48 57.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.728 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 m -78.65 103.76 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.794 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -102.04 158.25 32.13 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.07 -17.89 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.57 1.513 . . . . 0.0 110.99 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 65.8 m-20 -89.74 -4.95 57.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' ASP . 97.1 m-20 -35.43 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.255 0.55 . . . . 0.0 110.84 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -87.82 -43.07 12.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.096 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.97 -39.32 61.35 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.466 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 15.2 p90 -126.32 166.16 17.66 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.271 0.558 . . . . 0.0 111.304 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.3 p -129.62 156.87 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -132.72 120.84 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.3 p -147.89 157.73 43.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.73 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.02 111.53 5.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.63 107.82 18.83 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.08 -123.88 34.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.608 ' HG ' ' CE1' ' A' ' 59' ' ' HIS . 67.2 p -93.55 43.1 1.11 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.521 0.2 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.608 ' CE1' ' HG ' ' A' ' 58' ' ' SER . 63.5 m80 -147.78 138.86 23.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.901 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.449 ' O ' ' OG1' ' A' ' 23' ' ' THR . 96.2 m-70 -120.22 134.91 55.15 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.02 132.83 34.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.517 0.675 . . . . 0.0 111.28 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tp -126.3 128.94 47.91 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.815 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' TRP . 72.7 mt -105.81 162.91 13.14 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.995 0.903 . . . . 0.0 112.145 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.9 tp -141.69 108.3 5.34 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -68.01 -121.98 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -83.84 104.75 14.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.524 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.38 108.0 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.5 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 70' ' ' HIS . 51.4 mt-30 -108.13 145.95 32.52 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -48.85 88.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.758 1.639 . . . . 0.0 111.164 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 9.5 m-70 176.83 -28.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.827 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 22.8 p80 -76.99 -8.02 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.663 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.8 147.4 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 110.909 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.3 -131.26 2.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -141.53 146.69 36.68 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.655 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.58 115.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -118.7 126.55 52.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.358 0.599 . . . . 0.0 111.447 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 28.9 t80 -130.08 124.28 32.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.003 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.97 157.01 24.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.4 t -151.18 -155.04 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -55.19 82.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.007 0.432 . . . . 0.0 110.389 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 79' ' ' CYS . 95.1 m-20 57.47 -2.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.681 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -88.75 100.23 12.98 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 p -86.48 124.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.278 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.03 32.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.025 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.5 p -171.07 155.21 4.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.2 156.08 43.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.086 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -82.17 138.66 34.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.68 131.65 50.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -142.97 151.94 41.44 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.229 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 p -111.99 123.44 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.44 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.586 0.231 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -89.84 119.06 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 9.5 mp -91.07 -71.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.494 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.26 138.31 29.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.44 158.69 44.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.258 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.8 mt -108.89 131.9 54.57 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 111.508 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -142.55 -171.37 3.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.617 ' H ' ' CB ' ' A' ' 86' ' ' ALA . 66.3 t30 56.05 109.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.2 142.15 14.33 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.38 132.96 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.285 -1.779 . . . . 0.0 107.346 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.31 124.26 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.656 0.741 . . . . 0.0 112.74 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -87.9 165.97 14.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.479 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.35 114.7 2.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.752 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.11 29.71 27.53 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.47 149.83 38.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 110.128 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -113.34 148.35 35.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.71 145.48 51.15 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.215 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 p -124.81 134.34 52.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -133.32 126.22 30.93 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.172 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 t -142.14 142.74 32.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 m -129.28 95.67 4.1 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -77.07 110.13 11.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.12 -174.23 2.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.416 0.627 . . . . 0.0 111.617 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 t -98.7 -20.54 16.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.597 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -142.0 151.16 42.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.008 0.433 . . . . 0.0 111.218 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.6 128.45 35.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.043 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.52 134.77 19.66 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.71 -151.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.028 1.152 . . . . 0.0 110.616 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.93 103.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.84 -37.77 0.66 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.83 -13.09 52.11 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.8 139.84 48.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.376 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -122.97 126.01 46.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.625 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 99.2 m95 -124.66 100.04 6.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.949 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 90.8 m-85 -152.91 149.02 27.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 110.559 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.94 125.09 69.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -48.43 132.76 16.71 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.584 -0.698 . . . . 0.0 111.257 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.63 8.1 56.21 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.205 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.16 125.91 1.35 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.376 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.28 112.83 24.47 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.88 104.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 112.487 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.475 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.6 mp0 -92.21 157.46 40.72 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -53.29 -23.4 23.35 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.613 1.542 . . . . 0.0 111.495 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -98.35 17.23 19.28 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 45' ' ' GLN . 87.3 m-20 -49.18 128.83 17.24 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.4 p -91.96 -37.25 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.755 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 66.2 t0 -96.48 -32.45 12.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.659 0.266 . . . . 0.0 111.694 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -102.83 139.86 37.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.477 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 m -132.3 130.46 40.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.5 133.21 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -143.34 154.57 43.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.634 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.47 106.0 4.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.327 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.01 105.67 15.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.951 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.32 -126.34 41.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 23.0 t -95.44 37.56 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.633 0.254 . . . . 0.0 110.938 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 58' ' ' SER . 22.1 m-70 -142.81 153.85 43.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.844 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.27 161.8 28.52 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.92 94.2 1.11 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.755 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.05 128.18 54.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.503 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -121.73 -178.29 3.78 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.162 0.982 . . . . 0.0 112.357 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.2 tp -145.01 120.74 10.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.01 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' LEU . 82.8 mmt-85 -64.1 -130.23 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.307 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 m -82.84 108.28 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.95 142.46 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.672 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' HIS . 80.9 mt-30 -134.42 144.8 52.58 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.42 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.29 83.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.296 1.331 . . . . 0.0 111.153 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.3 t60 178.39 -26.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -87.09 -1.16 57.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.837 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.08 145.96 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.18 -123.04 1.0 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -142.47 154.2 44.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.508 0.194 . . . . 0.0 110.531 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -121.22 117.99 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -128.95 129.16 45.09 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.13 0.49 . . . . 0.0 112.145 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.625 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 16.4 t80 -136.65 141.16 43.17 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.35 154.8 39.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' ASP . 3.0 t -157.33 -147.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.703 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.488 ' C ' ' H ' ' A' ' 82' ' ' ALA . 24.6 mmm180 -53.79 89.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' CYS . 53.2 t0 50.58 10.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.14 93.99 8.58 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.23 125.69 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.838 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.24 123.24 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.472 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.8 p -158.53 138.21 11.93 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.692 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.617 ' CB ' ' H ' ' A' ' 11' ' ' ASN . . . -139.62 151.31 45.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -81.21 144.27 31.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.344 0.593 . . . . 0.0 112.35 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.2 tp -111.95 133.12 54.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.386 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -137.86 139.08 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.104 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.8 126.67 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.239 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.3 tp . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 121.033 0.444 . . . . 0.0 111.043 -179.752 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 18.1 tt -89.67 119.46 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.091 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.58 -63.79 1.17 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.928 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -154.12 146.95 24.35 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.946 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.07 145.54 44.07 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.806 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.38 115.54 30.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -131.78 -169.99 2.31 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.071 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' LYS . 60.1 t-20 53.42 107.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.409 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.26 147.93 3.83 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.76 148.62 45.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.111 -1.859 . . . . 0.0 106.631 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.87 110.05 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.288 0.566 . . . . 0.0 111.155 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -76.31 155.77 33.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.24 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.91 136.12 47.51 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.823 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.35 28.27 68.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.12 143.85 46.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.286 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -98.51 159.24 15.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.846 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.0 148.39 31.65 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.58 124.55 41.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.141 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.43 117.27 21.07 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -143.81 153.99 42.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.11 98.43 3.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.314 0.578 . . . . 0.0 111.05 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -71.13 110.44 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.11 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.04 -177.17 4.06 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 110.781 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 100.0 p -108.3 -12.56 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.116 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -134.29 145.97 49.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.949 0.405 . . . . 0.0 110.902 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.79 129.83 35.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.64 141.57 24.31 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.94 -145.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 120.642 1.265 . . . . 0.0 111.086 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 p -123.15 123.6 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.43 -26.4 6.34 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.39 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.4 -21.21 23.17 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.162 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 143.69 30.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -120.88 126.86 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.572 ' CE2' ' CD2' ' A' ' 77' ' ' PHE . 37.2 m95 -134.45 115.04 13.52 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.657 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -170.37 166.1 8.63 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.287 0.565 . . . . 0.0 112.213 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.78 127.66 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -66.8 132.15 47.43 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 120.772 -1.205 . . . . 0.0 109.713 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.1 -3.92 33.57 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -146.32 -27.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.339 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' ALA . . . 48.3 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.3 p -60.05 118.93 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.491 0.662 . . . . 0.0 112.52 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -110.98 152.19 43.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.513 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.38 -20.31 47.69 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.911 1.074 . . . . 0.0 111.855 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.82 4.63 49.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.01 137.96 57.97 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.194 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 p -89.31 -33.51 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 51' ' ' TRP . 38.6 p-10 -92.48 -29.34 16.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.662 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.443 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 97.4 m95 -110.6 139.14 46.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 111.245 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 93.9 m -127.16 130.28 49.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -125.39 132.91 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 p -144.64 155.82 43.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.501 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.36 105.76 4.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.66 113.78 21.73 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.008 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.26 -133.52 42.48 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -98.26 38.61 1.31 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.815 0.341 . . . . 0.0 110.555 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -139.96 137.92 35.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.125 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -122.08 134.25 54.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 129.36 36.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.36 0.6 . . . . 0.0 111.835 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.44 151.56 41.15 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.245 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 5.0 mp -133.68 165.07 25.78 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.399 1.095 . . . . 0.0 113.156 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 65' ' ' ARG . 34.4 tp -143.6 108.39 4.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.643 -2.071 . . . . 0.0 106.365 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.6 mtt-85 -64.58 -121.26 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.2 m -81.87 109.63 16.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.27 134.6 53.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.586 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 0.8 OUTLIER -136.02 147.19 59.76 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.067 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.3 Cg_endo -48.22 90.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.668 1.578 . . . . 0.0 111.693 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.6 m-70 170.63 -29.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.199 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.586 ' ND1' ' O ' ' A' ' 68' ' ' GLN . 49.1 p-80 -83.25 -15.0 52.01 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.27 146.83 27.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.311 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.26 -137.48 4.61 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.527 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 53.6 mp0 -126.87 147.79 50.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.38 111.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -123.45 123.16 40.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.274 0.559 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -145.64 145.94 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.736 179.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.3 151.61 28.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.319 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 81' ' ' ASP . 4.8 t -156.73 -140.96 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.939 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ALA . 19.0 mmm180 -54.23 89.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.979 0.419 . . . . 0.0 110.135 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 44.54 16.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -103.41 69.94 1.02 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 135.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.88 132.51 7.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -141.62 119.36 11.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.141 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.77 -160.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.49 0.662 . . . . 0.0 111.67 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -146.04 121.19 10.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.586 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.7 tp -110.07 130.51 55.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.923 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 t -136.17 146.51 46.94 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.613 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 90' ' ' VAL . 9.6 p -113.29 125.53 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 3.0 mm? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.354 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 121.324 0.583 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -77.51 121.69 30.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.767 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.21 -68.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -135.0 124.86 25.49 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -110.73 152.68 26.29 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.037 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.02 108.79 12.75 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' CE ' ' N ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -130.19 -168.53 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.506 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 m120 54.78 105.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.782 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.93 134.86 6.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.984 0.897 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.73 130.09 54.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.838 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' ARG . 5.1 m -129.91 103.28 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.214 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 14' ' ' VAL . 93.7 mtt180 -47.54 175.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.48 128.91 38.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.099 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.29 42.41 10.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.58 160.91 36.06 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.495 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -95.24 154.63 17.09 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.25 133.66 46.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 p -119.62 122.62 41.96 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -132.6 117.85 18.45 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.0 p -144.52 151.69 39.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.261 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.99 95.74 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.991 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 p -67.83 123.52 20.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -123.63 143.23 50.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.906 0.384 . . . . 0.0 111.288 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 m -76.77 -13.28 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.921 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -116.94 132.89 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 0.0 111.805 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.97 149.56 30.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.8 t -124.74 122.58 25.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.48 -147.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.229 1.118 . . . . 0.0 110.998 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.9 p -120.97 118.84 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.742 0.782 . . . . 0.0 109.102 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.28 -25.28 9.36 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -91.78 -19.21 22.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.144 0.497 . . . . 0.0 109.678 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.08 166.59 19.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.3 m -146.52 116.75 7.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.462 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.09 97.79 3.06 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -155.07 156.31 35.65 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' A' ' 42' ' ' ALA . 4.9 mm -73.42 101.06 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -47.72 97.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 128.42 -36.28 2.5 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . -125.04 98.28 5.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.07 139.73 51.43 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.824 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.52 113.8 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -104.67 152.39 39.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.37 -19.82 18.33 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.286 1.324 . . . . 0.0 109.989 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.54 31.3 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.51 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 42.4 p-10 -97.48 104.94 17.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.508 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -87.44 -52.78 5.17 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.469 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -67.39 -37.53 83.26 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 110.112 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.409 ' CZ2' ' CD1' ' A' ' 39' ' ' ILE . 59.7 t-105 -105.17 148.01 27.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.028 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -146.26 143.74 29.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.644 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -124.79 138.0 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -142.83 158.65 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 111.235 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.01 100.83 3.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -108.86 105.15 14.57 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 -131.22 30.22 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -100.43 37.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.064 0.459 . . . . 0.0 110.595 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -135.75 132.34 36.68 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -115.24 123.23 48.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.73 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.27 122.88 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -141.15 131.43 25.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.63 ' N ' ' CD1' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.32 -169.98 2.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.208 1.004 . . . . 0.0 113.7 -175.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.7 tp -146.4 119.9 9.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 113.366 -1.743 . . . . 0.0 106.954 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -68.51 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.8 p -71.46 103.54 2.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.167 0.508 . . . . 0.0 110.225 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.4 135.92 53.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 70' ' ' HIS . 73.8 mt-30 -130.87 144.1 52.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -48.57 92.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.515 1.476 . . . . 0.0 111.599 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 3.7 m-70 166.9 -27.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.891 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -86.36 -0.79 56.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.389 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 145.27 56.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.213 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.05 -150.3 15.36 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -118.66 166.7 12.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.626 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.8 t -132.2 133.7 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.7 m -132.6 129.16 38.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.382 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -132.78 140.34 47.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.284 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -161.69 144.36 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.645 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' ASP . 25.4 p -157.6 -135.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.539 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -51.81 81.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 44.1 t0 51.28 6.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -96.29 91.38 5.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.91 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.315 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.01 -179.49 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.326 0.584 . . . . 0.0 110.992 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 m -158.0 178.9 9.7 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.466 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -169.47 160.97 9.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.212 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -119.27 132.8 55.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.911 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 tp -121.76 127.04 50.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.535 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 t -146.79 153.85 40.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.284 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.4 110.94 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.992 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.923 -179.599 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.413 ' OE2' ' O ' ' A' ' 80' ' ' ARG . 34.2 tp10 . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -99.3 121.12 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.554 0.342 . . . . 0.0 110.739 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.8 -71.15 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -126.5 118.38 24.81 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.408 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 1.7 pt? -122.18 144.64 48.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.23 115.69 31.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -132.26 179.56 6.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.683 -178.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 10' ' ' LYS . 86.4 m-20 51.88 108.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.292 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.36 140.74 7.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.95 0.881 . . . . 0.0 112.76 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 127.81 53.45 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -113.06 111.38 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -63.64 166.65 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.186 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 133.83 48.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.998 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.53 43.11 98.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.26 151.73 48.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.345 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -92.83 157.68 16.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.976 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.81 153.82 36.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.42 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.1 t -142.09 148.23 38.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.435 0.636 . . . . 0.0 111.391 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.65 128.92 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.722 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -148.13 152.04 36.62 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.974 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.4 p -142.01 98.06 3.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.402 0.62 . . . . 0.0 111.756 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 m -71.81 120.32 17.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.138 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.16 139.56 47.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.051 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 t -70.79 -13.21 61.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.19 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -131.66 139.96 49.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.129 0.49 . . . . 0.0 111.367 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.74 146.44 33.88 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.915 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -125.24 134.92 26.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.5 -148.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.318 1.149 . . . . 0.0 110.232 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.88 115.01 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.6 -47.44 0.9 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -68.03 -36.79 80.5 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.08 127.76 34.12 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.909 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.5 t -135.56 138.04 42.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.556 ' CZ2' ' CG ' ' A' ' 77' ' ' PHE . 90.5 m95 -137.76 112.99 9.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.0 p90 -157.91 155.62 29.9 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.202 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.477 ' H ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.7 94.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' ILE . 23.8 t-20 -37.61 106.03 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.242 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.77 -9.82 8.55 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.83 102.74 3.44 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 110.496 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 106.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.55 128.37 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.913 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.38 150.1 42.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.18 -25.64 65.34 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.674 1.583 . . . . 0.0 111.78 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -82.29 11.46 5.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 35.8 p-10 -62.28 133.27 54.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.727 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -90.93 -50.07 6.08 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -64.61 -38.68 91.85 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.015 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -104.72 151.38 23.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.4 m -135.07 136.69 42.22 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.34 135.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 p -144.21 157.47 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.269 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.92 113.0 3.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.086 0.47 . . . . 0.0 110.757 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 65.8 t0 -130.33 123.68 30.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 -124.84 11.68 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.4 m -115.55 43.02 2.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.739 0.304 . . . . 0.0 110.801 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 56' ' ' ASP . 34.9 p80 -154.26 146.62 23.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.742 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.64 168.1 9.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.97 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.12 100.91 1.4 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.647 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tt -109.93 129.19 55.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.055 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pp -118.18 173.66 6.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.957 0.885 . . . . 0.0 112.382 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.2 tp -140.42 115.2 9.58 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 113.54 -1.664 . . . . 0.0 106.602 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.556 HH21 ' HG ' ' A' ' 66' ' ' SER . 61.7 ttp85 -68.17 -128.04 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.556 ' HG ' HH21 ' A' ' 65' ' ' ARG . 82.5 p -75.55 108.61 8.49 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.369 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.26 56.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 66' ' ' SER . 2.8 mp0 -124.91 141.79 39.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.553 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -53.13 86.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.282 1.321 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.1 m-70 174.2 -33.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.708 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -70.64 -5.09 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.795 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.02 145.8 15.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.681 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.88 -167.43 35.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 40' ' ' ASN . 93.2 mt-10 -100.55 165.44 11.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.516 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.9 t -128.12 129.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.784 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.2 m -133.42 137.87 45.98 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.462 0.649 . . . . 0.0 110.783 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.556 ' CG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -131.98 134.07 45.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.071 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.462 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -134.59 137.59 43.85 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -151.36 -155.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 82' ' ' ALA . 79.8 mtp85 -57.77 90.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.8 t0 49.35 14.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -89.73 95.31 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.602 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.48 134.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.395 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.53 154.7 41.85 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.225 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.8 p -156.98 173.69 16.64 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.789 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 178.21 175.41 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.193 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -136.98 109.06 7.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.095 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.7 tp -93.47 129.79 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.773 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -137.13 135.08 37.08 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.054 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.18 118.04 41.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.8 mt -83.8 118.52 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.08 -67.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.269 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -139.81 131.32 27.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.513 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 119.72 36.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 9.4 mp -93.84 104.91 16.96 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 11' ' ' ASN . 7.3 mmpt? -132.91 -169.16 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' LYS . 15.6 t-20 59.17 109.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.56 145.84 2.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.832 0.825 . . . . 0.0 111.963 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.09 130.85 53.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.283 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 m -119.92 122.75 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 122.226 1.013 . . . . 0.0 113.397 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.86 167.81 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.048 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.83 55.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.723 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.38 50.76 59.96 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.12 25.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.536 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -100.82 147.36 26.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.141 0.496 . . . . 0.0 110.305 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.2 140.15 52.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.195 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.01 137.0 47.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.386 0.612 . . . . 0.0 111.83 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -145.67 130.07 17.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.353 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -144.58 148.76 34.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -133.36 95.21 3.47 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.197 0.522 . . . . 0.0 111.666 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.4 m -75.16 113.51 12.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.694 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -107.14 -163.18 0.89 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.481 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -114.03 -7.28 13.11 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.332 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -146.22 154.79 42.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.121 0.486 . . . . 0.0 111.28 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.46 129.31 35.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.748 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.23 133.58 22.83 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.559 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -63.0 -146.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.255 1.127 . . . . 0.0 111.283 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.5 t -120.5 120.85 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.14 -28.67 5.77 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 53.5 mp0 -85.2 -18.02 35.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.748 0.308 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.0 134.75 51.8 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 m -113.6 140.1 48.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.619 0.247 . . . . 0.0 110.554 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.571 ' CZ2' ' CD1' ' A' ' 77' ' ' PHE . 91.7 m95 -147.27 102.41 3.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.61 153.89 32.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 mp -80.81 145.18 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.819 0.819 . . . . 0.0 111.634 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -78.82 106.17 10.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.517 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.24 -9.18 7.02 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.86 120.71 1.22 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.56 0.219 . . . . 0.0 111.065 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.48 53.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.946 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.0 t -98.54 116.25 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 157.92 45.21 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.51 -34.83 90.9 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.675 1.583 . . . . 0.0 112.12 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -82.22 20.23 1.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.584 0.231 . . . . 0.0 111.593 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 28.8 p-10 -55.05 122.83 11.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.087 0.47 . . . . 0.0 112.118 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -88.93 -51.31 5.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.574 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' OD2' ' CE1' ' A' ' 71' ' ' HIS . 97.5 m-20 -66.17 -38.11 87.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.229 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.479 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 8.7 m-90 -105.94 155.29 19.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.412 0.625 . . . . 0.0 112.128 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -132.55 132.53 42.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -125.0 134.1 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 p -145.87 156.04 43.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.12 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.77 109.7 4.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 33.1 p-10 -119.32 102.44 8.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.06 -133.67 31.38 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.47 ' HG ' ' C ' ' A' ' 28' ' ' GLU . 56.4 m -89.94 21.47 3.63 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 122.607 -0.349 . . . . 0.0 111.115 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 77.9 m80 -123.11 124.05 42.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.63 153.07 21.03 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.97 98.0 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.497 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.32 132.66 53.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.41 HD11 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -130.05 -177.25 4.22 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.483 1.135 . . . . 0.0 112.295 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 51' ' ' TRP . 9.2 tp -145.99 115.24 7.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.532 -2.122 . . . . 0.0 107.362 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 49.7 ttp180 -64.65 -128.45 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -69.01 106.03 2.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.945 0.402 . . . . 0.0 109.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.29 143.13 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.887 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -133.59 139.68 34.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -53.8 89.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.318 1.345 . . . . 0.0 112.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.566 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER 168.18 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.808 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 50' ' ' ASP . 7.2 m-70 -85.71 0.64 52.2 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.96 146.21 33.17 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.707 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.42 -149.5 18.85 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 57.7 mp0 -145.03 119.2 9.47 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.63 144.35 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.635 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -124.84 128.0 48.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.662 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CD1' ' CZ2' ' A' ' 37' ' ' TRP . 3.4 t80 -132.47 138.05 47.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -160.24 144.18 14.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 81' ' ' ASP . 29.9 p -155.91 -132.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.508 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 95.6 mtt-85 -54.53 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.434 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 79' ' ' CYS . 27.9 t70 46.85 14.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.08 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -101.35 88.73 3.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.78 153.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.04 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -179.64 115.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.79 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.2 t -93.21 -173.91 3.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.987 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.03 154.68 22.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.024 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -114.94 113.76 24.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.445 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 73' ' ' GLY . 38.6 tp -115.11 124.92 52.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -140.49 123.52 16.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.107 0.48 . . . . 0.0 110.715 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.84 119.94 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.181 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.183 0.516 . . . . 0.0 110.086 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tp -82.85 120.5 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.14 -70.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.7 135.58 29.98 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 112.42 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.26 135.05 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.67 112.17 23.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.572 ' NZ ' ' O ' ' A' ' 85' ' ' SER . 1.8 mmpt? -127.78 -176.17 3.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.037 0.446 . . . . 0.0 111.295 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 10' ' ' LYS . 93.2 m-20 55.92 108.63 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.341 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.74 138.81 9.73 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.91 147.93 44.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.421 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.7 m -133.18 114.98 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.423 0.63 . . . . 0.0 111.189 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -85.25 147.58 26.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.379 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.53 124.98 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.586 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.74 27.13 51.93 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.47 147.0 41.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -103.58 156.3 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.333 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.43 144.35 31.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.91 0.386 . . . . 0.0 110.567 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -127.69 136.26 51.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.472 0.653 . . . . 0.0 111.13 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -137.51 122.01 18.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.552 ' OG1' ' CE1' ' A' ' 59' ' ' HIS . 1.7 t -144.3 152.71 41.15 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.536 -0.466 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 26' ' ' LEU . 14.1 t -127.51 92.45 3.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.171 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 m -73.07 114.86 11.71 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' CD2' ' SG ' ' A' ' 24' ' ' CYS . 84.2 mt -103.81 -169.41 1.63 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.31 0.576 . . . . 0.0 111.362 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.8 t -113.85 -5.13 13.25 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.234 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -140.85 146.11 37.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.64 133.45 35.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.968 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 10.9 t -108.25 134.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.364 -0.35 . . . . 0.0 110.507 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -61.7 -143.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 119.975 1.027 . . . . 0.0 110.047 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.52 111.56 29.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.566 0.698 . . . . 0.0 109.421 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.79 -47.37 0.7 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -67.53 -45.62 75.18 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.069 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.25 138.35 38.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -142.61 112.71 7.06 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.663 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.638 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 98.5 m95 -106.78 107.13 17.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 68.0 m-85 -150.13 150.22 31.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.535 0.683 . . . . 0.0 110.563 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.496 ' H ' ' CD1' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -125.35 129.27 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -61.07 110.53 1.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.101 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.85 -4.35 6.48 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.811 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 44' ' ' VAL . . . -160.29 76.92 0.62 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.761 0.78 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.92 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 42' ' ' ALA . 6.2 p -67.97 101.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.506 0.669 . . . . 0.0 110.739 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 48' ' ' ASP . 16.2 mt-30 -92.07 155.94 42.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.486 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.37 -30.51 15.56 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.667 1.578 . . . . 0.0 111.616 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.63 10.01 19.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 11.0 p-10 -51.0 128.81 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.7 p -92.44 -47.34 7.21 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.071 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 46.2 t0 -72.11 -39.36 68.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.641 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -106.84 151.07 25.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.316 0.579 . . . . 0.0 111.341 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -128.56 130.28 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.878 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.99 133.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.011 0.434 . . . . 0.0 109.833 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -142.01 153.39 44.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.43 98.58 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.086 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -113.19 105.76 13.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.27 -132.45 48.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -93.34 35.49 1.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.285 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.552 ' CE1' ' OG1' ' A' ' 23' ' ' THR . 63.7 t-80 -139.65 131.77 28.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 80.7 m80 -118.52 137.02 53.49 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.77 137.94 51.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.301 0.572 . . . . 0.0 111.472 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 tp -132.63 138.16 47.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.32 162.16 25.36 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.265 1.031 . . . . 0.0 112.864 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 65' ' ' ARG . 17.9 tp -140.88 110.9 6.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 112.774 -2.012 . . . . 0.0 106.323 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.7 mtt-85 -62.87 -128.96 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.105 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.6 p -77.61 107.15 9.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.08 0.467 . . . . 0.0 110.285 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 137.55 57.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.35 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 84.2 mt-30 -133.94 135.06 23.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.02 88.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.002 1.135 . . . . 0.0 111.658 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 2.0 t60 -173.48 -39.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.603 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 22.8 p-80 -82.12 -7.65 59.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.883 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.21 152.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.34 -162.03 34.01 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.16 149.11 21.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.777 0.322 . . . . 0.0 110.581 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.0 t -117.51 119.71 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.886 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 137.31 49.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.638 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 2.3 t80 -137.95 134.98 35.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.466 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -133.06 144.25 49.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.8 t -156.88 -151.2 0.31 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.32 0.581 . . . . 0.0 111.502 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -55.84 84.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.122 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' CYS . 90.5 m-20 51.27 8.62 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.4 94.21 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.74 129.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.935 0.398 . . . . 0.0 110.471 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.76 165.39 25.38 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.438 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.572 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 96.9 p -161.68 -179.69 7.46 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 174.59 178.64 0.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 128.86 24.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.274 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.3 tp -113.99 130.07 56.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 t -142.34 155.97 45.21 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.665 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.9 t -121.0 123.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.394 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.269 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.69 119.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.6 mp -86.79 -71.44 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.651 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -132.14 128.17 37.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.057 0.456 . . . . 0.0 111.183 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 1.8 pt? -129.66 136.69 50.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.79 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' C ' ' CD2' ' A' ' 9' ' ' LEU . 2.5 tt -104.55 108.99 20.7 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 11' ' ' ASN . 12.4 mmmt -118.39 -171.22 2.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.3 m120 57.04 108.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.91 130.34 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.91 128.45 46.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -131.31 123.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.51 172.6 13.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.433 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 133.18 54.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.114 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.73 23.8 74.07 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.8 152.87 28.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.9 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.67 152.48 20.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.5 144.74 46.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -142.48 120.61 12.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 112.193 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -123.6 116.35 22.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.4 t -144.95 150.84 37.66 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.472 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.7 100.75 4.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.429 ' OG1' ' ND1' ' A' ' 59' ' ' HIS . 23.6 m -72.69 112.05 8.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.374 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.04 -166.45 1.23 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.341 0.591 . . . . 0.0 111.245 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.1 p -114.72 -4.83 12.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.915 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -138.37 141.58 39.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.423 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.86 130.59 36.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.515 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 31' ' ' PRO . 26.3 t -104.16 134.9 19.46 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.268 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.15 -147.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 120.022 1.044 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.22 109.52 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.56 -42.2 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.46 -43.58 80.74 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.074 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.34 150.2 33.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.64 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -126.8 126.25 43.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 111.036 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -131.48 112.13 12.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -155.42 153.76 30.87 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.505 0.669 . . . . 0.0 111.508 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.99 121.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.32 125.65 24.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.174 0.897 . . . . 0.0 109.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.47 -3.9 31.06 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.4 96.55 0.4 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.271 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.32 139.41 54.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.868 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.43 103.18 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -90.48 153.74 46.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.12 -29.11 27.35 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.767 1.644 . . . . 0.0 111.352 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -97.21 14.21 26.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -46.45 124.73 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -88.09 -44.21 11.11 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.25 -26.19 19.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -110.18 139.92 44.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.48 ' OG1' ' CD1' ' A' ' 63' ' ' LEU . 23.4 p -136.94 152.72 50.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.56 137.0 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 p -142.43 153.45 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.93 102.39 5.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.027 0.441 . . . . 0.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -109.33 107.65 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.943 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.89 -131.42 45.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.5 p -97.03 47.16 1.04 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.729 0.299 . . . . 0.0 111.008 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.553 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 63.6 t60 -152.44 137.06 16.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.672 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -117.01 135.75 53.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.05 126.51 26.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 111.008 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 tt -131.22 133.86 45.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.322 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.48 ' CD1' ' OG1' ' A' ' 52' ' ' THR . 1.5 pp -119.56 -176.63 3.2 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.254 1.026 . . . . 0.0 112.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 65' ' ' ARG . 44.5 tp -146.12 122.22 10.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.144 -1.844 . . . . 0.0 106.302 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' LEU . 93.2 mtt-85 -63.51 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.611 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -78.28 108.1 11.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.73 134.89 50.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.898 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.673 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 74.0 mt-30 -132.4 145.1 55.84 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.64 84.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.416 1.41 . . . . 0.0 111.246 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 68' ' ' GLN . 81.4 t60 176.97 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.087 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.673 ' HD1' ' H ' ' A' ' 68' ' ' GLN . 30.0 m80 -82.03 -8.97 59.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.61 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.11 148.71 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.593 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.9 -171.31 42.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -97.68 151.68 19.87 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -119.39 118.14 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 117.757 0.253 . . . . 0.0 110.915 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 m -127.97 129.81 47.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.116 0.484 . . . . 0.0 111.115 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.37 139.34 37.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.293 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.91 153.13 31.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.165 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.9 t -157.32 -140.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 82' ' ' ALA . 77.9 mtp85 -55.97 86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.079 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 79' ' ' CYS . 26.9 t0 52.18 10.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -92.59 87.43 5.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.78 125.85 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -155.62 122.59 5.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.165 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 m -95.43 -174.2 3.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.888 0.375 . . . . 0.0 111.26 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 176.04 173.02 0.35 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -149.0 136.23 20.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 tp -112.74 130.91 55.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -138.57 132.22 30.74 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.701 0.286 . . . . 0.0 111.52 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.81 124.23 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.541 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.466 0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.097 179.4 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 55.1 mp0 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.06 107.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.05 -64.06 1.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -120.4 110.46 16.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.0 tp -114.07 129.57 56.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -113.25 125.94 54.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.735 0.303 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.381 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.01 128.64 11.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.49 0.662 . . . . 0.0 111.893 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.82 53.76 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.1 108.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -66.86 174.94 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.31 120.77 8.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.532 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.93 49.67 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.718 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.76 43.3 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.11 152.66 19.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 112.337 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.71 141.11 49.7 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.746 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 p -123.96 110.65 15.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.298 0.57 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -117.19 103.97 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -133.66 139.71 46.62 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.405 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.6 p -137.96 96.94 3.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 m -69.19 117.77 11.25 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.119 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' SER . 46.9 mt -101.65 -174.77 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 t -114.09 3.15 15.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.864 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -126.18 127.76 46.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.512 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.38 75.23 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.92 132.46 74.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.915 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.1 -143.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.925 1.084 . . . . 0.0 110.935 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 19.9 m -118.94 109.96 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.629 0.728 . . . . 0.0 109.301 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.36 -56.38 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 80' ' ' ARG . 96.5 mt-10 -69.46 -40.93 76.84 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 149.75 31.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -137.67 137.98 38.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.013 0.435 . . . . 0.0 110.594 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.466 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 63.7 m95 -136.59 105.1 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.87 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 76.8 m-85 -149.54 150.2 31.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.666 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.2 130.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -62.65 132.79 53.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.269 -0.894 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.76 40.57 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.14 138.57 5.66 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.967 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.18 130.67 47.31 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.87 111.04 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.633 0.254 . . . . 0.0 110.579 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.515 ' C ' ' H ' ' A' ' 47' ' ' ASP . 37.0 mt-30 -126.73 153.11 75.75 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.68 -10.26 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.091 1.861 . . . . 0.0 111.488 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' GLN . 45.7 p-10 -108.64 29.42 7.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' ASP . 44.4 p-10 -34.25 161.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.77 0.795 . . . . 0.0 112.378 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -95.79 -62.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.707 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -124.79 -36.02 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -86.98 159.21 19.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.573 0.702 . . . . 0.0 111.312 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.6 m -130.53 144.69 51.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.773 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.43 130.1 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.9 p -143.81 154.91 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.37 100.85 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.351 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -103.21 108.29 19.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.073 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 -132.24 41.11 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 26' ' ' LEU . 10.2 m -97.17 50.87 1.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.391 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -153.67 145.72 23.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -127.36 142.36 51.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.89 12.1 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.287 0.565 . . . . 0.0 111.141 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tt -122.78 125.2 45.01 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.926 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 pp -139.73 135.65 33.35 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 71' ' ' HIS . 12.4 tp -107.59 111.02 23.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -63.39 -95.59 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.469 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -83.47 103.4 12.79 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 122.09 -0.381 . . . . 0.0 111.729 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.51 55.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.685 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.656 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 40.6 mt-30 -134.22 140.62 36.56 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.74 85.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.059 1.172 . . . . 0.0 111.625 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' GLN . 55.7 t-80 -177.24 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.656 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 35.0 p80 -82.58 -11.24 58.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.366 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.41 146.06 3.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 110.99 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.93 -154.85 25.19 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.38 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.4 mp0 -106.38 154.45 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -116.37 119.56 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.903 0.382 . . . . 0.0 110.688 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.6 m -127.01 130.09 49.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.432 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.64 138.59 36.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.28 153.86 38.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' ' 81' ' ' ASP . 15.1 t -157.07 -132.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.531 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.454 ' C ' ' N ' ' A' ' 82' ' ' ALA . 30.6 mmt180 -57.22 86.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.809 0.338 . . . . 0.0 110.406 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.7 t0 45.41 18.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.454 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -102.77 91.22 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.164 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.76 129.98 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.333 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.56 124.22 10.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.154 0.502 . . . . 0.0 110.802 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.3 p -92.14 -173.58 3.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 176.4 174.7 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.117 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -137.43 137.69 39.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.449 . . . . 0.0 111.056 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.2 121.64 31.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.531 ' HG1' ' N ' ' A' ' 90' ' ' VAL . 6.0 t -142.35 152.06 42.53 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.68 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.531 ' N ' ' HG1' ' A' ' 89' ' ' THR . 5.8 p -108.88 108.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.833 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -178.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' CD1' ' A' ' 6' ' ' LEU . 95.2 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 5' ' ' ILE . 96.0 mt -86.63 108.59 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 6.9 mp -78.98 -64.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.332 -177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.13 113.83 18.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.964 0.411 . . . . 0.0 111.423 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.1 tp -106.73 123.58 48.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.766 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.8 tp -112.07 123.41 50.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.653 ' HZ1' ' N ' ' A' ' 85' ' ' SER . 5.3 mmmm -138.67 -165.44 1.82 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.351 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 10' ' ' LYS . 65.7 t30 57.6 107.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.808 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.18 140.2 8.78 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.292 1.044 . . . . 0.0 113.402 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.23 144.37 51.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.617 -1.629 . . . . 0.0 107.454 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.62 128.95 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.713 0.768 . . . . 0.0 112.704 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ALA . 89.7 mtt180 -96.19 158.0 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.505 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 113.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.574 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.85 62.06 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . -104.54 153.13 21.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.503 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.436 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 9.9 mp0 -106.21 156.4 18.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.204 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.88 138.11 54.26 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 t -120.83 109.69 15.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.27 0.557 . . . . 0.0 112.272 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -114.08 108.43 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -144.98 152.12 39.67 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.482 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.9 p -139.28 102.98 4.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 p -74.38 112.25 10.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.302 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.1 mt -101.22 -173.36 2.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.272 0.558 . . . . 0.0 111.359 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.46 -2.71 17.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.54 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -135.19 139.12 44.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.483 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.19 133.92 33.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.264 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' PRO . 61.1 t -108.31 131.34 21.82 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -60.77 -144.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.949 1.018 . . . . 0.0 110.188 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -119.91 122.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.29 -29.25 6.24 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.709 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.98 -12.61 52.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.86 0.362 . . . . 0.0 110.435 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.94 140.91 37.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 m -118.49 125.97 51.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 66.6 m95 -138.72 118.93 13.55 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.856 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -158.28 153.21 25.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.001 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.71 119.85 57.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -56.88 112.8 1.42 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.425 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.62 9.95 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.32 107.01 0.68 Allowed 'General case' 0 C--O 1.23 0.067 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.75 139.94 53.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.02 98.22 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 0.0 111.171 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.463 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.2 pt20 -102.77 151.43 38.32 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.51 -20.03 8.12 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.309 1.34 . . . . 0.0 110.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -98.05 8.31 44.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 45' ' ' GLN . 64.7 m-20 -42.78 113.31 0.45 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.888 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 t -69.64 -44.26 70.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.048 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.24 -35.76 10.25 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.65 138.83 31.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.082 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.649 ' HG1' HH12 ' A' ' 65' ' ' ARG . 87.4 m -124.52 131.74 53.48 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.4 130.01 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 p -146.07 154.29 41.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.86 98.33 5.49 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -100.68 110.82 22.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.464 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.17 -129.2 31.87 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.404 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 61.0 m -93.29 46.84 1.22 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.757 0.313 . . . . 0.0 110.721 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.404 ' CG ' ' C ' ' A' ' 58' ' ' SER . 39.6 m-70 -149.31 143.81 26.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -124.49 132.03 53.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.69 130.6 49.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.109 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -140.59 114.17 8.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.405 ' H ' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -142.35 153.14 43.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.5 tp -106.53 128.89 54.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.316 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.649 HH12 ' HG1' ' A' ' 52' ' ' THR . 84.0 mtt85 -67.14 -107.75 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.62 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 p -83.59 108.81 16.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.127 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' CB ' ' CE1' ' A' ' 71' ' ' HIS . . . -69.72 139.05 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.61 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 94.5 mt-30 -130.43 140.46 38.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.554 ' O ' ' ND1' ' A' ' 70' ' ' HIS . 2.6 Cg_endo -46.42 89.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.152 1.235 . . . . 0.0 111.742 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' A' ' 69' ' ' PRO . 1.3 m80 163.81 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.843 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.61 ' ND1' ' O ' ' A' ' 68' ' ' GLN . 28.5 p-80 -78.49 -13.29 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.645 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.544 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.91 -178.07 40.76 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.446 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.37 149.95 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.22 110.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.666 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.0 m -126.04 125.68 43.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.39 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.67 154.46 28.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.4 t -156.33 -132.8 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -57.86 88.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 79' ' ' CYS . 98.8 m-20 46.24 12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -96.6 66.24 2.3 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.1 t -79.81 129.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.865 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -161.81 144.85 12.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.13 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.653 ' N ' ' HZ1' ' A' ' 10' ' ' LYS . 24.9 m -153.84 132.11 11.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.91 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.92 -158.68 0.68 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.396 0.617 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -144.56 129.27 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.753 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.6 tp -117.46 126.3 52.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.586 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 t -139.47 148.4 42.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.132 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.51 128.15 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.008 0.432 . . . . 0.0 111.599 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 N--CA 1.463 0.187 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.012 179.592 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.46 0.062 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.7 mt -86.67 119.03 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.74 -69.5 0.58 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -134.65 130.39 36.31 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.126 0.489 . . . . 0.0 111.774 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.62 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -126.08 146.58 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.457 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.61 113.61 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -127.39 173.32 9.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.218 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 63.3 108.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 136.43 13.43 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.11 130.92 48.91 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.18 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 6.6 m -126.14 124.25 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.914 0.864 . . . . 0.0 113.319 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -78.04 170.19 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.766 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.68 130.68 45.24 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.49 34.35 54.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.04 147.9 40.75 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.935 0.397 . . . . 0.0 110.919 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -95.54 149.12 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.12 144.35 51.05 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.7 p -139.8 133.35 30.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.128 0.489 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -139.12 126.31 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 p -140.03 144.86 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.9 t -133.53 92.38 2.98 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 110.971 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -74.13 115.42 13.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.622 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.9 mt -105.37 -177.35 3.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.871 0.843 . . . . 0.0 112.501 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 m -105.31 -15.45 15.04 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.578 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -129.42 129.23 44.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.54 119.64 32.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.578 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -109.81 148.11 37.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.616 -178.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.8 Cg_endo -57.89 -140.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.776 1.651 . . . . 0.0 110.362 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 m -119.21 103.76 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.34 -44.45 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -64.36 -45.59 87.12 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.858 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.47 141.75 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.6 m -135.54 98.58 3.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.562 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 94.3 m95 -102.13 113.89 27.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 88.3 m-85 -150.84 148.03 27.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.183 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.99 122.03 68.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -54.44 122.1 9.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.043 0.838 . . . . 0.0 110.008 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.71 -5.71 14.2 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 124.113 0.883 . . . . 0.0 110.974 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' CZ3' ' A' ' 51' ' ' TRP . . . -165.26 111.06 0.92 Allowed 'General case' 0 C--O 1.231 0.085 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.04 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.26 139.59 48.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.916 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -86.36 99.54 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.385 0.612 . . . . 0.0 110.506 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.696 ' C ' ' H ' ' A' ' 47' ' ' ASP . 31.1 mt-30 -124.74 163.69 35.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.8 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.89 20.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.312 1.341 . . . . 0.0 111.677 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.696 ' H ' ' C ' ' A' ' 45' ' ' GLN . 39.0 m-20 -112.22 -19.7 12.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 45' ' ' GLN . 49.2 m-20 -46.12 105.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.226 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 47.9 t -93.12 -39.21 11.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' OD1' ' CZ ' ' A' ' 65' ' ' ARG . 95.3 m-20 -87.14 -25.12 24.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.322 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.441 ' CZ3' ' CB ' ' A' ' 42' ' ' ALA . 5.6 m-90 -112.91 142.99 44.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.074 0.464 . . . . 0.0 111.11 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 m -132.16 136.29 46.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.86 134.68 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -141.94 154.29 44.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.62 107.97 5.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 111.56 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -119.28 105.27 11.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.14 -133.58 45.86 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.9 m -92.29 30.06 1.55 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.641 0.258 . . . . 0.0 111.103 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -134.43 130.13 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.27 137.03 54.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.94 119.21 15.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.255 0.55 . . . . 0.0 111.523 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.0 135.34 55.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.537 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.23 179.36 5.11 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.068 0.937 . . . . 0.0 113.141 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 65' ' ' ARG . 39.1 tp -145.68 118.52 8.7 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.56 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' CZ ' ' OD1' ' A' ' 50' ' ' ASP . 28.2 ptt180 -63.94 -127.93 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.436 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.0 p -73.06 110.62 7.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.64 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.62 112.38 2.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.979 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' HIS . 2.8 pt20 -112.48 145.69 33.42 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.92 83.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.623 1.549 . . . . 0.0 111.763 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 175.95 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.635 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 12.3 p80 -73.98 -13.63 60.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.732 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.82 147.6 8.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 110.869 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.84 -170.41 40.6 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -99.51 149.63 23.03 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.7 t -117.53 115.35 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.7 m -129.3 130.94 46.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.25 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 9.5 t80 -136.79 138.38 40.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.98 147.82 27.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.107 0.479 . . . . 0.0 111.479 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.22 -148.57 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.99 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' A' ' 82' ' ' ALA . 45.1 mmm-85 -60.66 90.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.069 0.461 . . . . 0.0 110.454 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 t0 48.18 14.8 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.193 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -104.37 73.63 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.8 t -80.39 151.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.906 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.17 170.38 22.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.286 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -159.1 178.87 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 174.77 179.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 111.179 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -142.07 128.03 19.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.5 tp -113.58 129.46 56.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 t -144.29 153.07 41.64 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.019 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 p -117.65 126.58 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.4 tp . . . . . 0 C--N 1.333 -0.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.08 -179.736 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.94 114.83 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 10.2 mp -92.06 -72.46 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.12 121.58 35.55 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.193 0.452 . . . . 0.0 111.966 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.16 126.86 49.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.343 179.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.65 111.77 23.51 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -126.47 -179.88 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.906 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t30 60.37 108.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.72 15.05 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.664 0.986 . . . . 0.0 113.664 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.04 129.65 50.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.15 126.41 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.898 0.856 . . . . 0.0 112.994 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.56 163.88 25.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.618 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 130.44 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.58 40.1 67.29 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.3 46.01 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.962 0.411 . . . . 0.0 110.962 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -101.99 159.78 15.07 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.744 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 151.68 37.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -133.65 135.76 44.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.327 0.584 . . . . 0.0 111.925 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.88 123.56 26.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -135.71 134.57 39.24 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.096 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.56 89.57 3.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 p -71.78 112.42 7.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 58' ' ' SER . 95.5 mt -112.0 144.2 41.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.76 0.791 . . . . 0.0 112.415 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -63.26 -27.84 69.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.605 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.433 ' C ' ' HG ' ' A' ' 58' ' ' SER . 77.7 tt0 -125.14 143.79 50.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.122 0.487 . . . . 0.0 111.719 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.58 143.82 29.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.342 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' PRO . 38.7 t -117.89 138.0 24.93 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.202 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -62.32 -143.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.229 1.118 . . . . 0.0 110.649 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -125.76 115.64 43.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.45 -29.37 3.16 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.89 -16.07 28.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.967 0.413 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.39 140.35 38.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -128.64 139.47 52.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.115 0.483 . . . . 0.0 111.553 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 96.6 m95 -140.23 106.78 5.32 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.438 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 84.0 m-85 -158.88 157.84 32.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.671 0.748 . . . . 0.0 111.714 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.515 ' H ' ' CD1' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.49 129.8 75.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -66.17 120.64 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.264 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.43 -2.35 18.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.06 62.16 0.12 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.639 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.49 110.95 0.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 4.1 m -79.03 116.75 23.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.616 0.722 . . . . 0.0 112.17 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -82.91 155.12 67.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.043 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -49.28 -24.46 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.486 1.458 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -106.58 27.26 9.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 49' ' ' SER . 41.8 t0 -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.189 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 42.8 p -88.33 -37.69 15.75 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -86.45 -32.9 20.59 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -110.81 145.79 37.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.774 0.321 . . . . 0.0 110.823 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.5 m -132.07 127.57 36.39 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.34 135.13 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 p -144.55 156.9 44.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.417 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.6 100.57 4.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.45 112.0 24.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.674 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.23 -123.92 34.67 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 26' ' ' LEU . 6.0 t -106.62 48.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -144.13 139.6 28.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -117.8 118.05 30.98 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.26 106.1 14.97 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.272 0.558 . . . . 0.0 111.659 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 tp -114.24 126.88 55.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.503 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.617 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -125.35 -177.41 3.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.302 1.048 . . . . 0.0 111.032 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 65' ' ' ARG . 40.8 tp -144.16 117.72 9.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.792 -2.004 . . . . 0.0 106.931 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 64' ' ' LEU . 24.5 mmt85 -64.14 -129.07 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.521 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.6 p -78.23 108.9 11.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.94 141.32 56.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 27.1 mt-30 -129.55 142.08 44.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.876 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.73 84.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.296 1.33 . . . . 0.0 111.473 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' GLN . 45.4 t-80 174.15 -23.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.084 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.4 -7.42 59.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.819 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.47 145.62 22.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.611 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.11 -165.38 38.53 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.42 150.47 20.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.8 t -117.4 115.33 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.508 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 m -131.55 130.89 42.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -142.23 146.99 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.3 155.1 30.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.164 0.507 . . . . 0.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' ASP . 8.4 t -156.12 -138.59 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.109 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' ALA . 24.3 mmm180 -55.57 89.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.0 p-10 39.52 22.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.767 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -105.84 75.21 1.1 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.98 137.46 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.438 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -151.74 117.43 5.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.9 m -92.38 -173.88 3.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.342 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 176.1 172.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.203 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -140.88 135.62 31.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.229 0.538 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.0 tp -120.03 128.34 53.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -142.84 146.51 34.22 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.8 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.1 p -109.85 126.73 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 110.919 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 3.1 mm? . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.1 mt -91.85 119.1 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.545 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.1 mp -82.94 -70.83 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -141.83 136.63 30.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.303 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.73 143.71 50.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.594 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 117.82 29.93 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.2 mmpt? -130.36 178.02 6.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.867 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' LYS . 13.0 m120 52.22 108.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.412 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.86 137.04 9.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.57 0.7 . . . . 0.0 112.028 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.53 125.42 48.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.816 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.65 103.88 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.351 0.596 . . . . 0.0 111.675 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -61.77 141.01 58.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.947 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.85 114.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.58 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.78 7.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.56 155.41 46.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -100.8 153.99 19.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.044 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.26 143.77 34.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 p -121.57 135.62 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.324 0.583 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.97 122.84 27.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -137.08 136.37 38.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 m -127.07 92.88 3.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.916 0.388 . . . . 0.0 111.822 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.8 m -74.71 110.16 8.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.575 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.87 -167.05 1.32 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.105 0.478 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 t -107.93 -11.64 15.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.261 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.4 pm0 -140.68 149.11 41.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.703 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.65 146.38 23.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 31' ' ' PRO . 59.4 t -102.02 125.97 35.12 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.611 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.81 -141.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.181 1.254 . . . . 0.0 110.411 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.94 124.52 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.01 31.69 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.687 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.14 -11.58 49.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.309 0.554 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -143.16 53.29 1.36 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -90.37 110.53 21.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.402 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -157.96 152.69 25.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.583 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 mm -74.73 117.07 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.78 95.04 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 133.57 -24.6 3.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 106.01 4.76 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.49 58.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.7 m -82.46 124.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.359 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.02 153.85 60.29 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.29 -33.38 45.22 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.334 1.356 . . . . 0.0 111.072 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 49' ' ' SER . 87.5 m-20 -88.44 14.73 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.881 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' ASP . 48.8 p-10 -32.97 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.507 . . . . 0.0 111.719 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 47' ' ' ASP . 16.1 t -68.01 -40.13 83.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.236 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.06 -27.55 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -115.24 152.15 33.21 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.39 -0.194 . . . . 0.0 110.699 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -144.87 152.24 39.95 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 111.228 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.44 139.25 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.855 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p -140.75 156.05 46.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.544 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.15 107.53 4.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -108.72 104.02 13.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.735 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.38 -134.61 45.15 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.1 m -89.48 38.55 0.91 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.68 0.276 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -137.59 142.42 41.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.55 159.88 20.68 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.57 82.98 1.23 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.669 0.747 . . . . 0.0 110.749 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -92.15 144.59 25.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.249 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 pp -141.02 174.07 10.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.281 1.039 . . . . 0.0 112.654 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 65' ' ' ARG . 48.7 tp -142.24 118.16 10.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 113.057 -1.883 . . . . 0.0 106.895 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LEU . 69.5 mtt180 -66.04 -131.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.477 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.1 m -81.57 106.58 13.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.91 0.386 . . . . 0.0 110.815 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.53 54.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.727 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.587 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 55.0 mt-30 -124.66 148.02 57.77 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -44.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.704 1.603 . . . . 0.0 111.451 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . 13.7 t-80 164.15 -21.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HD1' ' H ' ' A' ' 68' ' ' GLN . 76.1 m80 -79.87 -8.91 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.17 145.45 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.96 -141.82 7.64 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -134.47 169.99 16.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.547 0.339 . . . . 0.0 110.171 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.87 129.15 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.318 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -133.69 130.01 37.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.974 0.416 . . . . 0.0 111.222 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -132.27 141.83 49.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.441 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . -159.13 143.8 15.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 10.6 t -158.86 -136.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.286 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 43.8 mtm180 -59.87 85.52 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.186 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' CYS . 94.3 m-20 51.65 14.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.21 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.03 91.36 8.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 110.194 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -81.27 138.72 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.013 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.94 160.46 19.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 p -160.38 -178.49 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.764 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 179.84 170.88 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.201 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -129.68 121.38 26.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.195 0.521 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' GLY . 41.6 tp -104.34 128.64 52.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.922 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 t -143.58 125.03 14.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.695 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.51 113.47 28.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.631 -178.692 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.587 0.232 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -92.85 94.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.327 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.65 -46.78 88.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.118 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.51 114.62 18.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.907 0.384 . . . . 0.0 110.226 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 116.85 33.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.689 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' A' ' 23' ' ' THR . 34.6 tp -101.4 120.52 40.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.371 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.674 ' H ' ' CE ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.64 -163.88 1.85 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.295 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.84 108.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.76 139.07 9.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.825 0.821 . . . . 0.0 113.014 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.06 130.95 53.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.688 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 m -136.14 108.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -77.48 169.85 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.146 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.33 107.01 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.34 -7.68 40.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 65' ' ' ARG . . . -76.39 -178.35 4.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.411 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -136.86 149.76 47.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.52 133.47 55.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.216 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.2 t -121.22 106.7 11.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.131 0.491 . . . . 0.0 111.45 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -118.57 106.83 13.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 3.7 p -138.23 147.34 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 31.1 p -134.56 99.45 4.35 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.818 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 m -69.98 110.72 5.21 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.373 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -94.05 175.62 6.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.704 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 t -114.92 -5.57 12.56 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -127.06 137.82 53.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.3 136.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.018 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.3 133.71 24.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.519 -0.277 . . . . 0.0 110.68 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.96 -154.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 119.844 0.98 . . . . 0.0 109.938 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.97 104.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.74 -50.9 0.4 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -69.58 -43.64 72.44 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.8 143.89 37.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.591 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -142.25 127.9 19.15 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 121.011 0.434 . . . . 0.0 111.075 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 33.6 m95 -122.96 111.97 17.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.145 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 87.0 m-85 -157.54 157.73 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 111.336 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.78 128.57 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.335 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -61.85 118.66 7.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.576 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.7 -0.99 20.1 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.43 68.8 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.821 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.34 131.07 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.69 110.67 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.857 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -92.94 154.42 41.85 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.582 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.65 -25.78 43.29 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 120.999 1.133 . . . . 0.0 110.633 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.89 11.47 29.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.708 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 51' ' ' TRP . 44.4 p-10 -42.77 115.96 0.8 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.5 p -87.87 -39.68 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.665 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -88.97 -26.03 21.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.435 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 10.6 m-90 -110.5 145.31 37.94 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.7 m -124.54 126.11 45.29 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 p -125.03 129.92 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -143.99 153.16 41.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.43 98.54 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.995 0.426 . . . . 0.0 110.107 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.67 96.83 7.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.04 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.27 -128.17 41.27 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 m -92.79 42.68 1.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -149.41 135.53 18.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -121.74 140.52 52.23 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 130.55 37.83 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 111.548 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.4 tp -135.28 122.7 21.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.865 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pp -141.02 139.76 34.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.1 tp -106.34 119.61 39.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mtt-85 -63.91 -101.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.902 -177.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.6 p -82.81 99.19 9.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.917 0.389 . . . . 0.0 111.312 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.68 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.423 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.639 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 83.6 mt-30 -130.62 139.34 35.3 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.012 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -55.36 85.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.072 1.181 . . . . 0.0 110.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.1 t60 -175.06 -48.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.639 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 25.5 p80 -76.96 -0.37 24.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.635 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.05 146.88 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.0 -148.57 12.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.0 mp0 -115.32 156.36 25.63 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.76 0.314 . . . . 0.0 110.399 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.7 t -117.93 116.56 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.489 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.3 m -123.73 131.78 53.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.192 0.52 . . . . 0.0 110.774 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -136.13 130.96 34.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.231 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.46 150.73 51.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.447 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.5 t -153.33 -144.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.649 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' ALA . 21.1 mmm180 -52.77 88.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.953 0.406 . . . . 0.0 109.966 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.8 p30 42.71 17.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -101.7 86.23 2.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -82.31 127.33 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.09 129.32 21.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.535 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 p -92.83 -175.26 3.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.479 0.657 . . . . 0.0 111.631 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 175.68 171.97 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.81 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -146.52 138.57 24.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.985 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.2 tp -117.95 128.85 55.2 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.548 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 t -141.31 153.33 45.1 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.525 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 7.0 p -106.6 116.11 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.283 -179.265 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.0 mt -82.52 123.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -95.39 -38.84 10.31 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.69 146.32 25.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.207 0.527 . . . . 0.0 110.909 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -161.28 121.67 2.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -125.92 116.18 21.11 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -146.95 -164.22 1.94 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.434 0.635 . . . . 0.0 111.2 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 56.02 97.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.789 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.27 140.67 3.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.403 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.87 140.33 36.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.65 130.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.922 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -58.76 -172.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.44 150.04 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.476 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 -3.18 81.88 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.3 144.97 25.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.127 0.489 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.29 145.94 25.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.67 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.69 52.35 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.2 p -152.95 123.36 7.17 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.341 0.591 . . . . 0.0 112.009 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -125.94 143.96 50.88 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.95 143.76 31.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.076 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.0 t -127.57 88.28 2.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.787 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -75.07 94.06 2.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.853 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.1 mt -82.58 -160.9 0.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.956 0.884 . . . . 0.0 112.949 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.3 t -117.39 -19.08 9.68 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.77 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -121.24 150.0 42.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.189 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.32 141.04 30.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 31' ' ' PRO . 22.6 t -117.04 128.19 26.2 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.623 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.2 Cg_exo -60.17 -146.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.913 1.076 . . . . 0.0 111.217 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.01 120.4 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.67 -26.57 8.4 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.955 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 75.8 tt0 -87.1 -12.12 48.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.918 0.359 . . . . 0.0 110.392 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.53 122.69 47.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -92.79 141.13 28.78 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 95.9 m95 -153.21 101.32 2.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.117 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -160.86 167.09 27.4 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.196 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' ASN . 2.0 mp -118.24 94.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ILE . 22.3 t-20 -32.46 123.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 -2.29 29.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.65 79.1 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.133 -0.533 . . . . 0.0 109.683 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.23 58.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.91 131.78 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.991 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -96.42 151.15 37.87 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.91 -29.69 91.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.051 1.167 . . . . 0.0 112.752 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -94.83 0.56 54.95 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -69.01 130.47 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.5 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -97.69 -2.56 41.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -80.2 -29.25 38.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.949 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -112.52 140.52 47.19 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.4 m -131.82 125.95 33.11 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.27 131.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.3 p -143.82 147.39 34.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.534 0.683 . . . . 0.0 112.291 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.97 112.37 24.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.578 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -120.81 101.44 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.78 -122.11 25.33 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' ND1' ' A' ' 59' ' ' HIS . 47.9 t -110.81 44.77 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.431 ' ND1' ' C ' ' A' ' 58' ' ' SER . 32.7 m80 -141.93 135.62 29.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.998 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -117.69 126.74 53.03 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.44 119.06 29.86 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tt -130.51 123.8 30.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.496 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 pp -121.55 162.65 20.21 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 0.0 110.535 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 65' ' ' ARG . 28.5 tp -124.44 117.71 25.03 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 64' ' ' LEU . 56.4 ttp180 -57.39 -109.19 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.001 -177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.1 p -87.38 121.24 29.56 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.48 138.6 58.5 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' HIS . 23.3 pt20 -133.21 137.23 28.85 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 119.681 -0.199 . . . . 0.0 110.476 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.71 84.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 120.795 0.996 . . . . 0.0 110.722 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 -177.74 -39.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.735 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' A' ' 72' ' ' ALA . 2.7 p-80 -71.99 -33.69 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.78 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' N ' ' CD2' ' A' ' 71' ' ' HIS . . . -35.54 143.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.88 -132.42 3.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.82 129.86 53.73 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.535 0.207 . . . . 0.0 110.634 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.99 130.86 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 m -132.7 123.77 26.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -139.14 128.16 23.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.183 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.441 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -156.99 154.7 30.05 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.549 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 18.1 p -154.67 -132.78 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.623 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 30.8 mmt180 -54.3 84.24 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.109 0.48 . . . . 0.0 109.796 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' CYS . 87.9 m-20 46.16 13.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.56 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -94.47 70.18 3.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.2 t -81.27 132.52 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.242 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.01 117.95 5.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.971 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.4 p -127.43 147.17 50.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.549 0.69 . . . . 0.0 111.537 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.9 151.93 24.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.939 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -97.62 131.66 43.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.3 tp -106.48 134.78 49.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -136.13 162.17 33.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.334 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.54 132.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.151 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 91' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.745 0.307 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.3 mt -100.18 120.9 50.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.049 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.97 -69.35 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.93 124.13 34.34 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.8 146.56 36.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.388 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.4 tt -109.05 114.22 27.78 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 174.36 10.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.691 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 60.76 107.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.602 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.23 135.7 11.33 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.853 0.835 . . . . 0.0 112.859 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 158.09 16.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.826 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.84 164.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 111.623 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -128.32 159.32 35.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.845 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.79 101.66 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.578 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.96 -9.27 54.95 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.09 174.93 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 111.015 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -115.22 153.64 30.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.75 149.4 47.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.26 142.8 44.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -148.25 133.35 18.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 3.3 t -149.14 155.53 40.82 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.859 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 t -148.67 96.04 2.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 111.927 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 m -69.92 123.03 20.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.58 150.66 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.5 0.667 . . . . 0.0 112.668 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 m -74.68 -18.23 60.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.341 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -138.02 140.82 40.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.474 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.0 147.67 42.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.532 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 31' ' ' PRO . 41.3 t -105.53 134.77 19.53 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.2 Cg_exo -61.36 -144.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 CA-C-N 120.218 1.114 . . . . 0.0 110.405 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.78 125.12 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.3 -16.05 57.14 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.617 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -89.89 -19.94 23.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.74 23.8 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.432 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 8.6 t -154.29 129.12 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.738 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.544 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 77.7 m95 -150.37 102.42 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 14.6 p90 -155.57 154.51 31.81 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -68.81 97.97 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -48.53 96.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 142.25 -20.08 2.46 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 110.41 4.5 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.34 138.01 58.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.3 t -91.83 128.26 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 111.673 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -84.93 153.24 60.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.652 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 48' ' ' ASP . 2.0 Cg_endo -55.44 -34.08 88.05 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.574 1.516 . . . . 0.0 111.717 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -78.58 21.06 0.4 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.749 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 46' ' ' PRO . 27.5 p-10 -47.53 98.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.7 t -81.41 -49.18 10.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.246 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -64.34 -37.93 89.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.926 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -110.18 161.73 15.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.284 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -138.16 141.02 40.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.94 134.58 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 p -141.75 153.75 44.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.477 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 120.6 3.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.63 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -138.03 116.47 12.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.396 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.26 -108.72 2.61 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -130.67 31.83 4.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.75 0.31 . . . . 0.0 110.476 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.499 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 8.7 t-80 -130.75 132.09 45.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.268 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.42 159.98 16.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.51 97.73 1.35 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.996 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.02 130.91 53.86 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.541 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -178.71 4.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.954 0.883 . . . . 0.0 112.016 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -144.67 120.12 10.32 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.049 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -69.0 -130.54 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.278 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.9 p -58.73 100.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 0.0 111.897 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 139.51 58.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.958 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.26 144.63 52.08 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.571 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -52.5 91.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.337 1.358 . . . . 0.0 111.262 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 8.2 m-70 165.11 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -83.3 -7.42 59.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 148.66 43.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.791 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.75 -160.62 31.65 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.3 167.02 11.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.828 0.347 . . . . 0.0 110.39 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -133.28 133.27 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.75 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 m -131.98 128.23 37.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.311 0.577 . . . . 0.0 111.52 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 0.3 OUTLIER -131.05 137.93 49.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.759 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -164.35 152.43 12.49 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 21.2 p -156.48 -133.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.816 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 49.3 mmm-85 -59.14 92.08 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 42.54 18.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -107.3 73.7 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.12 153.79 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.798 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.22 178.67 8.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.602 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 p -154.69 -179.14 7.72 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.537 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -178.16 166.55 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.282 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -126.47 135.98 52.04 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.04 0.447 . . . . 0.0 110.353 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 130.53 54.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -152.88 149.66 28.49 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.619 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 p -110.66 120.51 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.46 0.475 . . . . 0.0 109.905 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -73.66 121.48 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -82.02 -70.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -127.85 119.72 26.24 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.895 0.378 . . . . 0.0 111.08 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 tp -114.58 130.58 56.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.92 123.01 43.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.259 0.552 . . . . 0.0 110.61 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ASN . 4.5 mmpt? -138.75 -178.34 5.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.282 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 10' ' ' LYS . 58.8 t-20 55.14 109.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.553 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.38 136.62 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.964 0.888 . . . . 0.0 113.217 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.84 135.9 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.434 ' CG2' ' NE2' ' A' ' 71' ' ' HIS . 15.6 m -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.018 0.913 . . . . 0.0 112.895 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -81.74 151.99 27.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.493 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.94 128.28 32.67 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.95 39.85 53.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.88 149.69 47.28 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.809 0.338 . . . . 0.0 111.434 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -102.66 151.06 22.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.96 28.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.397 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.55 147.32 48.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.411 0.624 . . . . 0.0 111.993 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -140.55 127.04 20.09 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.607 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 t -144.53 147.29 33.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.287 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.7 t -130.86 93.1 3.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 111.258 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -72.56 113.87 10.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -113.98 145.32 41.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.09 0.472 . . . . 0.0 111.899 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -71.46 -10.45 59.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.982 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -133.53 137.24 45.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.15 143.33 32.46 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.555 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 31' ' ' PRO . 31.2 t -124.03 128.75 24.99 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.06 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.9 Cg_endo -58.41 -150.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.944 1.096 . . . . 0.0 111.056 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -114.37 102.99 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.34 -49.39 0.48 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.73 -40.46 76.2 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.664 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.63 37.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -124.52 131.1 53.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.039 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.509 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 93.5 m95 -133.37 100.29 4.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.085 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 78.4 m-85 -152.63 153.84 34.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.114 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.486 ' H ' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.16 129.32 74.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.788 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.07 123.55 19.79 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.569 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.2 3.96 20.86 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -171.56 96.44 0.18 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.977 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 135.83 50.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.86 104.99 14.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.426 0.632 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.63 153.13 47.79 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.363 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.46 -27.87 26.06 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.299 1.333 . . . . 0.0 110.903 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -96.67 12.41 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.508 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 22.9 p30 -39.21 110.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.292 0.568 . . . . 0.0 110.756 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.43 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 2.9 t -76.79 -52.51 9.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.341 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.41 -31.9 37.56 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -107.47 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.8 m -130.2 138.98 50.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.3 131.57 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.8 p -144.5 156.12 44.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.167 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 107.15 4.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.551 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -112.56 103.74 11.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.15 -131.59 27.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -97.13 39.36 1.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.572 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -137.35 138.5 40.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.431 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -110.85 156.33 21.29 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -158.83 93.7 1.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.924 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -110.18 129.89 55.64 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.76 -177.25 3.6 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.064 0.935 . . . . 0.0 112.886 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 65' ' ' ARG . 31.5 tp -144.21 116.54 8.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.141 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' NH2' ' O ' ' A' ' 49' ' ' SER . 13.9 ptp180 -64.67 -129.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.917 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -76.4 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 0.0 110.372 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.68 142.2 58.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 0.0 110.846 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' HIS . 18.9 mm100 -132.97 145.5 57.32 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.778 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.92 85.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.422 1.414 . . . . 0.0 111.303 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' GLN . 67.9 t60 175.98 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.216 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.469 ' ND1' ' C ' ' A' ' 71' ' ' HIS . 5.8 p80 -76.99 -7.05 54.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.99 145.39 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.003 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.08 36.41 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -88.46 152.03 22.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.413 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -120.93 121.18 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.85 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -131.83 132.19 43.5 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.308 0.575 . . . . 0.0 112.218 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 2.2 t80 -138.92 140.55 38.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.137 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.59 152.81 41.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -156.53 -151.64 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.112 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.66 87.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.285 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' CYS . 96.0 m-20 54.0 17.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.663 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.77 68.27 0.92 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.102 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.25 132.72 31.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.136 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.68 130.37 8.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.27 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 t -92.98 -170.88 2.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 178.48 169.24 0.83 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.979 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -138.59 136.87 36.44 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.702 0.287 . . . . 0.0 110.782 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.03 128.04 50.95 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -142.96 146.92 34.39 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.805 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.98 124.53 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.829 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 -178.882 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.0 m95 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.54 -172.09 3.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER -126.45 45.76 2.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.315 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -75.58 136.44 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.65 119.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 mp -77.03 -67.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.445 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -146.64 142.01 27.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.825 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.31 137.47 52.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.002 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.95 108.41 21.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.82 175.85 5.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.348 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.19 108.38 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.252 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.64 134.18 13.6 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.67 0.748 . . . . 0.0 112.778 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.47 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.42 114.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -76.94 171.06 15.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.181 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.59 129.78 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.143 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.8 89.11 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.219 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.72 -171.15 3.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 20' ' ' ALA . 5.4 tm0? -141.48 157.13 45.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 19' ' ' GLN . . . -117.74 138.95 51.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.784 0.326 . . . . 0.0 110.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 27.0 p -125.38 104.55 8.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.324 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -124.4 117.55 24.69 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.429 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -144.54 150.03 36.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 33.3 t -132.75 98.86 4.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.964 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.3 m -79.92 114.72 19.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -105.64 -167.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.838 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -112.87 -2.27 14.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.66 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -145.09 143.31 30.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.277 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.0 137.0 33.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.909 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 20.5 t -114.01 133.92 22.25 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.611 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.5 Cg_exo -61.51 -142.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.816 1.011 . . . . 0.0 109.978 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.0 t -121.45 110.13 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.43 -45.0 0.71 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.84 -12.89 59.73 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.31 132.67 52.08 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -127.52 118.95 24.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.623 ' CE2' ' CD1' ' A' ' 77' ' ' PHE . 75.4 m95 -118.52 106.32 12.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -151.05 149.2 29.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.594 0.711 . . . . 0.0 111.749 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.12 122.85 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -61.02 126.68 28.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.596 1.089 . . . . 0.0 110.341 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 -4.93 24.44 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.18 94.2 0.24 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.307 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.63 132.56 45.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.3 m -85.25 106.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.245 0.545 . . . . 0.0 111.193 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -80.78 156.4 72.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -47.99 -26.72 7.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.264 1.31 . . . . 0.0 110.54 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -107.22 27.25 9.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -57.66 132.06 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.09 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.3 p -90.66 -43.28 10.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.057 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.85 -40.1 63.51 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -106.68 152.79 23.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.188 0.518 . . . . 0.0 110.699 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.8 m -132.12 132.59 43.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.89 138.1 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 110.301 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -146.1 158.81 43.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.135 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.96 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.368 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -129.57 102.95 6.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.973 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.84 -134.22 23.54 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -91.73 20.04 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.456 0.169 . . . . 0.0 111.445 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -123.61 124.32 42.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.62 0.248 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -112.21 119.36 38.08 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.71 131.03 56.33 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.416 0.626 . . . . 0.0 111.339 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.35 131.85 28.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.943 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.65 -174.61 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.301 1.048 . . . . 0.0 111.643 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 65' ' ' ARG . 8.0 tp -142.21 119.64 11.63 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 113.007 -1.906 . . . . 0.0 107.351 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.9 mtt180 -61.65 -138.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 p -69.57 112.93 6.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.97 137.89 57.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 70' ' ' HIS . 83.6 mm-40 -129.54 143.14 47.75 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.622 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.44 83.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.09 1.193 . . . . 0.0 111.145 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 68' ' ' GLN . 86.1 t60 174.85 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.887 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -76.38 -1.75 28.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.67 144.27 43.89 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.993 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.94 179.66 40.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -87.29 157.6 19.26 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.687 -0.302 . . . . 0.0 110.351 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.31 116.81 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.675 0.274 . . . . 0.0 110.558 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -131.38 133.96 45.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 12.5 t80 -141.23 142.47 33.95 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.527 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.28 145.52 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -156.67 -153.09 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.379 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -55.08 87.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.846 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 55.11 13.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.03 90.36 6.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.404 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -87.91 136.58 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 164.17 35.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.155 0.503 . . . . 0.0 111.212 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.3 p -159.95 178.64 9.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.646 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 175.49 179.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.259 0.552 . . . . 0.0 111.364 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -133.42 110.34 9.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.396 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -102.29 128.69 48.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 147.28 33.15 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.7 132.46 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.986 0.422 . . . . 0.0 110.811 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 2.9 mm? -86.98 132.24 33.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.99 14.44 11.21 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' A' ' 95' ' ' ASP . 28.7 mt -103.05 108.05 57.33 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.497 -0.287 . . . . 0.0 110.65 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -69.97 21.42 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.169 1.246 . . . . 0.0 111.348 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 93' ' ' LEU . 95.1 m-20 -84.03 -1.35 54.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.86 103.45 2.22 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.6 mp -87.72 142.14 28.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.794 0.331 . . . . 0.0 110.457 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -133.8 149.7 51.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.239 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -83.61 117.1 22.94 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -86.14 -9.21 57.05 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -97.85 110.72 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.633 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -66.83 -43.34 83.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.542 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 84.3 t60 -150.39 167.45 27.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.764 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.542 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 98.0 m-70 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.436 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 4' ' ' GLU . 88.9 mtm180 -97.06 173.67 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 mp -75.43 37.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 2' ' ' ARG . 9.6 pt-20 -79.18 149.27 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.659 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.56 119.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.19 -68.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.753 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.29 140.93 30.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.425 0.631 . . . . 0.0 112.164 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 1.4 pt? -130.1 134.12 47.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.623 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.0 tp -101.7 116.99 33.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.12 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -129.75 -170.25 2.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.5 t30 61.4 108.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.496 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.62 133.86 13.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.018 0.913 . . . . 0.0 113.216 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.34 133.89 54.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.2 112.39 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.754 0.788 . . . . 0.0 112.163 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ALA . 56.2 ttm-85 -84.68 147.22 27.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.937 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ARG . . . -34.75 121.83 0.52 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.377 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 14.1 61.34 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.0 150.74 28.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.749 0.309 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -101.69 172.19 7.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.096 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.95 138.39 48.31 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.845 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -128.48 112.28 14.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.345 0.593 . . . . 0.0 111.843 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -124.22 116.73 23.17 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -138.49 141.37 39.4 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.793 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -127.01 96.2 4.54 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.9 m -73.78 107.23 5.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.528 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' SER . 98.3 mt -100.24 -171.85 2.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 t -112.12 -11.2 13.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.605 ' H ' HH21 ' A' ' 80' ' ' ARG . 47.7 tp10 -138.75 145.58 40.39 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.161 0.505 . . . . 0.0 110.952 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.21 139.27 39.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.942 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 31' ' ' PRO . 8.7 t -112.9 128.53 25.49 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.78 -145.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 120.074 1.062 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.56 110.67 27.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.26 -29.5 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.52 -17.82 29.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.79 141.98 43.4 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -130.81 132.53 45.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.651 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.563 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 94.9 m95 -130.27 110.42 11.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 85.7 m-85 -158.98 154.35 25.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.201 0.524 . . . . 0.0 111.476 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.33 122.77 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.04 124.41 20.73 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.682 1.128 . . . . 0.0 110.346 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.43 2.39 31.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 100.17 0.79 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.91 136.09 50.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.89 100.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASP . 43.7 mt-30 -87.42 151.17 50.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.73 -22.42 13.36 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.335 1.357 . . . . 0.0 110.644 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.91 14.75 12.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.929 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' GLN . 25.9 p30 -42.8 112.22 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.207 0.527 . . . . 0.0 111.435 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 t -84.7 -46.58 11.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.917 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -85.14 -25.44 27.46 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -113.44 147.56 37.58 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.5 m -126.65 130.04 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.4 130.46 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 p -144.6 153.99 42.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.904 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.21 103.72 6.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.432 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 35.9 p-10 -114.43 110.78 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.176 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.91 -133.71 52.61 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.54 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 24.4 m -95.41 38.87 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 110.42 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.54 ' ND1' ' O ' ' A' ' 58' ' ' SER . 12.9 m-70 -141.04 141.28 34.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.07 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -129.29 137.27 50.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.74 131.03 47.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.231 0.539 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -124.02 131.6 53.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.399 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.67 165.66 12.79 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.507 1.146 . . . . 0.0 113.711 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 24.9 tp -141.68 113.67 7.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 111.835 -2.439 . . . . 0.0 106.152 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' LEU . 61.8 ttt180 -64.08 -126.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -80.87 109.59 15.58 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.662 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.93 136.05 55.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -133.81 144.57 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.928 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -51.49 94.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.366 1.377 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER 160.82 -21.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.462 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.71 -6.75 55.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.485 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 150.21 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.48 39.21 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.255 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -98.41 151.57 20.42 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.46 115.04 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.6 m -122.36 132.94 54.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 111.568 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 4.2 t80 -144.66 135.38 24.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.977 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ASP . 28.6 p -153.76 -134.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.805 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.605 HH21 ' H ' ' A' ' 28' ' ' GLU . 47.0 mtm180 -52.56 82.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' CYS . 97.3 m-20 45.12 10.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.826 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -97.62 91.38 5.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.2 126.4 39.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.35 133.19 13.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -152.26 133.0 14.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.24 -159.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.769 0.795 . . . . 0.0 111.458 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -142.7 117.25 9.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.852 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.9 tp -107.64 133.02 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 t -136.51 148.66 47.76 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.6 t -111.91 125.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.2 mp -92.93 135.63 33.98 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.091 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.55 -117.92 0.51 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.96 107.15 54.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.79 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.202 1.268 . . . . 0.0 111.423 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.34 -79.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.371 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.61 -15.14 2.24 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.26 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -75.38 134.81 40.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.411 0.606 . . . . 0.0 110.388 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -100.22 -13.2 19.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.065 0.459 . . . . 0.0 109.984 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.435 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 4.0 p80 -126.34 137.01 53.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.009 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 100' ' ' HIS . 14.2 p80 -90.73 127.95 36.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 101' ' ' HIS . 86.0 t60 -130.6 -3.24 4.23 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.398 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.53 162.02 41.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.471 . . . . 0.0 111.002 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -46.89 170.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.827 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.3 m0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -97.17 150.25 21.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.1 mt -102.15 7.16 41.05 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.298 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -96.1 -134.72 0.22 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.793 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.61 97.79 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.82 -54.2 42.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.051 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -138.4 132.38 31.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.775 0.322 . . . . 0.0 110.258 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.55 147.3 43.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mp -121.48 123.0 41.0 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' H ' ' HE3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.23 -165.64 2.27 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.56 108.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 144.67 3.8 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.89 0.852 . . . . 0.0 113.033 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.09 135.91 51.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.796 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.1 113.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -76.39 170.02 17.15 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.42 109.72 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.168 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.36 -1.23 50.14 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.45 152.12 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.091 0.445 . . . . 0.0 110.136 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.94 154.22 21.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.863 0.363 . . . . 0.0 111.809 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.74 142.11 51.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.711 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -130.67 123.54 29.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 0.0 111.529 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -133.12 123.25 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.558 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.0 t -147.62 154.22 40.37 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.326 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.01 99.93 3.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 109.968 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -81.05 120.68 25.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.084 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.2 -174.79 2.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.44 1.99 14.53 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -138.9 143.93 38.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.135 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -75.84 138.99 41.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.402 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.44 136.81 19.88 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.56 -148.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.319 1.15 . . . . 0.0 110.501 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -121.99 124.66 71.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.1 -35.59 4.3 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -70.93 -42.06 70.37 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 140.67 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -148.06 116.25 6.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.866 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.549 ' NE1' ' CE1' ' A' ' 77' ' ' PHE . 48.6 m95 -109.68 125.14 52.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.442 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 91.3 m-85 -156.86 152.26 26.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 111.517 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.09 119.52 60.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -58.69 116.84 3.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.05 -3.11 9.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.9 107.05 0.13 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.39 132.21 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.072 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.78 104.61 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.197 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -89.14 154.65 49.46 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.44 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -53.07 -25.79 30.17 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.462 1.441 . . . . 0.0 110.057 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -91.31 11.96 21.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.149 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 39.3 p-10 -37.69 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -73.11 -45.8 54.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.484 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.0 -29.08 17.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -102.34 147.06 27.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.187 0.518 . . . . 0.0 111.015 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.1 m -122.15 126.12 47.63 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.91 128.18 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.1 p -142.82 151.76 41.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.056 0.455 . . . . 0.0 111.151 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.14 103.84 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.867 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -104.91 109.12 20.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.715 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.85 -119.17 16.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -105.31 47.43 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.662 0.267 . . . . 0.0 110.449 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.558 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 9.3 t-160 -145.82 138.88 25.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.422 ' O ' ' OG1' ' A' ' 23' ' ' THR . 78.3 m80 -127.05 138.49 53.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.67 109.1 4.33 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tt -112.67 127.13 56.03 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.396 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.38 143.24 39.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 tp -101.83 128.4 48.21 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -71.59 -108.58 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.209 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.9 p -79.91 96.21 6.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 111.234 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.39 142.29 55.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.739 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 70' ' ' HIS . 17.0 mm100 -130.97 144.15 52.36 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.63 84.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.402 1.401 . . . . 0.0 111.378 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' GLN . 78.6 t60 176.25 -28.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -81.77 -6.14 58.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 148.49 9.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.88 -164.91 38.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -104.06 153.71 20.56 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.64 115.9 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.106 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -133.01 133.24 42.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.013 0.435 . . . . 0.0 110.965 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.549 ' CE1' ' NE1' ' A' ' 37' ' ' TRP . 56.0 t80 -127.66 133.99 49.62 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 142.89 50.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.878 0.371 . . . . 0.0 110.678 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 81' ' ' ASP . 17.7 p -154.36 -156.83 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.363 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.597 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.4 ptp180 -50.7 84.67 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.096 0.474 . . . . 0.0 111.6 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' CYS . 99.1 m-20 51.93 0.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -92.82 94.14 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.91 146.99 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.73 165.19 27.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.0 p -151.67 169.85 21.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 177.96 172.1 0.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.836 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -137.55 136.08 37.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -118.55 126.2 51.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.881 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.9 t -144.09 154.18 42.94 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.722 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -115.0 122.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.368 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.5 tp -78.6 127.83 32.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.787 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 150.17 43.44 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 93' ' ' LEU . 1.8 mm? -106.45 168.71 7.76 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 29.12 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.105 1.204 . . . . 0.0 111.738 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 93' ' ' LEU . 54.1 t0 -62.66 138.75 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.853 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.12 59.12 4.97 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 166.12 22.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.6 127.7 33.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.27 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -105.25 127.59 53.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.295 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.0 p-80 -114.47 99.15 7.35 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -103.63 130.07 51.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.308 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -94.56 92.95 7.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.938 0.399 . . . . 0.0 110.584 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -98.21 -19.26 17.97 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.998 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.378 179.81 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -100.32 139.11 36.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 110.878 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -164.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.059 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 6' ' ' LEU . 80.2 mm-40 -64.35 -13.04 48.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 5' ' ' ILE . 1.1 pt -41.78 70.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' GLU . 42.2 mt -81.54 -28.99 33.66 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -107.28 118.83 37.75 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.82 2.1 . . . . 0.0 112.625 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.42 127.96 32.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -90.4 114.93 27.16 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 11' ' ' ASN . 3.2 mmpt? -121.68 -168.1 1.64 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 10' ' ' LYS . 27.1 m120 53.79 103.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.61 121.2 35.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.698 0.761 . . . . 0.0 113.002 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.37 126.16 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.6 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 28.1 m -137.74 121.23 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -76.35 -166.72 0.66 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.71 124.42 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.22 65.96 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.231 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.71 143.91 44.71 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -92.79 163.34 13.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 148.01 27.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -130.49 123.99 30.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.12 116.53 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.479 ' HG1' ' N ' ' A' ' 24' ' ' CYS . 1.8 t -143.69 150.36 38.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.153 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.479 ' N ' ' HG1' ' A' ' 23' ' ' THR . 3.9 m -122.08 94.12 4.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.663 0.268 . . . . 0.0 110.712 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -71.51 109.9 5.76 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.238 0.542 . . . . 0.0 110.206 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 mt -99.48 -178.57 3.94 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.24 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.86 -3.84 13.39 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 1.1 pm0 -137.45 146.38 44.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.094 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.27 139.24 37.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.421 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' PRO . 21.8 t -107.11 133.24 20.39 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -58.23 -154.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 120.809 1.006 . . . . 0.0 110.187 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -115.53 102.54 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.71 -46.35 0.65 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.76 -43.31 89.29 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.155 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.0 139.97 38.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -140.97 144.37 35.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.714 0.292 . . . . 0.0 110.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 82.9 m95 -140.42 121.79 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.615 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -156.54 152.18 26.99 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.613 0.72 . . . . 0.0 112.127 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.36 114.12 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.01 112.06 3.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.013 1.279 . . . . 0.0 107.616 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.5 -15.67 9.85 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.65 89.38 1.17 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.386 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.33 140.48 57.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.728 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 m -78.65 103.76 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.794 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -102.04 158.25 32.13 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.07 -17.89 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.57 1.513 . . . . 0.0 110.99 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 65.8 m-20 -89.74 -4.95 57.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' ASP . 97.1 m-20 -35.43 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.255 0.55 . . . . 0.0 110.84 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -87.82 -43.07 12.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.096 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.97 -39.32 61.35 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.466 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 15.2 p90 -126.32 166.16 17.66 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.271 0.558 . . . . 0.0 111.304 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.3 p -129.62 156.87 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -132.72 120.84 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.3 p -147.89 157.73 43.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.73 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.02 111.53 5.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.63 107.82 18.83 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.08 -123.88 34.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.608 ' HG ' ' CE1' ' A' ' 59' ' ' HIS . 67.2 p -93.55 43.1 1.11 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.521 0.2 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.608 ' CE1' ' HG ' ' A' ' 58' ' ' SER . 63.5 m80 -147.78 138.86 23.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.901 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.449 ' O ' ' OG1' ' A' ' 23' ' ' THR . 96.2 m-70 -120.22 134.91 55.15 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.02 132.83 34.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.517 0.675 . . . . 0.0 111.28 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tp -126.3 128.94 47.91 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.815 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' TRP . 72.7 mt -105.81 162.91 13.14 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.995 0.903 . . . . 0.0 112.145 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.9 tp -141.69 108.3 5.34 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -68.01 -121.98 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -83.84 104.75 14.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.524 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.38 108.0 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.5 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 70' ' ' HIS . 51.4 mt-30 -108.13 145.95 32.52 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -48.85 88.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.758 1.639 . . . . 0.0 111.164 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 9.5 m-70 176.83 -28.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.827 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 22.8 p80 -76.99 -8.02 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.663 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.8 147.4 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 110.909 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.3 -131.26 2.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -141.53 146.69 36.68 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.655 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.58 115.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -118.7 126.55 52.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.358 0.599 . . . . 0.0 111.447 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 28.9 t80 -130.08 124.28 32.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.003 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.97 157.01 24.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.4 t -151.18 -155.04 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -55.19 82.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.007 0.432 . . . . 0.0 110.389 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 79' ' ' CYS . 95.1 m-20 57.47 -2.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.681 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -88.75 100.23 12.98 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 p -86.48 124.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.278 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.03 32.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.025 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.5 p -171.07 155.21 4.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.2 156.08 43.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.086 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -82.17 138.66 34.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.68 131.65 50.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -142.97 151.94 41.44 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.229 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 p -111.99 123.44 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.44 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.7 mp -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.395 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.61 -171.07 41.48 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.956 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 93' ' ' LEU . 2.2 mm? -101.33 152.95 38.07 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -50.1 138.97 35.5 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 121.122 1.215 . . . . 0.0 110.889 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -55.6 168.32 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.599 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.91 -69.58 0.1 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.76 91.54 4.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.807 0.336 . . . . 0.0 110.192 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.74 156.93 45.58 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -75.35 139.72 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -73.82 137.56 43.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.742 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -69.51 -160.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -66.9 -41.41 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -76.39 130.9 38.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.786 -179.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.4 ' H1 ' ' H ' ' A' ' 2' ' ' ARG . 90.9 m95 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' LEU . 99.7 mtt180 -92.98 159.23 15.41 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 2' ' ' ARG . 7.9 tt 39.43 96.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -78.12 135.3 37.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.664 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -89.84 119.06 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 9.5 mp -91.07 -71.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.494 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.26 138.31 29.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.44 158.69 44.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.258 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.8 mt -108.89 131.9 54.57 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 111.508 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -142.55 -171.37 3.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.617 ' H ' ' CB ' ' A' ' 86' ' ' ALA . 66.3 t30 56.05 109.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.2 142.15 14.33 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.38 132.96 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.285 -1.779 . . . . 0.0 107.346 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.31 124.26 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.656 0.741 . . . . 0.0 112.74 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -87.9 165.97 14.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.479 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.35 114.7 2.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.752 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.11 29.71 27.53 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.47 149.83 38.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 110.128 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -113.34 148.35 35.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.71 145.48 51.15 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.215 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 p -124.81 134.34 52.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -133.32 126.22 30.93 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.172 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 t -142.14 142.74 32.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 m -129.28 95.67 4.1 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -77.07 110.13 11.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.12 -174.23 2.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.416 0.627 . . . . 0.0 111.617 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 t -98.7 -20.54 16.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.597 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -142.0 151.16 42.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.008 0.433 . . . . 0.0 111.218 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.6 128.45 35.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.043 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.52 134.77 19.66 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.71 -151.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.028 1.152 . . . . 0.0 110.616 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.93 103.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.84 -37.77 0.66 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.83 -13.09 52.11 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.8 139.84 48.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.376 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -122.97 126.01 46.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.625 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 99.2 m95 -124.66 100.04 6.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.949 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 90.8 m-85 -152.91 149.02 27.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 110.559 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.94 125.09 69.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -48.43 132.76 16.71 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.584 -0.698 . . . . 0.0 111.257 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.63 8.1 56.21 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.205 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.16 125.91 1.35 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.376 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.28 112.83 24.47 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.88 104.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 112.487 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.475 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.6 mp0 -92.21 157.46 40.72 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -53.29 -23.4 23.35 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.613 1.542 . . . . 0.0 111.495 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -98.35 17.23 19.28 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 45' ' ' GLN . 87.3 m-20 -49.18 128.83 17.24 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.4 p -91.96 -37.25 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.755 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 66.2 t0 -96.48 -32.45 12.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.659 0.266 . . . . 0.0 111.694 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -102.83 139.86 37.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.477 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 m -132.3 130.46 40.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.5 133.21 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -143.34 154.57 43.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.634 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.47 106.0 4.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.327 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.01 105.67 15.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.951 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.32 -126.34 41.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 23.0 t -95.44 37.56 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.633 0.254 . . . . 0.0 110.938 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 58' ' ' SER . 22.1 m-70 -142.81 153.85 43.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.844 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.27 161.8 28.52 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.92 94.2 1.11 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.755 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.05 128.18 54.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.503 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -121.73 -178.29 3.78 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.162 0.982 . . . . 0.0 112.357 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.2 tp -145.01 120.74 10.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.01 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' LEU . 82.8 mmt-85 -64.1 -130.23 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.307 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 m -82.84 108.28 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.95 142.46 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.672 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' HIS . 80.9 mt-30 -134.42 144.8 52.58 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.42 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.29 83.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.296 1.331 . . . . 0.0 111.153 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.3 t60 178.39 -26.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -87.09 -1.16 57.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.837 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.08 145.96 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.18 -123.04 1.0 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -142.47 154.2 44.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.508 0.194 . . . . 0.0 110.531 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -121.22 117.99 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -128.95 129.16 45.09 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.13 0.49 . . . . 0.0 112.145 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.625 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 16.4 t80 -136.65 141.16 43.17 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.35 154.8 39.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' ASP . 3.0 t -157.33 -147.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.703 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.488 ' C ' ' H ' ' A' ' 82' ' ' ALA . 24.6 mmm180 -53.79 89.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' CYS . 53.2 t0 50.58 10.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.14 93.99 8.58 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.23 125.69 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.838 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.24 123.24 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.472 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.8 p -158.53 138.21 11.93 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.692 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.617 ' CB ' ' H ' ' A' ' 11' ' ' ASN . . . -139.62 151.31 45.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -81.21 144.27 31.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.344 0.593 . . . . 0.0 112.35 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.2 tp -111.95 133.12 54.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.386 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -137.86 139.08 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.104 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.8 126.67 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.239 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.3 tp -117.29 131.56 56.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.033 0.444 . . . . 0.0 111.043 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -160.18 159.89 31.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 8.3 mp -98.6 108.38 47.87 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.61 -18.4 42.79 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.05 1.166 . . . . 0.0 111.941 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.79 143.09 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.92 0.391 . . . . 0.0 111.467 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.39 98.59 2.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' A' ' 97' ' ' LEU . 8.9 mp -81.29 145.37 30.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.842 0.353 . . . . 0.0 110.531 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.64 -37.65 79.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -151.54 143.0 23.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.68 ' CG ' ' H ' ' A' ' 101' ' ' HIS . 28.4 t60 -102.01 -167.89 1.47 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 97.1 m-70 -67.72 142.75 56.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.445 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.604 ' N ' ' HD1' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -69.2 130.3 42.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.419 ' CG ' ' C ' ' A' ' 102' ' ' HIS . 8.0 p80 35.3 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.525 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.3 m95 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -91.75 163.85 13.92 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 2.8 mm? -69.17 126.54 30.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -82.91 143.13 30.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.745 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 18.1 tt -89.67 119.46 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.091 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.58 -63.79 1.17 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.928 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -154.12 146.95 24.35 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.946 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.07 145.54 44.07 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.806 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.38 115.54 30.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -131.78 -169.99 2.31 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.071 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' LYS . 60.1 t-20 53.42 107.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.409 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.26 147.93 3.83 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.76 148.62 45.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.111 -1.859 . . . . 0.0 106.631 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.87 110.05 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.288 0.566 . . . . 0.0 111.155 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -76.31 155.77 33.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.24 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.91 136.12 47.51 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.823 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.35 28.27 68.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.12 143.85 46.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.286 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -98.51 159.24 15.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.846 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.0 148.39 31.65 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.58 124.55 41.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.141 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.43 117.27 21.07 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -143.81 153.99 42.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.11 98.43 3.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.314 0.578 . . . . 0.0 111.05 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -71.13 110.44 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.11 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.04 -177.17 4.06 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 110.781 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 100.0 p -108.3 -12.56 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.116 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -134.29 145.97 49.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.949 0.405 . . . . 0.0 110.902 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.79 129.83 35.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.64 141.57 24.31 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.94 -145.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 120.642 1.265 . . . . 0.0 111.086 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 p -123.15 123.6 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.43 -26.4 6.34 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.39 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.4 -21.21 23.17 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.162 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 143.69 30.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -120.88 126.86 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.572 ' CE2' ' CD2' ' A' ' 77' ' ' PHE . 37.2 m95 -134.45 115.04 13.52 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.657 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -170.37 166.1 8.63 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.287 0.565 . . . . 0.0 112.213 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.78 127.66 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -66.8 132.15 47.43 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 120.772 -1.205 . . . . 0.0 109.713 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.1 -3.92 33.57 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -146.32 -27.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.339 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' ALA . . . 48.3 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 1.3 p -60.05 118.93 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.491 0.662 . . . . 0.0 112.52 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -110.98 152.19 43.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.513 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.38 -20.31 47.69 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.911 1.074 . . . . 0.0 111.855 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.82 4.63 49.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.01 137.96 57.97 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.194 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 p -89.31 -33.51 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 51' ' ' TRP . 38.6 p-10 -92.48 -29.34 16.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.662 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.443 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 97.4 m95 -110.6 139.14 46.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 111.245 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 93.9 m -127.16 130.28 49.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -125.39 132.91 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 p -144.64 155.82 43.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.501 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.36 105.76 4.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.66 113.78 21.73 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.008 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.26 -133.52 42.48 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -98.26 38.61 1.31 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.815 0.341 . . . . 0.0 110.555 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -139.96 137.92 35.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.125 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -122.08 134.25 54.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 129.36 36.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.36 0.6 . . . . 0.0 111.835 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.44 151.56 41.15 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.245 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 5.0 mp -133.68 165.07 25.78 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.399 1.095 . . . . 0.0 113.156 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 65' ' ' ARG . 34.4 tp -143.6 108.39 4.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.643 -2.071 . . . . 0.0 106.365 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.6 mtt-85 -64.58 -121.26 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.2 m -81.87 109.63 16.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.27 134.6 53.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.586 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 0.8 OUTLIER -136.02 147.19 59.76 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.067 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.3 Cg_endo -48.22 90.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.668 1.578 . . . . 0.0 111.693 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.6 m-70 170.63 -29.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.199 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.586 ' ND1' ' O ' ' A' ' 68' ' ' GLN . 49.1 p-80 -83.25 -15.0 52.01 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.27 146.83 27.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.311 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.26 -137.48 4.61 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.527 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 53.6 mp0 -126.87 147.79 50.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.38 111.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -123.45 123.16 40.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.274 0.559 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -145.64 145.94 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.736 179.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.3 151.61 28.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.319 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 81' ' ' ASP . 4.8 t -156.73 -140.96 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.939 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ALA . 19.0 mmm180 -54.23 89.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.979 0.419 . . . . 0.0 110.135 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 44.54 16.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -103.41 69.94 1.02 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 135.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.88 132.51 7.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -141.62 119.36 11.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.141 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.77 -160.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.49 0.662 . . . . 0.0 111.67 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -146.04 121.19 10.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.586 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.7 tp -110.07 130.51 55.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.923 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 t -136.17 146.51 46.94 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.613 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 90' ' ' VAL . 9.6 p -113.29 125.53 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 3.0 mm? -95.49 130.21 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.354 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -105.58 -91.44 2.22 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mp -106.65 170.92 5.19 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.54 50.34 3.48 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.373 1.382 . . . . 0.0 111.824 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -87.45 91.83 8.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 110.668 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.11 -13.19 50.14 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -108.27 125.85 52.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.773 0.32 . . . . 0.0 111.62 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.71 134.35 53.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.391 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' HIS . 36.2 p-80 -67.77 -43.97 78.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.51 ' N ' ' CG ' ' A' ' 100' ' ' HIS . 52.8 t60 -106.62 117.55 34.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.551 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.485 ' O ' ' CG ' ' A' ' 102' ' ' HIS . 47.7 p-80 -103.47 110.6 22.69 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.774 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -61.2 -47.07 87.83 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.242 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.08 -179.522 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -99.81 136.07 40.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.05 0.452 . . . . 0.0 110.699 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' N ' ' CD1' ' A' ' 3' ' ' LEU . 6.1 mp -93.55 81.18 4.32 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.961 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.12 167.5 19.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.714 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -77.51 121.69 30.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.767 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.21 -68.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -135.0 124.86 25.49 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -110.73 152.68 26.29 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.037 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.02 108.79 12.75 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' CE ' ' N ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -130.19 -168.53 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.506 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 m120 54.78 105.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.782 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.93 134.86 6.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.984 0.897 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.73 130.09 54.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.838 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' ARG . 5.1 m -129.91 103.28 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.214 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 14' ' ' VAL . 93.7 mtt180 -47.54 175.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.48 128.91 38.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.099 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.29 42.41 10.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.58 160.91 36.06 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.495 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -95.24 154.63 17.09 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.25 133.66 46.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 p -119.62 122.62 41.96 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -132.6 117.85 18.45 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.0 p -144.52 151.69 39.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.261 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.99 95.74 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.991 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 p -67.83 123.52 20.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -123.63 143.23 50.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.906 0.384 . . . . 0.0 111.288 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 m -76.77 -13.28 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.921 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -116.94 132.89 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 0.0 111.805 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.97 149.56 30.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.8 t -124.74 122.58 25.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.48 -147.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.229 1.118 . . . . 0.0 110.998 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.9 p -120.97 118.84 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.742 0.782 . . . . 0.0 109.102 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.28 -25.28 9.36 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -91.78 -19.21 22.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.144 0.497 . . . . 0.0 109.678 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.08 166.59 19.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.3 m -146.52 116.75 7.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.462 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.09 97.79 3.06 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -155.07 156.31 35.65 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' A' ' 42' ' ' ALA . 4.9 mm -73.42 101.06 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -47.72 97.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 128.42 -36.28 2.5 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . -125.04 98.28 5.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.07 139.73 51.43 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.824 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.52 113.8 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -104.67 152.39 39.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.37 -19.82 18.33 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.286 1.324 . . . . 0.0 109.989 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.54 31.3 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.51 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 42.4 p-10 -97.48 104.94 17.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.508 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -87.44 -52.78 5.17 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.469 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -67.39 -37.53 83.26 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 110.112 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.409 ' CZ2' ' CD1' ' A' ' 39' ' ' ILE . 59.7 t-105 -105.17 148.01 27.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.028 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -146.26 143.74 29.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.644 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -124.79 138.0 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -142.83 158.65 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 111.235 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.01 100.83 3.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -108.86 105.15 14.57 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 -131.22 30.22 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -100.43 37.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.064 0.459 . . . . 0.0 110.595 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -135.75 132.34 36.68 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -115.24 123.23 48.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.73 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.27 122.88 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -141.15 131.43 25.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.63 ' N ' ' CD1' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.32 -169.98 2.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.208 1.004 . . . . 0.0 113.7 -175.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.7 tp -146.4 119.9 9.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 113.366 -1.743 . . . . 0.0 106.954 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -68.51 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.8 p -71.46 103.54 2.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.167 0.508 . . . . 0.0 110.225 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.4 135.92 53.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 70' ' ' HIS . 73.8 mt-30 -130.87 144.1 52.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -48.57 92.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.515 1.476 . . . . 0.0 111.599 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 3.7 m-70 166.9 -27.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.891 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -86.36 -0.79 56.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.389 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 145.27 56.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.213 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.05 -150.3 15.36 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -118.66 166.7 12.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.626 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.8 t -132.2 133.7 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.7 m -132.6 129.16 38.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.382 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -132.78 140.34 47.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.284 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -161.69 144.36 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.645 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' ASP . 25.4 p -157.6 -135.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.539 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -51.81 81.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 44.1 t0 51.28 6.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -96.29 91.38 5.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.91 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.315 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.01 -179.49 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.326 0.584 . . . . 0.0 110.992 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 m -158.0 178.9 9.7 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.466 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -169.47 160.97 9.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.212 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -119.27 132.8 55.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.911 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 tp -121.76 127.04 50.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.535 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 t -146.79 153.85 40.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.284 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.4 110.94 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.992 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.9 mt -82.38 133.24 35.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.923 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.02 116.8 3.28 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.5 mt -114.58 147.03 37.21 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -53.35 125.75 19.45 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 120.794 0.996 . . . . 0.0 110.68 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -88.71 138.42 31.43 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.753 0.311 . . . . 0.0 111.073 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.27 -118.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.2 mt -99.19 -2.26 37.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.527 0.203 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -77.02 124.93 28.5 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.931 0.396 . . . . 0.0 111.313 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -155.97 139.8 16.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -129.1 135.99 49.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.685 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.09 166.48 14.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.199 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -102.85 123.6 46.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.459 . . . . 0.0 110.735 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -66.75 -38.26 86.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.572 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -92.69 140.44 29.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.226 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.555 ' CD1' ' N ' ' A' ' 3' ' ' LEU . 2.9 mp -100.37 116.26 31.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' OE2' ' O ' ' A' ' 80' ' ' ARG . 34.2 tp10 -139.11 -119.76 0.13 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.208 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -99.3 121.12 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.554 0.342 . . . . 0.0 110.739 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.8 -71.15 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -126.5 118.38 24.81 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 1.7 pt? -122.18 144.64 48.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.23 115.69 31.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -132.26 179.56 6.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.683 -178.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 10' ' ' LYS . 86.4 m-20 51.88 108.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.292 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.36 140.74 7.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.95 0.881 . . . . 0.0 112.76 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 127.81 53.45 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -113.06 111.38 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -63.64 166.65 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.186 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 133.83 48.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.998 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.53 43.11 98.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.26 151.73 48.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.345 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -92.83 157.68 16.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.976 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.81 153.82 36.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.42 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.1 t -142.09 148.23 38.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.435 0.636 . . . . 0.0 111.391 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.65 128.92 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.722 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -148.13 152.04 36.62 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.974 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.4 p -142.01 98.06 3.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.402 0.62 . . . . 0.0 111.756 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 m -71.81 120.32 17.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.138 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.16 139.56 47.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.051 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 t -70.79 -13.21 61.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.19 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -131.66 139.96 49.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.129 0.49 . . . . 0.0 111.367 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.74 146.44 33.88 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.915 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -125.24 134.92 26.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.5 -148.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.318 1.149 . . . . 0.0 110.232 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.88 115.01 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.6 -47.44 0.9 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -68.03 -36.79 80.5 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.08 127.76 34.12 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.909 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.5 t -135.56 138.04 42.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.556 ' CZ2' ' CG ' ' A' ' 77' ' ' PHE . 90.5 m95 -137.76 112.99 9.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.0 p90 -157.91 155.62 29.9 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.202 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 ' H ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.7 94.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' ILE . 23.8 t-20 -37.61 106.03 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.242 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.77 -9.82 8.55 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.83 102.74 3.44 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 110.496 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 106.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.55 128.37 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.913 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.38 150.1 42.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.18 -25.64 65.34 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.674 1.583 . . . . 0.0 111.78 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -82.29 11.46 5.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 35.8 p-10 -62.28 133.27 54.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.727 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -90.93 -50.07 6.08 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -64.61 -38.68 91.85 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.015 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -104.72 151.38 23.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.4 m -135.07 136.69 42.22 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.34 135.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 p -144.21 157.47 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.269 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.92 113.0 3.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.086 0.47 . . . . 0.0 110.757 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 65.8 t0 -130.33 123.68 30.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 -124.84 11.68 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.4 m -115.55 43.02 2.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.739 0.304 . . . . 0.0 110.801 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 56' ' ' ASP . 34.9 p80 -154.26 146.62 23.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.742 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.64 168.1 9.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.97 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.12 100.91 1.4 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.647 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tt -109.93 129.19 55.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.055 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pp -118.18 173.66 6.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.957 0.885 . . . . 0.0 112.382 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.2 tp -140.42 115.2 9.58 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 113.54 -1.664 . . . . 0.0 106.602 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.556 HH21 ' HG ' ' A' ' 66' ' ' SER . 61.7 ttp85 -68.17 -128.04 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.556 ' HG ' HH21 ' A' ' 65' ' ' ARG . 82.5 p -75.55 108.61 8.49 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.369 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.26 56.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 66' ' ' SER . 2.8 mp0 -124.91 141.79 39.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.553 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -53.13 86.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.282 1.321 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.1 m-70 174.2 -33.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.708 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -70.64 -5.09 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.795 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.02 145.8 15.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.681 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.88 -167.43 35.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 40' ' ' ASN . 93.2 mt-10 -100.55 165.44 11.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.516 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.9 t -128.12 129.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.784 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.2 m -133.42 137.87 45.98 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.462 0.649 . . . . 0.0 110.783 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.556 ' CG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -131.98 134.07 45.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.071 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.462 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -134.59 137.59 43.85 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -151.36 -155.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 82' ' ' ALA . 79.8 mtp85 -57.77 90.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.8 t0 49.35 14.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -89.73 95.31 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.602 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.48 134.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.395 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.53 154.7 41.85 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.225 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.8 p -156.98 173.69 16.64 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.789 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 178.21 175.41 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.193 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -136.98 109.06 7.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.095 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.7 tp -93.47 129.79 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.773 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -137.13 135.08 37.08 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.054 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.18 118.04 41.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.19 120.31 10.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.05 95.57 0.1 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.19 109.11 62.0 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.39 -158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.896 1.064 . . . . 0.0 111.121 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.17 114.44 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.74 1.38 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 97' ' ' LEU . 10.3 mp -88.32 2.97 51.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.204 0.526 . . . . 0.0 110.275 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -68.96 -34.39 75.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.669 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.96 -175.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -115.8 176.89 4.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.1 m170 54.42 84.63 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -59.75 -42.99 94.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -136.58 -40.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.701 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.597 -179.718 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 99.3 m95 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 4' ' ' GLU . 84.0 mtp180 -97.76 -174.13 2.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.394 0.14 . . . . 0.0 111.321 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.559 ' CA ' ' HG ' ' A' ' 27' ' ' SER . 1.2 pt? 33.5 30.18 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.379 0.609 . . . . 0.0 110.557 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 2' ' ' ARG . 10.3 pt-20 -77.02 143.49 39.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.157 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.8 mt -83.8 118.52 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.08 -67.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.269 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -139.81 131.32 27.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.513 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 119.72 36.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 9.4 mp -93.84 104.91 16.96 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 11' ' ' ASN . 7.3 mmpt? -132.91 -169.16 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' LYS . 15.6 t-20 59.17 109.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.56 145.84 2.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.832 0.825 . . . . 0.0 111.963 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.09 130.85 53.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.283 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 m -119.92 122.75 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 122.226 1.013 . . . . 0.0 113.397 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.86 167.81 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.048 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.83 55.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.723 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.38 50.76 59.96 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.12 25.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.536 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -100.82 147.36 26.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.141 0.496 . . . . 0.0 110.305 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.2 140.15 52.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.195 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.01 137.0 47.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.386 0.612 . . . . 0.0 111.83 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -145.67 130.07 17.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.353 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -144.58 148.76 34.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -133.36 95.21 3.47 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.197 0.522 . . . . 0.0 111.666 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.4 m -75.16 113.51 12.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.694 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -107.14 -163.18 0.89 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.481 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.559 ' HG ' ' CA ' ' A' ' 3' ' ' LEU . 22.4 p -114.03 -7.28 13.11 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.332 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -146.22 154.79 42.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.121 0.486 . . . . 0.0 111.28 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.46 129.31 35.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.748 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.23 133.58 22.83 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.559 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -63.0 -146.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.255 1.127 . . . . 0.0 111.283 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.5 t -120.5 120.85 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.14 -28.67 5.77 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 53.5 mp0 -85.2 -18.02 35.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.748 0.308 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.0 134.75 51.8 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 m -113.6 140.1 48.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.619 0.247 . . . . 0.0 110.554 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.571 ' CZ2' ' CD1' ' A' ' 77' ' ' PHE . 91.7 m95 -147.27 102.41 3.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.61 153.89 32.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 mp -80.81 145.18 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.819 0.819 . . . . 0.0 111.634 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -78.82 106.17 10.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.517 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.24 -9.18 7.02 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.86 120.71 1.22 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.56 0.219 . . . . 0.0 111.065 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.48 53.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.946 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.0 t -98.54 116.25 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 157.92 45.21 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.51 -34.83 90.9 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.675 1.583 . . . . 0.0 112.12 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -82.22 20.23 1.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.584 0.231 . . . . 0.0 111.593 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 28.8 p-10 -55.05 122.83 11.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.087 0.47 . . . . 0.0 112.118 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -88.93 -51.31 5.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.574 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' OD2' ' CE1' ' A' ' 71' ' ' HIS . 97.5 m-20 -66.17 -38.11 87.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.229 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.479 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 8.7 m-90 -105.94 155.29 19.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.412 0.625 . . . . 0.0 112.128 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -132.55 132.53 42.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -125.0 134.1 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 p -145.87 156.04 43.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.12 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.77 109.7 4.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 33.1 p-10 -119.32 102.44 8.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.06 -133.67 31.38 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.47 ' HG ' ' C ' ' A' ' 28' ' ' GLU . 56.4 m -89.94 21.47 3.63 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 122.607 -0.349 . . . . 0.0 111.115 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 77.9 m80 -123.11 124.05 42.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.63 153.07 21.03 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.97 98.0 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.497 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.32 132.66 53.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.41 HD11 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -130.05 -177.25 4.22 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.483 1.135 . . . . 0.0 112.295 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 51' ' ' TRP . 9.2 tp -145.99 115.24 7.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.532 -2.122 . . . . 0.0 107.362 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 49.7 ttp180 -64.65 -128.45 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -69.01 106.03 2.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.945 0.402 . . . . 0.0 109.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.29 143.13 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.887 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -133.59 139.68 34.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -53.8 89.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.318 1.345 . . . . 0.0 112.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.566 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER 168.18 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.808 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 50' ' ' ASP . 7.2 m-70 -85.71 0.64 52.2 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.96 146.21 33.17 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.707 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.42 -149.5 18.85 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 57.7 mp0 -145.03 119.2 9.47 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.63 144.35 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.635 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -124.84 128.0 48.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.662 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CD1' ' CZ2' ' A' ' 37' ' ' TRP . 3.4 t80 -132.47 138.05 47.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -160.24 144.18 14.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 81' ' ' ASP . 29.9 p -155.91 -132.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.508 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 95.6 mtt-85 -54.53 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.434 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 79' ' ' CYS . 27.9 t70 46.85 14.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.08 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -101.35 88.73 3.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.78 153.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.04 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -179.64 115.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.79 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.2 t -93.21 -173.91 3.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.987 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.03 154.68 22.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.024 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -114.94 113.76 24.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.445 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 73' ' ' GLY . 38.6 tp -115.11 124.92 52.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -140.49 123.52 16.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.107 0.48 . . . . 0.0 110.715 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.84 119.94 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.181 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.0 tp -92.52 111.55 23.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.183 0.516 . . . . 0.0 110.086 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.57 -24.44 0.92 Allowed Glycine 0 N--CA 1.466 0.665 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.036 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.4 mp -105.9 108.3 61.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.95 139.69 89.21 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 CA-C-N 119.793 0.962 . . . . 0.0 111.244 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 46.1 p-10 -89.71 109.26 20.25 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.564 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 94.39 0.15 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.71 143.76 26.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.004 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -81.23 161.59 23.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.229 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.669 ' CG ' ' H ' ' A' ' 100' ' ' HIS . 30.6 t60 67.87 -152.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.311 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.669 ' H ' ' CG ' ' A' ' 99' ' ' HIS . 7.0 t-80 46.16 82.79 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.61 ' N ' ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -61.55 112.45 2.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.148 0.499 . . . . 0.0 110.189 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.426 ' NE2' ' C ' ' A' ' 104' ' ' HIS . 80.9 t60 -149.04 103.53 3.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.792 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.92 -46.13 90.67 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.752 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.426 ' C ' ' NE2' ' A' ' 102' ' ' HIS . 50.6 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.014 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.4 m0 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -90.0 147.08 23.9 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.247 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -88.3 94.14 9.74 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 121.268 0.556 . . . . 0.0 110.089 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.18 151.36 29.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.008 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tp -82.85 120.5 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.14 -70.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.7 135.58 29.98 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 112.42 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.26 135.05 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.67 112.17 23.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.572 ' NZ ' ' O ' ' A' ' 85' ' ' SER . 1.8 mmpt? -127.78 -176.17 3.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.037 0.446 . . . . 0.0 111.295 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 10' ' ' LYS . 93.2 m-20 55.92 108.63 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.341 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.74 138.81 9.73 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.91 147.93 44.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.421 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.7 m -133.18 114.98 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.423 0.63 . . . . 0.0 111.189 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -85.25 147.58 26.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.379 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.53 124.98 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.586 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.74 27.13 51.93 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.47 147.0 41.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -103.58 156.3 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.333 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.43 144.35 31.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.91 0.386 . . . . 0.0 110.567 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -127.69 136.26 51.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.472 0.653 . . . . 0.0 111.13 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -137.51 122.01 18.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.552 ' OG1' ' CE1' ' A' ' 59' ' ' HIS . 1.7 t -144.3 152.71 41.15 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.536 -0.466 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 26' ' ' LEU . 14.1 t -127.51 92.45 3.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.171 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 m -73.07 114.86 11.71 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' CD2' ' SG ' ' A' ' 24' ' ' CYS . 84.2 mt -103.81 -169.41 1.63 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.31 0.576 . . . . 0.0 111.362 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.8 t -113.85 -5.13 13.25 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.234 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -140.85 146.11 37.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.64 133.45 35.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.968 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 10.9 t -108.25 134.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.364 -0.35 . . . . 0.0 110.507 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -61.7 -143.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 119.975 1.027 . . . . 0.0 110.047 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.52 111.56 29.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.566 0.698 . . . . 0.0 109.421 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.79 -47.37 0.7 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -67.53 -45.62 75.18 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.069 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.25 138.35 38.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -142.61 112.71 7.06 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.663 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.638 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 98.5 m95 -106.78 107.13 17.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 68.0 m-85 -150.13 150.22 31.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.535 0.683 . . . . 0.0 110.563 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.496 ' H ' ' CD1' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -125.35 129.27 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -61.07 110.53 1.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.101 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.85 -4.35 6.48 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.811 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 44' ' ' VAL . . . -160.29 76.92 0.62 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.761 0.78 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.92 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 42' ' ' ALA . 6.2 p -67.97 101.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.506 0.669 . . . . 0.0 110.739 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 48' ' ' ASP . 16.2 mt-30 -92.07 155.94 42.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.486 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.37 -30.51 15.56 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.667 1.578 . . . . 0.0 111.616 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.63 10.01 19.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 11.0 p-10 -51.0 128.81 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.7 p -92.44 -47.34 7.21 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.071 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 46.2 t0 -72.11 -39.36 68.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.641 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -106.84 151.07 25.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.316 0.579 . . . . 0.0 111.341 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -128.56 130.28 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.878 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.99 133.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.011 0.434 . . . . 0.0 109.833 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -142.01 153.39 44.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.43 98.58 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.086 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -113.19 105.76 13.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.27 -132.45 48.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -93.34 35.49 1.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.285 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.552 ' CE1' ' OG1' ' A' ' 23' ' ' THR . 63.7 t-80 -139.65 131.77 28.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 80.7 m80 -118.52 137.02 53.49 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.77 137.94 51.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.301 0.572 . . . . 0.0 111.472 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 tp -132.63 138.16 47.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.32 162.16 25.36 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.265 1.031 . . . . 0.0 112.864 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 65' ' ' ARG . 17.9 tp -140.88 110.9 6.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 112.774 -2.012 . . . . 0.0 106.323 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.7 mtt-85 -62.87 -128.96 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.105 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.6 p -77.61 107.15 9.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.08 0.467 . . . . 0.0 110.285 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 137.55 57.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.35 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 84.2 mt-30 -133.94 135.06 23.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.02 88.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.002 1.135 . . . . 0.0 111.658 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 2.0 t60 -173.48 -39.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.603 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 22.8 p-80 -82.12 -7.65 59.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.883 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.21 152.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.34 -162.03 34.01 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.16 149.11 21.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.777 0.322 . . . . 0.0 110.581 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.0 t -117.51 119.71 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.886 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 137.31 49.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.638 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 2.3 t80 -137.95 134.98 35.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.466 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -133.06 144.25 49.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.8 t -156.88 -151.2 0.31 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.32 0.581 . . . . 0.0 111.502 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -55.84 84.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.122 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' CYS . 90.5 m-20 51.27 8.62 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.4 94.21 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.74 129.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.935 0.398 . . . . 0.0 110.471 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.76 165.39 25.38 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.438 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.572 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 96.9 p -161.68 -179.69 7.46 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 174.59 178.64 0.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 128.86 24.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.274 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.3 tp -113.99 130.07 56.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 t -142.34 155.97 45.21 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.665 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.9 t -121.0 123.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.394 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.3 mt -79.44 138.46 37.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.35 -37.72 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.31 108.85 62.39 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -61.43 142.81 96.67 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 119.671 0.918 . . . . 0.0 111.0 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -106.57 -29.21 9.79 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.4 -124.24 4.01 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.7 128.61 55.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.68 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -148.01 -98.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.245 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 101' ' ' HIS . 56.3 t-80 -105.15 58.62 0.68 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.23 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -62.29 -41.53 98.58 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.603 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.528 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 11.6 t60 -63.52 121.6 14.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.153 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -67.36 -45.31 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.626 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -72.66 141.47 48.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.4 m80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.761 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.97 143.6 26.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 111.111 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 1.3 mm? -90.97 111.01 22.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.027 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -82.86 151.99 25.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.202 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.69 119.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.6 mp -86.79 -71.44 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.651 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -132.14 128.17 37.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.057 0.456 . . . . 0.0 111.183 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 1.8 pt? -129.66 136.69 50.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.79 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 2.5 tt -104.55 108.99 20.7 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 11' ' ' ASN . 12.4 mmmt -118.39 -171.22 2.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.3 m120 57.04 108.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.91 130.34 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.91 128.45 46.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -131.31 123.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.51 172.6 13.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.433 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 133.18 54.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.114 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.73 23.8 74.07 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.8 152.87 28.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.9 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.67 152.48 20.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.5 144.74 46.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -142.48 120.61 12.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 112.193 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -123.6 116.35 22.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.4 t -144.95 150.84 37.66 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.472 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.7 100.75 4.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.429 ' OG1' ' ND1' ' A' ' 59' ' ' HIS . 23.6 m -72.69 112.05 8.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.374 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.04 -166.45 1.23 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.341 0.591 . . . . 0.0 111.245 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.1 p -114.72 -4.83 12.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.915 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -138.37 141.58 39.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.423 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.86 130.59 36.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.515 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 31' ' ' PRO . 26.3 t -104.16 134.9 19.46 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.268 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.15 -147.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 120.022 1.044 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.22 109.52 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.56 -42.2 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.46 -43.58 80.74 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.074 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.34 150.2 33.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.64 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -126.8 126.25 43.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 111.036 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -131.48 112.13 12.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -155.42 153.76 30.87 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.505 0.669 . . . . 0.0 111.508 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.99 121.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.32 125.65 24.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.174 0.897 . . . . 0.0 109.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.47 -3.9 31.06 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.4 96.55 0.4 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.271 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.32 139.41 54.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.868 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.43 103.18 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -90.48 153.74 46.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.12 -29.11 27.35 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.767 1.644 . . . . 0.0 111.352 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -97.21 14.21 26.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -46.45 124.73 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -88.09 -44.21 11.11 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.25 -26.19 19.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -110.18 139.92 44.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.48 ' OG1' ' CD1' ' A' ' 63' ' ' LEU . 23.4 p -136.94 152.72 50.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.56 137.0 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 p -142.43 153.45 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.93 102.39 5.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.027 0.441 . . . . 0.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -109.33 107.65 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.943 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.89 -131.42 45.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.5 p -97.03 47.16 1.04 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.729 0.299 . . . . 0.0 111.008 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.553 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 63.6 t60 -152.44 137.06 16.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.672 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -117.01 135.75 53.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.05 126.51 26.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 111.008 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 tt -131.22 133.86 45.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.322 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.48 ' CD1' ' OG1' ' A' ' 52' ' ' THR . 1.5 pp -119.56 -176.63 3.2 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.254 1.026 . . . . 0.0 112.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 65' ' ' ARG . 44.5 tp -146.12 122.22 10.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.144 -1.844 . . . . 0.0 106.302 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' LEU . 93.2 mtt-85 -63.51 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.611 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -78.28 108.1 11.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.73 134.89 50.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.898 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.673 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 74.0 mt-30 -132.4 145.1 55.84 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.64 84.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.416 1.41 . . . . 0.0 111.246 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 68' ' ' GLN . 81.4 t60 176.97 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.087 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.673 ' HD1' ' H ' ' A' ' 68' ' ' GLN . 30.0 m80 -82.03 -8.97 59.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.61 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.11 148.71 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.593 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.9 -171.31 42.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -97.68 151.68 19.87 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -119.39 118.14 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 117.757 0.253 . . . . 0.0 110.915 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 m -127.97 129.81 47.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.116 0.484 . . . . 0.0 111.115 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.37 139.34 37.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.293 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.91 153.13 31.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.165 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.9 t -157.32 -140.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 82' ' ' ALA . 77.9 mtp85 -55.97 86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.079 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 79' ' ' CYS . 26.9 t0 52.18 10.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -92.59 87.43 5.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.78 125.85 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -155.62 122.59 5.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.165 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 m -95.43 -174.2 3.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.888 0.375 . . . . 0.0 111.26 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 176.04 173.02 0.35 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -149.0 136.23 20.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 tp -112.74 130.91 55.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -138.57 132.22 30.74 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.701 0.286 . . . . 0.0 111.52 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.81 124.23 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.541 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.8 tp -136.73 116.31 12.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.097 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.41 -166.03 36.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.729 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 94' ' ' PRO . 2.5 mm? -96.5 157.34 35.56 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 93' ' ' LEU . 2.5 Cg_endo -45.36 -174.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.953 1.769 . . . . 0.0 111.622 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -60.44 -43.4 96.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.236 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.94 -107.0 0.31 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.71 135.33 38.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -86.62 122.11 30.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.575 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.526 ' CD2' ' H ' ' A' ' 99' ' ' HIS . 7.1 p80 -79.36 -16.7 55.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.563 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -99.94 178.67 4.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 110.799 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -136.34 136.97 40.14 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.219 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -155.67 159.23 39.39 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.657 ' N ' ' HD1' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -156.5 148.68 23.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.389 179.798 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 2' ' ' ARG . 75.8 t-105 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 85.3 mtt85 -75.73 150.85 37.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.488 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.71 85.51 1.63 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 110.052 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 55.1 mp0 -138.09 -73.34 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.647 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.06 107.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.05 -64.06 1.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -120.4 110.46 16.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.0 tp -114.07 129.57 56.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -113.25 125.94 54.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.735 0.303 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.381 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.01 128.64 11.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.49 0.662 . . . . 0.0 111.893 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.82 53.76 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.1 108.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -66.86 174.94 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.31 120.77 8.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.532 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.93 49.67 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.718 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.76 43.3 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.11 152.66 19.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 112.337 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.71 141.11 49.7 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.746 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 p -123.96 110.65 15.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.298 0.57 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -117.19 103.97 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -133.66 139.71 46.62 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.405 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.6 p -137.96 96.94 3.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 m -69.19 117.77 11.25 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.119 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' SER . 46.9 mt -101.65 -174.77 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 t -114.09 3.15 15.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.864 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -126.18 127.76 46.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.512 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.38 75.23 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.92 132.46 74.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.915 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.1 -143.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.925 1.084 . . . . 0.0 110.935 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 19.9 m -118.94 109.96 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.629 0.728 . . . . 0.0 109.301 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.36 -56.38 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 80' ' ' ARG . 96.5 mt-10 -69.46 -40.93 76.84 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 149.75 31.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -137.67 137.98 38.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.013 0.435 . . . . 0.0 110.594 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.466 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 63.7 m95 -136.59 105.1 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.87 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 76.8 m-85 -149.54 150.2 31.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.666 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.2 130.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -62.65 132.79 53.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.269 -0.894 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.76 40.57 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.14 138.57 5.66 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.967 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.18 130.67 47.31 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.87 111.04 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.633 0.254 . . . . 0.0 110.579 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.515 ' C ' ' H ' ' A' ' 47' ' ' ASP . 37.0 mt-30 -126.73 153.11 75.75 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.68 -10.26 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.091 1.861 . . . . 0.0 111.488 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' GLN . 45.7 p-10 -108.64 29.42 7.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' ASP . 44.4 p-10 -34.25 161.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.77 0.795 . . . . 0.0 112.378 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -95.79 -62.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.707 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -124.79 -36.02 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -86.98 159.21 19.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.573 0.702 . . . . 0.0 111.312 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.6 m -130.53 144.69 51.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.773 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.43 130.1 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.9 p -143.81 154.91 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.37 100.85 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.351 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -103.21 108.29 19.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.073 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 -132.24 41.11 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 26' ' ' LEU . 10.2 m -97.17 50.87 1.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.391 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -153.67 145.72 23.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -127.36 142.36 51.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.89 12.1 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.287 0.565 . . . . 0.0 111.141 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tt -122.78 125.2 45.01 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.926 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 pp -139.73 135.65 33.35 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 71' ' ' HIS . 12.4 tp -107.59 111.02 23.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -63.39 -95.59 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.469 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -83.47 103.4 12.79 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 122.09 -0.381 . . . . 0.0 111.729 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.51 55.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.685 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.656 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 40.6 mt-30 -134.22 140.62 36.56 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.74 85.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.059 1.172 . . . . 0.0 111.625 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' GLN . 55.7 t-80 -177.24 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.656 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 35.0 p80 -82.58 -11.24 58.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.366 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.41 146.06 3.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 110.99 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.93 -154.85 25.19 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.38 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.4 mp0 -106.38 154.45 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -116.37 119.56 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.903 0.382 . . . . 0.0 110.688 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.6 m -127.01 130.09 49.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.432 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.64 138.59 36.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.28 153.86 38.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' ' 81' ' ' ASP . 15.1 t -157.07 -132.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.531 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.454 ' C ' ' N ' ' A' ' 82' ' ' ALA . 30.6 mmt180 -57.22 86.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.809 0.338 . . . . 0.0 110.406 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.7 t0 45.41 18.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.454 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -102.77 91.22 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.164 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.76 129.98 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.333 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.56 124.22 10.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.154 0.502 . . . . 0.0 110.802 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.3 p -92.14 -173.58 3.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 176.4 174.7 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.117 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -137.43 137.69 39.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.449 . . . . 0.0 111.056 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.2 121.64 31.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.531 ' HG1' ' N ' ' A' ' 90' ' ' VAL . 6.0 t -142.35 152.06 42.53 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.68 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.531 ' N ' ' HG1' ' A' ' 89' ' ' THR . 5.8 p -108.88 108.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.833 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 tp -73.69 128.45 35.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.5 -78.1 1.34 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.28 146.94 33.71 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.01 140.89 48.66 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 121.12 1.213 . . . . 0.0 110.958 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -64.21 162.11 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.943 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.11 98.48 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.09 127.5 32.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.83 120.66 34.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.725 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.61 -36.44 84.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -138.47 147.5 43.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.21 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -120.65 -1.02 10.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -65.64 -43.4 89.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.206 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -62.01 -47.84 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m80 . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.376 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -100.73 126.4 47.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.195 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.78 40.89 1.29 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.684 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' CD1' ' A' ' 6' ' ' LEU . 95.2 mt-10 -75.73 149.77 37.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.859 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 5' ' ' ILE . 96.0 mt -86.63 108.59 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 6.9 mp -78.98 -64.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.332 -177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.13 113.83 18.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.964 0.411 . . . . 0.0 111.423 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.1 tp -106.73 123.58 48.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.766 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.8 tp -112.07 123.41 50.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.653 ' HZ1' ' N ' ' A' ' 85' ' ' SER . 5.3 mmmm -138.67 -165.44 1.82 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.351 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 10' ' ' LYS . 65.7 t30 57.6 107.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.808 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.18 140.2 8.78 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.292 1.044 . . . . 0.0 113.402 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.23 144.37 51.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.617 -1.629 . . . . 0.0 107.454 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.62 128.95 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.713 0.768 . . . . 0.0 112.704 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ALA . 89.7 mtt180 -96.19 158.0 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.505 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 113.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.574 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.85 62.06 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . -104.54 153.13 21.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.503 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.436 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 9.9 mp0 -106.21 156.4 18.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.204 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.88 138.11 54.26 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 t -120.83 109.69 15.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.27 0.557 . . . . 0.0 112.272 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -114.08 108.43 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -144.98 152.12 39.67 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.482 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.9 p -139.28 102.98 4.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 p -74.38 112.25 10.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.302 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.1 mt -101.22 -173.36 2.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.272 0.558 . . . . 0.0 111.359 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.46 -2.71 17.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.54 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -135.19 139.12 44.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.483 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.19 133.92 33.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.264 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' PRO . 61.1 t -108.31 131.34 21.82 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -60.77 -144.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.949 1.018 . . . . 0.0 110.188 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -119.91 122.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.29 -29.25 6.24 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.709 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.98 -12.61 52.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.86 0.362 . . . . 0.0 110.435 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.94 140.91 37.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 m -118.49 125.97 51.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 66.6 m95 -138.72 118.93 13.55 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.856 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -158.28 153.21 25.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.001 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.71 119.85 57.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -56.88 112.8 1.42 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.425 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.62 9.95 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.32 107.01 0.68 Allowed 'General case' 0 C--O 1.23 0.067 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.75 139.94 53.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.02 98.22 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 0.0 111.171 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.463 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.2 pt20 -102.77 151.43 38.32 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.51 -20.03 8.12 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.309 1.34 . . . . 0.0 110.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -98.05 8.31 44.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 45' ' ' GLN . 64.7 m-20 -42.78 113.31 0.45 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.888 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 t -69.64 -44.26 70.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.048 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.24 -35.76 10.25 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.65 138.83 31.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.082 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.649 ' HG1' HH12 ' A' ' 65' ' ' ARG . 87.4 m -124.52 131.74 53.48 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.4 130.01 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 p -146.07 154.29 41.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.86 98.33 5.49 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -100.68 110.82 22.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.464 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.17 -129.2 31.87 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.404 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 61.0 m -93.29 46.84 1.22 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.757 0.313 . . . . 0.0 110.721 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.404 ' CG ' ' C ' ' A' ' 58' ' ' SER . 39.6 m-70 -149.31 143.81 26.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -124.49 132.03 53.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.69 130.6 49.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.109 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -140.59 114.17 8.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' H ' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -142.35 153.14 43.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.5 tp -106.53 128.89 54.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.316 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.649 HH12 ' HG1' ' A' ' 52' ' ' THR . 84.0 mtt85 -67.14 -107.75 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.62 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 p -83.59 108.81 16.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.127 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' CB ' ' CE1' ' A' ' 71' ' ' HIS . . . -69.72 139.05 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.61 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 94.5 mt-30 -130.43 140.46 38.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.554 ' O ' ' ND1' ' A' ' 70' ' ' HIS . 2.6 Cg_endo -46.42 89.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.152 1.235 . . . . 0.0 111.742 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' A' ' 69' ' ' PRO . 1.3 m80 163.81 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.843 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.61 ' ND1' ' O ' ' A' ' 68' ' ' GLN . 28.5 p-80 -78.49 -13.29 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.645 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.544 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.91 -178.07 40.76 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.446 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.37 149.95 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.22 110.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.666 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.0 m -126.04 125.68 43.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.39 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.67 154.46 28.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.4 t -156.33 -132.8 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -57.86 88.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 79' ' ' CYS . 98.8 m-20 46.24 12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -96.6 66.24 2.3 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.1 t -79.81 129.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.865 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -161.81 144.85 12.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.13 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.653 ' N ' ' HZ1' ' A' ' 10' ' ' LYS . 24.9 m -153.84 132.11 11.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.91 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.92 -158.68 0.68 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.396 0.617 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -144.56 129.27 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.753 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.6 tp -117.46 126.3 52.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.586 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 t -139.47 148.4 42.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.132 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.51 128.15 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.008 0.432 . . . . 0.0 111.599 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.6 tp -92.41 124.51 36.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.012 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.25 -68.9 0.42 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.03 157.42 37.04 Favored Pre-proline 0 CA--C 1.527 0.058 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -44.95 161.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.777 1.652 . . . . 0.0 111.477 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.59 -9.43 2.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.734 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.99 44.91 22.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.23 136.89 55.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -70.67 126.65 30.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.58 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 86.0 t60 -171.88 31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.532 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -67.5 -45.25 76.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -74.62 119.86 19.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 110.84 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -74.25 -19.45 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -48.47 -79.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.457 ' OXT' ' CG ' ' A' ' 104' ' ' HIS . 55.4 p-80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.601 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.543 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 31.8 t90 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 4' ' ' GLU . 97.5 mtt180 -101.09 95.67 6.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 2' ' ' ARG . 4.8 mp 35.93 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 1' ' ' TRP . 17.2 pt-20 -84.66 144.95 28.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.237 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.7 mt -86.67 119.03 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.74 -69.5 0.58 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -134.65 130.39 36.31 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.126 0.489 . . . . 0.0 111.774 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.62 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -126.08 146.58 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.457 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.61 113.61 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -127.39 173.32 9.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.218 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 63.3 108.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 136.43 13.43 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.11 130.92 48.91 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.18 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 6.6 m -126.14 124.25 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.914 0.864 . . . . 0.0 113.319 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -78.04 170.19 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.766 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.68 130.68 45.24 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.49 34.35 54.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.04 147.9 40.75 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.935 0.397 . . . . 0.0 110.919 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -95.54 149.12 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.12 144.35 51.05 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.7 p -139.8 133.35 30.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.128 0.489 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -139.12 126.31 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 p -140.03 144.86 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.9 t -133.53 92.38 2.98 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 110.971 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -74.13 115.42 13.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.622 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.9 mt -105.37 -177.35 3.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.871 0.843 . . . . 0.0 112.501 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 m -105.31 -15.45 15.04 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.578 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -129.42 129.23 44.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.54 119.64 32.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.578 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -109.81 148.11 37.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.616 -178.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.8 Cg_endo -57.89 -140.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.776 1.651 . . . . 0.0 110.362 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 m -119.21 103.76 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.34 -44.45 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -64.36 -45.59 87.12 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.858 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.47 141.75 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.6 m -135.54 98.58 3.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.562 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 94.3 m95 -102.13 113.89 27.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 88.3 m-85 -150.84 148.03 27.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.183 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.99 122.03 68.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -54.44 122.1 9.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.043 0.838 . . . . 0.0 110.008 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.71 -5.71 14.2 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 124.113 0.883 . . . . 0.0 110.974 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' CZ3' ' A' ' 51' ' ' TRP . . . -165.26 111.06 0.92 Allowed 'General case' 0 C--O 1.231 0.085 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.04 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.26 139.59 48.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.916 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -86.36 99.54 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.385 0.612 . . . . 0.0 110.506 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.696 ' C ' ' H ' ' A' ' 47' ' ' ASP . 31.1 mt-30 -124.74 163.69 35.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.8 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.89 20.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.312 1.341 . . . . 0.0 111.677 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.696 ' H ' ' C ' ' A' ' 45' ' ' GLN . 39.0 m-20 -112.22 -19.7 12.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 45' ' ' GLN . 49.2 m-20 -46.12 105.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.226 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 47.9 t -93.12 -39.21 11.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' OD1' ' CZ ' ' A' ' 65' ' ' ARG . 95.3 m-20 -87.14 -25.12 24.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.322 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.441 ' CZ3' ' CB ' ' A' ' 42' ' ' ALA . 5.6 m-90 -112.91 142.99 44.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.074 0.464 . . . . 0.0 111.11 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 m -132.16 136.29 46.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.86 134.68 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -141.94 154.29 44.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.62 107.97 5.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 111.56 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -119.28 105.27 11.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.14 -133.58 45.86 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.9 m -92.29 30.06 1.55 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.641 0.258 . . . . 0.0 111.103 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -134.43 130.13 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.27 137.03 54.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.94 119.21 15.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.255 0.55 . . . . 0.0 111.523 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.0 135.34 55.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.537 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.23 179.36 5.11 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.068 0.937 . . . . 0.0 113.141 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 65' ' ' ARG . 39.1 tp -145.68 118.52 8.7 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.56 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' CZ ' ' OD1' ' A' ' 50' ' ' ASP . 28.2 ptt180 -63.94 -127.93 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.436 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.0 p -73.06 110.62 7.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.64 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.62 112.38 2.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.979 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' HIS . 2.8 pt20 -112.48 145.69 33.42 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.92 83.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.623 1.549 . . . . 0.0 111.763 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 175.95 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.635 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 12.3 p80 -73.98 -13.63 60.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.732 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.82 147.6 8.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 110.869 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.84 -170.41 40.6 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -99.51 149.63 23.03 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.7 t -117.53 115.35 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.7 m -129.3 130.94 46.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.25 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 9.5 t80 -136.79 138.38 40.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.98 147.82 27.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.107 0.479 . . . . 0.0 111.479 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.22 -148.57 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.99 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' A' ' 82' ' ' ALA . 45.1 mmm-85 -60.66 90.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.069 0.461 . . . . 0.0 110.454 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 t0 48.18 14.8 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.193 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -104.37 73.63 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.8 t -80.39 151.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.906 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.17 170.38 22.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.286 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -159.1 178.87 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 174.77 179.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 111.179 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -142.07 128.03 19.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.5 tp -113.58 129.46 56.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 t -144.29 153.07 41.64 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.019 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 p -117.65 126.58 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.4 tp -62.55 134.33 56.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.08 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.92 59.73 0.48 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 19.7 mt -99.2 108.52 50.25 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.72 136.48 66.87 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.819 0.971 . . . . 0.0 112.17 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -78.84 175.71 10.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.279 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.05 17.84 33.59 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.13 145.05 46.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.151 0.501 . . . . 0.0 111.051 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -102.24 116.3 32.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.142 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -84.02 146.22 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.695 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.516 ' O ' ' CD2' ' A' ' 100' ' ' HIS . 0.4 OUTLIER -61.54 131.47 50.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 0.0 110.609 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 41.63 80.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.499 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 103' ' ' HIS . 60.1 t-80 -67.44 148.43 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.331 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.48 ' N ' ' HD1' ' A' ' 103' ' ' HIS . 2.8 m80 -85.26 132.89 34.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.227 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.665 -179.332 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 95.3 m95 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -98.84 149.31 23.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.251 0.548 . . . . 0.0 111.369 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.1 tt -84.24 93.87 8.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.088 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -72.86 131.44 42.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.222 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.94 114.83 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 10.2 mp -92.06 -72.46 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.12 121.58 35.55 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.193 0.452 . . . . 0.0 111.966 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.16 126.86 49.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.343 179.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.65 111.77 23.51 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -126.47 -179.88 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.906 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t30 60.37 108.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.72 15.05 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.664 0.986 . . . . 0.0 113.664 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.04 129.65 50.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.15 126.41 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.898 0.856 . . . . 0.0 112.994 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.56 163.88 25.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.618 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 130.44 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.58 40.1 67.29 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.3 46.01 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.962 0.411 . . . . 0.0 110.962 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -101.99 159.78 15.07 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.744 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 151.68 37.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -133.65 135.76 44.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.327 0.584 . . . . 0.0 111.925 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.88 123.56 26.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -135.71 134.57 39.24 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.096 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.56 89.57 3.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 p -71.78 112.42 7.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 58' ' ' SER . 95.5 mt -112.0 144.2 41.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.76 0.791 . . . . 0.0 112.415 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -63.26 -27.84 69.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.605 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.433 ' C ' ' HG ' ' A' ' 58' ' ' SER . 77.7 tt0 -125.14 143.79 50.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.122 0.487 . . . . 0.0 111.719 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.58 143.82 29.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.342 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' PRO . 38.7 t -117.89 138.0 24.93 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.202 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -62.32 -143.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.229 1.118 . . . . 0.0 110.649 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -125.76 115.64 43.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.45 -29.37 3.16 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.89 -16.07 28.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.967 0.413 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.39 140.35 38.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -128.64 139.47 52.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.115 0.483 . . . . 0.0 111.553 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 96.6 m95 -140.23 106.78 5.32 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.438 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 84.0 m-85 -158.88 157.84 32.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.671 0.748 . . . . 0.0 111.714 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.515 ' H ' ' CD1' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.49 129.8 75.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -66.17 120.64 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.264 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.43 -2.35 18.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.06 62.16 0.12 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.639 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.49 110.95 0.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 4.1 m -79.03 116.75 23.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.616 0.722 . . . . 0.0 112.17 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -82.91 155.12 67.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.043 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -49.28 -24.46 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.486 1.458 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -106.58 27.26 9.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 49' ' ' SER . 41.8 t0 -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.189 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 42.8 p -88.33 -37.69 15.75 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -86.45 -32.9 20.59 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -110.81 145.79 37.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.774 0.321 . . . . 0.0 110.823 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.5 m -132.07 127.57 36.39 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.34 135.13 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 p -144.55 156.9 44.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.417 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.6 100.57 4.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.45 112.0 24.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.674 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.23 -123.92 34.67 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 26' ' ' LEU . 6.0 t -106.62 48.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -144.13 139.6 28.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -117.8 118.05 30.98 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.26 106.1 14.97 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.272 0.558 . . . . 0.0 111.659 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 tp -114.24 126.88 55.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.503 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.617 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -125.35 -177.41 3.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.302 1.048 . . . . 0.0 111.032 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 65' ' ' ARG . 40.8 tp -144.16 117.72 9.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.792 -2.004 . . . . 0.0 106.931 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 64' ' ' LEU . 24.5 mmt85 -64.14 -129.07 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.521 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.6 p -78.23 108.9 11.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.94 141.32 56.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 27.1 mt-30 -129.55 142.08 44.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.876 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.73 84.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.296 1.33 . . . . 0.0 111.473 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' GLN . 45.4 t-80 174.15 -23.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.084 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.4 -7.42 59.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.819 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.47 145.62 22.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.611 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.11 -165.38 38.53 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.42 150.47 20.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.8 t -117.4 115.33 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.508 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 m -131.55 130.89 42.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -142.23 146.99 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.3 155.1 30.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.164 0.507 . . . . 0.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' ASP . 8.4 t -156.12 -138.59 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.109 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' ALA . 24.3 mmm180 -55.57 89.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.0 p-10 39.52 22.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.767 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -105.84 75.21 1.1 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.98 137.46 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.438 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -151.74 117.43 5.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.9 m -92.38 -173.88 3.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.342 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 176.1 172.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.203 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -140.88 135.62 31.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.229 0.538 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.0 tp -120.03 128.34 53.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -142.84 146.51 34.22 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.8 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.1 p -109.85 126.73 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 110.919 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 3.1 mm? -101.28 128.13 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.07 -33.06 0.07 OUTLIER Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -111.59 127.53 26.74 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.6 144.82 99.34 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 CA-C-N 120.013 1.04 . . . . 0.0 111.799 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -70.45 140.62 52.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.072 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.17 -37.45 0.8 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.01 -86.16 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.98 155.09 20.01 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.39 115.26 27.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.572 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -157.74 -17.49 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.295 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.77 111.28 21.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.315 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -83.18 -57.5 3.25 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.718 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -153.02 172.04 17.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.595 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.396 179.596 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.2 mtm-85 -59.89 -113.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 3' ' ' LEU . 9.5 mp -89.65 74.48 7.56 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -77.43 136.75 38.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.425 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.1 mt -91.85 119.1 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.545 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.1 mp -82.94 -70.83 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -141.83 136.63 30.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.303 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.73 143.71 50.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.594 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 117.82 29.93 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.2 mmpt? -130.36 178.02 6.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.867 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' LYS . 13.0 m120 52.22 108.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.412 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.86 137.04 9.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.57 0.7 . . . . 0.0 112.028 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.53 125.42 48.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.816 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.65 103.88 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.351 0.596 . . . . 0.0 111.675 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -61.77 141.01 58.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.947 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.85 114.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.58 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.78 7.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.56 155.41 46.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -100.8 153.99 19.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.044 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.26 143.77 34.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 p -121.57 135.62 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.324 0.583 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.97 122.84 27.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -137.08 136.37 38.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 m -127.07 92.88 3.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.916 0.388 . . . . 0.0 111.822 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.8 m -74.71 110.16 8.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.575 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.87 -167.05 1.32 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.105 0.478 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 t -107.93 -11.64 15.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.261 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.4 pm0 -140.68 149.11 41.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.703 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.65 146.38 23.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 31' ' ' PRO . 59.4 t -102.02 125.97 35.12 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.611 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.81 -141.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.181 1.254 . . . . 0.0 110.411 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.94 124.52 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.01 31.69 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.687 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.14 -11.58 49.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.309 0.554 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -143.16 53.29 1.36 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -90.37 110.53 21.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.402 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -157.96 152.69 25.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.583 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 mm -74.73 117.07 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.78 95.04 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 133.57 -24.6 3.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 106.01 4.76 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.49 58.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.7 m -82.46 124.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.359 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.02 153.85 60.29 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.29 -33.38 45.22 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.334 1.356 . . . . 0.0 111.072 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 49' ' ' SER . 87.5 m-20 -88.44 14.73 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.881 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' ASP . 48.8 p-10 -32.97 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.507 . . . . 0.0 111.719 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 47' ' ' ASP . 16.1 t -68.01 -40.13 83.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.236 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.06 -27.55 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -115.24 152.15 33.21 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.39 -0.194 . . . . 0.0 110.699 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -144.87 152.24 39.95 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 111.228 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.44 139.25 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.855 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p -140.75 156.05 46.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.544 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.15 107.53 4.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -108.72 104.02 13.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.735 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.38 -134.61 45.15 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.1 m -89.48 38.55 0.91 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.68 0.276 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -137.59 142.42 41.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.55 159.88 20.68 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.57 82.98 1.23 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.669 0.747 . . . . 0.0 110.749 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -92.15 144.59 25.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.249 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 pp -141.02 174.07 10.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.281 1.039 . . . . 0.0 112.654 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 65' ' ' ARG . 48.7 tp -142.24 118.16 10.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 113.057 -1.883 . . . . 0.0 106.895 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LEU . 69.5 mtt180 -66.04 -131.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.477 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.1 m -81.57 106.58 13.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.91 0.386 . . . . 0.0 110.815 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.53 54.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.727 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.587 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 55.0 mt-30 -124.66 148.02 57.77 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -44.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.704 1.603 . . . . 0.0 111.451 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . 13.7 t-80 164.15 -21.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HD1' ' H ' ' A' ' 68' ' ' GLN . 76.1 m80 -79.87 -8.91 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.17 145.45 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.96 -141.82 7.64 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -134.47 169.99 16.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.547 0.339 . . . . 0.0 110.171 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.87 129.15 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.318 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -133.69 130.01 37.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.974 0.416 . . . . 0.0 111.222 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -132.27 141.83 49.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.441 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . -159.13 143.8 15.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 10.6 t -158.86 -136.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.286 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 43.8 mtm180 -59.87 85.52 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.186 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' CYS . 94.3 m-20 51.65 14.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.21 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.03 91.36 8.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 110.194 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -81.27 138.72 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.013 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.94 160.46 19.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 p -160.38 -178.49 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.764 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 179.84 170.88 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.201 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -129.68 121.38 26.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.195 0.521 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' GLY . 41.6 tp -104.34 128.64 52.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.922 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 t -143.58 125.03 14.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.695 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.51 113.47 28.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.64 156.24 23.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.631 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.2 -174.81 14.42 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.3 mt -107.62 170.53 5.49 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.13 -2.91 11.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.828 1.685 . . . . 0.0 111.376 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.98 107.9 12.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.043 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.05 97.75 2.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 pp -89.95 147.55 23.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 111.098 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -144.46 -80.58 0.18 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.946 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -154.89 -11.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.829 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -70.92 -78.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.39 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 102' ' ' HIS . 83.7 t60 -134.21 136.2 43.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.574 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.427 ' O ' ' CD2' ' A' ' 101' ' ' HIS . 92.7 m-70 -104.67 -170.88 1.83 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.119 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -61.82 -6.16 2.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 102' ' ' HIS . 98.9 m-70 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.679 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -100.5 91.79 4.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.943 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.0 mt -76.93 146.69 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -140.62 -141.36 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -92.85 94.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.327 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.65 -46.78 88.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.118 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.51 114.62 18.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.907 0.384 . . . . 0.0 110.226 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 116.85 33.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.689 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' A' ' 23' ' ' THR . 34.6 tp -101.4 120.52 40.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.371 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.674 ' H ' ' CE ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.64 -163.88 1.85 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.295 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.84 108.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.76 139.07 9.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.825 0.821 . . . . 0.0 113.014 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.06 130.95 53.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.688 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 m -136.14 108.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -77.48 169.85 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.146 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.33 107.01 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.34 -7.68 40.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 65' ' ' ARG . . . -76.39 -178.35 4.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.411 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -136.86 149.76 47.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.52 133.47 55.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.216 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.2 t -121.22 106.7 11.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.131 0.491 . . . . 0.0 111.45 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -118.57 106.83 13.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 3.7 p -138.23 147.34 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 31.1 p -134.56 99.45 4.35 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.818 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 m -69.98 110.72 5.21 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.373 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -94.05 175.62 6.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.704 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 t -114.92 -5.57 12.56 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -127.06 137.82 53.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.3 136.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.018 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.3 133.71 24.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.519 -0.277 . . . . 0.0 110.68 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.96 -154.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 119.844 0.98 . . . . 0.0 109.938 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.97 104.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.74 -50.9 0.4 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -69.58 -43.64 72.44 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.8 143.89 37.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.591 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -142.25 127.9 19.15 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 121.011 0.434 . . . . 0.0 111.075 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 33.6 m95 -122.96 111.97 17.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.145 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 87.0 m-85 -157.54 157.73 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 111.336 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.78 128.57 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.335 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -61.85 118.66 7.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.576 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.7 -0.99 20.1 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.43 68.8 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.821 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.34 131.07 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.69 110.67 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.857 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -92.94 154.42 41.85 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.582 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.65 -25.78 43.29 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 120.999 1.133 . . . . 0.0 110.633 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.89 11.47 29.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.708 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 51' ' ' TRP . 44.4 p-10 -42.77 115.96 0.8 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.5 p -87.87 -39.68 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.665 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -88.97 -26.03 21.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 10.6 m-90 -110.5 145.31 37.94 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.7 m -124.54 126.11 45.29 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 p -125.03 129.92 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -143.99 153.16 41.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.43 98.54 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.995 0.426 . . . . 0.0 110.107 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.67 96.83 7.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.04 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.27 -128.17 41.27 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 m -92.79 42.68 1.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -149.41 135.53 18.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -121.74 140.52 52.23 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 130.55 37.83 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 111.548 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.4 tp -135.28 122.7 21.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.865 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pp -141.02 139.76 34.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.1 tp -106.34 119.61 39.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mtt-85 -63.91 -101.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.902 -177.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.6 p -82.81 99.19 9.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.917 0.389 . . . . 0.0 111.312 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.68 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.423 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.639 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 83.6 mt-30 -130.62 139.34 35.3 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.012 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -55.36 85.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.072 1.181 . . . . 0.0 110.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.1 t60 -175.06 -48.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.639 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 25.5 p80 -76.96 -0.37 24.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.635 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.05 146.88 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.0 -148.57 12.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.0 mp0 -115.32 156.36 25.63 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.76 0.314 . . . . 0.0 110.399 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.7 t -117.93 116.56 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.489 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.3 m -123.73 131.78 53.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.192 0.52 . . . . 0.0 110.774 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -136.13 130.96 34.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.231 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.46 150.73 51.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.447 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.5 t -153.33 -144.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.649 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' ALA . 21.1 mmm180 -52.77 88.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.953 0.406 . . . . 0.0 109.966 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.8 p30 42.71 17.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -101.7 86.23 2.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -82.31 127.33 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.09 129.32 21.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.535 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 p -92.83 -175.26 3.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.479 0.657 . . . . 0.0 111.631 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 175.68 171.97 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.81 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -146.52 138.57 24.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.985 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.2 tp -117.95 128.85 55.2 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.548 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 t -141.31 153.33 45.1 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.525 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 7.0 p -106.6 116.11 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 tp -78.92 126.3 30.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.283 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.77 3.94 4.64 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.18 107.54 55.83 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.3 -13.27 35.54 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 120.934 1.089 . . . . 0.0 111.305 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.28 122.44 18.87 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.625 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 100' ' ' HIS . . . -156.82 84.56 0.14 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.3 1.08 46.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.46 -35.61 75.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.28 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.511 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 81.1 m-70 -130.46 103.71 6.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.047 0.451 . . . . 0.0 111.394 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.52 ' C ' ' H ' ' A' ' 102' ' ' HIS . 12.4 m80 -156.34 168.96 25.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 86.6 t60 56.02 2.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 100' ' ' HIS . 3.2 m-70 -62.04 -92.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -66.7 -44.15 82.45 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.985 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.447 ' CD2' ' H ' ' A' ' 104' ' ' HIS . 9.6 p80 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.701 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.4 m0 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.531 ' C ' ' H ' ' A' ' 4' ' ' GLU . 99.6 mtt180 -96.24 133.29 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.793 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -70.07 21.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.597 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 2' ' ' ARG . 15.8 pt-20 -57.03 143.42 38.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.326 0.584 . . . . 0.0 111.732 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.0 mt -82.52 123.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -95.39 -38.84 10.31 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.69 146.32 25.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.207 0.527 . . . . 0.0 110.909 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -161.28 121.67 2.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -125.92 116.18 21.11 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -146.95 -164.22 1.94 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.434 0.635 . . . . 0.0 111.2 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 56.02 97.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.789 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.27 140.67 3.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.403 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.87 140.33 36.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.65 130.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.922 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -58.76 -172.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.44 150.04 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.476 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 -3.18 81.88 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.3 144.97 25.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.127 0.489 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.29 145.94 25.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.67 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.69 52.35 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.2 p -152.95 123.36 7.17 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.341 0.591 . . . . 0.0 112.009 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -125.94 143.96 50.88 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.95 143.76 31.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.076 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.0 t -127.57 88.28 2.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.787 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -75.07 94.06 2.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.853 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.1 mt -82.58 -160.9 0.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.956 0.884 . . . . 0.0 112.949 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 2' ' ' ARG . 31.3 t -117.39 -19.08 9.68 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.77 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -121.24 150.0 42.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.189 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.32 141.04 30.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 31' ' ' PRO . 22.6 t -117.04 128.19 26.2 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.623 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.2 Cg_exo -60.17 -146.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.913 1.076 . . . . 0.0 111.217 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.01 120.4 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.67 -26.57 8.4 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.955 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 75.8 tt0 -87.1 -12.12 48.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.918 0.359 . . . . 0.0 110.392 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.53 122.69 47.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -92.79 141.13 28.78 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 95.9 m95 -153.21 101.32 2.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.117 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -160.86 167.09 27.4 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.196 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' ASN . 2.0 mp -118.24 94.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ILE . 22.3 t-20 -32.46 123.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 -2.29 29.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.65 79.1 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.133 -0.533 . . . . 0.0 109.683 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.23 58.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.91 131.78 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.991 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -96.42 151.15 37.87 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.91 -29.69 91.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.051 1.167 . . . . 0.0 112.752 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -94.83 0.56 54.95 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -69.01 130.47 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.5 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -97.69 -2.56 41.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -80.2 -29.25 38.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.949 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -112.52 140.52 47.19 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.4 m -131.82 125.95 33.11 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.27 131.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.3 p -143.82 147.39 34.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.534 0.683 . . . . 0.0 112.291 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.97 112.37 24.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.578 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -120.81 101.44 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.78 -122.11 25.33 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' ND1' ' A' ' 59' ' ' HIS . 47.9 t -110.81 44.77 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.431 ' ND1' ' C ' ' A' ' 58' ' ' SER . 32.7 m80 -141.93 135.62 29.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.998 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -117.69 126.74 53.03 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.44 119.06 29.86 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tt -130.51 123.8 30.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.496 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 pp -121.55 162.65 20.21 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 0.0 110.535 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 65' ' ' ARG . 28.5 tp -124.44 117.71 25.03 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 64' ' ' LEU . 56.4 ttp180 -57.39 -109.19 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.001 -177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.1 p -87.38 121.24 29.56 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.48 138.6 58.5 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' HIS . 23.3 pt20 -133.21 137.23 28.85 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 119.681 -0.199 . . . . 0.0 110.476 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.71 84.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 120.795 0.996 . . . . 0.0 110.722 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 -177.74 -39.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.735 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' A' ' 72' ' ' ALA . 2.7 p-80 -71.99 -33.69 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.78 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' N ' ' CD2' ' A' ' 71' ' ' HIS . . . -35.54 143.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.88 -132.42 3.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.82 129.86 53.73 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.535 0.207 . . . . 0.0 110.634 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.99 130.86 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 m -132.7 123.77 26.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -139.14 128.16 23.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.183 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.441 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -156.99 154.7 30.05 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.549 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 18.1 p -154.67 -132.78 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.623 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 30.8 mmt180 -54.3 84.24 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.109 0.48 . . . . 0.0 109.796 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' CYS . 87.9 m-20 46.16 13.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.56 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -94.47 70.18 3.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.2 t -81.27 132.52 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.242 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.01 117.95 5.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.971 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.4 p -127.43 147.17 50.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.549 0.69 . . . . 0.0 111.537 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.9 151.93 24.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.939 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -97.62 131.66 43.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.3 tp -106.48 134.78 49.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -136.13 162.17 33.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.334 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.54 132.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.151 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 91' ' ' LEU . 1.9 tm? -98.78 124.01 43.37 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.27 105.32 0.18 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.221 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -109.59 106.52 58.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.44 135.21 41.65 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.912 1.004 . . . . 0.0 111.296 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -89.16 95.62 10.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -98.17 -16.76 31.63 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.9 pp -86.7 128.47 35.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 110.793 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.64 149.22 31.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.537 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -87.62 132.44 34.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 81.5 t60 -148.64 9.58 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.94 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -139.31 151.08 46.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -86.93 139.39 30.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.942 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -142.11 137.77 31.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.18 179.703 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.6 m95 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -100.7 133.73 44.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.625 0.25 . . . . 0.0 110.471 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 3' ' ' LEU . 9.4 mp -96.89 129.12 44.38 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -137.83 -115.43 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.3 mt -100.18 120.9 50.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.049 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.97 -69.35 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.93 124.13 34.34 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.8 146.56 36.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.388 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.4 tt -109.05 114.22 27.78 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 174.36 10.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.691 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 60.76 107.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.602 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.23 135.7 11.33 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.853 0.835 . . . . 0.0 112.859 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 158.09 16.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.826 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.84 164.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 111.623 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -128.32 159.32 35.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.845 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.79 101.66 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.578 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.96 -9.27 54.95 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.09 174.93 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 111.015 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -115.22 153.64 30.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.75 149.4 47.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.26 142.8 44.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -148.25 133.35 18.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 3.3 t -149.14 155.53 40.82 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.859 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 t -148.67 96.04 2.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 111.927 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 m -69.92 123.03 20.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.58 150.66 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.5 0.667 . . . . 0.0 112.668 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 m -74.68 -18.23 60.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.341 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -138.02 140.82 40.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.474 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.0 147.67 42.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.532 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 31' ' ' PRO . 41.3 t -105.53 134.77 19.53 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.2 Cg_exo -61.36 -144.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 CA-C-N 120.218 1.114 . . . . 0.0 110.405 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.78 125.12 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.3 -16.05 57.14 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.617 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -89.89 -19.94 23.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.74 23.8 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.432 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 8.6 t -154.29 129.12 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.738 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.544 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 77.7 m95 -150.37 102.42 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 14.6 p90 -155.57 154.51 31.81 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -68.81 97.97 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -48.53 96.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 142.25 -20.08 2.46 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 110.41 4.5 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.34 138.01 58.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.3 t -91.83 128.26 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 111.673 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -84.93 153.24 60.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.652 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 48' ' ' ASP . 2.0 Cg_endo -55.44 -34.08 88.05 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.574 1.516 . . . . 0.0 111.717 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -78.58 21.06 0.4 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.749 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 46' ' ' PRO . 27.5 p-10 -47.53 98.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.7 t -81.41 -49.18 10.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.246 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -64.34 -37.93 89.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.926 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -110.18 161.73 15.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.284 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -138.16 141.02 40.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.94 134.58 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 p -141.75 153.75 44.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.477 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 120.6 3.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.63 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -138.03 116.47 12.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.396 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.26 -108.72 2.61 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -130.67 31.83 4.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.75 0.31 . . . . 0.0 110.476 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.499 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 8.7 t-80 -130.75 132.09 45.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.268 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.42 159.98 16.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.51 97.73 1.35 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.996 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.02 130.91 53.86 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.541 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -178.71 4.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.954 0.883 . . . . 0.0 112.016 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -144.67 120.12 10.32 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.049 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -69.0 -130.54 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.278 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.9 p -58.73 100.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 0.0 111.897 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 139.51 58.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.958 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.26 144.63 52.08 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.571 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -52.5 91.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.337 1.358 . . . . 0.0 111.262 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 8.2 m-70 165.11 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -83.3 -7.42 59.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 148.66 43.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.791 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.75 -160.62 31.65 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.3 167.02 11.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.828 0.347 . . . . 0.0 110.39 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -133.28 133.27 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.75 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 m -131.98 128.23 37.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.311 0.577 . . . . 0.0 111.52 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 0.3 OUTLIER -131.05 137.93 49.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.759 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -164.35 152.43 12.49 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 21.2 p -156.48 -133.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.816 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 49.3 mmm-85 -59.14 92.08 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 42.54 18.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -107.3 73.7 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.12 153.79 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.798 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.22 178.67 8.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.602 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 p -154.69 -179.14 7.72 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.537 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -178.16 166.55 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.282 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -126.47 135.98 52.04 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.04 0.447 . . . . 0.0 110.353 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 130.53 54.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -152.88 149.66 28.49 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.619 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 p -110.66 120.51 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.46 0.475 . . . . 0.0 109.905 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.03 118.99 38.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -169.49 -175.02 38.35 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.6 mt -107.03 150.46 39.87 Favored Pre-proline 0 CA--C 1.521 -0.172 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.39 -27.2 23.32 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 CA-C-N 119.497 0.856 . . . . 0.0 110.68 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -65.76 136.64 56.49 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.5 -5.61 66.87 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.31 134.06 43.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.164 0.507 . . . . 0.0 111.34 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -126.92 -88.87 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.051 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -168.86 126.98 1.03 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.672 ' N ' ' HD1' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -179.37 65.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.212 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.24 -47.01 84.26 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.909 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -165.0 -56.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.36 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -91.19 105.33 17.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.881 -1.057 . . . . 0.0 110.823 -179.54 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.41 ' H1 ' ' H ' ' A' ' 2' ' ' ARG . 54.7 t-105 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.41 ' H ' ' H1 ' ' A' ' 1' ' ' TRP . 89.5 mtm180 -94.53 174.33 7.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.461 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -144.66 23.98 1.56 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.04 135.23 44.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -73.66 121.48 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -82.02 -70.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -127.85 119.72 26.24 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.895 0.378 . . . . 0.0 111.08 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 tp -114.58 130.58 56.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.92 123.01 43.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.259 0.552 . . . . 0.0 110.61 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ASN . 4.5 mmpt? -138.75 -178.34 5.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.282 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 10' ' ' LYS . 58.8 t-20 55.14 109.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.553 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.38 136.62 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.964 0.888 . . . . 0.0 113.217 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.84 135.9 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.434 ' CG2' ' NE2' ' A' ' 71' ' ' HIS . 15.6 m -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.018 0.913 . . . . 0.0 112.895 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -81.74 151.99 27.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.493 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.94 128.28 32.67 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.95 39.85 53.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.88 149.69 47.28 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.809 0.338 . . . . 0.0 111.434 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -102.66 151.06 22.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.96 28.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.397 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.55 147.32 48.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.411 0.624 . . . . 0.0 111.993 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -140.55 127.04 20.09 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.607 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 t -144.53 147.29 33.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.287 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.7 t -130.86 93.1 3.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 111.258 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -72.56 113.87 10.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -113.98 145.32 41.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.09 0.472 . . . . 0.0 111.899 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -71.46 -10.45 59.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.982 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -133.53 137.24 45.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.15 143.33 32.46 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.555 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 31' ' ' PRO . 31.2 t -124.03 128.75 24.99 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.06 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.9 Cg_endo -58.41 -150.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.944 1.096 . . . . 0.0 111.056 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -114.37 102.99 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.34 -49.39 0.48 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.73 -40.46 76.2 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.664 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.63 37.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -124.52 131.1 53.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.039 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.509 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 93.5 m95 -133.37 100.29 4.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.085 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 78.4 m-85 -152.63 153.84 34.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.114 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.486 ' H ' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.16 129.32 74.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.788 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.07 123.55 19.79 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.569 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.2 3.96 20.86 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -171.56 96.44 0.18 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.977 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 135.83 50.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.86 104.99 14.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.426 0.632 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.63 153.13 47.79 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.363 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.46 -27.87 26.06 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.299 1.333 . . . . 0.0 110.903 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -96.67 12.41 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.508 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 22.9 p30 -39.21 110.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.292 0.568 . . . . 0.0 110.756 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.43 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 2.9 t -76.79 -52.51 9.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.341 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.41 -31.9 37.56 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -107.47 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.8 m -130.2 138.98 50.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.3 131.57 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.8 p -144.5 156.12 44.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.167 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 107.15 4.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.551 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -112.56 103.74 11.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.15 -131.59 27.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -97.13 39.36 1.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.572 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -137.35 138.5 40.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.431 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -110.85 156.33 21.29 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -158.83 93.7 1.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.924 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -110.18 129.89 55.64 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.76 -177.25 3.6 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.064 0.935 . . . . 0.0 112.886 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 65' ' ' ARG . 31.5 tp -144.21 116.54 8.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.141 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' NH2' ' O ' ' A' ' 49' ' ' SER . 13.9 ptp180 -64.67 -129.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.917 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -76.4 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 0.0 110.372 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.68 142.2 58.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 0.0 110.846 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' HIS . 18.9 mm100 -132.97 145.5 57.32 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.778 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.92 85.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.422 1.414 . . . . 0.0 111.303 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' GLN . 67.9 t60 175.98 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.216 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.469 ' C ' ' ND1' ' A' ' 71' ' ' HIS . 5.8 p80 -76.99 -7.05 54.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.99 145.39 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.003 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.08 36.41 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -88.46 152.03 22.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.413 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -120.93 121.18 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.85 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -131.83 132.19 43.5 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.308 0.575 . . . . 0.0 112.218 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 2.2 t80 -138.92 140.55 38.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.137 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.59 152.81 41.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -156.53 -151.64 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.112 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.66 87.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.285 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' CYS . 96.0 m-20 54.0 17.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.663 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.77 68.27 0.92 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.102 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.25 132.72 31.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.136 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.68 130.37 8.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.27 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 t -92.98 -170.88 2.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 178.48 169.24 0.83 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.979 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -138.59 136.87 36.44 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.702 0.287 . . . . 0.0 110.782 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.03 128.04 50.95 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -142.96 146.92 34.39 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.805 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.98 124.53 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.829 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -91.45 130.95 37.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.72 168.77 32.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.26 108.16 53.72 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.47 -26.92 40.17 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.909 1.073 . . . . 0.0 110.999 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 24.5 p30 -77.13 153.16 34.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.362 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.92 -103.25 0.27 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.7 147.61 43.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -132.19 27.53 4.48 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.54 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 59.0 t-80 -123.89 51.52 1.53 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.031 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -151.79 137.22 17.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 110.376 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -159.02 150.15 20.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.008 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -85.7 129.43 34.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.77 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -69.13 134.27 49.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 110.889 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.517 ' OXT' ' CG ' ' A' ' 104' ' ' HIS . 16.4 p80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.442 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 5' ' ' ILE . 2.7 pt -80.65 119.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD12 ' H ' ' A' ' 6' ' ' LEU . 5.5 mp -77.03 -67.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.445 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -146.64 142.01 27.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.825 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.31 137.47 52.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.002 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 9' ' ' LEU . 10.1 mp -96.95 108.41 21.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -116.82 175.85 5.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.348 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.19 108.38 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.252 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.64 134.18 13.6 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.67 0.748 . . . . 0.0 112.778 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.47 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.42 114.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -76.94 171.06 15.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.181 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.59 129.78 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.143 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.8 89.11 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.219 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.72 -171.15 3.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 20' ' ' ALA . 5.4 tm0? -141.48 157.13 45.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 19' ' ' GLN . . . -117.74 138.95 51.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.784 0.326 . . . . 0.0 110.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 27.0 p -125.38 104.55 8.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.324 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -124.4 117.55 24.69 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.429 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -144.54 150.03 36.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.578 ' SG ' HD21 ' A' ' 26' ' ' LEU . 33.3 t -132.75 98.86 4.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.964 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.415 HG23 ' NE2' ' A' ' 59' ' ' HIS . 57.3 m -79.92 114.72 19.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.578 HD21 ' SG ' ' A' ' 24' ' ' CYS . 84.6 mt -105.64 -167.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.838 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -112.87 -2.27 14.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.66 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -145.09 143.31 30.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.277 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.0 137.0 33.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.909 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 20.5 t -114.01 133.92 22.25 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.611 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.5 Cg_exo -61.51 -142.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.816 1.011 . . . . 0.0 109.978 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.0 t -121.45 110.13 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.43 -45.0 0.71 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.84 -12.89 59.73 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.31 132.67 52.08 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -127.52 118.95 24.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.623 ' CE2' ' CD1' ' A' ' 77' ' ' PHE . 75.4 m95 -118.52 106.32 12.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -151.05 149.2 29.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.594 0.711 . . . . 0.0 111.749 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 74' ' ' GLU . 4.1 mp -117.12 122.85 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -61.02 126.68 28.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.596 1.089 . . . . 0.0 110.341 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 -4.93 24.44 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.18 94.2 0.24 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.307 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.63 132.56 45.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 44' ' ' VAL . 35.3 m -85.25 106.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.245 0.545 . . . . 0.0 111.193 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -80.78 156.4 72.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -47.99 -26.72 7.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.264 1.31 . . . . 0.0 110.54 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -107.22 27.25 9.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -57.66 132.06 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.09 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.3 p -90.66 -43.28 10.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.057 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.85 -40.1 63.51 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.443 ' NE1' HD13 ' A' ' 64' ' ' LEU . 28.7 m-90 -106.68 152.79 23.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.188 0.518 . . . . 0.0 110.699 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.8 m -132.12 132.59 43.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.89 138.1 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 110.301 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -146.1 158.81 43.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.135 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.96 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.368 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -129.57 102.95 6.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.973 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.84 -134.22 23.54 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -91.73 20.04 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.456 0.169 . . . . 0.0 111.445 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.415 ' NE2' HG23 ' A' ' 25' ' ' THR . 75.4 m80 -123.61 124.32 42.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.62 0.248 . . . . 0.0 111.166 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -112.21 119.36 38.08 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.71 131.03 56.33 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.416 0.626 . . . . 0.0 111.339 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.35 131.85 28.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.943 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.65 -174.61 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.301 1.048 . . . . 0.0 111.643 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 65' ' ' ARG . 8.0 tp -142.21 119.64 11.63 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 113.007 -1.906 . . . . 0.0 107.351 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.9 mtt180 -61.65 -138.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 p -69.57 112.93 6.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.97 137.89 57.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 70' ' ' HIS . 83.6 mm-40 -129.54 143.14 47.75 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.622 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.44 83.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.09 1.193 . . . . 0.0 111.145 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 68' ' ' GLN . 86.1 t60 174.85 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.887 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -76.38 -1.75 28.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.67 144.27 43.89 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.993 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.94 179.66 40.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 39' ' ' ILE . 94.9 mt-10 -87.29 157.6 19.26 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.687 -0.302 . . . . 0.0 110.351 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.635 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 44.6 t -120.31 116.81 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.675 0.274 . . . . 0.0 110.558 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -131.38 133.96 45.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 12.5 t80 -141.23 142.47 33.95 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.527 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.28 145.52 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -156.67 -153.09 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.379 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.413 ' HE ' HG22 ' A' ' 30' ' ' VAL . 96.0 mtt-85 -55.08 87.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.846 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 55.11 13.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.03 90.36 6.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.404 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -87.91 136.58 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 164.17 35.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.155 0.503 . . . . 0.0 111.212 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 88.3 p -159.95 178.64 9.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.646 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.635 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 175.49 179.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.259 0.552 . . . . 0.0 111.364 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -133.42 110.34 9.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.396 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -102.29 128.69 48.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 147.28 33.15 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.7 132.46 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.986 0.422 . . . . 0.0 110.811 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.494 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.631 0.253 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.56 119.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.19 -68.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.753 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.29 140.93 30.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.425 0.631 . . . . 0.0 112.164 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.4 pt? -130.1 134.12 47.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.623 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.0 tp -101.7 116.99 33.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.12 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -129.75 -170.25 2.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.5 t30 61.4 108.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.496 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.62 133.86 13.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.018 0.913 . . . . 0.0 113.216 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.34 133.89 54.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.2 m -134.2 112.39 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.754 0.788 . . . . 0.0 112.163 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ALA . 56.2 ttm-85 -84.68 147.22 27.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.937 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ARG . . . -34.75 121.83 0.52 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.377 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 14.1 61.34 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.0 150.74 28.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.749 0.309 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -101.69 172.19 7.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.096 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -131.95 138.39 48.31 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.845 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -128.48 112.28 14.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.345 0.593 . . . . 0.0 111.843 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CE2' ' HB1' ' A' ' 20' ' ' ALA . 82.4 m-85 -124.22 116.73 23.17 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -138.49 141.37 39.4 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.793 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -127.01 96.2 4.54 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.516 HG23 ' ND1' ' A' ' 59' ' ' HIS . 16.9 m -73.78 107.23 5.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.528 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -100.24 -171.85 2.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 t -112.12 -11.2 13.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.664 ' H ' HH21 ' A' ' 80' ' ' ARG . 47.7 tp10 -138.75 145.58 40.39 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.161 0.505 . . . . 0.0 110.952 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.21 139.27 39.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.942 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 31' ' ' PRO . 8.7 t -112.9 128.53 25.49 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.78 -145.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 120.074 1.062 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.56 110.67 27.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.26 -29.5 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.52 -17.82 29.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.79 141.98 43.4 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -130.81 132.53 45.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.651 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.563 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 94.9 m95 -130.27 110.42 11.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 85.7 m-85 -158.98 154.35 25.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.201 0.524 . . . . 0.0 111.476 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.33 122.77 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.04 124.41 20.73 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.682 1.128 . . . . 0.0 110.346 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.43 2.39 31.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 100.17 0.79 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.91 136.09 50.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.89 100.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASP . 43.7 mt-30 -87.42 151.17 50.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.73 -22.42 13.36 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.335 1.357 . . . . 0.0 110.644 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.91 14.75 12.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.929 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' GLN . 25.9 p30 -42.8 112.22 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.207 0.527 . . . . 0.0 111.435 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 t -84.7 -46.58 11.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.917 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -85.14 -25.44 27.46 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -113.44 147.56 37.58 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.5 m -126.65 130.04 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.4 130.46 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 p -144.6 153.99 42.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.904 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.21 103.72 6.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.432 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.43 110.78 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.176 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.91 -133.71 52.61 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.54 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 24.4 m -95.41 38.87 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 110.42 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.54 ' ND1' ' O ' ' A' ' 58' ' ' SER . 12.9 m-70 -141.04 141.28 34.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.07 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -129.29 137.27 50.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.74 131.03 47.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.231 0.539 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -124.02 131.6 53.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.399 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.67 165.66 12.79 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.507 1.146 . . . . 0.0 113.711 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 24.9 tp -141.68 113.67 7.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 111.835 -2.439 . . . . 0.0 106.152 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' LEU . 61.8 ttt180 -64.08 -126.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -80.87 109.59 15.58 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.662 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.93 136.05 55.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -133.81 144.57 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.928 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -51.49 94.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.366 1.377 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER 160.82 -21.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.462 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.71 -6.75 55.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.485 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 150.21 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.48 39.21 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.255 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -98.41 151.57 20.42 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.46 115.04 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.6 m -122.36 132.94 54.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 111.568 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 4.2 t80 -144.66 135.38 24.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.977 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ASP . 28.6 p -153.76 -134.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.805 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.664 HH21 ' H ' ' A' ' 28' ' ' GLU . 47.0 mtm180 -52.56 82.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' CYS . 97.3 m-20 45.12 10.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.826 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -97.62 91.38 5.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 83' ' ' VAL . 10.6 p -81.2 126.4 39.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.35 133.19 13.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -152.26 133.0 14.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.24 -159.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.769 0.795 . . . . 0.0 111.458 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -142.7 117.25 9.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.852 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.9 tp -107.64 133.02 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 t -136.51 148.66 47.76 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.6 t -111.91 125.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 91' ' ' LEU . 9.2 mp . . . . . 0 N--CA 1.462 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.091 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.61 97.79 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.639 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.82 -54.2 42.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.051 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -138.4 132.38 31.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.775 0.322 . . . . 0.0 110.258 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -118.55 147.3 43.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 8' ' ' LEU . 10.9 mp -121.48 123.0 41.0 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.478 ' H ' ' HE3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.23 -165.64 2.27 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.56 108.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 144.67 3.8 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.89 0.852 . . . . 0.0 113.033 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.09 135.91 51.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.796 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.1 113.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -76.39 170.02 17.15 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.42 109.72 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.168 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.36 -1.23 50.14 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.45 152.12 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.091 0.445 . . . . 0.0 110.136 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -106.94 154.22 21.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.863 0.363 . . . . 0.0 111.809 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.74 142.11 51.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.711 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -130.67 123.54 29.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 0.0 111.529 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -133.12 123.25 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.55 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.0 t -147.62 154.22 40.37 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.326 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HG ' ' HZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -140.01 99.93 3.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 109.968 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -81.05 120.68 25.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.084 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.2 -174.79 2.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.44 1.99 14.53 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -138.9 143.93 38.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.135 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -75.84 138.99 41.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.402 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.44 136.81 19.88 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.56 -148.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.319 1.15 . . . . 0.0 110.501 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -121.99 124.66 71.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.1 -35.59 4.3 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -70.93 -42.06 70.37 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 140.67 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -148.06 116.25 6.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.866 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.595 ' HZ2' ' HG ' ' A' ' 24' ' ' CYS . 48.6 m95 -109.68 125.14 52.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.442 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 91.3 m-85 -156.86 152.26 26.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 111.517 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.09 119.52 60.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -58.69 116.84 3.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.05 -3.11 9.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.9 107.05 0.13 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.39 132.21 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.072 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.78 104.61 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.197 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -89.14 154.65 49.46 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.44 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -53.07 -25.79 30.17 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.462 1.441 . . . . 0.0 110.057 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -91.31 11.96 21.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.149 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 39.3 p-10 -37.69 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -73.11 -45.8 54.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.484 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.0 -29.08 17.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -102.34 147.06 27.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.187 0.518 . . . . 0.0 111.015 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.1 m -122.15 126.12 47.63 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.91 128.18 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.1 p -142.82 151.76 41.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.056 0.455 . . . . 0.0 111.151 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.14 103.84 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.867 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -104.91 109.12 20.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.715 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.85 -119.17 16.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -105.31 47.43 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.662 0.267 . . . . 0.0 110.449 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.55 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 9.3 t-160 -145.82 138.88 25.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 78.3 m80 -127.05 138.49 53.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.67 109.1 4.33 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.581 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.0 tt -112.67 127.13 56.03 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.396 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 62' ' ' LEU . 2.1 pp -138.38 143.24 39.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 tp -101.83 128.4 48.21 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -71.59 -108.58 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.209 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.9 p -79.91 96.21 6.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 111.234 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.39 142.29 55.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.739 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 70' ' ' HIS . 17.0 mm100 -130.97 144.15 52.36 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.63 84.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.402 1.401 . . . . 0.0 111.378 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' GLN . 78.6 t60 176.25 -28.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -81.77 -6.14 58.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 148.49 9.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.88 -164.91 38.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -104.06 153.71 20.56 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 60.8 t -121.64 115.9 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.106 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -133.01 133.24 42.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.013 0.435 . . . . 0.0 110.965 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.549 ' CE1' ' NE1' ' A' ' 37' ' ' TRP . 56.0 t80 -127.66 133.99 49.62 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 142.89 50.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.878 0.371 . . . . 0.0 110.678 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.823 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 17.7 p -154.36 -156.83 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.363 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.4 ptp180 -50.7 84.67 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.096 0.474 . . . . 0.0 111.6 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' CYS . 99.1 m-20 51.93 0.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -92.82 94.14 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.91 146.99 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.73 165.19 27.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.0 p -151.67 169.85 21.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 177.96 172.1 0.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.836 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -137.55 136.08 37.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -118.55 126.2 51.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.881 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.9 t -144.09 154.18 42.94 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.722 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -115.0 122.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.368 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.787 -179.474 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 6' ' ' LEU . 80.2 mm-40 . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 HD22 ' A' ' 26' ' ' LEU . 1.1 pt -41.78 70.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' GLU . 42.2 mt -81.54 -28.99 33.66 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -107.28 118.83 37.75 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.82 2.1 . . . . 0.0 112.625 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.42 127.96 32.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -90.4 114.93 27.16 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 11' ' ' ASN . 3.2 mmpt? -121.68 -168.1 1.64 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 10' ' ' LYS . 27.1 m120 53.79 103.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.61 121.2 35.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.698 0.761 . . . . 0.0 113.002 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.37 126.16 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.6 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 28.1 m -137.74 121.23 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -76.35 -166.72 0.66 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.71 124.42 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.22 65.96 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.231 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.71 143.91 44.71 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -92.79 163.34 13.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 148.01 27.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -130.49 123.99 30.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.12 116.53 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.69 150.36 38.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -122.08 94.12 4.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.663 0.268 . . . . 0.0 110.712 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 59' ' ' HIS . 19.7 m -71.51 109.9 5.76 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.238 0.542 . . . . 0.0 110.206 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 5' ' ' ILE . 8.2 mt -99.48 -178.57 3.94 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.24 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.86 -3.84 13.39 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 1.1 pm0 -137.45 146.38 44.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.094 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.27 139.24 37.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.421 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' PRO . 21.8 t -107.11 133.24 20.39 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -58.23 -154.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 120.809 1.006 . . . . 0.0 110.187 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -115.53 102.54 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.71 -46.35 0.65 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.76 -43.31 89.29 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.155 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.0 139.97 38.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -140.97 144.37 35.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.714 0.292 . . . . 0.0 110.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 82.9 m95 -140.42 121.79 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.615 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -156.54 152.18 26.99 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.613 0.72 . . . . 0.0 112.127 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -110.36 114.12 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.01 112.06 3.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.013 1.279 . . . . 0.0 107.616 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.5 -15.67 9.85 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.65 89.38 1.17 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.386 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.33 140.48 57.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.728 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.518 HG12 ' HE1' ' A' ' 51' ' ' TRP . 1.8 m -78.65 103.76 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.794 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.04 158.25 32.13 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.07 -17.89 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.57 1.513 . . . . 0.0 110.99 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 65.8 m-20 -89.74 -4.95 57.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' ASP . 97.1 m-20 -35.43 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.255 0.55 . . . . 0.0 110.84 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -87.82 -43.07 12.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.096 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.97 -39.32 61.35 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.518 ' HE1' HG12 ' A' ' 44' ' ' VAL . 15.2 p90 -126.32 166.16 17.66 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.271 0.558 . . . . 0.0 111.304 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.3 p -129.62 156.87 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -132.72 120.84 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.3 p -147.89 157.73 43.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.73 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.02 111.53 5.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.63 107.82 18.83 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.08 -123.88 34.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.2 p -93.55 43.1 1.11 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.521 0.2 . . . . 0.0 111.082 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.509 ' CD2' HG23 ' A' ' 25' ' ' THR . 63.5 m80 -147.78 138.86 23.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.901 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -120.22 134.91 55.15 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.02 132.83 34.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.517 0.675 . . . . 0.0 111.28 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tp -126.3 128.94 47.91 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.815 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' TRP . 72.7 mt -105.81 162.91 13.14 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.995 0.903 . . . . 0.0 112.145 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 67' ' ' ALA . 32.9 tp -141.69 108.3 5.34 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -68.01 -121.98 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -83.84 104.75 14.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.524 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB1' ' NE2' ' A' ' 71' ' ' HIS . . . -66.38 108.0 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.5 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 70' ' ' HIS . 51.4 mt-30 -108.13 145.95 32.52 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -48.85 88.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.758 1.639 . . . . 0.0 111.164 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.5 m80 176.83 -28.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.827 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 22.8 p80 -76.99 -8.02 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.663 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.8 147.4 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 110.909 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.3 -131.26 2.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -141.53 146.69 36.68 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.655 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.58 115.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -118.7 126.55 52.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.358 0.599 . . . . 0.0 111.447 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 28.9 t80 -130.08 124.28 32.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.003 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.97 157.01 24.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.4 t -151.18 -155.04 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -55.19 82.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.007 0.432 . . . . 0.0 110.389 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 79' ' ' CYS . 95.1 m-20 57.47 -2.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.681 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -88.75 100.23 12.98 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 83' ' ' VAL . 11.3 p -86.48 124.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.278 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.03 32.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.025 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.5 p -171.07 155.21 4.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.2 156.08 43.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.086 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -82.17 138.66 34.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.68 131.65 50.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -142.97 151.94 41.44 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.229 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.53 ' C ' HD12 ' A' ' 91' ' ' LEU . 14.7 p -111.99 123.44 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.44 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 91' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.586 0.231 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 5' ' ' ILE . 18.4 tt -89.84 119.06 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 6' ' ' LEU . 9.5 mp -91.07 -71.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.494 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.26 138.31 29.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.72 HD22 ' C ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.44 158.69 44.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.258 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.8 mt -108.89 131.9 54.57 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 111.508 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -142.55 -171.37 3.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.707 ' H ' ' CB ' ' A' ' 86' ' ' ALA . 66.3 t30 56.05 109.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -159.2 142.15 14.33 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.38 132.96 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.285 -1.779 . . . . 0.0 107.346 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 90' ' ' VAL . 4.2 m -122.31 124.26 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.656 0.741 . . . . 0.0 112.74 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -87.9 165.97 14.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.479 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.35 114.7 2.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.752 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.11 29.71 27.53 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.47 149.83 38.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 110.128 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -113.34 148.35 35.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.71 145.48 51.15 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.215 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 p -124.81 134.34 52.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -133.32 126.22 30.93 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.172 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 t -142.14 142.74 32.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 m -129.28 95.67 4.1 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -77.07 110.13 11.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.12 -174.23 2.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.416 0.627 . . . . 0.0 111.617 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 t -98.7 -20.54 16.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.597 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -142.0 151.16 42.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.008 0.433 . . . . 0.0 111.218 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.6 128.45 35.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.043 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.52 134.77 19.66 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.71 -151.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.028 1.152 . . . . 0.0 110.616 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.93 103.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.84 -37.77 0.66 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.83 -13.09 52.11 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.8 139.84 48.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.376 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -122.97 126.01 46.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.625 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 99.2 m95 -124.66 100.04 6.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.949 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 90.8 m-85 -152.91 149.02 27.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 110.559 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.94 125.09 69.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -48.43 132.76 16.71 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.584 -0.698 . . . . 0.0 111.257 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.63 8.1 56.21 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.205 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.626 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -167.16 125.91 1.35 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.376 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.28 112.83 24.47 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 44' ' ' VAL . 1.0 OUTLIER -74.88 104.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 112.487 -177.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.475 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.3 mp0 -92.21 157.46 40.72 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -53.29 -23.4 23.35 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.613 1.542 . . . . 0.0 111.495 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -98.35 17.23 19.28 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 45' ' ' GLN . 87.3 m-20 -49.18 128.83 17.24 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.4 p -91.96 -37.25 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.755 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 66.2 t0 -96.48 -32.45 12.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.659 0.266 . . . . 0.0 111.694 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -102.83 139.86 37.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.477 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 m -132.3 130.46 40.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.5 133.21 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -143.34 154.57 43.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.634 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.47 106.0 4.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.327 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.01 105.67 15.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.951 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.32 -126.34 41.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 23.0 t -95.44 37.56 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.633 0.254 . . . . 0.0 110.938 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 58' ' ' SER . 22.1 m-70 -142.81 153.85 43.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.844 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.27 161.8 28.52 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.92 94.2 1.11 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.755 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.05 128.18 54.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.503 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 63' ' ' LEU . 1.9 pp -121.73 -178.29 3.78 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.162 0.982 . . . . 0.0 112.357 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.2 tp -145.01 120.74 10.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.01 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' LEU . 82.8 mmt-85 -64.1 -130.23 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.307 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 m -82.84 108.28 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.95 142.46 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.672 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' HIS . 80.9 mt-30 -134.42 144.8 52.58 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.42 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.29 83.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.296 1.331 . . . . 0.0 111.153 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.3 t60 178.39 -26.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -87.09 -1.16 57.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.837 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.08 145.96 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.18 -123.04 1.0 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -142.47 154.2 44.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.508 0.194 . . . . 0.0 110.531 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -121.22 117.99 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -128.95 129.16 45.09 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.13 0.49 . . . . 0.0 112.145 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.625 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 16.4 t80 -136.65 141.16 43.17 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.35 154.8 39.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' ASP . 3.0 t -157.33 -147.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.703 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 82' ' ' ALA . 24.6 mmm180 -53.79 89.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' CYS . 53.2 t0 50.58 10.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.469 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.14 93.99 8.58 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.1 p -92.23 125.69 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.838 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.24 123.24 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.472 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.8 p -158.53 138.21 11.93 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.692 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.707 ' CB ' ' H ' ' A' ' 11' ' ' ASN . . . -139.62 151.31 45.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -81.21 144.27 31.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.344 0.593 . . . . 0.0 112.35 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 12' ' ' ALA . 49.2 tp -111.95 133.12 54.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.386 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -137.86 139.08 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.104 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 14' ' ' VAL . 97.1 t -104.8 126.67 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.239 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.3 tp . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 121.033 0.444 . . . . 0.0 111.043 -179.752 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 5' ' ' ILE . 18.1 tt -89.67 119.46 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.091 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.58 -63.79 1.17 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.928 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -154.12 146.95 24.35 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.946 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -137.07 145.54 44.07 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.806 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.38 115.54 30.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -131.78 -169.99 2.31 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.071 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' LYS . 60.1 t-20 53.42 107.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.409 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.26 147.93 3.83 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.76 148.62 45.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.111 -1.859 . . . . 0.0 106.631 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.0 m -132.87 110.05 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.288 0.566 . . . . 0.0 111.155 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 53.9 ttt85 -76.31 155.77 33.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.24 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.91 136.12 47.51 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.823 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.35 28.27 68.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 15' ' ' ARG . . . -119.12 143.85 46.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.286 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -98.51 159.24 15.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.846 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.0 148.39 31.65 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.58 124.55 41.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.141 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.43 117.27 21.07 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -143.81 153.99 42.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.11 98.43 3.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.314 0.578 . . . . 0.0 111.05 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -71.13 110.44 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.11 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.04 -177.17 4.06 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 110.781 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 100.0 p -108.3 -12.56 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.116 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -134.29 145.97 49.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.949 0.405 . . . . 0.0 110.902 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.79 129.83 35.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.64 141.57 24.31 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.94 -145.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 120.642 1.265 . . . . 0.0 111.086 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 32' ' ' VAL . 14.0 p -123.15 123.6 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.43 -26.4 6.34 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.39 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.4 -21.21 23.17 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.162 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 143.69 30.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -120.88 126.86 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.572 ' CE2' ' CD2' ' A' ' 77' ' ' PHE . 37.2 m95 -134.45 115.04 13.52 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.657 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -170.37 166.1 8.63 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.287 0.565 . . . . 0.0 112.213 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.78 127.66 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -66.8 132.15 47.43 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 120.772 -1.205 . . . . 0.0 109.713 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.1 -3.92 33.57 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -146.32 -27.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.339 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' ALA . . . 48.3 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' VAL . 1.3 p -60.05 118.93 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.491 0.662 . . . . 0.0 112.52 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -110.98 152.19 43.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.513 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.38 -20.31 47.69 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.911 1.074 . . . . 0.0 111.855 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.82 4.63 49.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.01 137.96 57.97 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.194 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 p -89.31 -33.51 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 51' ' ' TRP . 38.6 p-10 -92.48 -29.34 16.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.662 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.478 ' CE2' HD13 ' A' ' 64' ' ' LEU . 97.4 m95 -110.6 139.14 46.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 111.245 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 93.9 m -127.16 130.28 49.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -125.39 132.91 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 p -144.64 155.82 43.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.501 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.36 105.76 4.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.66 113.78 21.73 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.008 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.26 -133.52 42.48 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -98.26 38.61 1.31 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.815 0.341 . . . . 0.0 110.555 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -139.96 137.92 35.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.125 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -122.08 134.25 54.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 129.36 36.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.36 0.6 . . . . 0.0 111.835 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.44 151.56 41.15 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.245 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 5.0 mp -133.68 165.07 25.78 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.399 1.095 . . . . 0.0 113.156 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' A' ' 51' ' ' TRP . 34.4 tp -143.6 108.39 4.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.643 -2.071 . . . . 0.0 106.365 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.6 mtt-85 -64.58 -121.26 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.2 m -81.87 109.63 16.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 71' ' ' HIS . . . -65.27 134.6 53.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.579 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 9.9 pt20 -136.02 147.19 59.76 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.067 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.3 Cg_endo -48.22 90.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.668 1.578 . . . . 0.0 111.693 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.6 m-70 170.63 -29.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.199 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.62 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 49.1 p-80 -83.25 -15.0 52.01 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.27 146.83 27.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.311 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.26 -137.48 4.61 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.527 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 53.6 mp0 -126.87 147.79 50.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.38 111.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -123.45 123.16 40.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.274 0.559 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -145.64 145.94 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.736 179.192 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.3 151.61 28.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.319 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 81' ' ' ASP . 4.8 t -156.73 -140.96 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.939 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ALA . 19.0 mmm180 -54.23 89.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.979 0.419 . . . . 0.0 110.135 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 44.54 16.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -103.41 69.94 1.02 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 135.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.88 132.51 7.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -141.62 119.36 11.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.141 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.77 -160.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.49 0.662 . . . . 0.0 111.67 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -146.04 121.19 10.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.586 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.7 tp -110.07 130.51 55.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.923 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 t -136.17 146.51 46.94 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.613 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 14' ' ' VAL . 9.6 p -113.29 125.53 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.464 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 3.0 mm? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.354 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 121.324 0.583 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -77.51 121.69 30.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.767 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.21 -68.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' C ' HD12 ' A' ' 8' ' ' LEU . 97.2 mt-10 -135.0 124.86 25.49 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 8' ' ' LEU . 7.9 mp -110.73 152.68 26.29 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.037 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 23' ' ' THR . 48.1 tp -124.02 108.79 12.75 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' CE ' ' N ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -130.19 -168.53 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.506 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 m120 54.78 105.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.782 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.93 134.86 6.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.984 0.897 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.73 130.09 54.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.838 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' ARG . 5.1 m -129.91 103.28 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.214 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 14' ' ' VAL . 93.7 mtt180 -47.54 175.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.48 128.91 38.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.099 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.29 42.41 10.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.58 160.91 36.06 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.495 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -95.24 154.63 17.09 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . . . -130.25 133.66 46.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 p -119.62 122.62 41.96 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -132.6 117.85 18.45 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 59.0 p -144.52 151.69 39.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.261 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.99 95.74 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.991 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 p -67.83 123.52 20.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -123.63 143.23 50.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.906 0.384 . . . . 0.0 111.288 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 m -76.77 -13.28 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.921 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -116.94 132.89 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 0.0 111.805 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.97 149.56 30.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.8 t -124.74 122.58 25.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.48 -147.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.229 1.118 . . . . 0.0 110.998 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 32' ' ' VAL . 12.9 p -120.97 118.84 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.742 0.782 . . . . 0.0 109.102 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.28 -25.28 9.36 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -91.78 -19.21 22.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.144 0.497 . . . . 0.0 109.678 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.08 166.59 19.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.408 ' HB2' ' H ' ' A' ' 78' ' ' ALA . 16.3 m -146.52 116.75 7.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.462 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.09 97.79 3.06 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -155.07 156.31 35.65 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.854 HD11 ' CE2' ' A' ' 51' ' ' TRP . 4.9 mm -73.42 101.06 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -47.72 97.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 128.42 -36.28 2.5 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . -125.04 98.28 5.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.07 139.73 51.43 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.824 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.52 113.8 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -104.67 152.39 39.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.37 -19.82 18.33 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.286 1.324 . . . . 0.0 109.989 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.54 31.3 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.51 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 42.4 p-10 -97.48 104.94 17.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.508 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -87.44 -52.78 5.17 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.469 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 64' ' ' LEU . 46.2 m-20 -67.39 -37.53 83.26 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 110.112 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.854 ' CE2' HD11 ' A' ' 39' ' ' ILE . 59.7 t-105 -105.17 148.01 27.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.028 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -146.26 143.74 29.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.644 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -124.79 138.0 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -142.83 158.65 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 111.235 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.01 100.83 3.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -108.86 105.15 14.57 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 -131.22 30.22 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -100.43 37.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.064 0.459 . . . . 0.0 110.595 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -135.75 132.34 36.68 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -115.24 123.23 48.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.73 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.27 122.88 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.626 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.5 pt? -141.15 131.43 25.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.32 -169.98 2.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.208 1.004 . . . . 0.0 113.7 -175.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 36.7 tp -146.4 119.9 9.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 113.366 -1.743 . . . . 0.0 106.954 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -68.51 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.8 p -71.46 103.54 2.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.167 0.508 . . . . 0.0 110.225 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.4 135.92 53.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 70' ' ' HIS . 73.8 mt-30 -130.87 144.1 52.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -48.57 92.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.515 1.476 . . . . 0.0 111.599 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 3.7 m-70 166.9 -27.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.891 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -86.36 -0.79 56.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.389 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 145.27 56.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.213 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.05 -150.3 15.36 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -118.66 166.7 12.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.626 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 69.8 t -132.2 133.7 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.7 m -132.6 129.16 38.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.382 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -132.78 140.34 47.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.284 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -161.69 144.36 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.645 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' ASP . 25.4 p -157.6 -135.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -51.81 81.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 44.1 t0 51.28 6.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -96.29 91.38 5.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.91 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.315 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . . . -160.01 -179.49 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.326 0.584 . . . . 0.0 110.992 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 m -158.0 178.9 9.7 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.466 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . -169.47 160.97 9.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.212 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -119.27 132.8 55.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.911 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 tp -121.76 127.04 50.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.535 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 t -146.79 153.85 40.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.284 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.3 p -128.4 110.94 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.992 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.923 -179.599 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.413 ' OE2' ' O ' ' A' ' 80' ' ' ARG . 34.2 tp10 . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.456 HD11 ' HB1' ' A' ' 82' ' ' ALA . 81.8 mt -99.3 121.12 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.554 0.342 . . . . 0.0 110.739 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.8 -71.15 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -126.5 118.38 24.81 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.7 pt? -122.18 144.64 48.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.23 115.69 31.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.662 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -132.26 179.56 6.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.683 -178.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 10' ' ' LYS . 86.4 m-20 51.88 108.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.292 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.36 140.74 7.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.95 0.881 . . . . 0.0 112.76 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 127.81 53.45 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 14' ' ' VAL . 33.1 m -113.06 111.38 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -63.64 166.65 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.186 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 133.83 48.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.998 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.53 43.11 98.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.26 151.73 48.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.345 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -92.83 157.68 16.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.976 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.81 153.82 36.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.42 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.1 t -142.09 148.23 38.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.435 0.636 . . . . 0.0 111.391 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.65 128.92 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.722 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -148.13 152.04 36.62 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.974 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.4 p -142.01 98.06 3.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.402 0.62 . . . . 0.0 111.756 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 m -71.81 120.32 17.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.138 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.16 139.56 47.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.051 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 t -70.79 -13.21 61.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.19 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -131.66 139.96 49.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.129 0.49 . . . . 0.0 111.367 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.74 146.44 33.88 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.915 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -125.24 134.92 26.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.5 -148.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.318 1.149 . . . . 0.0 110.232 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.88 115.01 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.6 -47.44 0.9 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -68.03 -36.79 80.5 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' ' SG ' ' A' ' 79' ' ' CYS . . . -84.08 127.76 34.12 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.909 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.5 t -135.56 138.04 42.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.556 ' CZ2' ' CG ' ' A' ' 77' ' ' PHE . 90.5 m95 -137.76 112.99 9.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.0 p90 -157.91 155.62 29.9 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.202 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.598 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.7 94.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' ILE . 23.8 t-20 -37.61 106.03 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.242 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.77 -9.82 8.55 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.83 102.74 3.44 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 110.496 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 106.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.55 128.37 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.913 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.38 150.1 42.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.18 -25.64 65.34 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.674 1.583 . . . . 0.0 111.78 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -82.29 11.46 5.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 35.8 p-10 -62.28 133.27 54.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.727 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -90.93 -50.07 6.08 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -64.61 -38.68 91.85 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.015 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -104.72 151.38 23.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.432 ' OG1' HD11 ' A' ' 63' ' ' LEU . 10.4 m -135.07 136.69 42.22 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.34 135.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 p -144.21 157.47 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.269 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.92 113.0 3.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.086 0.47 . . . . 0.0 110.757 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 65.8 t0 -130.33 123.68 30.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 -124.84 11.68 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.4 m -115.55 43.02 2.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.739 0.304 . . . . 0.0 110.801 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 56' ' ' ASP . 34.9 p80 -154.26 146.62 23.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.742 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.64 168.1 9.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.97 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.12 100.91 1.4 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.647 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tt -109.93 129.19 55.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.055 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.47 HD12 ' C ' ' A' ' 63' ' ' LEU . 2.0 pp -118.18 173.66 6.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.957 0.885 . . . . 0.0 112.382 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 64' ' ' LEU . 47.2 tp -140.42 115.2 9.58 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 113.54 -1.664 . . . . 0.0 106.602 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.535 ' NH2' ' OG ' ' A' ' 66' ' ' SER . 61.7 ttp85 -68.17 -128.04 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.552 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 82.5 p -75.55 108.61 8.49 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.369 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.26 56.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 66' ' ' SER . 2.8 mp0 -124.91 141.79 39.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.553 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -53.13 86.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.282 1.321 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.1 m-70 174.2 -33.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.708 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -70.64 -5.09 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.795 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.02 145.8 15.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.681 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.88 -167.43 35.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 40' ' ' ASN . 93.2 mt-10 -100.55 165.44 11.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.516 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 37.9 t -128.12 129.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.784 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.2 m -133.42 137.87 45.98 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.462 0.649 . . . . 0.0 110.783 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.556 ' CG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -131.98 134.07 45.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.071 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.462 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -134.59 137.59 43.85 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -151.36 -155.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.468 ' C ' ' N ' ' A' ' 82' ' ' ALA . 79.8 mtp85 -57.77 90.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.8 t0 49.35 14.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -89.73 95.31 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.602 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.48 134.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.395 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.53 154.7 41.85 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.225 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 36.8 p -156.98 173.69 16.64 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.789 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . . . 178.21 175.41 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.193 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -136.98 109.06 7.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.095 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.7 tp -93.47 129.79 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.773 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -137.13 135.08 37.08 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.054 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.18 118.04 41.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' N ' ' HG ' ' A' ' 27' ' ' SER . 10.3 pt-20 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.8 mt -83.8 118.52 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.08 -67.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.269 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -139.81 131.32 27.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.513 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 119.72 36.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 9' ' ' LEU . 9.4 mp -93.84 104.91 16.96 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.677 ' HD3' ' HB2' ' A' ' 86' ' ' ALA . 7.3 mmpt? -132.91 -169.16 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' LYS . 15.6 t-20 59.17 109.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.56 145.84 2.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.832 0.825 . . . . 0.0 111.963 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.09 130.85 53.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.283 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 20' ' ' ALA . 32.8 m -119.92 122.75 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 122.226 1.013 . . . . 0.0 113.397 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.86 167.81 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.048 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.83 55.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.723 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.38 50.76 59.96 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.12 25.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.536 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -100.82 147.36 26.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.141 0.496 . . . . 0.0 110.305 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.697 ' HB2' HG11 ' A' ' 14' ' ' VAL . . . -128.2 140.15 52.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.195 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.01 137.0 47.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.386 0.612 . . . . 0.0 111.83 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -145.67 130.07 17.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.353 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -144.58 148.76 34.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -133.36 95.21 3.47 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.197 0.522 . . . . 0.0 111.666 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.4 m -75.16 113.51 12.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.694 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -107.14 -163.18 0.89 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.481 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.425 ' HG ' ' N ' ' A' ' 4' ' ' GLU . 22.4 p -114.03 -7.28 13.11 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.332 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -146.22 154.79 42.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.121 0.486 . . . . 0.0 111.28 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.46 129.31 35.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.748 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.23 133.58 22.83 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.559 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -63.0 -146.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.255 1.127 . . . . 0.0 111.283 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.5 t -120.5 120.85 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.14 -28.67 5.77 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 53.5 mp0 -85.2 -18.02 35.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.748 0.308 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.0 134.75 51.8 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 m -113.6 140.1 48.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.619 0.247 . . . . 0.0 110.554 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.571 ' CZ2' ' CD1' ' A' ' 77' ' ' PHE . 91.7 m95 -147.27 102.41 3.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.61 153.89 32.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 39' ' ' ILE . 5.2 mp -80.81 145.18 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.819 0.819 . . . . 0.0 111.634 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -78.82 106.17 10.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.517 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.24 -9.18 7.02 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.86 120.71 1.22 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.56 0.219 . . . . 0.0 111.065 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.48 53.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.946 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.0 t -98.54 116.25 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 157.92 45.21 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.51 -34.83 90.9 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.675 1.583 . . . . 0.0 112.12 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -82.22 20.23 1.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.584 0.231 . . . . 0.0 111.593 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 28.8 p-10 -55.05 122.83 11.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.087 0.47 . . . . 0.0 112.118 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -88.93 -51.31 5.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.574 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' OD2' ' CE1' ' A' ' 71' ' ' HIS . 97.5 m-20 -66.17 -38.11 87.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.229 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.479 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 8.7 m-90 -105.94 155.29 19.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.412 0.625 . . . . 0.0 112.128 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -132.55 132.53 42.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -125.0 134.1 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 p -145.87 156.04 43.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.12 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.77 109.7 4.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 59' ' ' HIS . 33.1 p-10 -119.32 102.44 8.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.06 -133.67 31.38 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.4 m -89.94 21.47 3.63 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 122.607 -0.349 . . . . 0.0 111.115 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 77.9 m80 -123.11 124.05 42.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.63 153.07 21.03 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.97 98.0 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.497 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.32 132.66 53.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -130.05 -177.25 4.22 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.483 1.135 . . . . 0.0 112.295 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 51' ' ' TRP . 9.2 tp -145.99 115.24 7.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.532 -2.122 . . . . 0.0 107.362 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 49.7 ttp180 -64.65 -128.45 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -69.01 106.03 2.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.945 0.402 . . . . 0.0 109.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.29 143.13 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.887 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -133.59 139.68 34.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -53.8 89.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.318 1.345 . . . . 0.0 112.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.566 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER 168.18 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.808 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 50' ' ' ASP . 7.2 m-70 -85.71 0.64 52.2 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.96 146.21 33.17 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.707 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.42 -149.5 18.85 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 57.7 mp0 -145.03 119.2 9.47 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 2.8 t -70.63 144.35 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.635 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -124.84 128.0 48.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.662 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CD1' ' CZ2' ' A' ' 37' ' ' TRP . 3.4 t80 -132.47 138.05 47.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -160.24 144.18 14.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 29.9 p -155.91 -132.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.508 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 95.6 mtt-85 -54.53 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.434 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 79' ' ' CYS . 27.9 t70 46.85 14.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.08 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -101.35 88.73 3.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 84' ' ' ALA . 10.4 p -83.78 153.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.426 ' N ' HG22 ' A' ' 83' ' ' VAL . . . -179.64 115.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.79 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.2 t -93.21 -173.91 3.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.987 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.677 ' HB2' ' HD3' ' A' ' 10' ' ' LYS . . . -161.03 154.68 22.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.024 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -114.94 113.76 24.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.445 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 73' ' ' GLY . 38.6 tp -115.11 124.92 52.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -140.49 123.52 16.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.107 0.48 . . . . 0.0 110.715 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.84 119.94 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.181 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.183 0.516 . . . . 0.0 110.086 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tp -82.85 120.5 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.14 -70.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.7 135.58 29.98 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 112.42 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.26 135.05 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.675 HD12 HG22 ' A' ' 23' ' ' THR . 89.7 mt -95.67 112.17 23.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.572 ' NZ ' ' O ' ' A' ' 85' ' ' SER . 1.8 mmpt? -127.78 -176.17 3.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.037 0.446 . . . . 0.0 111.295 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 10' ' ' LYS . 93.2 m-20 55.92 108.63 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.341 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.74 138.81 9.73 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.91 147.93 44.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.421 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 90' ' ' VAL . 1.7 m -133.18 114.98 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.423 0.63 . . . . 0.0 111.189 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -85.25 147.58 26.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.379 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.53 124.98 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.586 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.74 27.13 51.93 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.47 147.0 41.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -103.58 156.3 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.333 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.43 144.35 31.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.91 0.386 . . . . 0.0 110.567 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -127.69 136.26 51.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.472 0.653 . . . . 0.0 111.13 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -137.51 122.01 18.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.675 HG22 HD12 ' A' ' 9' ' ' LEU . 1.7 t -144.3 152.71 41.15 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.536 -0.466 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 26' ' ' LEU . 14.1 t -127.51 92.45 3.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.171 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 m -73.07 114.86 11.71 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 24' ' ' CYS . 84.2 mt -103.81 -169.41 1.63 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.31 0.576 . . . . 0.0 111.362 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.8 t -113.85 -5.13 13.25 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.234 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -140.85 146.11 37.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.64 133.45 35.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.968 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 10.9 t -108.25 134.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.364 -0.35 . . . . 0.0 110.507 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -61.7 -143.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 119.975 1.027 . . . . 0.0 110.047 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.52 111.56 29.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.566 0.698 . . . . 0.0 109.421 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.79 -47.37 0.7 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -67.53 -45.62 75.18 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.069 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.25 138.35 38.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -142.61 112.71 7.06 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.663 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.638 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 98.5 m95 -106.78 107.13 17.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 68.0 m-85 -150.13 150.22 31.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.535 0.683 . . . . 0.0 110.563 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.875 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -125.35 129.27 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -61.07 110.53 1.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.101 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.85 -4.35 6.48 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.811 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.702 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -160.29 76.92 0.62 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.761 0.78 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.92 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 42' ' ' ALA . 6.2 p -67.97 101.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.506 0.669 . . . . 0.0 110.739 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.07 155.94 42.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.37 -30.51 15.56 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.667 1.578 . . . . 0.0 111.616 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.63 10.01 19.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 11.0 p-10 -51.0 128.81 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.7 p -92.44 -47.34 7.21 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.071 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 46.2 t0 -72.11 -39.36 68.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.641 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.537 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 3.7 m-90 -106.84 151.07 25.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.316 0.579 . . . . 0.0 111.341 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -128.56 130.28 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.878 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.99 133.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.011 0.434 . . . . 0.0 109.833 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -142.01 153.39 44.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.43 98.58 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.086 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -113.19 105.76 13.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.27 -132.45 48.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -93.34 35.49 1.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.285 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.488 ' CE1' ' OG1' ' A' ' 23' ' ' THR . 15.7 t60 -139.65 131.77 28.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 80.7 m80 -118.52 137.02 53.49 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.77 137.94 51.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.301 0.572 . . . . 0.0 111.472 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 tp -132.63 138.16 47.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.32 162.16 25.36 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.265 1.031 . . . . 0.0 112.864 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 65' ' ' ARG . 17.9 tp -140.88 110.9 6.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 112.774 -2.012 . . . . 0.0 106.323 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.7 mtt-85 -62.87 -128.96 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.105 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.6 p -77.61 107.15 9.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.08 0.467 . . . . 0.0 110.285 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 137.55 57.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.35 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 84.2 mt-30 -133.94 135.06 23.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.02 88.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.002 1.135 . . . . 0.0 111.658 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 2.0 t60 -173.48 -39.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 68' ' ' GLN . 22.8 p-80 -82.12 -7.65 59.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.883 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.21 152.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.34 -162.03 34.01 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.16 149.11 21.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.777 0.322 . . . . 0.0 110.581 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 63.0 t -117.51 119.71 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.886 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 137.31 49.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.638 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 2.3 t80 -137.95 134.98 35.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.466 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -133.06 144.25 49.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.8 t -156.88 -151.2 0.31 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.32 0.581 . . . . 0.0 111.502 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -55.84 84.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.122 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' CYS . 90.5 m-20 51.27 8.62 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.4 94.21 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 83' ' ' VAL . 7.5 p -81.74 129.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.935 0.398 . . . . 0.0 110.471 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -134.76 165.39 25.38 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.438 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.572 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 96.9 p -161.68 -179.69 7.46 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 174.59 178.64 0.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 128.86 24.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.274 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.3 tp -113.99 130.07 56.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 t -142.34 155.97 45.21 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.665 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 14' ' ' VAL . 65.9 t -121.0 123.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.394 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.269 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.69 119.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.6 mp -86.79 -71.44 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.651 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -132.14 128.17 37.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.057 0.456 . . . . 0.0 111.183 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.8 pt? -129.66 136.69 50.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.79 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.5 tt -104.55 108.99 20.7 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.483 ' N ' HD23 ' A' ' 9' ' ' LEU . 12.4 mmmt -118.39 -171.22 2.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.3 m120 57.04 108.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.91 130.34 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.91 128.45 46.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -131.31 123.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 95.8 mtt180 -80.51 172.6 13.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.433 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 133.18 54.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.114 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.73 23.8 74.07 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ARG . . . -112.8 152.87 28.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.9 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.67 152.48 20.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG11 ' A' ' 14' ' ' VAL . . . -119.5 144.74 46.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -142.48 120.61 12.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 112.193 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -123.6 116.35 22.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.4 t -144.95 150.84 37.66 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.472 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.7 100.75 4.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.573 ' HG1' ' CE1' ' A' ' 59' ' ' HIS . 23.6 m -72.69 112.05 8.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.374 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.04 -166.45 1.23 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.341 0.591 . . . . 0.0 111.245 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.1 p -114.72 -4.83 12.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.915 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -138.37 141.58 39.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.423 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.86 130.59 36.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.515 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 31' ' ' PRO . 26.3 t -104.16 134.9 19.46 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.268 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.15 -147.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 120.022 1.044 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.22 109.52 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.56 -42.2 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.46 -43.58 80.74 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.074 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.34 150.2 33.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.64 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -126.8 126.25 43.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 111.036 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -131.48 112.13 12.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -155.42 153.76 30.87 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.505 0.669 . . . . 0.0 111.508 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 74' ' ' GLU . 4.4 mp -120.99 121.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.32 125.65 24.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.174 0.897 . . . . 0.0 109.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.47 -3.9 31.06 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.4 96.55 0.4 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.271 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.32 139.41 54.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.868 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.43 103.18 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -90.48 153.74 46.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.12 -29.11 27.35 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.767 1.644 . . . . 0.0 111.352 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -97.21 14.21 26.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -46.45 124.73 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -88.09 -44.21 11.11 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.25 -26.19 19.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.444 ' NE1' HD13 ' A' ' 64' ' ' LEU . 8.2 m-90 -110.18 139.92 44.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.493 ' OG1' HD11 ' A' ' 63' ' ' LEU . 23.4 p -136.94 152.72 50.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.56 137.0 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 p -142.43 153.45 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.93 102.39 5.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.027 0.441 . . . . 0.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -109.33 107.65 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.943 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.89 -131.42 45.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.5 p -97.03 47.16 1.04 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.729 0.299 . . . . 0.0 111.008 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.573 ' CE1' ' HG1' ' A' ' 25' ' ' THR . 63.6 t60 -152.44 137.06 16.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.672 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -117.01 135.75 53.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.05 126.51 26.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 111.008 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 tt -131.22 133.86 45.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.322 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.493 HD11 ' OG1' ' A' ' 52' ' ' THR . 1.5 pp -119.56 -176.63 3.2 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.254 1.026 . . . . 0.0 112.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 44.5 tp -146.12 122.22 10.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.144 -1.844 . . . . 0.0 106.302 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' LEU . 93.2 mtt-85 -63.51 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.611 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -78.28 108.1 11.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.73 134.89 50.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.898 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 70' ' ' HIS . 74.0 mt-30 -132.4 145.1 55.84 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.64 84.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.416 1.41 . . . . 0.0 111.246 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 68' ' ' GLN . 81.4 t60 176.97 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.087 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.03 -8.97 59.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.61 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.11 148.71 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.593 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.9 -171.31 42.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 39' ' ' ILE . 84.5 tt0 -97.68 151.68 19.87 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -119.39 118.14 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 117.757 0.253 . . . . 0.0 110.915 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 m -127.97 129.81 47.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.116 0.484 . . . . 0.0 111.115 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.37 139.34 37.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.293 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.91 153.13 31.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.165 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.9 t -157.32 -140.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 82' ' ' ALA . 77.9 mtp85 -55.97 86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.079 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 79' ' ' CYS . 26.9 t0 52.18 10.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -92.59 87.43 5.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 83' ' ' VAL . 10.6 p -89.78 125.85 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HB1' ' NZ ' ' A' ' 10' ' ' LYS . . . -155.62 122.59 5.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.165 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 40.8 m -95.43 -174.2 3.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.888 0.375 . . . . 0.0 111.26 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 176.04 173.02 0.35 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -149.0 136.23 20.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 tp -112.74 130.91 55.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -138.57 132.22 30.74 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.701 0.286 . . . . 0.0 111.52 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.81 124.23 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.541 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.466 0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.097 179.4 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 55.1 mp0 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.06 107.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 6' ' ' LEU . 11.2 mp -97.05 -64.06 1.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -120.4 110.46 16.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.0 tp -114.07 129.57 56.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -113.25 125.94 54.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.735 0.303 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.381 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.01 128.64 11.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.49 0.662 . . . . 0.0 111.893 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.82 53.76 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.1 108.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -66.86 174.94 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.31 120.77 8.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.532 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.93 49.67 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.718 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.76 43.3 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.11 152.66 19.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 112.337 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.71 141.11 49.7 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.746 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 p -123.96 110.65 15.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.298 0.57 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -117.19 103.97 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -133.66 139.71 46.62 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.405 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.6 p -137.96 96.94 3.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 m -69.19 117.77 11.25 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.119 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 58' ' ' SER . 46.9 mt -101.65 -174.77 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 t -114.09 3.15 15.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.864 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -126.18 127.76 46.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.512 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.38 75.23 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.92 132.46 74.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.915 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.1 -143.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.925 1.084 . . . . 0.0 110.935 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.618 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.9 m -118.94 109.96 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.629 0.728 . . . . 0.0 109.301 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.36 -56.38 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 80' ' ' ARG . 96.5 mt-10 -69.46 -40.93 76.84 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 149.75 31.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -137.67 137.98 38.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.013 0.435 . . . . 0.0 110.594 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.466 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 63.7 m95 -136.59 105.1 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.87 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 76.8 m-85 -149.54 150.2 31.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.666 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.847 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.2 130.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -62.65 132.79 53.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.269 -0.894 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.76 40.57 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.563 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -164.14 138.57 5.66 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.967 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.18 130.67 47.31 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.87 111.04 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.633 0.254 . . . . 0.0 110.579 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' ASP . 37.0 mt-30 -126.73 153.11 75.75 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.68 -10.26 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.091 1.861 . . . . 0.0 111.488 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' GLN . 45.7 p-10 -108.64 29.42 7.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' ASP . 44.4 p-10 -34.25 161.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.77 0.795 . . . . 0.0 112.378 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -95.79 -62.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.707 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -124.79 -36.02 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -86.98 159.21 19.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.573 0.702 . . . . 0.0 111.312 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.6 m -130.53 144.69 51.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.773 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.43 130.1 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.9 p -143.81 154.91 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.37 100.85 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.351 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -103.21 108.29 19.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.073 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 -132.24 41.11 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 26' ' ' LEU . 10.2 m -97.17 50.87 1.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.391 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -153.67 145.72 23.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -127.36 142.36 51.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.89 12.1 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.287 0.565 . . . . 0.0 111.141 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 63' ' ' LEU . 6.3 tt -122.78 125.2 45.01 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.926 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 62' ' ' LEU . 3.1 pp -139.73 135.65 33.35 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 71' ' ' HIS . 12.4 tp -107.59 111.02 23.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -63.39 -95.59 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.469 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -83.47 103.4 12.79 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 122.09 -0.381 . . . . 0.0 111.729 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.51 55.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.685 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.693 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 40.6 mt-30 -134.22 140.62 36.56 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.74 85.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.059 1.172 . . . . 0.0 111.625 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' GLN . 55.7 t-80 -177.24 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.693 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 35.0 p80 -82.58 -11.24 58.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.366 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.41 146.06 3.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 110.99 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.93 -154.85 25.19 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.38 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.4 mp0 -106.38 154.45 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 72.0 t -116.37 119.56 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.903 0.382 . . . . 0.0 110.688 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.6 m -127.01 130.09 49.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.432 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.64 138.59 36.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.28 153.86 38.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' ' 81' ' ' ASP . 15.1 t -157.07 -132.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.531 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.454 ' C ' ' N ' ' A' ' 82' ' ' ALA . 30.6 mmt180 -57.22 86.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.809 0.338 . . . . 0.0 110.406 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.7 t0 45.41 18.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.454 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -102.77 91.22 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.164 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.9 p -91.76 129.98 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.333 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.56 124.22 10.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.154 0.502 . . . . 0.0 110.802 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 10.3 p -92.14 -173.58 3.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 176.4 174.7 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.117 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -137.43 137.69 39.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.449 . . . . 0.0 111.056 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.2 121.64 31.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 t -142.35 152.06 42.53 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.68 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 90' ' ' VAL . 5.8 p -108.88 108.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.833 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -178.848 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' CD1' ' A' ' 6' ' ' LEU . 95.2 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.0 mt -86.63 108.59 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.9 mp -78.98 -64.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.332 -177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.13 113.83 18.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.964 0.411 . . . . 0.0 111.423 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.1 tp -106.73 123.58 48.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.766 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.8 tp -112.07 123.41 50.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.645 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 5.3 mmmm -138.67 -165.44 1.82 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.351 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 10' ' ' LYS . 65.7 t30 57.6 107.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.808 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.18 140.2 8.78 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.292 1.044 . . . . 0.0 113.402 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.23 144.37 51.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.617 -1.629 . . . . 0.0 107.454 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.2 m -123.62 128.95 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.713 0.768 . . . . 0.0 112.704 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ALA . 89.7 mtt180 -96.19 158.0 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.505 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 113.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.574 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.85 62.06 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . -104.54 153.13 21.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.503 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.436 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 9.9 mp0 -106.21 156.4 18.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.204 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . . . -124.88 138.11 54.26 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 t -120.83 109.69 15.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.27 0.557 . . . . 0.0 112.272 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -114.08 108.43 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -144.98 152.12 39.67 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.482 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.9 p -139.28 102.98 4.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 p -74.38 112.25 10.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.302 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.1 mt -101.22 -173.36 2.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.272 0.558 . . . . 0.0 111.359 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.46 -2.71 17.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.54 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -135.19 139.12 44.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.483 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.19 133.92 33.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.264 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' PRO . 61.1 t -108.31 131.34 21.82 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -60.77 -144.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.949 1.018 . . . . 0.0 110.188 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -119.91 122.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.29 -29.25 6.24 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.709 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.98 -12.61 52.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.86 0.362 . . . . 0.0 110.435 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.94 140.91 37.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 m -118.49 125.97 51.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 66.6 m95 -138.72 118.93 13.55 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.856 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -158.28 153.21 25.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.001 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.71 119.85 57.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -56.88 112.8 1.42 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.425 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.62 9.95 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.32 107.01 0.68 Allowed 'General case' 0 C--O 1.23 0.067 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.75 139.94 53.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.02 98.22 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 0.0 111.171 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.463 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.2 pt20 -102.77 151.43 38.32 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.51 -20.03 8.12 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.309 1.34 . . . . 0.0 110.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -98.05 8.31 44.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 45' ' ' GLN . 64.7 m-20 -42.78 113.31 0.45 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.888 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 t -69.64 -44.26 70.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.048 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.24 -35.76 10.25 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.65 138.83 31.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.082 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -124.52 131.74 53.48 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.4 130.01 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 p -146.07 154.29 41.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.86 98.33 5.49 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -100.68 110.82 22.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.464 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.17 -129.2 31.87 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.404 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 61.0 m -93.29 46.84 1.22 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.757 0.313 . . . . 0.0 110.721 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.404 ' CG ' ' C ' ' A' ' 58' ' ' SER . 39.6 m-70 -149.31 143.81 26.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -124.49 132.03 53.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.69 130.6 49.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.109 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.547 HD13 ' C ' ' A' ' 62' ' ' LEU . 2.3 tm? -140.59 114.17 8.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -142.35 153.14 43.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.5 tp -106.53 128.89 54.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.316 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -67.14 -107.75 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.62 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 p -83.59 108.81 16.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.127 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.967 ' HB1' ' CE1' ' A' ' 71' ' ' HIS . . . -69.72 139.05 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.667 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 94.5 mt-30 -130.43 140.46 38.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.554 ' O ' ' ND1' ' A' ' 70' ' ' HIS . 2.6 Cg_endo -46.42 89.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.152 1.235 . . . . 0.0 111.742 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' A' ' 69' ' ' PRO . 1.3 m80 163.81 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.843 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.967 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 28.5 p-80 -78.49 -13.29 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.645 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.544 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.91 -178.07 40.76 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.446 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.37 149.95 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.22 110.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.666 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.0 m -126.04 125.68 43.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.39 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.67 154.46 28.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.4 t -156.33 -132.8 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -57.86 88.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 79' ' ' CYS . 98.8 m-20 46.24 12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -96.6 66.24 2.3 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.1 t -79.81 129.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.865 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.645 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -161.81 144.85 12.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.13 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -153.84 132.11 11.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.91 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.92 -158.68 0.68 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.396 0.617 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -144.56 129.27 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.753 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.6 tp -117.46 126.3 52.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.586 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 t -139.47 148.4 42.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.132 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 14' ' ' VAL . 9.8 p -115.51 128.15 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.008 0.432 . . . . 0.0 111.599 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 N--CA 1.463 0.187 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.012 179.592 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.46 0.062 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.6 HD11 ' HA ' ' A' ' 82' ' ' ALA . 28.7 mt -86.67 119.03 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.74 -69.5 0.58 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' C ' HD13 ' A' ' 8' ' ' LEU . 99.0 mt-10 -134.65 130.39 36.31 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.126 0.489 . . . . 0.0 111.774 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.895 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -126.08 146.58 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.457 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.412 HD12 ' H ' ' A' ' 23' ' ' THR . 88.3 mt -104.61 113.61 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.764 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 3.0 mmpt? -127.39 173.32 9.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.218 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 63.3 108.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 136.43 13.43 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.11 130.92 48.91 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.18 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 6.6 m -126.14 124.25 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.914 0.864 . . . . 0.0 113.319 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -78.04 170.19 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.766 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.68 130.68 45.24 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.49 34.35 54.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.04 147.9 40.75 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.935 0.397 . . . . 0.0 110.919 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -95.54 149.12 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . . . -127.12 144.35 51.05 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.7 p -139.8 133.35 30.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.128 0.489 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -139.12 126.31 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.412 ' H ' HD12 ' A' ' 9' ' ' LEU . 33.5 p -140.03 144.86 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 26' ' ' LEU . 41.9 t -133.53 92.38 2.98 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 110.971 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -74.13 115.42 13.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.622 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 24' ' ' CYS . 91.9 mt -105.37 -177.35 3.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.871 0.843 . . . . 0.0 112.501 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 m -105.31 -15.45 15.04 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.578 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -129.42 129.23 44.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.54 119.64 32.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.578 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -109.81 148.11 37.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.616 -178.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.8 Cg_endo -57.89 -140.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.776 1.651 . . . . 0.0 110.362 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 m -119.21 103.76 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.34 -44.45 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -64.36 -45.59 87.12 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.858 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.47 141.75 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.6 m -135.54 98.58 3.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.562 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 94.3 m95 -102.13 113.89 27.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 88.3 m-85 -150.84 148.03 27.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.183 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 74' ' ' GLU . 1.9 mp -118.99 122.03 68.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -54.44 122.1 9.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.043 0.838 . . . . 0.0 110.008 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.71 -5.71 14.2 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 124.113 0.883 . . . . 0.0 110.974 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' CZ3' ' A' ' 51' ' ' TRP . . . -165.26 111.06 0.92 Allowed 'General case' 0 C--O 1.231 0.085 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.04 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.26 139.59 48.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.916 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -86.36 99.54 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.385 0.612 . . . . 0.0 110.506 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.645 ' C ' ' H ' ' A' ' 47' ' ' ASP . 31.1 mt-30 -124.74 163.69 35.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.8 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.89 20.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.312 1.341 . . . . 0.0 111.677 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.645 ' H ' ' C ' ' A' ' 45' ' ' GLN . 39.0 m-20 -112.22 -19.7 12.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 45' ' ' GLN . 49.2 m-20 -46.12 105.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.226 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 47.9 t -93.12 -39.21 11.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' OD1' ' CZ ' ' A' ' 65' ' ' ARG . 95.3 m-20 -87.14 -25.12 24.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.322 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.441 ' CZ3' ' CB ' ' A' ' 42' ' ' ALA . 5.6 m-90 -112.91 142.99 44.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.074 0.464 . . . . 0.0 111.11 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 m -132.16 136.29 46.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.86 134.68 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -141.94 154.29 44.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.62 107.97 5.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 111.56 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -119.28 105.27 11.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.14 -133.58 45.86 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.9 m -92.29 30.06 1.55 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.641 0.258 . . . . 0.0 111.103 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -134.43 130.13 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.27 137.03 54.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.94 119.21 15.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.255 0.55 . . . . 0.0 111.523 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.0 135.34 55.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.537 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 63' ' ' LEU . 2.2 pp -125.23 179.36 5.11 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.068 0.937 . . . . 0.0 113.141 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 39.1 tp -145.68 118.52 8.7 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.56 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' CZ ' ' OD1' ' A' ' 50' ' ' ASP . 28.2 ptt180 -63.94 -127.93 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.436 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.0 p -73.06 110.62 7.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.64 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB1' ' CD2' ' A' ' 71' ' ' HIS . . . -63.62 112.38 2.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.979 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' HIS . 16.8 pt20 -112.48 145.69 33.42 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.92 83.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.623 1.549 . . . . 0.0 111.763 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 175.95 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.635 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 12.3 p80 -73.98 -13.63 60.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.732 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.82 147.6 8.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 110.869 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.84 -170.41 40.6 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 39' ' ' ILE . 80.7 tt0 -99.51 149.63 23.03 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 75.7 t -117.53 115.35 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.7 m -129.3 130.94 46.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.25 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 9.5 t80 -136.79 138.38 40.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.98 147.82 27.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.107 0.479 . . . . 0.0 111.479 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.22 -148.57 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.99 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' A' ' 82' ' ' ALA . 45.1 mmm-85 -60.66 90.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.069 0.461 . . . . 0.0 110.454 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 t0 48.18 14.8 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.193 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.6 ' HA ' HD11 ' A' ' 5' ' ' ILE . . . -104.37 73.63 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.8 t -80.39 151.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.906 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.764 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -157.17 170.38 22.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.286 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 37.1 m -159.1 178.87 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 174.77 179.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 111.179 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 87' ' ' ARG . 83.1 mtt85 -142.07 128.03 19.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.5 tp -113.58 129.46 56.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 t -144.29 153.07 41.64 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.019 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 90' ' ' VAL . 13.9 p -117.65 126.58 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.4 tp . . . . . 0 C--N 1.333 -0.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.08 -179.736 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.554 HG12 HD22 ' A' ' 8' ' ' LEU . 20.2 tt -92.94 114.83 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.2 mp -92.06 -72.46 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.12 121.58 35.55 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.193 0.452 . . . . 0.0 111.966 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.16 126.86 49.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.343 179.265 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.65 111.77 23.51 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -126.47 -179.88 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.906 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t30 60.37 108.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.72 15.05 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.664 0.986 . . . . 0.0 113.664 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.04 129.65 50.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.15 126.41 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.898 0.856 . . . . 0.0 112.994 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.56 163.88 25.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.618 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 130.44 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.58 40.1 67.29 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.3 46.01 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.962 0.411 . . . . 0.0 110.962 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -101.99 159.78 15.07 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.744 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 151.68 37.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -133.65 135.76 44.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.327 0.584 . . . . 0.0 111.925 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.88 123.56 26.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -135.71 134.57 39.24 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.096 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.56 89.57 3.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 p -71.78 112.42 7.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' O ' ' OG ' ' A' ' 58' ' ' SER . 95.5 mt -112.0 144.2 41.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.76 0.791 . . . . 0.0 112.415 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -63.26 -27.84 69.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.605 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -125.14 143.79 50.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.122 0.487 . . . . 0.0 111.719 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.58 143.82 29.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.342 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' PRO . 38.7 t -117.89 138.0 24.93 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.202 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -62.32 -143.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.229 1.118 . . . . 0.0 110.649 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -125.76 115.64 43.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.45 -29.37 3.16 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.89 -16.07 28.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.967 0.413 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.39 140.35 38.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -128.64 139.47 52.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.115 0.483 . . . . 0.0 111.553 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 96.6 m95 -140.23 106.78 5.32 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.438 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 84.0 m-85 -158.88 157.84 32.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.671 0.748 . . . . 0.0 111.714 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.927 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.49 129.8 75.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -66.17 120.64 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.264 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.43 -2.35 18.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.572 ' O ' HD11 ' A' ' 39' ' ' ILE . . . -165.06 62.16 0.12 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.639 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.49 110.95 0.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 44' ' ' VAL . 4.1 m -79.03 116.75 23.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.616 0.722 . . . . 0.0 112.17 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -82.91 155.12 67.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.043 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -49.28 -24.46 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.486 1.458 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -106.58 27.26 9.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 49' ' ' SER . 41.8 t0 -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.189 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 42.8 p -88.33 -37.69 15.75 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -86.45 -32.9 20.59 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.444 ' NE1' HD13 ' A' ' 64' ' ' LEU . 19.0 m-90 -110.81 145.79 37.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.774 0.321 . . . . 0.0 110.823 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.421 ' HB ' HD23 ' A' ' 63' ' ' LEU . 88.5 m -132.07 127.57 36.39 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.34 135.13 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 p -144.55 156.9 44.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.417 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.6 100.57 4.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.45 112.0 24.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.674 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.23 -123.92 34.67 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 26' ' ' LEU . 6.0 t -106.62 48.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -144.13 139.6 28.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -117.8 118.05 30.98 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.26 106.1 14.97 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.272 0.558 . . . . 0.0 111.659 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.798 ' C ' HD13 ' A' ' 63' ' ' LEU . 10.6 tp -114.24 126.88 55.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.503 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.913 HD22 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -125.35 -177.41 3.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.302 1.048 . . . . 0.0 111.032 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 65' ' ' ARG . 40.8 tp -144.16 117.72 9.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.792 -2.004 . . . . 0.0 106.931 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 64' ' ' LEU . 24.5 mmt85 -64.14 -129.07 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.521 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.6 p -78.23 108.9 11.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.94 141.32 56.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 81.0 mt-30 -129.55 142.08 44.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.876 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.73 84.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.296 1.33 . . . . 0.0 111.473 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' GLN . 45.4 t-80 174.15 -23.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.084 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.4 -7.42 59.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.819 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.47 145.62 22.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.611 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.11 -165.38 38.53 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.42 150.47 20.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 85.8 t -117.4 115.33 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.508 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 m -131.55 130.89 42.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -142.23 146.99 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.3 155.1 30.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.164 0.507 . . . . 0.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' ASP . 8.4 t -156.12 -138.59 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.109 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' ALA . 24.3 mmm180 -55.57 89.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.0 p-10 39.52 22.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.767 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -105.84 75.21 1.1 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.98 137.46 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.438 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -151.74 117.43 5.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 41.9 m -92.38 -173.88 3.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.342 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 176.1 172.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.203 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -140.88 135.62 31.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.229 0.538 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.0 tp -120.03 128.34 53.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -142.84 146.51 34.22 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.8 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.1 p -109.85 126.73 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 110.919 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 3.1 mm? . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.1 mt -91.85 119.1 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.717 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.1 mp -82.94 -70.83 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -141.83 136.63 30.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.303 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.881 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.73 143.71 50.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.594 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 117.82 29.93 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 1.2 mmpt? -130.36 178.02 6.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.867 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' LYS . 78.5 m-20 52.22 108.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.412 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.86 137.04 9.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.57 0.7 . . . . 0.0 112.028 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.53 125.42 48.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.816 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.65 103.88 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.351 0.596 . . . . 0.0 111.675 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -61.77 141.01 58.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.947 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.85 114.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.58 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.78 7.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.56 155.41 46.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -100.8 153.99 19.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.044 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.26 143.77 34.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 p -121.57 135.62 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.324 0.583 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.97 122.84 27.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -137.08 136.37 38.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 m -127.07 92.88 3.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.916 0.388 . . . . 0.0 111.822 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.572 HG23 ' NE2' ' A' ' 59' ' ' HIS . 72.8 m -74.71 110.16 8.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.575 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.87 -167.05 1.32 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.105 0.478 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 t -107.93 -11.64 15.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.261 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.4 pm0 -140.68 149.11 41.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.703 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.65 146.38 23.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 31' ' ' PRO . 59.4 t -102.02 125.97 35.12 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.611 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.81 -141.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.181 1.254 . . . . 0.0 110.411 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.94 124.52 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.01 31.69 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.687 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.14 -11.58 49.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.309 0.554 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -143.16 53.29 1.36 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -90.37 110.53 21.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.402 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -157.96 152.69 25.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.583 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 39' ' ' ILE . 3.5 mm -74.73 117.07 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.78 95.04 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 133.57 -24.6 3.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 106.01 4.76 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.49 58.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.7 m -82.46 124.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.359 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.02 153.85 60.29 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.29 -33.38 45.22 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.334 1.356 . . . . 0.0 111.072 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 49' ' ' SER . 87.5 m-20 -88.44 14.73 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.881 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' ASP . 48.8 p-10 -32.97 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.507 . . . . 0.0 111.719 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 47' ' ' ASP . 16.1 t -68.01 -40.13 83.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.236 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.06 -27.55 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.447 ' CE3' HD13 ' A' ' 64' ' ' LEU . 4.5 m95 -115.24 152.15 33.21 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.39 -0.194 . . . . 0.0 110.699 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -144.87 152.24 39.95 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 111.228 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.44 139.25 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.855 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 61' ' ' ALA . 2.2 p -140.75 156.05 46.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.544 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.15 107.53 4.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -108.72 104.02 13.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.735 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.38 -134.61 45.15 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.1 m -89.48 38.55 0.91 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.68 0.276 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.572 ' NE2' HG23 ' A' ' 25' ' ' THR . 57.4 m80 -137.59 142.42 41.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.839 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.55 159.88 20.68 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -152.57 82.98 1.23 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.669 0.747 . . . . 0.0 110.749 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -92.15 144.59 25.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.249 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 63' ' ' LEU . 2.8 pp -141.02 174.07 10.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.281 1.039 . . . . 0.0 112.654 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.447 HD13 ' CE3' ' A' ' 51' ' ' TRP . 48.7 tp -142.24 118.16 10.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 113.057 -1.883 . . . . 0.0 106.895 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LEU . 69.5 mtt180 -66.04 -131.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.477 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.1 m -81.57 106.58 13.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.91 0.386 . . . . 0.0 110.815 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.53 54.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.727 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.665 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 55.0 mt-30 -124.66 148.02 57.77 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -44.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.704 1.603 . . . . 0.0 111.451 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . 13.7 t-80 164.15 -21.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.665 ' HD1' ' H ' ' A' ' 68' ' ' GLN . 76.1 m80 -79.87 -8.91 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.17 145.45 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.96 -141.82 7.64 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 39' ' ' ILE . 91.3 mt-10 -134.47 169.99 16.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.547 0.339 . . . . 0.0 110.171 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 44.8 t -128.87 129.15 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.318 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -133.69 130.01 37.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.974 0.416 . . . . 0.0 111.222 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -132.27 141.83 49.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.13 143.8 15.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 10.6 t -158.86 -136.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.286 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 43.8 mtm180 -59.87 85.52 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.186 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' CYS . 94.3 m-20 51.65 14.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.21 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.03 91.36 8.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 110.194 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -81.27 138.72 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.013 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.461 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -164.94 160.46 19.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 16.8 p -160.38 -178.49 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.764 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.65 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 179.84 170.88 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.201 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -129.68 121.38 26.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.195 0.521 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' GLY . 41.6 tp -104.34 128.64 52.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.922 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 t -143.58 125.03 14.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.695 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.51 113.47 28.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.631 -178.692 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.587 0.232 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -92.85 94.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.327 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 6' ' ' LEU . 8.3 mp -61.65 -46.78 88.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.118 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.51 114.62 18.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.907 0.384 . . . . 0.0 110.226 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 116.85 33.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.689 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HB3' ' H ' ' A' ' 23' ' ' THR . 34.6 tp -101.4 120.52 40.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.371 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.725 ' CE ' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.64 -163.88 1.85 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.295 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 57.84 108.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.76 139.07 9.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.825 0.821 . . . . 0.0 113.014 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.06 130.95 53.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.688 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 90' ' ' VAL . 9.1 m -136.14 108.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -77.48 169.85 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.146 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.33 107.01 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.34 -7.68 40.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 65' ' ' ARG . . . -76.39 -178.35 4.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.411 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -136.86 149.76 47.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.52 133.47 55.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.216 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.2 t -121.22 106.7 11.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.131 0.491 . . . . 0.0 111.45 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -118.57 106.83 13.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 3.7 p -138.23 147.34 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 31.1 p -134.56 99.45 4.35 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.818 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 m -69.98 110.72 5.21 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.373 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -94.05 175.62 6.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.704 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 t -114.92 -5.57 12.56 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -127.06 137.82 53.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.3 136.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.018 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.3 133.71 24.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.519 -0.277 . . . . 0.0 110.68 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.96 -154.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 119.844 0.98 . . . . 0.0 109.938 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.97 104.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.74 -50.9 0.4 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -69.58 -43.64 72.44 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.8 143.89 37.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.591 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -142.25 127.9 19.15 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 121.011 0.434 . . . . 0.0 111.075 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 33.6 m95 -122.96 111.97 17.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.145 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 87.0 m-85 -157.54 157.73 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 111.336 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.846 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.78 128.57 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.335 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -61.85 118.66 7.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.576 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.7 -0.99 20.1 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.523 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -164.43 68.8 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.821 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.34 131.07 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.69 110.67 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.857 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -92.94 154.42 41.85 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.582 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.65 -25.78 43.29 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 120.999 1.133 . . . . 0.0 110.633 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.89 11.47 29.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.708 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 51' ' ' TRP . 44.4 p-10 -42.77 115.96 0.8 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.5 p -87.87 -39.68 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.665 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -88.97 -26.03 21.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 10.6 m-90 -110.5 145.31 37.94 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HD12 ' A' ' 62' ' ' LEU . 96.7 m -124.54 126.11 45.29 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 p -125.03 129.92 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -143.99 153.16 41.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.43 98.54 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.995 0.426 . . . . 0.0 110.107 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.67 96.83 7.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.04 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.27 -128.17 41.27 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 m -92.79 42.68 1.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -149.41 135.53 18.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -121.74 140.52 52.23 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 130.55 37.83 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 111.548 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 52' ' ' THR . 40.4 tp -135.28 122.7 21.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.865 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' HD12 ' A' ' 63' ' ' LEU . 2.5 pp -141.02 139.76 34.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.1 tp -106.34 119.61 39.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mtt-85 -63.91 -101.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.902 -177.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.6 p -82.81 99.19 9.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.917 0.389 . . . . 0.0 111.312 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.68 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.423 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.686 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 83.6 mt-30 -130.62 139.34 35.3 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.012 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -55.36 85.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.072 1.181 . . . . 0.0 110.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.1 t60 -175.06 -48.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 25.5 p80 -76.96 -0.37 24.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.635 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.05 146.88 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.0 -148.57 12.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.0 mp0 -115.32 156.36 25.63 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.76 0.314 . . . . 0.0 110.399 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.7 t -117.93 116.56 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.489 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.3 m -123.73 131.78 53.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.192 0.52 . . . . 0.0 110.774 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -136.13 130.96 34.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.231 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.46 150.73 51.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.447 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.5 t -153.33 -144.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.649 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' ALA . 21.1 mmm180 -52.77 88.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.953 0.406 . . . . 0.0 109.966 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.8 p30 42.71 17.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -101.7 86.23 2.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 83' ' ' VAL . 10.5 p -82.31 127.33 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.09 129.32 21.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.535 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 11.1 p -92.83 -175.26 3.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.479 0.657 . . . . 0.0 111.631 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 175.68 171.97 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.81 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -146.52 138.57 24.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.985 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.2 tp -117.95 128.85 55.2 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.548 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 t -141.31 153.33 45.1 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.525 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.0 p -106.6 116.11 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.283 -179.265 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.0 mt -82.52 123.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 6' ' ' LEU . 8.3 mp -95.39 -38.84 10.31 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.69 146.32 25.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.207 0.527 . . . . 0.0 110.909 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 8' ' ' LEU . 3.1 pp -161.28 121.67 2.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -125.92 116.18 21.11 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 45.2 mtpt -146.95 -164.22 1.94 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.434 0.635 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.554 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 33.0 t-20 56.02 97.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.789 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -167.27 140.67 3.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.403 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.87 140.33 36.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.65 130.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.922 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -58.76 -172.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . . . -76.44 150.04 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.476 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 -3.18 81.88 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.3 144.97 25.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.127 0.489 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -88.29 145.94 25.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.67 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.69 52.35 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.2 p -152.95 123.36 7.17 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.341 0.591 . . . . 0.0 112.009 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -125.94 143.96 50.88 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.95 143.76 31.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.076 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 26' ' ' LEU . 5.0 t -127.57 88.28 2.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.787 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.634 HG23 ' NE2' ' A' ' 59' ' ' HIS . 44.1 m -75.07 94.06 2.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.853 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.571 HD21 ' SG ' ' A' ' 24' ' ' CYS . 66.1 mt -82.58 -160.9 0.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.956 0.884 . . . . 0.0 112.949 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.3 t -117.39 -19.08 9.68 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.77 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -121.24 150.0 42.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.189 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.32 141.04 30.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 31' ' ' PRO . 22.6 t -117.04 128.19 26.2 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.623 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.2 Cg_exo -60.17 -146.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.913 1.076 . . . . 0.0 111.217 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.01 120.4 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.67 -26.57 8.4 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.955 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 75.8 tt0 -87.1 -12.12 48.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.918 0.359 . . . . 0.0 110.392 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.53 122.69 47.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -92.79 141.13 28.78 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 95.9 m95 -153.21 101.32 2.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.117 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -160.86 167.09 27.4 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.196 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' ASN . 2.0 mp -118.24 94.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ILE . 22.3 t-20 -32.46 123.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 -2.29 29.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.65 79.1 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.133 -0.533 . . . . 0.0 109.683 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.23 58.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.91 131.78 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.991 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -96.42 151.15 37.87 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.91 -29.69 91.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.051 1.167 . . . . 0.0 112.752 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -94.83 0.56 54.95 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -69.01 130.47 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.5 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -97.69 -2.56 41.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -80.2 -29.25 38.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.949 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -112.52 140.52 47.19 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.4 m -131.82 125.95 33.11 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.27 131.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.3 p -143.82 147.39 34.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.534 0.683 . . . . 0.0 112.291 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.97 112.37 24.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.578 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -120.81 101.44 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.78 -122.11 25.33 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' ND1' ' A' ' 59' ' ' HIS . 47.9 t -110.81 44.77 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.634 ' NE2' HG23 ' A' ' 25' ' ' THR . 32.7 m80 -141.93 135.62 29.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.998 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -117.69 126.74 53.03 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.44 119.06 29.86 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.61 ' C ' HD23 ' A' ' 62' ' ' LEU . 6.5 tt -130.51 123.8 30.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.496 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 62' ' ' LEU . 2.8 pp -121.55 162.65 20.21 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 0.0 110.535 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 65' ' ' ARG . 28.5 tp -124.44 117.71 25.03 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 64' ' ' LEU . 56.4 ttp180 -57.39 -109.19 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.001 -177.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.1 p -87.38 121.24 29.56 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 16' ' ' ALA . . . -64.48 138.6 58.5 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' HIS . 23.3 pt20 -133.21 137.23 28.85 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 119.681 -0.199 . . . . 0.0 110.476 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.71 84.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 120.795 0.996 . . . . 0.0 110.722 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 -177.74 -39.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.735 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.477 ' CD2' HD21 ' A' ' 64' ' ' LEU . 3.5 p80 -71.99 -33.69 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.78 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 71' ' ' HIS . . . -35.54 143.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.88 -132.42 3.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.82 129.86 53.73 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.535 0.207 . . . . 0.0 110.634 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.99 130.86 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 m -132.7 123.77 26.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -139.14 128.16 23.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.183 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.441 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -156.99 154.7 30.05 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.549 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 18.1 p -154.67 -132.78 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.623 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 30.8 mmt180 -54.3 84.24 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.109 0.48 . . . . 0.0 109.796 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' CYS . 87.9 m-20 46.16 13.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.56 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.612 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -94.47 70.18 3.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.2 t -81.27 132.52 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.242 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.01 117.95 5.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.971 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.4 p -127.43 147.17 50.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.549 0.69 . . . . 0.0 111.537 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 11' ' ' ASN . . . -157.9 151.93 24.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.939 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -97.62 131.66 43.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 12' ' ' ALA . 46.3 tp -106.48 134.78 49.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -136.13 162.17 33.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.334 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.54 132.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.151 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.571 HD13 ' C ' ' A' ' 91' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.745 0.307 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG13 ' HB1' ' A' ' 82' ' ' ALA . 91.3 mt -100.18 120.9 50.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.049 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.603 HD21 ' OG ' ' A' ' 27' ' ' SER . 86.8 mt -80.97 -69.35 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.93 124.13 34.34 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -110.8 146.56 36.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.388 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.574 ' C ' HD23 ' A' ' 9' ' ' LEU . 6.4 tt -109.05 114.22 27.78 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.408 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -136.2 174.36 10.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.691 -176.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 60.76 107.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.602 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.23 135.7 11.33 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.853 0.835 . . . . 0.0 112.859 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 158.09 16.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.826 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.84 164.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 111.623 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 18' ' ' ALA . 95.2 mtm-85 -128.32 159.32 35.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.845 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.79 101.66 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.578 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.96 -9.27 54.95 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB3' ' H ' ' A' ' 15' ' ' ARG . . . -78.09 174.93 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 111.015 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -115.22 153.64 30.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.75 149.4 47.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.26 142.8 44.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -148.25 133.35 18.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 3.3 t -149.14 155.53 40.82 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.859 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 t -148.67 96.04 2.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 111.927 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 m -69.92 123.03 20.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.58 150.66 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.5 0.667 . . . . 0.0 112.668 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.603 ' OG ' HD21 ' A' ' 6' ' ' LEU . 17.5 m -74.68 -18.23 60.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.341 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -138.02 140.82 40.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.474 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.0 147.67 42.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.532 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 31' ' ' PRO . 41.3 t -105.53 134.77 19.53 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.2 Cg_exo -61.36 -144.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 CA-C-N 120.218 1.114 . . . . 0.0 110.405 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.78 125.12 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.3 -16.05 57.14 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.617 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -89.89 -19.94 23.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.74 23.8 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.432 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 8.6 t -154.29 129.12 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.738 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.544 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 77.7 m95 -150.37 102.42 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 14.6 p90 -155.57 154.51 31.81 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.777 HD13 ' N ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -68.81 97.97 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -48.53 96.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 142.25 -20.08 2.46 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 110.41 4.5 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.34 138.01 58.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.3 t -91.83 128.26 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 111.673 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -84.93 153.24 60.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.652 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 48' ' ' ASP . 2.0 Cg_endo -55.44 -34.08 88.05 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.574 1.516 . . . . 0.0 111.717 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -78.58 21.06 0.4 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.749 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 46' ' ' PRO . 27.5 p-10 -47.53 98.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.7 t -81.41 -49.18 10.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.246 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -64.34 -37.93 89.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.926 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -110.18 161.73 15.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.284 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -138.16 141.02 40.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.94 134.58 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 p -141.75 153.75 44.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.477 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 120.6 3.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.63 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -138.03 116.47 12.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.396 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.26 -108.72 2.61 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -130.67 31.83 4.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.75 0.31 . . . . 0.0 110.476 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.499 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 8.7 t-80 -130.75 132.09 45.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.268 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.42 159.98 16.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.51 97.73 1.35 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.996 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.02 130.91 53.86 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.541 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -178.71 4.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.954 0.883 . . . . 0.0 112.016 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -144.67 120.12 10.32 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.049 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -69.0 -130.54 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.278 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.9 p -58.73 100.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 0.0 111.897 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 139.51 58.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.958 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.26 144.63 52.08 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.571 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -52.5 91.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.337 1.358 . . . . 0.0 111.262 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 8.2 m-70 165.11 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -83.3 -7.42 59.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 148.66 43.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.791 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.75 -160.62 31.65 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.3 167.02 11.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.828 0.347 . . . . 0.0 110.39 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 50.8 t -133.28 133.27 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.75 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 m -131.98 128.23 37.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.311 0.577 . . . . 0.0 111.52 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 0.3 OUTLIER -131.05 137.93 49.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.759 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -164.35 152.43 12.49 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 21.2 p -156.48 -133.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.816 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 49.3 mmm-85 -59.14 92.08 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 42.54 18.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.773 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -107.3 73.7 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.12 153.79 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.798 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.22 178.67 8.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.602 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 p -154.69 -179.14 7.72 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.537 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . -178.16 166.55 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.282 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -126.47 135.98 52.04 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.04 0.447 . . . . 0.0 110.353 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 130.53 54.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -152.88 149.66 28.49 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.619 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.3 p -110.66 120.51 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.46 0.475 . . . . 0.0 109.905 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 91' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -73.66 121.48 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.524 HD12 ' H ' ' A' ' 6' ' ' LEU . 5.0 mp -82.02 -70.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -127.85 119.72 26.24 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.895 0.378 . . . . 0.0 111.08 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 tp -114.58 130.58 56.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 23' ' ' THR . 10.8 mp -99.92 123.01 43.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.259 0.552 . . . . 0.0 110.61 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ASN . 4.5 mmpt? -138.75 -178.34 5.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.282 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 10' ' ' LYS . 58.8 t-20 55.14 109.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.553 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.38 136.62 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.964 0.888 . . . . 0.0 113.217 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.84 135.9 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.434 ' CG2' ' NE2' ' A' ' 71' ' ' HIS . 15.6 m -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.018 0.913 . . . . 0.0 112.895 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -81.74 151.99 27.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.493 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.94 128.28 32.67 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.95 39.85 53.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.88 149.69 47.28 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.809 0.338 . . . . 0.0 111.434 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -102.66 151.06 22.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.96 28.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.397 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.55 147.32 48.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.411 0.624 . . . . 0.0 111.993 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -140.55 127.04 20.09 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.607 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.503 HG22 HD22 ' A' ' 9' ' ' LEU . 2.9 t -144.53 147.29 33.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.287 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.464 ' SG ' HD21 ' A' ' 26' ' ' LEU . 30.7 t -130.86 93.1 3.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 111.258 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 59' ' ' HIS . 32.2 m -72.56 113.87 10.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.464 HD21 ' SG ' ' A' ' 24' ' ' CYS . 96.2 mt -113.98 145.32 41.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.09 0.472 . . . . 0.0 111.899 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -71.46 -10.45 59.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.982 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -133.53 137.24 45.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.15 143.33 32.46 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.555 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 31' ' ' PRO . 31.2 t -124.03 128.75 24.99 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.06 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.9 Cg_endo -58.41 -150.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.944 1.096 . . . . 0.0 111.056 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -114.37 102.99 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.34 -49.39 0.48 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.73 -40.46 76.2 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.664 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.63 37.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -124.52 131.1 53.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.039 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.509 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 93.5 m95 -133.37 100.29 4.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.085 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 78.4 m-85 -152.63 153.84 34.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.114 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.16 129.32 74.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.788 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.07 123.55 19.79 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.569 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.2 3.96 20.86 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.471 ' HB1' ' CH2' ' A' ' 51' ' ' TRP . . . -171.56 96.44 0.18 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.977 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 135.83 50.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.86 104.99 14.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.426 0.632 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.63 153.13 47.79 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.363 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.46 -27.87 26.06 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.299 1.333 . . . . 0.0 110.903 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -96.67 12.41 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.508 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 22.9 p30 -39.21 110.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.292 0.568 . . . . 0.0 110.756 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.43 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 2.9 t -76.79 -52.51 9.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.341 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.41 -31.9 37.56 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.471 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 21.5 m-90 -107.47 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.403 ' OG1' HD11 ' A' ' 63' ' ' LEU . 15.8 m -130.2 138.98 50.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.3 131.57 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.8 p -144.5 156.12 44.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.167 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 107.15 4.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.551 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -112.56 103.74 11.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.15 -131.59 27.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -97.13 39.36 1.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.572 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.498 ' CE1' HG23 ' A' ' 25' ' ' THR . 80.4 m-70 -137.35 138.5 40.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.431 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -110.85 156.33 21.29 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -158.83 93.7 1.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.924 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -110.18 129.89 55.64 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.471 HD12 ' C ' ' A' ' 63' ' ' LEU . 1.9 pp -122.76 -177.25 3.6 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.064 0.935 . . . . 0.0 112.886 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 65' ' ' ARG . 31.5 tp -144.21 116.54 8.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.141 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' NH2' ' O ' ' A' ' 49' ' ' SER . 13.9 ptp180 -64.67 -129.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.917 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -76.4 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 0.0 110.372 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 71' ' ' HIS . . . -64.68 142.2 58.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 0.0 110.846 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' HIS . 18.9 mm100 -132.97 145.5 57.32 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.778 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.92 85.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.422 1.414 . . . . 0.0 111.303 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' GLN . 67.9 t60 175.98 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.216 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.509 ' CD2' ' HB1' ' A' ' 67' ' ' ALA . 5.8 p80 -76.99 -7.05 54.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.99 145.39 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.003 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.08 36.41 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -88.46 152.03 22.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.413 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 89.7 t -120.93 121.18 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -131.83 132.19 43.5 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.308 0.575 . . . . 0.0 112.218 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 2.2 t80 -138.92 140.55 38.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.137 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.59 152.81 41.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -156.53 -151.64 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.112 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.66 87.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.285 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' CYS . 96.0 m-20 54.0 17.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.663 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.77 68.27 0.92 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.102 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.25 132.72 31.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.136 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.68 130.37 8.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.27 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 1.5 t -92.98 -170.88 2.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 178.48 169.24 0.83 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.979 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -138.59 136.87 36.44 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.702 0.287 . . . . 0.0 110.782 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.03 128.04 50.95 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -142.96 146.92 34.39 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.805 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.5 p -110.98 124.53 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.829 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 -178.882 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.0 m95 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.54 -172.09 3.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.764 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -126.45 45.76 2.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.315 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -75.58 136.44 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 5' ' ' ILE . 2.7 pt -80.65 119.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD12 ' H ' ' A' ' 6' ' ' LEU . 5.5 mp -77.03 -67.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.445 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -146.64 142.01 27.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.825 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.31 137.47 52.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.002 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 9' ' ' LEU . 10.1 mp -96.95 108.41 21.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -116.82 175.85 5.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.348 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.19 108.38 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.252 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.64 134.18 13.6 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.67 0.748 . . . . 0.0 112.778 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.47 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.42 114.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -76.94 171.06 15.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.181 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.59 129.78 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.143 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.8 89.11 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.219 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.72 -171.15 3.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 20' ' ' ALA . 5.4 tm0? -141.48 157.13 45.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 19' ' ' GLN . . . -117.74 138.95 51.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.784 0.326 . . . . 0.0 110.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 27.0 p -125.38 104.55 8.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.324 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -124.4 117.55 24.69 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.429 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -144.54 150.03 36.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.578 ' SG ' HD21 ' A' ' 26' ' ' LEU . 33.3 t -132.75 98.86 4.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.964 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.415 HG23 ' NE2' ' A' ' 59' ' ' HIS . 57.3 m -79.92 114.72 19.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.578 HD21 ' SG ' ' A' ' 24' ' ' CYS . 84.6 mt -105.64 -167.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.838 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -112.87 -2.27 14.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.66 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -145.09 143.31 30.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.277 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.0 137.0 33.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.909 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 20.5 t -114.01 133.92 22.25 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.611 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.5 Cg_exo -61.51 -142.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.816 1.011 . . . . 0.0 109.978 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.0 t -121.45 110.13 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.43 -45.0 0.71 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.84 -12.89 59.73 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.31 132.67 52.08 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -127.52 118.95 24.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.623 ' CE2' ' CD1' ' A' ' 77' ' ' PHE . 75.4 m95 -118.52 106.32 12.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -151.05 149.2 29.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.594 0.711 . . . . 0.0 111.749 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 74' ' ' GLU . 4.1 mp -117.12 122.85 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -61.02 126.68 28.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.596 1.089 . . . . 0.0 110.341 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 -4.93 24.44 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.18 94.2 0.24 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.307 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.63 132.56 45.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 44' ' ' VAL . 35.3 m -85.25 106.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.245 0.545 . . . . 0.0 111.193 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -80.78 156.4 72.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -47.99 -26.72 7.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.264 1.31 . . . . 0.0 110.54 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -107.22 27.25 9.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -57.66 132.06 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.09 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.3 p -90.66 -43.28 10.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.057 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.85 -40.1 63.51 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.443 ' NE1' HD13 ' A' ' 64' ' ' LEU . 28.7 m-90 -106.68 152.79 23.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.188 0.518 . . . . 0.0 110.699 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.8 m -132.12 132.59 43.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.89 138.1 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 110.301 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -146.1 158.81 43.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.135 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.96 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.368 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -129.57 102.95 6.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.973 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.84 -134.22 23.54 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -91.73 20.04 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.456 0.169 . . . . 0.0 111.445 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.415 ' NE2' HG23 ' A' ' 25' ' ' THR . 75.4 m80 -123.61 124.32 42.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.62 0.248 . . . . 0.0 111.166 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -112.21 119.36 38.08 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.71 131.03 56.33 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.416 0.626 . . . . 0.0 111.339 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.35 131.85 28.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.943 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.65 -174.61 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.301 1.048 . . . . 0.0 111.643 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 65' ' ' ARG . 8.0 tp -142.21 119.64 11.63 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 113.007 -1.906 . . . . 0.0 107.351 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.9 mtt180 -61.65 -138.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 p -69.57 112.93 6.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.97 137.89 57.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 70' ' ' HIS . 83.6 mm-40 -129.54 143.14 47.75 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.622 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.44 83.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.09 1.193 . . . . 0.0 111.145 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 68' ' ' GLN . 86.1 t60 174.85 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.887 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -76.38 -1.75 28.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.67 144.27 43.89 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.993 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.94 179.66 40.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 39' ' ' ILE . 94.9 mt-10 -87.29 157.6 19.26 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.687 -0.302 . . . . 0.0 110.351 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.635 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 44.6 t -120.31 116.81 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.675 0.274 . . . . 0.0 110.558 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -131.38 133.96 45.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 12.5 t80 -141.23 142.47 33.95 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.527 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.28 145.52 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -156.67 -153.09 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.379 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' HE ' HG22 ' A' ' 30' ' ' VAL . 96.0 mtt-85 -55.08 87.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.846 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 55.11 13.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.03 90.36 6.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.404 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -87.91 136.58 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 164.17 35.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.155 0.503 . . . . 0.0 111.212 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 88.3 p -159.95 178.64 9.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.646 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.635 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 175.49 179.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.259 0.552 . . . . 0.0 111.364 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -133.42 110.34 9.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.396 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -102.29 128.69 48.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 147.28 33.15 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.7 132.46 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.986 0.422 . . . . 0.0 110.811 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.494 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 2.9 mm? -86.98 132.24 33.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.99 14.44 11.21 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 95' ' ' ASP . 28.7 mt -103.05 108.05 57.33 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.497 -0.287 . . . . 0.0 110.65 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -69.97 21.42 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.169 1.246 . . . . 0.0 111.348 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 93' ' ' LEU . 95.1 m-20 -84.03 -1.35 54.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.86 103.45 2.22 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 97' ' ' LEU . 9.6 mp -87.72 142.14 28.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.794 0.331 . . . . 0.0 110.457 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -133.8 149.7 51.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.239 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -83.61 117.1 22.94 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -86.14 -9.21 57.05 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -97.85 110.72 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.633 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -66.83 -43.34 83.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.542 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 84.3 t60 -150.39 167.45 27.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.764 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.542 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 98.0 m-70 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.436 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 4' ' ' GLU . 88.9 mtm180 -97.06 173.67 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 mp -75.43 37.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 2' ' ' ARG . 9.6 pt-20 -79.18 149.27 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.659 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.56 119.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.19 -68.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.753 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.29 140.93 30.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.425 0.631 . . . . 0.0 112.164 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.4 pt? -130.1 134.12 47.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.623 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.0 tp -101.7 116.99 33.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.12 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -129.75 -170.25 2.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.5 t30 61.4 108.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.496 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.62 133.86 13.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.018 0.913 . . . . 0.0 113.216 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.34 133.89 54.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.2 m -134.2 112.39 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.754 0.788 . . . . 0.0 112.163 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ALA . 56.2 ttm-85 -84.68 147.22 27.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.937 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ARG . . . -34.75 121.83 0.52 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.377 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 14.1 61.34 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.0 150.74 28.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.749 0.309 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -101.69 172.19 7.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.096 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -131.95 138.39 48.31 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.845 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -128.48 112.28 14.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.345 0.593 . . . . 0.0 111.843 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CE2' ' HB1' ' A' ' 20' ' ' ALA . 82.4 m-85 -124.22 116.73 23.17 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -138.49 141.37 39.4 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.793 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -127.01 96.2 4.54 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.516 HG23 ' ND1' ' A' ' 59' ' ' HIS . 16.9 m -73.78 107.23 5.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.528 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -100.24 -171.85 2.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 t -112.12 -11.2 13.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.664 ' H ' HH21 ' A' ' 80' ' ' ARG . 47.7 tp10 -138.75 145.58 40.39 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.161 0.505 . . . . 0.0 110.952 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.21 139.27 39.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.942 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 31' ' ' PRO . 8.7 t -112.9 128.53 25.49 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.78 -145.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 120.074 1.062 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.56 110.67 27.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.26 -29.5 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.52 -17.82 29.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.79 141.98 43.4 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -130.81 132.53 45.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.651 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.563 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 94.9 m95 -130.27 110.42 11.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 85.7 m-85 -158.98 154.35 25.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.201 0.524 . . . . 0.0 111.476 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.33 122.77 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.04 124.41 20.73 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.682 1.128 . . . . 0.0 110.346 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.43 2.39 31.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 100.17 0.79 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.91 136.09 50.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.89 100.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASP . 43.7 mt-30 -87.42 151.17 50.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.73 -22.42 13.36 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.335 1.357 . . . . 0.0 110.644 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.91 14.75 12.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.929 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' GLN . 25.9 p30 -42.8 112.22 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.207 0.527 . . . . 0.0 111.435 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 t -84.7 -46.58 11.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.917 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -85.14 -25.44 27.46 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -113.44 147.56 37.58 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.5 m -126.65 130.04 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.4 130.46 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 p -144.6 153.99 42.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.904 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.21 103.72 6.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.432 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.43 110.78 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.176 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.91 -133.71 52.61 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.54 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 24.4 m -95.41 38.87 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 110.42 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.54 ' ND1' ' O ' ' A' ' 58' ' ' SER . 12.9 m-70 -141.04 141.28 34.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.07 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -129.29 137.27 50.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.74 131.03 47.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.231 0.539 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -124.02 131.6 53.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.399 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.67 165.66 12.79 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.507 1.146 . . . . 0.0 113.711 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 24.9 tp -141.68 113.67 7.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 111.835 -2.439 . . . . 0.0 106.152 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' LEU . 61.8 ttt180 -64.08 -126.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -80.87 109.59 15.58 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.662 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.93 136.05 55.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -133.81 144.57 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.928 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -51.49 94.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.366 1.377 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER 160.82 -21.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.462 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.71 -6.75 55.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.485 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 150.21 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.48 39.21 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.255 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -98.41 151.57 20.42 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.46 115.04 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.6 m -122.36 132.94 54.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 111.568 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 4.2 t80 -144.66 135.38 24.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.977 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ASP . 28.6 p -153.76 -134.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.805 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.664 HH21 ' H ' ' A' ' 28' ' ' GLU . 47.0 mtm180 -52.56 82.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' CYS . 97.3 m-20 45.12 10.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.826 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -97.62 91.38 5.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 83' ' ' VAL . 10.6 p -81.2 126.4 39.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.35 133.19 13.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -152.26 133.0 14.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.24 -159.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.769 0.795 . . . . 0.0 111.458 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -142.7 117.25 9.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.852 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.9 tp -107.64 133.02 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 t -136.51 148.66 47.76 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.6 t -111.91 125.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 91' ' ' LEU . 9.2 mp -92.93 135.63 33.98 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.091 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.55 -117.92 0.51 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -102.96 107.15 54.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.79 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.202 1.268 . . . . 0.0 111.423 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.34 -79.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.371 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.61 -15.14 2.24 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.26 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.9 pt? -75.38 134.81 40.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.411 0.606 . . . . 0.0 110.388 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -100.22 -13.2 19.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.065 0.459 . . . . 0.0 109.984 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.435 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 4.0 p80 -126.34 137.01 53.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.009 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.456 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 14.2 p80 -90.73 127.95 36.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 101' ' ' HIS . 86.0 t60 -130.6 -3.24 4.23 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.398 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.53 162.02 41.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.471 . . . . 0.0 111.002 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -46.89 170.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.827 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.3 m0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -97.17 150.25 21.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.1 mt -102.15 7.16 41.05 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.298 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -96.1 -134.72 0.22 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.793 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.61 97.79 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.639 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.82 -54.2 42.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.051 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -138.4 132.38 31.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.775 0.322 . . . . 0.0 110.258 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -118.55 147.3 43.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 8' ' ' LEU . 10.9 mp -121.48 123.0 41.0 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' H ' ' HE3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.23 -165.64 2.27 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.56 108.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 144.67 3.8 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.89 0.852 . . . . 0.0 113.033 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.09 135.91 51.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.796 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.1 113.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -76.39 170.02 17.15 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.42 109.72 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.168 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.36 -1.23 50.14 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.45 152.12 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.091 0.445 . . . . 0.0 110.136 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -106.94 154.22 21.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.863 0.363 . . . . 0.0 111.809 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.74 142.11 51.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.711 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -130.67 123.54 29.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 0.0 111.529 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -133.12 123.25 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.55 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.0 t -147.62 154.22 40.37 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.326 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HG ' ' HZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -140.01 99.93 3.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 109.968 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -81.05 120.68 25.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.084 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.2 -174.79 2.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.44 1.99 14.53 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -138.9 143.93 38.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.135 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -75.84 138.99 41.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.402 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.44 136.81 19.88 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.56 -148.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.319 1.15 . . . . 0.0 110.501 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -121.99 124.66 71.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.1 -35.59 4.3 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -70.93 -42.06 70.37 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 140.67 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -148.06 116.25 6.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.866 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.595 ' HZ2' ' HG ' ' A' ' 24' ' ' CYS . 48.6 m95 -109.68 125.14 52.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.442 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 91.3 m-85 -156.86 152.26 26.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 111.517 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.09 119.52 60.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -58.69 116.84 3.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.05 -3.11 9.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.9 107.05 0.13 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.39 132.21 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.072 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.78 104.61 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.197 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -89.14 154.65 49.46 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.44 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -53.07 -25.79 30.17 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.462 1.441 . . . . 0.0 110.057 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -91.31 11.96 21.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.149 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 39.3 p-10 -37.69 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -73.11 -45.8 54.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.484 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.0 -29.08 17.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -102.34 147.06 27.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.187 0.518 . . . . 0.0 111.015 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.1 m -122.15 126.12 47.63 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.91 128.18 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.1 p -142.82 151.76 41.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.056 0.455 . . . . 0.0 111.151 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.14 103.84 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.867 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -104.91 109.12 20.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.715 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.85 -119.17 16.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -105.31 47.43 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.662 0.267 . . . . 0.0 110.449 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.55 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 9.3 t-160 -145.82 138.88 25.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 78.3 m80 -127.05 138.49 53.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.67 109.1 4.33 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.581 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.0 tt -112.67 127.13 56.03 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.396 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 62' ' ' LEU . 2.1 pp -138.38 143.24 39.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 tp -101.83 128.4 48.21 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -71.59 -108.58 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.209 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.9 p -79.91 96.21 6.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 111.234 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.39 142.29 55.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.739 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 70' ' ' HIS . 17.0 mm100 -130.97 144.15 52.36 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.63 84.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.402 1.401 . . . . 0.0 111.378 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' GLN . 78.6 t60 176.25 -28.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -81.77 -6.14 58.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 148.49 9.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.88 -164.91 38.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -104.06 153.71 20.56 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 60.8 t -121.64 115.9 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.106 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -133.01 133.24 42.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.013 0.435 . . . . 0.0 110.965 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.549 ' CE1' ' NE1' ' A' ' 37' ' ' TRP . 56.0 t80 -127.66 133.99 49.62 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 142.89 50.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.878 0.371 . . . . 0.0 110.678 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.823 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 17.7 p -154.36 -156.83 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.363 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.4 ptp180 -50.7 84.67 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.096 0.474 . . . . 0.0 111.6 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' CYS . 99.1 m-20 51.93 0.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -92.82 94.14 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.91 146.99 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.73 165.19 27.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.0 p -151.67 169.85 21.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 177.96 172.1 0.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.836 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -137.55 136.08 37.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -118.55 126.2 51.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.881 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.9 t -144.09 154.18 42.94 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.722 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -115.0 122.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.368 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.5 tp -78.6 127.83 32.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.787 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.483 ' C ' HD22 ' A' ' 93' ' ' LEU . . . 150.17 43.44 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 93' ' ' LEU . 1.8 mm? -106.45 168.71 7.76 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 29.12 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.105 1.204 . . . . 0.0 111.738 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -62.66 138.75 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.853 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.12 59.12 4.97 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' CD1' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -79.58 166.12 22.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.6 127.7 33.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.27 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -105.25 127.59 53.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.295 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.0 p-80 -114.47 99.15 7.35 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -103.63 130.07 51.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.308 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -94.56 92.95 7.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.938 0.399 . . . . 0.0 110.584 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -98.21 -19.26 17.97 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.998 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.378 179.81 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -100.32 139.11 36.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 110.878 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -164.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.059 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 6' ' ' LEU . 80.2 mm-40 -64.35 -13.04 48.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 HD22 ' A' ' 26' ' ' LEU . 1.1 pt -41.78 70.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' GLU . 42.2 mt -81.54 -28.99 33.66 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -107.28 118.83 37.75 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.82 2.1 . . . . 0.0 112.625 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.42 127.96 32.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -90.4 114.93 27.16 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 11' ' ' ASN . 3.2 mmpt? -121.68 -168.1 1.64 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 10' ' ' LYS . 27.1 m120 53.79 103.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.61 121.2 35.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.698 0.761 . . . . 0.0 113.002 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.37 126.16 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.6 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 28.1 m -137.74 121.23 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -76.35 -166.72 0.66 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.71 124.42 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.22 65.96 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.231 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.71 143.91 44.71 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -92.79 163.34 13.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 148.01 27.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -130.49 123.99 30.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.12 116.53 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.69 150.36 38.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -122.08 94.12 4.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.663 0.268 . . . . 0.0 110.712 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 59' ' ' HIS . 19.7 m -71.51 109.9 5.76 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.238 0.542 . . . . 0.0 110.206 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 5' ' ' ILE . 8.2 mt -99.48 -178.57 3.94 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.24 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.86 -3.84 13.39 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 1.1 pm0 -137.45 146.38 44.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.094 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.27 139.24 37.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.421 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' PRO . 21.8 t -107.11 133.24 20.39 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -58.23 -154.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 120.809 1.006 . . . . 0.0 110.187 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -115.53 102.54 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.71 -46.35 0.65 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.76 -43.31 89.29 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.155 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.0 139.97 38.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -140.97 144.37 35.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.714 0.292 . . . . 0.0 110.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 82.9 m95 -140.42 121.79 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.615 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -156.54 152.18 26.99 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.613 0.72 . . . . 0.0 112.127 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -110.36 114.12 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.01 112.06 3.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.013 1.279 . . . . 0.0 107.616 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.5 -15.67 9.85 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.65 89.38 1.17 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.386 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.33 140.48 57.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.728 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.518 HG12 ' HE1' ' A' ' 51' ' ' TRP . 1.8 m -78.65 103.76 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.794 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.04 158.25 32.13 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.07 -17.89 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.57 1.513 . . . . 0.0 110.99 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 65.8 m-20 -89.74 -4.95 57.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' ASP . 97.1 m-20 -35.43 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.255 0.55 . . . . 0.0 110.84 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -87.82 -43.07 12.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.096 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.97 -39.32 61.35 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.518 ' HE1' HG12 ' A' ' 44' ' ' VAL . 15.2 p90 -126.32 166.16 17.66 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.271 0.558 . . . . 0.0 111.304 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.3 p -129.62 156.87 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -132.72 120.84 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.3 p -147.89 157.73 43.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.73 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.02 111.53 5.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.63 107.82 18.83 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.08 -123.88 34.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.2 p -93.55 43.1 1.11 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.521 0.2 . . . . 0.0 111.082 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.509 ' CD2' HG23 ' A' ' 25' ' ' THR . 63.5 m80 -147.78 138.86 23.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.901 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -120.22 134.91 55.15 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.02 132.83 34.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.517 0.675 . . . . 0.0 111.28 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tp -126.3 128.94 47.91 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.815 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' TRP . 72.7 mt -105.81 162.91 13.14 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.995 0.903 . . . . 0.0 112.145 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 67' ' ' ALA . 32.9 tp -141.69 108.3 5.34 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -68.01 -121.98 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -83.84 104.75 14.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.524 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB1' ' NE2' ' A' ' 71' ' ' HIS . . . -66.38 108.0 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.5 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 70' ' ' HIS . 51.4 mt-30 -108.13 145.95 32.52 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -48.85 88.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.758 1.639 . . . . 0.0 111.164 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.5 m80 176.83 -28.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.827 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 22.8 p80 -76.99 -8.02 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.663 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.8 147.4 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 110.909 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.3 -131.26 2.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -141.53 146.69 36.68 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.655 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.58 115.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -118.7 126.55 52.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.358 0.599 . . . . 0.0 111.447 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 28.9 t80 -130.08 124.28 32.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.003 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.97 157.01 24.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.4 t -151.18 -155.04 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -55.19 82.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.007 0.432 . . . . 0.0 110.389 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 79' ' ' CYS . 95.1 m-20 57.47 -2.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.681 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -88.75 100.23 12.98 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 83' ' ' VAL . 11.3 p -86.48 124.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.278 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.03 32.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.025 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.5 p -171.07 155.21 4.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.2 156.08 43.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.086 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -82.17 138.66 34.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.68 131.65 50.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -142.97 151.94 41.44 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.229 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.53 ' C ' HD12 ' A' ' 91' ' ' LEU . 14.7 p -111.99 123.44 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.44 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 91' ' ' LEU . 9.7 mp -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.395 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.61 -171.07 41.48 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.956 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 2.2 mm? -101.33 152.95 38.07 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -50.1 138.97 35.5 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 121.122 1.215 . . . . 0.0 110.889 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -55.6 168.32 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.599 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.91 -69.58 0.1 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.76 91.54 4.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.807 0.336 . . . . 0.0 110.192 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.74 156.93 45.58 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -75.35 139.72 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -73.82 137.56 43.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.742 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -69.51 -160.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -66.9 -41.41 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -76.39 130.9 38.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.786 -179.691 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 90.9 m95 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' LEU . 99.7 mtt180 -92.98 159.23 15.41 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 3' ' ' LEU . 7.9 tt 39.43 96.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -78.12 135.3 37.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.664 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 5' ' ' ILE . 18.4 tt -89.84 119.06 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 6' ' ' LEU . 9.5 mp -91.07 -71.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.494 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.26 138.31 29.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.72 HD22 ' C ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.44 158.69 44.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.258 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.8 mt -108.89 131.9 54.57 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 111.508 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -142.55 -171.37 3.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.707 ' H ' ' CB ' ' A' ' 86' ' ' ALA . 66.3 t30 56.05 109.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -159.2 142.15 14.33 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.38 132.96 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.285 -1.779 . . . . 0.0 107.346 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 90' ' ' VAL . 4.2 m -122.31 124.26 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.656 0.741 . . . . 0.0 112.74 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -87.9 165.97 14.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.479 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.35 114.7 2.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.752 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.11 29.71 27.53 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.47 149.83 38.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 110.128 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -113.34 148.35 35.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.71 145.48 51.15 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.215 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 p -124.81 134.34 52.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -133.32 126.22 30.93 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.172 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 t -142.14 142.74 32.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 m -129.28 95.67 4.1 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -77.07 110.13 11.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.12 -174.23 2.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.416 0.627 . . . . 0.0 111.617 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 t -98.7 -20.54 16.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.597 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -142.0 151.16 42.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.008 0.433 . . . . 0.0 111.218 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.6 128.45 35.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.043 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.52 134.77 19.66 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.71 -151.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.028 1.152 . . . . 0.0 110.616 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.93 103.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.84 -37.77 0.66 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.83 -13.09 52.11 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.8 139.84 48.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.376 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -122.97 126.01 46.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.625 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 99.2 m95 -124.66 100.04 6.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.949 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 90.8 m-85 -152.91 149.02 27.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 110.559 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.94 125.09 69.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -48.43 132.76 16.71 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.584 -0.698 . . . . 0.0 111.257 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.63 8.1 56.21 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.205 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.626 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -167.16 125.91 1.35 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.376 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.28 112.83 24.47 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 44' ' ' VAL . 1.0 OUTLIER -74.88 104.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 112.487 -177.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.475 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.3 mp0 -92.21 157.46 40.72 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -53.29 -23.4 23.35 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.613 1.542 . . . . 0.0 111.495 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -98.35 17.23 19.28 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 45' ' ' GLN . 87.3 m-20 -49.18 128.83 17.24 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.4 p -91.96 -37.25 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.755 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 66.2 t0 -96.48 -32.45 12.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.659 0.266 . . . . 0.0 111.694 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -102.83 139.86 37.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.477 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 m -132.3 130.46 40.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.5 133.21 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -143.34 154.57 43.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.634 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.47 106.0 4.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.327 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.01 105.67 15.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.951 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.32 -126.34 41.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 23.0 t -95.44 37.56 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.633 0.254 . . . . 0.0 110.938 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 58' ' ' SER . 22.1 m-70 -142.81 153.85 43.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.844 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.27 161.8 28.52 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.92 94.2 1.11 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.755 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.05 128.18 54.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.503 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 63' ' ' LEU . 1.9 pp -121.73 -178.29 3.78 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.162 0.982 . . . . 0.0 112.357 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.2 tp -145.01 120.74 10.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.01 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' LEU . 82.8 mmt-85 -64.1 -130.23 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.307 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 m -82.84 108.28 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.95 142.46 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.672 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' HIS . 80.9 mt-30 -134.42 144.8 52.58 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.42 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.29 83.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.296 1.331 . . . . 0.0 111.153 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.3 t60 178.39 -26.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -87.09 -1.16 57.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.837 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.08 145.96 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.18 -123.04 1.0 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -142.47 154.2 44.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.508 0.194 . . . . 0.0 110.531 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -121.22 117.99 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -128.95 129.16 45.09 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.13 0.49 . . . . 0.0 112.145 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.625 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 16.4 t80 -136.65 141.16 43.17 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.35 154.8 39.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' ASP . 3.0 t -157.33 -147.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.703 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 82' ' ' ALA . 24.6 mmm180 -53.79 89.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' CYS . 53.2 t0 50.58 10.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.14 93.99 8.58 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.1 p -92.23 125.69 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.838 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.24 123.24 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.472 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.8 p -158.53 138.21 11.93 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.692 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.707 ' CB ' ' H ' ' A' ' 11' ' ' ASN . . . -139.62 151.31 45.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -81.21 144.27 31.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.344 0.593 . . . . 0.0 112.35 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 12' ' ' ALA . 49.2 tp -111.95 133.12 54.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.386 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -137.86 139.08 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.104 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 14' ' ' VAL . 97.1 t -104.8 126.67 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.239 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.3 tp -117.29 131.56 56.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.033 0.444 . . . . 0.0 111.043 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.443 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -160.18 159.89 31.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 93' ' ' LEU . 8.3 mp -98.6 108.38 47.87 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.61 -18.4 42.79 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.05 1.166 . . . . 0.0 111.941 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.79 143.09 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.92 0.391 . . . . 0.0 111.467 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.39 98.59 2.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 97' ' ' LEU . 8.9 mp -81.29 145.37 30.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.842 0.353 . . . . 0.0 110.531 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.64 -37.65 79.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -151.54 143.0 23.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.654 ' CG ' ' H ' ' A' ' 101' ' ' HIS . 28.4 t60 -102.01 -167.89 1.47 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.654 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 44.1 m80 -67.72 142.75 56.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.445 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -69.2 130.3 42.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.419 ' CG ' ' C ' ' A' ' 102' ' ' HIS . 8.0 p80 35.3 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.525 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.3 m95 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -91.75 163.85 13.92 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.671 HD22 ' N ' ' A' ' 3' ' ' LEU . 2.8 mm? -69.17 126.54 30.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -82.91 143.13 30.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.745 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 5' ' ' ILE . 18.1 tt -89.67 119.46 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.091 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.58 -63.79 1.17 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.928 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -154.12 146.95 24.35 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.946 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -137.07 145.54 44.07 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.806 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.38 115.54 30.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -131.78 -169.99 2.31 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.071 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' LYS . 60.1 t-20 53.42 107.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.409 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.26 147.93 3.83 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.76 148.62 45.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.111 -1.859 . . . . 0.0 106.631 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.0 m -132.87 110.05 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.288 0.566 . . . . 0.0 111.155 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 53.9 ttt85 -76.31 155.77 33.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.24 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.91 136.12 47.51 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.823 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.35 28.27 68.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 15' ' ' ARG . . . -119.12 143.85 46.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.286 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -98.51 159.24 15.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.846 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.0 148.39 31.65 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.58 124.55 41.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.141 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.43 117.27 21.07 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -143.81 153.99 42.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.11 98.43 3.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.314 0.578 . . . . 0.0 111.05 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -71.13 110.44 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.11 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.04 -177.17 4.06 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 110.781 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 100.0 p -108.3 -12.56 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.116 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HB2' HD12 ' A' ' 3' ' ' LEU . 50.6 tp10 -134.29 145.97 49.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.949 0.405 . . . . 0.0 110.902 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.79 129.83 35.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.64 141.57 24.31 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.94 -145.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 120.642 1.265 . . . . 0.0 111.086 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 32' ' ' VAL . 14.0 p -123.15 123.6 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.43 -26.4 6.34 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.39 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.4 -21.21 23.17 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.162 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 143.69 30.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -120.88 126.86 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.572 ' CE2' ' CD2' ' A' ' 77' ' ' PHE . 37.2 m95 -134.45 115.04 13.52 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.657 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -170.37 166.1 8.63 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.287 0.565 . . . . 0.0 112.213 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.78 127.66 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -66.8 132.15 47.43 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 120.772 -1.205 . . . . 0.0 109.713 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.1 -3.92 33.57 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -146.32 -27.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.339 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' ALA . . . 48.3 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' VAL . 1.3 p -60.05 118.93 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.491 0.662 . . . . 0.0 112.52 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -110.98 152.19 43.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.513 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.38 -20.31 47.69 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.911 1.074 . . . . 0.0 111.855 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.82 4.63 49.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.01 137.96 57.97 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.194 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 p -89.31 -33.51 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 51' ' ' TRP . 38.6 p-10 -92.48 -29.34 16.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.662 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.478 ' CE2' HD13 ' A' ' 64' ' ' LEU . 97.4 m95 -110.6 139.14 46.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 111.245 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 93.9 m -127.16 130.28 49.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -125.39 132.91 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 p -144.64 155.82 43.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.501 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.36 105.76 4.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.66 113.78 21.73 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.008 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.26 -133.52 42.48 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -98.26 38.61 1.31 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.815 0.341 . . . . 0.0 110.555 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -139.96 137.92 35.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.125 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -122.08 134.25 54.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 129.36 36.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.36 0.6 . . . . 0.0 111.835 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.44 151.56 41.15 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.245 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 5.0 mp -133.68 165.07 25.78 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.399 1.095 . . . . 0.0 113.156 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' A' ' 51' ' ' TRP . 34.4 tp -143.6 108.39 4.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.643 -2.071 . . . . 0.0 106.365 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.6 mtt-85 -64.58 -121.26 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.2 m -81.87 109.63 16.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 71' ' ' HIS . . . -65.27 134.6 53.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.579 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 9.9 pt20 -136.02 147.19 59.76 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.067 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.3 Cg_endo -48.22 90.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.668 1.578 . . . . 0.0 111.693 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.6 m-70 170.63 -29.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.199 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.62 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 49.1 p-80 -83.25 -15.0 52.01 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.27 146.83 27.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.311 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.26 -137.48 4.61 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.527 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 53.6 mp0 -126.87 147.79 50.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.38 111.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -123.45 123.16 40.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.274 0.559 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -145.64 145.94 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.736 179.192 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.3 151.61 28.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.319 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 81' ' ' ASP . 4.8 t -156.73 -140.96 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.939 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ALA . 19.0 mmm180 -54.23 89.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.979 0.419 . . . . 0.0 110.135 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 44.54 16.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -103.41 69.94 1.02 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 135.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.88 132.51 7.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -141.62 119.36 11.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.141 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.77 -160.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.49 0.662 . . . . 0.0 111.67 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -146.04 121.19 10.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.586 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.7 tp -110.07 130.51 55.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.923 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 t -136.17 146.51 46.94 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.613 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 14' ' ' VAL . 9.6 p -113.29 125.53 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.464 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 3.0 mm? -95.49 130.21 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.354 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -105.58 -91.44 2.22 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mp -106.65 170.92 5.19 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.54 50.34 3.48 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.373 1.382 . . . . 0.0 111.824 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -87.45 91.83 8.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 110.668 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.11 -13.19 50.14 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -108.27 125.85 52.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.773 0.32 . . . . 0.0 111.62 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.71 134.35 53.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.391 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' HIS . 36.2 p-80 -67.77 -43.97 78.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.51 ' N ' ' CG ' ' A' ' 100' ' ' HIS . 52.8 t60 -106.62 117.55 34.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.551 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 102' ' ' HIS . 47.7 p-80 -103.47 110.6 22.69 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.774 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -61.2 -47.07 87.83 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.242 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.08 -179.522 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.41 ' C ' HD12 ' A' ' 3' ' ' LEU . 96.8 mtt180 -99.81 136.07 40.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.05 0.452 . . . . 0.0 110.699 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 3' ' ' LEU . 6.1 mp -93.55 81.18 4.32 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.961 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.12 167.5 19.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.714 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -77.51 121.69 30.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.767 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.21 -68.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' C ' HD12 ' A' ' 8' ' ' LEU . 97.2 mt-10 -135.0 124.86 25.49 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 8' ' ' LEU . 7.9 mp -110.73 152.68 26.29 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.037 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 23' ' ' THR . 48.1 tp -124.02 108.79 12.75 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' CE ' ' N ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -130.19 -168.53 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.506 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 m120 54.78 105.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.782 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.93 134.86 6.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.984 0.897 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.73 130.09 54.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.838 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' ARG . 5.1 m -129.91 103.28 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.214 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 14' ' ' VAL . 93.7 mtt180 -47.54 175.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.48 128.91 38.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.099 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.29 42.41 10.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.58 160.91 36.06 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.495 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -95.24 154.63 17.09 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . . . -130.25 133.66 46.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 p -119.62 122.62 41.96 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -132.6 117.85 18.45 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 59.0 p -144.52 151.69 39.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.261 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.99 95.74 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.991 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 p -67.83 123.52 20.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -123.63 143.23 50.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.906 0.384 . . . . 0.0 111.288 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.425 ' O ' HD23 ' A' ' 3' ' ' LEU . 28.5 m -76.77 -13.28 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.921 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' OE1' HD22 ' A' ' 3' ' ' LEU . 49.4 tp10 -116.94 132.89 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 0.0 111.805 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.97 149.56 30.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.8 t -124.74 122.58 25.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.48 -147.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.229 1.118 . . . . 0.0 110.998 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 32' ' ' VAL . 12.9 p -120.97 118.84 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.742 0.782 . . . . 0.0 109.102 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.28 -25.28 9.36 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -91.78 -19.21 22.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.144 0.497 . . . . 0.0 109.678 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.08 166.59 19.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.408 ' HB2' ' H ' ' A' ' 78' ' ' ALA . 16.3 m -146.52 116.75 7.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.462 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.09 97.79 3.06 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -155.07 156.31 35.65 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.854 HD11 ' CE2' ' A' ' 51' ' ' TRP . 4.9 mm -73.42 101.06 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -47.72 97.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 128.42 -36.28 2.5 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . -125.04 98.28 5.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.07 139.73 51.43 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.824 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.52 113.8 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -104.67 152.39 39.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.37 -19.82 18.33 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.286 1.324 . . . . 0.0 109.989 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.54 31.3 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.51 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 42.4 p-10 -97.48 104.94 17.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.508 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -87.44 -52.78 5.17 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.469 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 64' ' ' LEU . 46.2 m-20 -67.39 -37.53 83.26 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 110.112 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.854 ' CE2' HD11 ' A' ' 39' ' ' ILE . 59.7 t-105 -105.17 148.01 27.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.028 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -146.26 143.74 29.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.644 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -124.79 138.0 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -142.83 158.65 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 111.235 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.01 100.83 3.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -108.86 105.15 14.57 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 -131.22 30.22 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -100.43 37.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.064 0.459 . . . . 0.0 110.595 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -135.75 132.34 36.68 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -115.24 123.23 48.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.73 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.27 122.88 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.626 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.5 pt? -141.15 131.43 25.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.32 -169.98 2.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.208 1.004 . . . . 0.0 113.7 -175.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 36.7 tp -146.4 119.9 9.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 113.366 -1.743 . . . . 0.0 106.954 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -68.51 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.8 p -71.46 103.54 2.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.167 0.508 . . . . 0.0 110.225 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.4 135.92 53.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 70' ' ' HIS . 73.8 mt-30 -130.87 144.1 52.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -48.57 92.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.515 1.476 . . . . 0.0 111.599 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 3.7 m-70 166.9 -27.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.891 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -86.36 -0.79 56.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.389 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 145.27 56.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.213 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.05 -150.3 15.36 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -118.66 166.7 12.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.626 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 69.8 t -132.2 133.7 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.7 m -132.6 129.16 38.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.382 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -132.78 140.34 47.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.284 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -161.69 144.36 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.645 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' ASP . 25.4 p -157.6 -135.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -51.81 81.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 44.1 t0 51.28 6.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -96.29 91.38 5.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.91 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.315 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . . . -160.01 -179.49 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.326 0.584 . . . . 0.0 110.992 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 m -158.0 178.9 9.7 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.466 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . -169.47 160.97 9.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.212 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -119.27 132.8 55.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.911 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 tp -121.76 127.04 50.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.535 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 t -146.79 153.85 40.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.284 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.3 p -128.4 110.94 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.992 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.9 mt -82.38 133.24 35.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.923 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.02 116.8 3.28 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.5 mt -114.58 147.03 37.21 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -53.35 125.75 19.45 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 120.794 0.996 . . . . 0.0 110.68 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -88.71 138.42 31.43 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.753 0.311 . . . . 0.0 111.073 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.27 -118.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.2 mt -99.19 -2.26 37.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.527 0.203 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -77.02 124.93 28.5 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.931 0.396 . . . . 0.0 111.313 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -155.97 139.8 16.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -129.1 135.99 49.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.685 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.09 166.48 14.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.199 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -102.85 123.6 46.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.459 . . . . 0.0 110.735 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -66.75 -38.26 86.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.572 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -92.69 140.44 29.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.226 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.794 HD12 ' N ' ' A' ' 3' ' ' LEU . 2.9 mp -100.37 116.26 31.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' OE2' ' O ' ' A' ' 80' ' ' ARG . 34.2 tp10 -139.11 -119.76 0.13 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.208 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.456 HD11 ' HB1' ' A' ' 82' ' ' ALA . 81.8 mt -99.3 121.12 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.554 0.342 . . . . 0.0 110.739 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.8 -71.15 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -126.5 118.38 24.81 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.7 pt? -122.18 144.64 48.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.23 115.69 31.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.662 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -132.26 179.56 6.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.683 -178.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 10' ' ' LYS . 86.4 m-20 51.88 108.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.292 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.36 140.74 7.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.95 0.881 . . . . 0.0 112.76 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 127.81 53.45 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 14' ' ' VAL . 33.1 m -113.06 111.38 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -63.64 166.65 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.186 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 133.83 48.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.998 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.53 43.11 98.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.26 151.73 48.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.345 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -92.83 157.68 16.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.976 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.81 153.82 36.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.42 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.1 t -142.09 148.23 38.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.435 0.636 . . . . 0.0 111.391 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.65 128.92 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.722 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -148.13 152.04 36.62 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.974 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.4 p -142.01 98.06 3.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.402 0.62 . . . . 0.0 111.756 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 m -71.81 120.32 17.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.138 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.16 139.56 47.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.051 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 t -70.79 -13.21 61.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.19 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -131.66 139.96 49.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.129 0.49 . . . . 0.0 111.367 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.74 146.44 33.88 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.915 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -125.24 134.92 26.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.5 -148.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.318 1.149 . . . . 0.0 110.232 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.88 115.01 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.6 -47.44 0.9 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -68.03 -36.79 80.5 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' ' SG ' ' A' ' 79' ' ' CYS . . . -84.08 127.76 34.12 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.909 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.5 t -135.56 138.04 42.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.556 ' CZ2' ' CG ' ' A' ' 77' ' ' PHE . 90.5 m95 -137.76 112.99 9.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.0 p90 -157.91 155.62 29.9 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.202 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.598 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.7 94.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' ILE . 23.8 t-20 -37.61 106.03 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.242 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.77 -9.82 8.55 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.83 102.74 3.44 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 110.496 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 106.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.55 128.37 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.913 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.38 150.1 42.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.18 -25.64 65.34 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.674 1.583 . . . . 0.0 111.78 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -82.29 11.46 5.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 35.8 p-10 -62.28 133.27 54.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.727 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -90.93 -50.07 6.08 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -64.61 -38.68 91.85 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.015 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -104.72 151.38 23.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.432 ' OG1' HD11 ' A' ' 63' ' ' LEU . 10.4 m -135.07 136.69 42.22 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.34 135.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 p -144.21 157.47 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.269 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.92 113.0 3.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.086 0.47 . . . . 0.0 110.757 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 65.8 t0 -130.33 123.68 30.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 -124.84 11.68 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.4 m -115.55 43.02 2.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.739 0.304 . . . . 0.0 110.801 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 56' ' ' ASP . 34.9 p80 -154.26 146.62 23.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.742 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.64 168.1 9.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.97 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.12 100.91 1.4 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.647 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tt -109.93 129.19 55.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.055 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.47 HD12 ' C ' ' A' ' 63' ' ' LEU . 2.0 pp -118.18 173.66 6.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.957 0.885 . . . . 0.0 112.382 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 64' ' ' LEU . 47.2 tp -140.42 115.2 9.58 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 113.54 -1.664 . . . . 0.0 106.602 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.535 ' NH2' ' OG ' ' A' ' 66' ' ' SER . 61.7 ttp85 -68.17 -128.04 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.552 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 82.5 p -75.55 108.61 8.49 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.369 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.26 56.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 66' ' ' SER . 2.8 mp0 -124.91 141.79 39.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.553 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -53.13 86.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.282 1.321 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.1 m-70 174.2 -33.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.708 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -70.64 -5.09 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.795 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.02 145.8 15.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.681 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.88 -167.43 35.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 40' ' ' ASN . 93.2 mt-10 -100.55 165.44 11.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.516 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 37.9 t -128.12 129.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.784 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.2 m -133.42 137.87 45.98 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.462 0.649 . . . . 0.0 110.783 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.556 ' CG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -131.98 134.07 45.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.071 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.462 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -134.59 137.59 43.85 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -151.36 -155.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.468 ' C ' ' N ' ' A' ' 82' ' ' ALA . 79.8 mtp85 -57.77 90.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.8 t0 49.35 14.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -89.73 95.31 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.602 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.48 134.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.395 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.53 154.7 41.85 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.225 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 36.8 p -156.98 173.69 16.64 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.789 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . . . 178.21 175.41 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.193 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -136.98 109.06 7.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.095 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.7 tp -93.47 129.79 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.773 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -137.13 135.08 37.08 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.054 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.18 118.04 41.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.582 HD13 ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -62.19 120.31 10.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' N ' HD13 ' A' ' 91' ' ' LEU . . . 166.05 95.57 0.1 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.19 109.11 62.0 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.39 -158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.896 1.064 . . . . 0.0 111.121 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.17 114.44 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.74 1.38 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 97' ' ' LEU . 10.3 mp -88.32 2.97 51.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.204 0.526 . . . . 0.0 110.275 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -68.96 -34.39 75.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.669 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.96 -175.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -115.8 176.89 4.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.1 m170 54.42 84.63 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -59.75 -42.99 94.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -136.58 -40.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.701 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.597 -179.718 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 99.3 m95 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.724 ' C ' HD23 ' A' ' 3' ' ' LEU . 84.0 mtp180 -97.76 -174.13 2.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.394 0.14 . . . . 0.0 111.321 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 2' ' ' ARG . 1.2 pt? 33.5 30.18 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.379 0.609 . . . . 0.0 110.557 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 2' ' ' ARG . 10.3 pt-20 -77.02 143.49 39.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.157 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.8 mt -83.8 118.52 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.08 -67.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.269 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -139.81 131.32 27.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.513 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 119.72 36.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 9' ' ' LEU . 9.4 mp -93.84 104.91 16.96 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.677 ' HD3' ' HB2' ' A' ' 86' ' ' ALA . 7.3 mmpt? -132.91 -169.16 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' LYS . 15.6 t-20 59.17 109.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.56 145.84 2.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.832 0.825 . . . . 0.0 111.963 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.09 130.85 53.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.283 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 20' ' ' ALA . 32.8 m -119.92 122.75 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 122.226 1.013 . . . . 0.0 113.397 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.86 167.81 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.048 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.83 55.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.723 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.38 50.76 59.96 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.12 25.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.536 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -100.82 147.36 26.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.141 0.496 . . . . 0.0 110.305 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.697 ' HB2' HG11 ' A' ' 14' ' ' VAL . . . -128.2 140.15 52.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.195 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.01 137.0 47.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.386 0.612 . . . . 0.0 111.83 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -145.67 130.07 17.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.353 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -144.58 148.76 34.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -133.36 95.21 3.47 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.197 0.522 . . . . 0.0 111.666 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.4 m -75.16 113.51 12.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.694 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -107.14 -163.18 0.89 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.481 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 22.4 p -114.03 -7.28 13.11 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.332 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -146.22 154.79 42.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.121 0.486 . . . . 0.0 111.28 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.46 129.31 35.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.748 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.23 133.58 22.83 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.559 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -63.0 -146.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.255 1.127 . . . . 0.0 111.283 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.5 t -120.5 120.85 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.14 -28.67 5.77 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 53.5 mp0 -85.2 -18.02 35.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.748 0.308 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.0 134.75 51.8 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 m -113.6 140.1 48.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.619 0.247 . . . . 0.0 110.554 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.571 ' CZ2' ' CD1' ' A' ' 77' ' ' PHE . 91.7 m95 -147.27 102.41 3.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.61 153.89 32.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 39' ' ' ILE . 5.2 mp -80.81 145.18 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.819 0.819 . . . . 0.0 111.634 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -78.82 106.17 10.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.517 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.24 -9.18 7.02 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.86 120.71 1.22 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.56 0.219 . . . . 0.0 111.065 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.48 53.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.946 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.0 t -98.54 116.25 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 157.92 45.21 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.51 -34.83 90.9 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.675 1.583 . . . . 0.0 112.12 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -82.22 20.23 1.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.584 0.231 . . . . 0.0 111.593 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 28.8 p-10 -55.05 122.83 11.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.087 0.47 . . . . 0.0 112.118 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -88.93 -51.31 5.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.574 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' OD2' ' CE1' ' A' ' 71' ' ' HIS . 97.5 m-20 -66.17 -38.11 87.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.229 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.479 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 8.7 m-90 -105.94 155.29 19.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.412 0.625 . . . . 0.0 112.128 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -132.55 132.53 42.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -125.0 134.1 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 p -145.87 156.04 43.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.12 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.77 109.7 4.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 59' ' ' HIS . 33.1 p-10 -119.32 102.44 8.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.06 -133.67 31.38 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.4 m -89.94 21.47 3.63 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 122.607 -0.349 . . . . 0.0 111.115 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 77.9 m80 -123.11 124.05 42.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.63 153.07 21.03 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.97 98.0 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.497 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.32 132.66 53.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -130.05 -177.25 4.22 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.483 1.135 . . . . 0.0 112.295 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 51' ' ' TRP . 9.2 tp -145.99 115.24 7.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.532 -2.122 . . . . 0.0 107.362 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 49.7 ttp180 -64.65 -128.45 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -69.01 106.03 2.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.945 0.402 . . . . 0.0 109.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.29 143.13 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.887 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -133.59 139.68 34.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -53.8 89.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.318 1.345 . . . . 0.0 112.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.566 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER 168.18 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.808 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 50' ' ' ASP . 7.2 m-70 -85.71 0.64 52.2 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.96 146.21 33.17 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.707 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.42 -149.5 18.85 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 57.7 mp0 -145.03 119.2 9.47 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 2.8 t -70.63 144.35 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.635 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -124.84 128.0 48.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.662 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CD1' ' CZ2' ' A' ' 37' ' ' TRP . 3.4 t80 -132.47 138.05 47.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -160.24 144.18 14.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 29.9 p -155.91 -132.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.508 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 95.6 mtt-85 -54.53 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.434 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 79' ' ' CYS . 27.9 t70 46.85 14.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.08 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -101.35 88.73 3.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 84' ' ' ALA . 10.4 p -83.78 153.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.426 ' N ' HG22 ' A' ' 83' ' ' VAL . . . -179.64 115.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.79 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.2 t -93.21 -173.91 3.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.987 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.677 ' HB2' ' HD3' ' A' ' 10' ' ' LYS . . . -161.03 154.68 22.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.024 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -114.94 113.76 24.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.445 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 73' ' ' GLY . 38.6 tp -115.11 124.92 52.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -140.49 123.52 16.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.107 0.48 . . . . 0.0 110.715 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.84 119.94 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.181 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.0 tp -92.52 111.55 23.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.183 0.516 . . . . 0.0 110.086 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.57 -24.44 0.92 Allowed Glycine 0 N--CA 1.466 0.665 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.036 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 93' ' ' LEU . 7.4 mp -105.9 108.3 61.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.95 139.69 89.21 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 CA-C-N 119.793 0.962 . . . . 0.0 111.244 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 95' ' ' ASP . 46.1 p-10 -89.71 109.26 20.25 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.564 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 94.39 0.15 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.71 143.76 26.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.004 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -81.23 161.59 23.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.229 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.634 ' CG ' ' H ' ' A' ' 100' ' ' HIS . 6.6 t-80 67.87 -152.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.311 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 99' ' ' HIS . 7.0 t-80 46.16 82.79 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.61 ' ND1' ' N ' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -61.55 112.45 2.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.148 0.499 . . . . 0.0 110.189 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.426 ' NE2' ' C ' ' A' ' 104' ' ' HIS . 80.9 t60 -149.04 103.53 3.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.792 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.92 -46.13 90.67 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.752 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.426 ' C ' ' NE2' ' A' ' 102' ' ' HIS . 50.6 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.014 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.4 m0 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -90.0 147.08 23.9 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.247 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -88.3 94.14 9.74 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 121.268 0.556 . . . . 0.0 110.089 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.18 151.36 29.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.008 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tp -82.85 120.5 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.14 -70.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.7 135.58 29.98 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 112.42 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.26 135.05 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.675 HD12 HG22 ' A' ' 23' ' ' THR . 89.7 mt -95.67 112.17 23.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.572 ' NZ ' ' O ' ' A' ' 85' ' ' SER . 1.8 mmpt? -127.78 -176.17 3.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.037 0.446 . . . . 0.0 111.295 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 10' ' ' LYS . 93.2 m-20 55.92 108.63 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.341 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.74 138.81 9.73 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.91 147.93 44.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.421 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 90' ' ' VAL . 1.7 m -133.18 114.98 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.423 0.63 . . . . 0.0 111.189 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -85.25 147.58 26.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.379 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.53 124.98 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.586 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.74 27.13 51.93 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.47 147.0 41.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -103.58 156.3 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.333 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.43 144.35 31.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.91 0.386 . . . . 0.0 110.567 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -127.69 136.26 51.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.472 0.653 . . . . 0.0 111.13 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -137.51 122.01 18.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.675 HG22 HD12 ' A' ' 9' ' ' LEU . 1.7 t -144.3 152.71 41.15 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.536 -0.466 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 26' ' ' LEU . 14.1 t -127.51 92.45 3.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.171 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 m -73.07 114.86 11.71 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 24' ' ' CYS . 84.2 mt -103.81 -169.41 1.63 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.31 0.576 . . . . 0.0 111.362 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.8 t -113.85 -5.13 13.25 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.234 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -140.85 146.11 37.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.64 133.45 35.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.968 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 10.9 t -108.25 134.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.364 -0.35 . . . . 0.0 110.507 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -61.7 -143.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 119.975 1.027 . . . . 0.0 110.047 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.52 111.56 29.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.566 0.698 . . . . 0.0 109.421 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.79 -47.37 0.7 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -67.53 -45.62 75.18 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.069 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.25 138.35 38.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -142.61 112.71 7.06 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.663 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.638 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 98.5 m95 -106.78 107.13 17.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 68.0 m-85 -150.13 150.22 31.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.535 0.683 . . . . 0.0 110.563 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.875 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -125.35 129.27 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -61.07 110.53 1.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.101 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.85 -4.35 6.48 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.811 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.702 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -160.29 76.92 0.62 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.761 0.78 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.92 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 42' ' ' ALA . 6.2 p -67.97 101.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.506 0.669 . . . . 0.0 110.739 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.07 155.94 42.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.37 -30.51 15.56 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.667 1.578 . . . . 0.0 111.616 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.63 10.01 19.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 11.0 p-10 -51.0 128.81 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.7 p -92.44 -47.34 7.21 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.071 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 46.2 t0 -72.11 -39.36 68.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.641 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.537 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 3.7 m-90 -106.84 151.07 25.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.316 0.579 . . . . 0.0 111.341 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -128.56 130.28 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.878 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.99 133.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.011 0.434 . . . . 0.0 109.833 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -142.01 153.39 44.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.43 98.58 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.086 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -113.19 105.76 13.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.27 -132.45 48.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -93.34 35.49 1.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.285 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.488 ' CE1' ' OG1' ' A' ' 23' ' ' THR . 15.7 t60 -139.65 131.77 28.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 80.7 m80 -118.52 137.02 53.49 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.77 137.94 51.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.301 0.572 . . . . 0.0 111.472 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 tp -132.63 138.16 47.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.32 162.16 25.36 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.265 1.031 . . . . 0.0 112.864 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 65' ' ' ARG . 17.9 tp -140.88 110.9 6.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 112.774 -2.012 . . . . 0.0 106.323 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.7 mtt-85 -62.87 -128.96 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.105 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.6 p -77.61 107.15 9.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.08 0.467 . . . . 0.0 110.285 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 137.55 57.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.35 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 84.2 mt-30 -133.94 135.06 23.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.02 88.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.002 1.135 . . . . 0.0 111.658 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 2.0 t60 -173.48 -39.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 68' ' ' GLN . 22.8 p-80 -82.12 -7.65 59.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.883 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.21 152.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.34 -162.03 34.01 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.16 149.11 21.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.777 0.322 . . . . 0.0 110.581 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 63.0 t -117.51 119.71 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.886 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 137.31 49.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.638 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 2.3 t80 -137.95 134.98 35.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.466 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -133.06 144.25 49.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.8 t -156.88 -151.2 0.31 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.32 0.581 . . . . 0.0 111.502 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -55.84 84.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.122 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' CYS . 90.5 m-20 51.27 8.62 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.4 94.21 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 83' ' ' VAL . 7.5 p -81.74 129.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.935 0.398 . . . . 0.0 110.471 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -134.76 165.39 25.38 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.438 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.572 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 96.9 p -161.68 -179.69 7.46 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 174.59 178.64 0.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 128.86 24.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.274 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.3 tp -113.99 130.07 56.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 t -142.34 155.97 45.21 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.665 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 14' ' ' VAL . 65.9 t -121.0 123.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.394 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.3 mt -79.44 138.46 37.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.35 -37.72 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.31 108.85 62.39 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -61.43 142.81 96.67 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 119.671 0.918 . . . . 0.0 111.0 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -106.57 -29.21 9.79 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.4 -124.24 4.01 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.7 128.61 55.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.68 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -148.01 -98.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.245 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 101' ' ' HIS . 56.3 t-80 -105.15 58.62 0.68 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.23 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -62.29 -41.53 98.58 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.603 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.528 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 11.6 t60 -63.52 121.6 14.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.153 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -67.36 -45.31 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.626 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -72.66 141.47 48.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.4 m80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.761 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.97 143.6 26.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 111.111 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.707 HD22 ' N ' ' A' ' 3' ' ' LEU . 1.3 mm? -90.97 111.01 22.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.027 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -82.86 151.99 25.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.202 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.69 119.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.6 mp -86.79 -71.44 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.651 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -132.14 128.17 37.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.057 0.456 . . . . 0.0 111.183 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.8 pt? -129.66 136.69 50.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.79 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.5 tt -104.55 108.99 20.7 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.483 ' N ' HD23 ' A' ' 9' ' ' LEU . 12.4 mmmt -118.39 -171.22 2.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.3 m120 57.04 108.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.91 130.34 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.91 128.45 46.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -131.31 123.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 95.8 mtt180 -80.51 172.6 13.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.433 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 133.18 54.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.114 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.73 23.8 74.07 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ARG . . . -112.8 152.87 28.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.9 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.67 152.48 20.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG11 ' A' ' 14' ' ' VAL . . . -119.5 144.74 46.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -142.48 120.61 12.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 112.193 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -123.6 116.35 22.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.4 t -144.95 150.84 37.66 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.472 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.7 100.75 4.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.573 ' HG1' ' CE1' ' A' ' 59' ' ' HIS . 23.6 m -72.69 112.05 8.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.374 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.04 -166.45 1.23 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.341 0.591 . . . . 0.0 111.245 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.1 p -114.72 -4.83 12.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.915 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -138.37 141.58 39.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.423 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.86 130.59 36.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.515 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 31' ' ' PRO . 26.3 t -104.16 134.9 19.46 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.268 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.15 -147.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 120.022 1.044 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.22 109.52 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.56 -42.2 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.46 -43.58 80.74 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.074 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.34 150.2 33.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.64 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -126.8 126.25 43.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 111.036 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -131.48 112.13 12.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -155.42 153.76 30.87 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.505 0.669 . . . . 0.0 111.508 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 74' ' ' GLU . 4.4 mp -120.99 121.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.32 125.65 24.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.174 0.897 . . . . 0.0 109.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.47 -3.9 31.06 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.4 96.55 0.4 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.271 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.32 139.41 54.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.868 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.43 103.18 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -90.48 153.74 46.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.12 -29.11 27.35 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.767 1.644 . . . . 0.0 111.352 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -97.21 14.21 26.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -46.45 124.73 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -88.09 -44.21 11.11 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.25 -26.19 19.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.444 ' NE1' HD13 ' A' ' 64' ' ' LEU . 8.2 m-90 -110.18 139.92 44.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.493 ' OG1' HD11 ' A' ' 63' ' ' LEU . 23.4 p -136.94 152.72 50.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.56 137.0 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 p -142.43 153.45 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.93 102.39 5.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.027 0.441 . . . . 0.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -109.33 107.65 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.943 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.89 -131.42 45.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.5 p -97.03 47.16 1.04 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.729 0.299 . . . . 0.0 111.008 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.573 ' CE1' ' HG1' ' A' ' 25' ' ' THR . 63.6 t60 -152.44 137.06 16.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.672 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -117.01 135.75 53.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.05 126.51 26.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 111.008 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 tt -131.22 133.86 45.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.322 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.493 HD11 ' OG1' ' A' ' 52' ' ' THR . 1.5 pp -119.56 -176.63 3.2 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.254 1.026 . . . . 0.0 112.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 44.5 tp -146.12 122.22 10.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.144 -1.844 . . . . 0.0 106.302 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' LEU . 93.2 mtt-85 -63.51 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.611 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -78.28 108.1 11.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.73 134.89 50.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.898 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 70' ' ' HIS . 74.0 mt-30 -132.4 145.1 55.84 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.64 84.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.416 1.41 . . . . 0.0 111.246 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 68' ' ' GLN . 81.4 t60 176.97 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.087 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.03 -8.97 59.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.61 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.11 148.71 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.593 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.9 -171.31 42.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 39' ' ' ILE . 84.5 tt0 -97.68 151.68 19.87 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -119.39 118.14 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 117.757 0.253 . . . . 0.0 110.915 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 m -127.97 129.81 47.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.116 0.484 . . . . 0.0 111.115 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.37 139.34 37.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.293 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.91 153.13 31.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.165 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.9 t -157.32 -140.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 82' ' ' ALA . 77.9 mtp85 -55.97 86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.079 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 79' ' ' CYS . 26.9 t0 52.18 10.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -92.59 87.43 5.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 83' ' ' VAL . 10.6 p -89.78 125.85 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HB1' ' NZ ' ' A' ' 10' ' ' LYS . . . -155.62 122.59 5.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.165 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 40.8 m -95.43 -174.2 3.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.888 0.375 . . . . 0.0 111.26 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 176.04 173.02 0.35 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -149.0 136.23 20.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 tp -112.74 130.91 55.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -138.57 132.22 30.74 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.701 0.286 . . . . 0.0 111.52 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.81 124.23 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.541 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.8 tp -136.73 116.31 12.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.097 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.41 -166.03 36.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.729 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 94' ' ' PRO . 2.5 mm? -96.5 157.34 35.56 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 93' ' ' LEU . 2.5 Cg_endo -45.36 -174.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.953 1.769 . . . . 0.0 111.622 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -60.44 -43.4 96.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.236 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.94 -107.0 0.31 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.71 135.33 38.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -86.62 122.11 30.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.575 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -79.36 -16.7 55.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.563 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -99.94 178.67 4.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 110.799 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -136.34 136.97 40.14 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.219 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -155.67 159.23 39.39 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.561 ' ND1' ' N ' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -156.5 148.68 23.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.389 179.798 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 2' ' ' ARG . 75.8 t-105 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 85.3 mtt85 -75.73 150.85 37.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.488 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.71 85.51 1.63 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 110.052 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 55.1 mp0 -138.09 -73.34 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.647 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.06 107.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 6' ' ' LEU . 11.2 mp -97.05 -64.06 1.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -120.4 110.46 16.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.0 tp -114.07 129.57 56.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -113.25 125.94 54.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.735 0.303 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.381 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.01 128.64 11.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.49 0.662 . . . . 0.0 111.893 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.82 53.76 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.1 108.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -66.86 174.94 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.31 120.77 8.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.532 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.93 49.67 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.718 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.76 43.3 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.11 152.66 19.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 112.337 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.71 141.11 49.7 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.746 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 p -123.96 110.65 15.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.298 0.57 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -117.19 103.97 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -133.66 139.71 46.62 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.405 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.6 p -137.96 96.94 3.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 m -69.19 117.77 11.25 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.119 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 58' ' ' SER . 46.9 mt -101.65 -174.77 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 t -114.09 3.15 15.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.864 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -126.18 127.76 46.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.512 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.38 75.23 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.92 132.46 74.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.915 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.1 -143.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.925 1.084 . . . . 0.0 110.935 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.618 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.9 m -118.94 109.96 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.629 0.728 . . . . 0.0 109.301 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.36 -56.38 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 80' ' ' ARG . 96.5 mt-10 -69.46 -40.93 76.84 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 149.75 31.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -137.67 137.98 38.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.013 0.435 . . . . 0.0 110.594 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.466 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 63.7 m95 -136.59 105.1 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.87 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 76.8 m-85 -149.54 150.2 31.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.666 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.847 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.2 130.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -62.65 132.79 53.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.269 -0.894 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.76 40.57 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.563 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -164.14 138.57 5.66 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.967 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.18 130.67 47.31 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.87 111.04 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.633 0.254 . . . . 0.0 110.579 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' ASP . 37.0 mt-30 -126.73 153.11 75.75 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.68 -10.26 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.091 1.861 . . . . 0.0 111.488 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' GLN . 45.7 p-10 -108.64 29.42 7.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' ASP . 44.4 p-10 -34.25 161.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.77 0.795 . . . . 0.0 112.378 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -95.79 -62.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.707 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -124.79 -36.02 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -86.98 159.21 19.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.573 0.702 . . . . 0.0 111.312 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.6 m -130.53 144.69 51.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.773 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.43 130.1 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.9 p -143.81 154.91 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.37 100.85 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.351 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -103.21 108.29 19.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.073 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 -132.24 41.11 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 26' ' ' LEU . 10.2 m -97.17 50.87 1.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.391 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -153.67 145.72 23.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -127.36 142.36 51.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.89 12.1 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.287 0.565 . . . . 0.0 111.141 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 63' ' ' LEU . 6.3 tt -122.78 125.2 45.01 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.926 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 62' ' ' LEU . 3.1 pp -139.73 135.65 33.35 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 71' ' ' HIS . 12.4 tp -107.59 111.02 23.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -63.39 -95.59 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.469 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -83.47 103.4 12.79 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 122.09 -0.381 . . . . 0.0 111.729 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.51 55.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.685 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.693 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 40.6 mt-30 -134.22 140.62 36.56 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.74 85.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.059 1.172 . . . . 0.0 111.625 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' GLN . 55.7 t-80 -177.24 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.693 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 35.0 p80 -82.58 -11.24 58.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.366 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.41 146.06 3.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 110.99 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.93 -154.85 25.19 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.38 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.4 mp0 -106.38 154.45 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 72.0 t -116.37 119.56 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.903 0.382 . . . . 0.0 110.688 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.6 m -127.01 130.09 49.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.432 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.64 138.59 36.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.28 153.86 38.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' ' 81' ' ' ASP . 15.1 t -157.07 -132.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.531 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.454 ' C ' ' N ' ' A' ' 82' ' ' ALA . 30.6 mmt180 -57.22 86.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.809 0.338 . . . . 0.0 110.406 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.7 t0 45.41 18.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.454 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -102.77 91.22 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.164 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.9 p -91.76 129.98 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.333 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.56 124.22 10.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.154 0.502 . . . . 0.0 110.802 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 10.3 p -92.14 -173.58 3.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 176.4 174.7 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.117 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -137.43 137.69 39.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.449 . . . . 0.0 111.056 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.2 121.64 31.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 t -142.35 152.06 42.53 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.68 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 90' ' ' VAL . 5.8 p -108.88 108.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.833 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 tp -73.69 128.45 35.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.5 -78.1 1.34 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 93' ' ' LEU . 6.6 mp -105.28 146.94 33.71 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.01 140.89 48.66 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 121.12 1.213 . . . . 0.0 110.958 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -64.21 162.11 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.943 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.11 98.48 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.09 127.5 32.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.83 120.66 34.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.725 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.61 -36.44 84.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -138.47 147.5 43.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.21 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -120.65 -1.02 10.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -65.64 -43.4 89.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.206 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -62.01 -47.84 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m80 . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.376 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -100.73 126.4 47.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.195 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -144.78 40.89 1.29 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.684 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' CD1' ' A' ' 6' ' ' LEU . 95.2 mt-10 -75.73 149.77 37.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.859 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.0 mt -86.63 108.59 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.9 mp -78.98 -64.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.332 -177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.13 113.83 18.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.964 0.411 . . . . 0.0 111.423 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.1 tp -106.73 123.58 48.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.766 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.8 tp -112.07 123.41 50.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.645 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 5.3 mmmm -138.67 -165.44 1.82 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.351 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 10' ' ' LYS . 65.7 t30 57.6 107.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.808 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.18 140.2 8.78 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.292 1.044 . . . . 0.0 113.402 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.23 144.37 51.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.617 -1.629 . . . . 0.0 107.454 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.2 m -123.62 128.95 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.713 0.768 . . . . 0.0 112.704 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ALA . 89.7 mtt180 -96.19 158.0 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.505 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 113.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.574 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.85 62.06 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . -104.54 153.13 21.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.503 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.436 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 9.9 mp0 -106.21 156.4 18.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.204 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . . . -124.88 138.11 54.26 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 t -120.83 109.69 15.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.27 0.557 . . . . 0.0 112.272 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -114.08 108.43 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -144.98 152.12 39.67 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.482 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.9 p -139.28 102.98 4.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 p -74.38 112.25 10.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.302 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.1 mt -101.22 -173.36 2.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.272 0.558 . . . . 0.0 111.359 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.46 -2.71 17.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.54 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -135.19 139.12 44.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.483 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.19 133.92 33.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.264 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' PRO . 61.1 t -108.31 131.34 21.82 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -60.77 -144.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.949 1.018 . . . . 0.0 110.188 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -119.91 122.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.29 -29.25 6.24 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.709 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.98 -12.61 52.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.86 0.362 . . . . 0.0 110.435 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.94 140.91 37.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 m -118.49 125.97 51.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 66.6 m95 -138.72 118.93 13.55 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.856 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -158.28 153.21 25.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.001 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.71 119.85 57.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -56.88 112.8 1.42 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.425 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.62 9.95 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.32 107.01 0.68 Allowed 'General case' 0 C--O 1.23 0.067 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.75 139.94 53.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.02 98.22 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 0.0 111.171 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.463 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.2 pt20 -102.77 151.43 38.32 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.51 -20.03 8.12 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.309 1.34 . . . . 0.0 110.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -98.05 8.31 44.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 45' ' ' GLN . 64.7 m-20 -42.78 113.31 0.45 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.888 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 t -69.64 -44.26 70.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.048 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.24 -35.76 10.25 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.65 138.83 31.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.082 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -124.52 131.74 53.48 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.4 130.01 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 p -146.07 154.29 41.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.86 98.33 5.49 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -100.68 110.82 22.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.464 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.17 -129.2 31.87 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.404 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 61.0 m -93.29 46.84 1.22 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.757 0.313 . . . . 0.0 110.721 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.404 ' CG ' ' C ' ' A' ' 58' ' ' SER . 39.6 m-70 -149.31 143.81 26.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -124.49 132.03 53.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.69 130.6 49.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.109 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.547 HD13 ' C ' ' A' ' 62' ' ' LEU . 2.3 tm? -140.59 114.17 8.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -142.35 153.14 43.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.5 tp -106.53 128.89 54.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.316 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -67.14 -107.75 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.62 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 p -83.59 108.81 16.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.127 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.967 ' HB1' ' CE1' ' A' ' 71' ' ' HIS . . . -69.72 139.05 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.667 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 94.5 mt-30 -130.43 140.46 38.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.554 ' O ' ' ND1' ' A' ' 70' ' ' HIS . 2.6 Cg_endo -46.42 89.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.152 1.235 . . . . 0.0 111.742 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' A' ' 69' ' ' PRO . 1.3 m80 163.81 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.843 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.967 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 28.5 p-80 -78.49 -13.29 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.645 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.544 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.91 -178.07 40.76 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.446 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.37 149.95 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.22 110.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.666 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.0 m -126.04 125.68 43.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.39 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.67 154.46 28.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.4 t -156.33 -132.8 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -57.86 88.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 79' ' ' CYS . 98.8 m-20 46.24 12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -96.6 66.24 2.3 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.1 t -79.81 129.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.865 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.645 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -161.81 144.85 12.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.13 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -153.84 132.11 11.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.91 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.92 -158.68 0.68 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.396 0.617 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -144.56 129.27 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.753 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.6 tp -117.46 126.3 52.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.586 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 t -139.47 148.4 42.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.132 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 14' ' ' VAL . 9.8 p -115.51 128.15 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.008 0.432 . . . . 0.0 111.599 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.6 tp -92.41 124.51 36.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.012 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.25 -68.9 0.42 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -109.03 157.42 37.04 Favored Pre-proline 0 CA--C 1.527 0.058 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -44.95 161.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.777 1.652 . . . . 0.0 111.477 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.59 -9.43 2.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.734 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.99 44.91 22.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.23 136.89 55.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -70.67 126.65 30.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.58 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 99' ' ' HIS . 44.9 t-80 -171.88 31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.532 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -67.5 -45.25 76.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -74.62 119.86 19.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 110.84 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -74.25 -19.45 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -48.47 -79.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.457 ' OXT' ' CG ' ' A' ' 104' ' ' HIS . 55.4 p-80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.601 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.53 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 31.8 t90 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 4' ' ' GLU . 97.5 mtt180 -101.09 95.67 6.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 2' ' ' ARG . 4.8 mp 35.93 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.53 ' OE2' ' N ' ' A' ' 1' ' ' TRP . 17.2 pt-20 -84.66 144.95 28.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.237 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.6 HD11 ' HA ' ' A' ' 82' ' ' ALA . 28.7 mt -86.67 119.03 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.74 -69.5 0.58 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' C ' HD13 ' A' ' 8' ' ' LEU . 99.0 mt-10 -134.65 130.39 36.31 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.126 0.489 . . . . 0.0 111.774 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.895 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -126.08 146.58 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.457 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.412 HD12 ' H ' ' A' ' 23' ' ' THR . 88.3 mt -104.61 113.61 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.764 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 3.0 mmpt? -127.39 173.32 9.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.218 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 63.3 108.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 136.43 13.43 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.11 130.92 48.91 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.18 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 6.6 m -126.14 124.25 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.914 0.864 . . . . 0.0 113.319 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -78.04 170.19 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.766 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.68 130.68 45.24 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.49 34.35 54.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.04 147.9 40.75 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.935 0.397 . . . . 0.0 110.919 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -95.54 149.12 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . . . -127.12 144.35 51.05 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.7 p -139.8 133.35 30.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.128 0.489 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -139.12 126.31 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.412 ' H ' HD12 ' A' ' 9' ' ' LEU . 33.5 p -140.03 144.86 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 26' ' ' LEU . 41.9 t -133.53 92.38 2.98 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 110.971 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -74.13 115.42 13.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.622 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 24' ' ' CYS . 91.9 mt -105.37 -177.35 3.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.871 0.843 . . . . 0.0 112.501 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 m -105.31 -15.45 15.04 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.578 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -129.42 129.23 44.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.54 119.64 32.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.578 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -109.81 148.11 37.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.616 -178.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.8 Cg_endo -57.89 -140.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.776 1.651 . . . . 0.0 110.362 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 m -119.21 103.76 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.34 -44.45 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -64.36 -45.59 87.12 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.858 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.47 141.75 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.6 m -135.54 98.58 3.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.562 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 94.3 m95 -102.13 113.89 27.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 88.3 m-85 -150.84 148.03 27.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.183 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 74' ' ' GLU . 1.9 mp -118.99 122.03 68.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -54.44 122.1 9.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.043 0.838 . . . . 0.0 110.008 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.71 -5.71 14.2 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 124.113 0.883 . . . . 0.0 110.974 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' CZ3' ' A' ' 51' ' ' TRP . . . -165.26 111.06 0.92 Allowed 'General case' 0 C--O 1.231 0.085 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.04 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.26 139.59 48.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.916 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -86.36 99.54 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.385 0.612 . . . . 0.0 110.506 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.645 ' C ' ' H ' ' A' ' 47' ' ' ASP . 31.1 mt-30 -124.74 163.69 35.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.8 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.89 20.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.312 1.341 . . . . 0.0 111.677 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.645 ' H ' ' C ' ' A' ' 45' ' ' GLN . 39.0 m-20 -112.22 -19.7 12.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 45' ' ' GLN . 49.2 m-20 -46.12 105.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.226 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 47.9 t -93.12 -39.21 11.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' OD1' ' CZ ' ' A' ' 65' ' ' ARG . 95.3 m-20 -87.14 -25.12 24.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.322 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.441 ' CZ3' ' CB ' ' A' ' 42' ' ' ALA . 5.6 m-90 -112.91 142.99 44.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.074 0.464 . . . . 0.0 111.11 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 m -132.16 136.29 46.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.86 134.68 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -141.94 154.29 44.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.62 107.97 5.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 111.56 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -119.28 105.27 11.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.14 -133.58 45.86 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.9 m -92.29 30.06 1.55 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.641 0.258 . . . . 0.0 111.103 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -134.43 130.13 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.27 137.03 54.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.94 119.21 15.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.255 0.55 . . . . 0.0 111.523 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.0 135.34 55.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.537 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 63' ' ' LEU . 2.2 pp -125.23 179.36 5.11 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.068 0.937 . . . . 0.0 113.141 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 39.1 tp -145.68 118.52 8.7 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.56 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' CZ ' ' OD1' ' A' ' 50' ' ' ASP . 28.2 ptt180 -63.94 -127.93 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.436 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.0 p -73.06 110.62 7.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.64 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB1' ' CD2' ' A' ' 71' ' ' HIS . . . -63.62 112.38 2.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.979 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' HIS . 16.8 pt20 -112.48 145.69 33.42 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.92 83.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.623 1.549 . . . . 0.0 111.763 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 175.95 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.635 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 12.3 p80 -73.98 -13.63 60.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.732 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.82 147.6 8.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 110.869 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.84 -170.41 40.6 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 39' ' ' ILE . 80.7 tt0 -99.51 149.63 23.03 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 75.7 t -117.53 115.35 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.7 m -129.3 130.94 46.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.25 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 9.5 t80 -136.79 138.38 40.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.98 147.82 27.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.107 0.479 . . . . 0.0 111.479 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.22 -148.57 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.99 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' A' ' 82' ' ' ALA . 45.1 mmm-85 -60.66 90.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.069 0.461 . . . . 0.0 110.454 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 t0 48.18 14.8 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.193 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.6 ' HA ' HD11 ' A' ' 5' ' ' ILE . . . -104.37 73.63 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.8 t -80.39 151.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.906 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.764 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -157.17 170.38 22.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.286 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 37.1 m -159.1 178.87 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 174.77 179.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 111.179 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 87' ' ' ARG . 83.1 mtt85 -142.07 128.03 19.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.5 tp -113.58 129.46 56.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 t -144.29 153.07 41.64 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.019 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 90' ' ' VAL . 13.9 p -117.65 126.58 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.4 tp -62.55 134.33 56.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.08 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.92 59.73 0.48 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 19.7 mt -99.2 108.52 50.25 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.72 136.48 66.87 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.819 0.971 . . . . 0.0 112.17 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -78.84 175.71 10.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.279 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.05 17.84 33.59 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 97' ' ' LEU . 10.6 mp -73.13 145.05 46.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.151 0.501 . . . . 0.0 111.051 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -102.24 116.3 32.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.142 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -84.02 146.22 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.695 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.54 131.47 50.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 0.0 110.609 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 41.63 80.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.499 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 103' ' ' HIS . 60.1 t-80 -67.44 148.43 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.331 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 103' ' ' HIS . 2.8 m80 -85.26 132.89 34.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.227 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.665 -179.332 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 95.3 m95 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -98.84 149.31 23.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.251 0.548 . . . . 0.0 111.369 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.632 HD21 HD22 ' A' ' 26' ' ' LEU . 10.1 tt -84.24 93.87 8.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.088 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -72.86 131.44 42.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.222 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.554 HG12 HD22 ' A' ' 8' ' ' LEU . 20.2 tt -92.94 114.83 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.2 mp -92.06 -72.46 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.12 121.58 35.55 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.193 0.452 . . . . 0.0 111.966 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.16 126.86 49.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.343 179.265 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.65 111.77 23.51 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -126.47 -179.88 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.906 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t30 60.37 108.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.72 15.05 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.664 0.986 . . . . 0.0 113.664 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.04 129.65 50.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.15 126.41 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.898 0.856 . . . . 0.0 112.994 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.56 163.88 25.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.618 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 130.44 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.58 40.1 67.29 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.3 46.01 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.962 0.411 . . . . 0.0 110.962 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -101.99 159.78 15.07 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.744 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 151.68 37.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -133.65 135.76 44.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.327 0.584 . . . . 0.0 111.925 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.88 123.56 26.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -135.71 134.57 39.24 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.096 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.56 89.57 3.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 p -71.78 112.42 7.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.632 HD22 HD21 ' A' ' 3' ' ' LEU . 95.5 mt -112.0 144.2 41.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.76 0.791 . . . . 0.0 112.415 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -63.26 -27.84 69.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.605 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -125.14 143.79 50.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.122 0.487 . . . . 0.0 111.719 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.58 143.82 29.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.342 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' PRO . 38.7 t -117.89 138.0 24.93 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.202 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -62.32 -143.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.229 1.118 . . . . 0.0 110.649 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -125.76 115.64 43.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.45 -29.37 3.16 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.89 -16.07 28.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.967 0.413 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.39 140.35 38.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -128.64 139.47 52.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.115 0.483 . . . . 0.0 111.553 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 96.6 m95 -140.23 106.78 5.32 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.438 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 84.0 m-85 -158.88 157.84 32.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.671 0.748 . . . . 0.0 111.714 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.927 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.49 129.8 75.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -66.17 120.64 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.264 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.43 -2.35 18.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.572 ' O ' HD11 ' A' ' 39' ' ' ILE . . . -165.06 62.16 0.12 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.639 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.49 110.95 0.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 44' ' ' VAL . 4.1 m -79.03 116.75 23.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.616 0.722 . . . . 0.0 112.17 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -82.91 155.12 67.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.043 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -49.28 -24.46 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.486 1.458 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -106.58 27.26 9.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 49' ' ' SER . 41.8 t0 -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.189 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 42.8 p -88.33 -37.69 15.75 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -86.45 -32.9 20.59 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.444 ' NE1' HD13 ' A' ' 64' ' ' LEU . 19.0 m-90 -110.81 145.79 37.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.774 0.321 . . . . 0.0 110.823 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.421 ' HB ' HD23 ' A' ' 63' ' ' LEU . 88.5 m -132.07 127.57 36.39 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.34 135.13 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 p -144.55 156.9 44.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.417 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.6 100.57 4.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.45 112.0 24.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.674 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.23 -123.92 34.67 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 26' ' ' LEU . 6.0 t -106.62 48.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -144.13 139.6 28.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -117.8 118.05 30.98 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.26 106.1 14.97 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.272 0.558 . . . . 0.0 111.659 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.798 ' C ' HD13 ' A' ' 63' ' ' LEU . 10.6 tp -114.24 126.88 55.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.503 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.913 HD22 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -125.35 -177.41 3.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.302 1.048 . . . . 0.0 111.032 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 65' ' ' ARG . 40.8 tp -144.16 117.72 9.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.792 -2.004 . . . . 0.0 106.931 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 64' ' ' LEU . 24.5 mmt85 -64.14 -129.07 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.521 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.6 p -78.23 108.9 11.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.94 141.32 56.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 81.0 mt-30 -129.55 142.08 44.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.876 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.73 84.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.296 1.33 . . . . 0.0 111.473 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' GLN . 45.4 t-80 174.15 -23.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.084 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.4 -7.42 59.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.819 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.47 145.62 22.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.611 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.11 -165.38 38.53 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.42 150.47 20.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 85.8 t -117.4 115.33 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.508 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 m -131.55 130.89 42.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -142.23 146.99 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.3 155.1 30.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.164 0.507 . . . . 0.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' ASP . 8.4 t -156.12 -138.59 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.109 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' ALA . 24.3 mmm180 -55.57 89.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.0 p-10 39.52 22.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.767 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -105.84 75.21 1.1 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.98 137.46 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.438 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -151.74 117.43 5.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 41.9 m -92.38 -173.88 3.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.342 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 176.1 172.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.203 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -140.88 135.62 31.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.229 0.538 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.0 tp -120.03 128.34 53.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -142.84 146.51 34.22 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.8 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.1 p -109.85 126.73 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 110.919 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 3.1 mm? -101.28 128.13 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.07 -33.06 0.07 OUTLIER Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -111.59 127.53 26.74 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.6 144.82 99.34 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 CA-C-N 120.013 1.04 . . . . 0.0 111.799 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -70.45 140.62 52.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.072 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.17 -37.45 0.8 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.01 -86.16 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.98 155.09 20.01 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.39 115.26 27.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.572 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -157.74 -17.49 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.295 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.77 111.28 21.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.315 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -83.18 -57.5 3.25 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.718 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -153.02 172.04 17.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.595 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.396 179.596 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.2 mtm-85 -59.89 -113.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 3' ' ' LEU . 9.5 mp -89.65 74.48 7.56 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -77.43 136.75 38.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.425 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.1 mt -91.85 119.1 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.717 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.1 mp -82.94 -70.83 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -141.83 136.63 30.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.303 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.881 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.73 143.71 50.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.594 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 117.82 29.93 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 1.2 mmpt? -130.36 178.02 6.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.867 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' LYS . 78.5 m-20 52.22 108.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.412 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.86 137.04 9.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.57 0.7 . . . . 0.0 112.028 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.53 125.42 48.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.816 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.65 103.88 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.351 0.596 . . . . 0.0 111.675 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -61.77 141.01 58.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.947 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.85 114.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.58 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.78 7.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.56 155.41 46.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -100.8 153.99 19.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.044 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.26 143.77 34.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 p -121.57 135.62 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.324 0.583 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.97 122.84 27.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -137.08 136.37 38.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 m -127.07 92.88 3.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.916 0.388 . . . . 0.0 111.822 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.572 HG23 ' NE2' ' A' ' 59' ' ' HIS . 72.8 m -74.71 110.16 8.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.575 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.87 -167.05 1.32 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.105 0.478 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 t -107.93 -11.64 15.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.261 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.4 pm0 -140.68 149.11 41.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.703 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.65 146.38 23.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 31' ' ' PRO . 59.4 t -102.02 125.97 35.12 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.611 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.81 -141.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.181 1.254 . . . . 0.0 110.411 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.94 124.52 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.01 31.69 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.687 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.14 -11.58 49.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.309 0.554 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -143.16 53.29 1.36 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -90.37 110.53 21.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.402 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -157.96 152.69 25.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.583 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 39' ' ' ILE . 3.5 mm -74.73 117.07 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.78 95.04 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 133.57 -24.6 3.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 106.01 4.76 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.49 58.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.7 m -82.46 124.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.359 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.02 153.85 60.29 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.29 -33.38 45.22 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.334 1.356 . . . . 0.0 111.072 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 49' ' ' SER . 87.5 m-20 -88.44 14.73 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.881 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' ASP . 48.8 p-10 -32.97 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.507 . . . . 0.0 111.719 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 47' ' ' ASP . 16.1 t -68.01 -40.13 83.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.236 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.06 -27.55 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.447 ' CE3' HD13 ' A' ' 64' ' ' LEU . 4.5 m95 -115.24 152.15 33.21 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.39 -0.194 . . . . 0.0 110.699 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -144.87 152.24 39.95 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 111.228 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.44 139.25 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.855 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 61' ' ' ALA . 2.2 p -140.75 156.05 46.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.544 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.15 107.53 4.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -108.72 104.02 13.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.735 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.38 -134.61 45.15 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.1 m -89.48 38.55 0.91 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.68 0.276 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.572 ' NE2' HG23 ' A' ' 25' ' ' THR . 57.4 m80 -137.59 142.42 41.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.839 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.55 159.88 20.68 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -152.57 82.98 1.23 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.669 0.747 . . . . 0.0 110.749 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -92.15 144.59 25.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.249 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 63' ' ' LEU . 2.8 pp -141.02 174.07 10.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.281 1.039 . . . . 0.0 112.654 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.447 HD13 ' CE3' ' A' ' 51' ' ' TRP . 48.7 tp -142.24 118.16 10.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 113.057 -1.883 . . . . 0.0 106.895 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LEU . 69.5 mtt180 -66.04 -131.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.477 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.1 m -81.57 106.58 13.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.91 0.386 . . . . 0.0 110.815 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.53 54.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.727 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.665 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 55.0 mt-30 -124.66 148.02 57.77 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -44.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.704 1.603 . . . . 0.0 111.451 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . 13.7 t-80 164.15 -21.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.665 ' HD1' ' H ' ' A' ' 68' ' ' GLN . 76.1 m80 -79.87 -8.91 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.17 145.45 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.96 -141.82 7.64 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 39' ' ' ILE . 91.3 mt-10 -134.47 169.99 16.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.547 0.339 . . . . 0.0 110.171 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 44.8 t -128.87 129.15 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.318 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -133.69 130.01 37.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.974 0.416 . . . . 0.0 111.222 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -132.27 141.83 49.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.13 143.8 15.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 10.6 t -158.86 -136.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.286 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 43.8 mtm180 -59.87 85.52 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.186 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' CYS . 94.3 m-20 51.65 14.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.21 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.03 91.36 8.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 110.194 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -81.27 138.72 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.013 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.461 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -164.94 160.46 19.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 16.8 p -160.38 -178.49 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.764 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.65 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 179.84 170.88 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.201 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -129.68 121.38 26.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.195 0.521 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' GLY . 41.6 tp -104.34 128.64 52.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.922 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 t -143.58 125.03 14.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.695 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.51 113.47 28.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.64 156.24 23.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.631 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.2 -174.81 14.42 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.3 mt -107.62 170.53 5.49 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.13 -2.91 11.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.828 1.685 . . . . 0.0 111.376 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.98 107.9 12.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.043 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.05 97.75 2.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 2.4 pp -89.95 147.55 23.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 111.098 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -144.46 -80.58 0.18 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.946 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.403 ' H ' ' H ' ' A' ' 100' ' ' HIS . 67.6 t60 -154.89 -11.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.829 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.403 ' H ' ' H ' ' A' ' 99' ' ' HIS . 97.6 m-70 -70.92 -78.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.39 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 102' ' ' HIS . 83.7 t60 -134.21 136.2 43.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.574 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.427 ' O ' ' CD2' ' A' ' 101' ' ' HIS . 92.7 m-70 -104.67 -170.88 1.83 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.119 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -61.82 -6.16 2.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.679 179.913 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -100.5 91.79 4.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.943 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.495 HD13 ' OG ' ' A' ' 27' ' ' SER . 97.0 mt -76.93 146.69 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -140.62 -141.36 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -92.85 94.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.327 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 6' ' ' LEU . 8.3 mp -61.65 -46.78 88.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.118 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.51 114.62 18.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.907 0.384 . . . . 0.0 110.226 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 116.85 33.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.689 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HB3' ' H ' ' A' ' 23' ' ' THR . 34.6 tp -101.4 120.52 40.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.371 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.725 ' CE ' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.64 -163.88 1.85 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.295 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 57.84 108.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.76 139.07 9.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.825 0.821 . . . . 0.0 113.014 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.06 130.95 53.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.688 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 90' ' ' VAL . 9.1 m -136.14 108.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -77.48 169.85 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.146 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.33 107.01 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.34 -7.68 40.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 65' ' ' ARG . . . -76.39 -178.35 4.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.411 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -136.86 149.76 47.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.52 133.47 55.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.216 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.2 t -121.22 106.7 11.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.131 0.491 . . . . 0.0 111.45 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -118.57 106.83 13.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 3.7 p -138.23 147.34 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 31.1 p -134.56 99.45 4.35 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.818 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 m -69.98 110.72 5.21 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.373 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -94.05 175.62 6.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.704 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.495 ' OG ' HD13 ' A' ' 3' ' ' LEU . 9.4 t -114.92 -5.57 12.56 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -127.06 137.82 53.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.3 136.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.018 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.3 133.71 24.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.519 -0.277 . . . . 0.0 110.68 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.96 -154.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 119.844 0.98 . . . . 0.0 109.938 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.97 104.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.74 -50.9 0.4 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -69.58 -43.64 72.44 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.8 143.89 37.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.591 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -142.25 127.9 19.15 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 121.011 0.434 . . . . 0.0 111.075 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 33.6 m95 -122.96 111.97 17.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.145 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 87.0 m-85 -157.54 157.73 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 111.336 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.846 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.78 128.57 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.335 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -61.85 118.66 7.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.576 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.7 -0.99 20.1 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.523 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -164.43 68.8 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.821 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.34 131.07 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.69 110.67 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.857 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -92.94 154.42 41.85 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.582 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.65 -25.78 43.29 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 120.999 1.133 . . . . 0.0 110.633 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.89 11.47 29.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.708 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 51' ' ' TRP . 44.4 p-10 -42.77 115.96 0.8 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.5 p -87.87 -39.68 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.665 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -88.97 -26.03 21.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 10.6 m-90 -110.5 145.31 37.94 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HD12 ' A' ' 62' ' ' LEU . 96.7 m -124.54 126.11 45.29 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 p -125.03 129.92 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -143.99 153.16 41.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.43 98.54 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.995 0.426 . . . . 0.0 110.107 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.67 96.83 7.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.04 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.27 -128.17 41.27 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 m -92.79 42.68 1.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -149.41 135.53 18.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -121.74 140.52 52.23 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 130.55 37.83 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 111.548 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 52' ' ' THR . 40.4 tp -135.28 122.7 21.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.865 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' HD12 ' A' ' 63' ' ' LEU . 2.5 pp -141.02 139.76 34.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.1 tp -106.34 119.61 39.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mtt-85 -63.91 -101.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.902 -177.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.6 p -82.81 99.19 9.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.917 0.389 . . . . 0.0 111.312 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.68 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.423 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.686 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 83.6 mt-30 -130.62 139.34 35.3 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.012 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -55.36 85.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.072 1.181 . . . . 0.0 110.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.1 t60 -175.06 -48.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 25.5 p80 -76.96 -0.37 24.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.635 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.05 146.88 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.0 -148.57 12.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.0 mp0 -115.32 156.36 25.63 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.76 0.314 . . . . 0.0 110.399 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.7 t -117.93 116.56 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.489 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.3 m -123.73 131.78 53.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.192 0.52 . . . . 0.0 110.774 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -136.13 130.96 34.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.231 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.46 150.73 51.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.447 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.5 t -153.33 -144.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.649 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' ALA . 21.1 mmm180 -52.77 88.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.953 0.406 . . . . 0.0 109.966 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.8 p30 42.71 17.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -101.7 86.23 2.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 83' ' ' VAL . 10.5 p -82.31 127.33 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.09 129.32 21.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.535 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 11.1 p -92.83 -175.26 3.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.479 0.657 . . . . 0.0 111.631 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 175.68 171.97 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.81 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -146.52 138.57 24.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.985 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.2 tp -117.95 128.85 55.2 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.548 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 t -141.31 153.33 45.1 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.525 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.0 p -106.6 116.11 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 tp -78.92 126.3 30.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.283 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.77 3.94 4.64 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.18 107.54 55.83 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.3 -13.27 35.54 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 120.934 1.089 . . . . 0.0 111.305 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.28 122.44 18.87 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.625 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 100' ' ' HIS . . . -156.82 84.56 0.14 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.3 1.08 46.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.46 -35.61 75.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.28 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.511 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 81.1 m-70 -130.46 103.71 6.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.047 0.451 . . . . 0.0 111.394 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 99' ' ' HIS . 12.4 m80 -156.34 168.96 25.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 86.6 t60 56.02 2.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 100' ' ' HIS . 3.2 m-70 -62.04 -92.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -66.7 -44.15 82.45 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.985 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.701 -179.581 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.4 m0 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 4' ' ' GLU . 99.6 mtt180 -96.24 133.29 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.793 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.499 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -70.07 21.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.597 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 2' ' ' ARG . 15.8 pt-20 -57.03 143.42 38.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.326 0.584 . . . . 0.0 111.732 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.0 mt -82.52 123.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 6' ' ' LEU . 8.3 mp -95.39 -38.84 10.31 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.69 146.32 25.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.207 0.527 . . . . 0.0 110.909 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 8' ' ' LEU . 3.1 pp -161.28 121.67 2.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -125.92 116.18 21.11 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 45.2 mtpt -146.95 -164.22 1.94 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.434 0.635 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.554 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 33.0 t-20 56.02 97.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.789 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -167.27 140.67 3.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.403 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.87 140.33 36.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.65 130.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.922 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -58.76 -172.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . . . -76.44 150.04 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.476 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 -3.18 81.88 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.3 144.97 25.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.127 0.489 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -88.29 145.94 25.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.67 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.69 52.35 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.2 p -152.95 123.36 7.17 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.341 0.591 . . . . 0.0 112.009 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -125.94 143.96 50.88 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.95 143.76 31.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.076 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 26' ' ' LEU . 5.0 t -127.57 88.28 2.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.787 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.634 HG23 ' NE2' ' A' ' 59' ' ' HIS . 44.1 m -75.07 94.06 2.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.853 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.571 HD21 ' SG ' ' A' ' 24' ' ' CYS . 66.1 mt -82.58 -160.9 0.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.956 0.884 . . . . 0.0 112.949 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.3 t -117.39 -19.08 9.68 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.77 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -121.24 150.0 42.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.189 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.32 141.04 30.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 31' ' ' PRO . 22.6 t -117.04 128.19 26.2 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.623 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.2 Cg_exo -60.17 -146.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.913 1.076 . . . . 0.0 111.217 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.01 120.4 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.67 -26.57 8.4 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.955 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 75.8 tt0 -87.1 -12.12 48.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.918 0.359 . . . . 0.0 110.392 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.53 122.69 47.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -92.79 141.13 28.78 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 95.9 m95 -153.21 101.32 2.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.117 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -160.86 167.09 27.4 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.196 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' ASN . 2.0 mp -118.24 94.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ILE . 22.3 t-20 -32.46 123.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 -2.29 29.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.65 79.1 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.133 -0.533 . . . . 0.0 109.683 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.23 58.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.91 131.78 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.991 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -96.42 151.15 37.87 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.91 -29.69 91.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.051 1.167 . . . . 0.0 112.752 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -94.83 0.56 54.95 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -69.01 130.47 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.5 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -97.69 -2.56 41.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -80.2 -29.25 38.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.949 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -112.52 140.52 47.19 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.4 m -131.82 125.95 33.11 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.27 131.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.3 p -143.82 147.39 34.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.534 0.683 . . . . 0.0 112.291 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.97 112.37 24.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.578 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -120.81 101.44 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.78 -122.11 25.33 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' ND1' ' A' ' 59' ' ' HIS . 47.9 t -110.81 44.77 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.634 ' NE2' HG23 ' A' ' 25' ' ' THR . 32.7 m80 -141.93 135.62 29.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.998 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -117.69 126.74 53.03 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.44 119.06 29.86 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' C ' HD23 ' A' ' 62' ' ' LEU . 6.5 tt -130.51 123.8 30.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.496 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 62' ' ' LEU . 2.8 pp -121.55 162.65 20.21 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 0.0 110.535 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 65' ' ' ARG . 28.5 tp -124.44 117.71 25.03 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 64' ' ' LEU . 56.4 ttp180 -57.39 -109.19 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.001 -177.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.1 p -87.38 121.24 29.56 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 16' ' ' ALA . . . -64.48 138.6 58.5 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' HIS . 23.3 pt20 -133.21 137.23 28.85 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 119.681 -0.199 . . . . 0.0 110.476 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.71 84.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 120.795 0.996 . . . . 0.0 110.722 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 -177.74 -39.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.735 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.477 ' CD2' HD21 ' A' ' 64' ' ' LEU . 3.5 p80 -71.99 -33.69 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.78 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 71' ' ' HIS . . . -35.54 143.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.88 -132.42 3.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.82 129.86 53.73 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.535 0.207 . . . . 0.0 110.634 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.99 130.86 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 m -132.7 123.77 26.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -139.14 128.16 23.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.183 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.441 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -156.99 154.7 30.05 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.549 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 18.1 p -154.67 -132.78 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.623 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 30.8 mmt180 -54.3 84.24 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.109 0.48 . . . . 0.0 109.796 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' CYS . 87.9 m-20 46.16 13.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.56 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.612 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -94.47 70.18 3.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.2 t -81.27 132.52 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.242 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.01 117.95 5.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.971 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.4 p -127.43 147.17 50.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.549 0.69 . . . . 0.0 111.537 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 11' ' ' ASN . . . -157.9 151.93 24.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.939 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -97.62 131.66 43.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 12' ' ' ALA . 46.3 tp -106.48 134.78 49.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -136.13 162.17 33.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.334 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.54 132.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.151 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 92' ' ' GLY . 1.9 tm? -98.78 124.01 43.37 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.679 ' N ' HD13 ' A' ' 91' ' ' LEU . . . 171.27 105.32 0.18 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.221 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -109.59 106.52 58.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.44 135.21 41.65 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.912 1.004 . . . . 0.0 111.296 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -89.16 95.62 10.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -98.17 -16.76 31.63 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.9 pp -86.7 128.47 35.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 110.793 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.64 149.22 31.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.537 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -87.62 132.44 34.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 81.5 t60 -148.64 9.58 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.94 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -139.31 151.08 46.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -86.93 139.39 30.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.942 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -142.11 137.77 31.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.18 179.703 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.6 m95 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.436 ' C ' HD12 ' A' ' 3' ' ' LEU . 96.9 mtt-85 -100.7 133.73 44.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.625 0.25 . . . . 0.0 110.471 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 3' ' ' LEU . 9.4 mp -96.89 129.12 44.38 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -137.83 -115.43 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG13 ' HB1' ' A' ' 82' ' ' ALA . 91.3 mt -100.18 120.9 50.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.049 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.603 HD21 ' OG ' ' A' ' 27' ' ' SER . 86.8 mt -80.97 -69.35 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.93 124.13 34.34 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -110.8 146.56 36.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.388 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.574 ' C ' HD23 ' A' ' 9' ' ' LEU . 6.4 tt -109.05 114.22 27.78 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -136.2 174.36 10.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.691 -176.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 60.76 107.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.602 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.23 135.7 11.33 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.853 0.835 . . . . 0.0 112.859 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 158.09 16.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.826 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.84 164.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 111.623 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 18' ' ' ALA . 95.2 mtm-85 -128.32 159.32 35.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.845 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.79 101.66 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.578 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.96 -9.27 54.95 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB3' ' H ' ' A' ' 15' ' ' ARG . . . -78.09 174.93 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 111.015 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -115.22 153.64 30.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.75 149.4 47.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.26 142.8 44.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -148.25 133.35 18.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 3.3 t -149.14 155.53 40.82 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.859 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 t -148.67 96.04 2.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 111.927 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 m -69.92 123.03 20.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.58 150.66 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.5 0.667 . . . . 0.0 112.668 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.603 ' OG ' HD21 ' A' ' 6' ' ' LEU . 17.5 m -74.68 -18.23 60.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.341 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -138.02 140.82 40.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.474 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.0 147.67 42.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.532 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 31' ' ' PRO . 41.3 t -105.53 134.77 19.53 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.2 Cg_exo -61.36 -144.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 CA-C-N 120.218 1.114 . . . . 0.0 110.405 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.78 125.12 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.3 -16.05 57.14 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.617 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -89.89 -19.94 23.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.74 23.8 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.432 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 8.6 t -154.29 129.12 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.738 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.544 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 77.7 m95 -150.37 102.42 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 14.6 p90 -155.57 154.51 31.81 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.777 HD13 ' N ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -68.81 97.97 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -48.53 96.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 142.25 -20.08 2.46 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 110.41 4.5 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.34 138.01 58.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.3 t -91.83 128.26 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 111.673 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -84.93 153.24 60.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.652 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 48' ' ' ASP . 2.0 Cg_endo -55.44 -34.08 88.05 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.574 1.516 . . . . 0.0 111.717 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -78.58 21.06 0.4 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.749 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 46' ' ' PRO . 27.5 p-10 -47.53 98.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.7 t -81.41 -49.18 10.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.246 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -64.34 -37.93 89.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.926 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -110.18 161.73 15.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.284 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -138.16 141.02 40.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.94 134.58 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 p -141.75 153.75 44.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.477 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 120.6 3.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.63 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -138.03 116.47 12.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.396 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.26 -108.72 2.61 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -130.67 31.83 4.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.75 0.31 . . . . 0.0 110.476 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.499 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 8.7 t-80 -130.75 132.09 45.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.268 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.42 159.98 16.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.51 97.73 1.35 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.996 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.02 130.91 53.86 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.541 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -178.71 4.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.954 0.883 . . . . 0.0 112.016 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -144.67 120.12 10.32 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.049 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -69.0 -130.54 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.278 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.9 p -58.73 100.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 0.0 111.897 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 139.51 58.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.958 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.26 144.63 52.08 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.571 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -52.5 91.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.337 1.358 . . . . 0.0 111.262 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 8.2 m-70 165.11 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -83.3 -7.42 59.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 148.66 43.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.791 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.75 -160.62 31.65 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.3 167.02 11.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.828 0.347 . . . . 0.0 110.39 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 50.8 t -133.28 133.27 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.75 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 m -131.98 128.23 37.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.311 0.577 . . . . 0.0 111.52 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 0.3 OUTLIER -131.05 137.93 49.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.759 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -164.35 152.43 12.49 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 21.2 p -156.48 -133.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.816 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 49.3 mmm-85 -59.14 92.08 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 42.54 18.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.773 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -107.3 73.7 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.12 153.79 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.798 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.22 178.67 8.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.602 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 p -154.69 -179.14 7.72 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.537 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . -178.16 166.55 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.282 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -126.47 135.98 52.04 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.04 0.447 . . . . 0.0 110.353 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 130.53 54.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -152.88 149.66 28.49 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.619 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.3 p -110.66 120.51 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.46 0.475 . . . . 0.0 109.905 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.61 HD13 ' N ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -108.03 118.99 38.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.61 ' N ' HD13 ' A' ' 91' ' ' LEU . . . -169.49 -175.02 38.35 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.6 mt -107.03 150.46 39.87 Favored Pre-proline 0 CA--C 1.521 -0.172 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.39 -27.2 23.32 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 CA-C-N 119.497 0.856 . . . . 0.0 110.68 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -65.76 136.64 56.49 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.5 -5.61 66.87 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.31 134.06 43.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.164 0.507 . . . . 0.0 111.34 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -126.92 -88.87 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.051 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -168.86 126.98 1.03 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.617 ' N ' ' ND1' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -179.37 65.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.212 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.24 -47.01 84.26 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.909 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -165.0 -56.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.36 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -91.19 105.33 17.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.881 -1.057 . . . . 0.0 110.823 -179.54 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -94.53 174.33 7.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -144.66 23.98 1.56 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.04 135.23 44.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -73.66 121.48 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD12 ' H ' ' A' ' 6' ' ' LEU . 5.0 mp -82.02 -70.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -127.85 119.72 26.24 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.895 0.378 . . . . 0.0 111.08 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 tp -114.58 130.58 56.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 23' ' ' THR . 10.8 mp -99.92 123.01 43.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.259 0.552 . . . . 0.0 110.61 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ASN . 4.5 mmpt? -138.75 -178.34 5.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.282 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 10' ' ' LYS . 58.8 t-20 55.14 109.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.553 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.38 136.62 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.964 0.888 . . . . 0.0 113.217 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.84 135.9 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.434 ' CG2' ' NE2' ' A' ' 71' ' ' HIS . 15.6 m -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.018 0.913 . . . . 0.0 112.895 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -81.74 151.99 27.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.493 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.94 128.28 32.67 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.95 39.85 53.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.88 149.69 47.28 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.809 0.338 . . . . 0.0 111.434 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -102.66 151.06 22.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.96 28.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.397 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.55 147.32 48.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.411 0.624 . . . . 0.0 111.993 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -140.55 127.04 20.09 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.607 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.503 HG22 HD22 ' A' ' 9' ' ' LEU . 2.9 t -144.53 147.29 33.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.287 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.464 ' SG ' HD21 ' A' ' 26' ' ' LEU . 30.7 t -130.86 93.1 3.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 111.258 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 59' ' ' HIS . 32.2 m -72.56 113.87 10.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.464 HD21 ' SG ' ' A' ' 24' ' ' CYS . 96.2 mt -113.98 145.32 41.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.09 0.472 . . . . 0.0 111.899 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -71.46 -10.45 59.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.982 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -133.53 137.24 45.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.15 143.33 32.46 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.555 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 31' ' ' PRO . 31.2 t -124.03 128.75 24.99 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.06 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.9 Cg_endo -58.41 -150.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.944 1.096 . . . . 0.0 111.056 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -114.37 102.99 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.34 -49.39 0.48 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.73 -40.46 76.2 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.664 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.63 37.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -124.52 131.1 53.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.039 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.509 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 93.5 m95 -133.37 100.29 4.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.085 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 78.4 m-85 -152.63 153.84 34.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.114 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.16 129.32 74.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.788 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.07 123.55 19.79 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.569 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.2 3.96 20.86 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' HB1' ' CH2' ' A' ' 51' ' ' TRP . . . -171.56 96.44 0.18 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.977 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 135.83 50.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.86 104.99 14.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.426 0.632 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.63 153.13 47.79 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.363 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.46 -27.87 26.06 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.299 1.333 . . . . 0.0 110.903 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -96.67 12.41 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.508 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 22.9 p30 -39.21 110.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.292 0.568 . . . . 0.0 110.756 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.43 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 2.9 t -76.79 -52.51 9.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.341 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.41 -31.9 37.56 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 21.5 m-90 -107.47 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.403 ' OG1' HD11 ' A' ' 63' ' ' LEU . 15.8 m -130.2 138.98 50.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.3 131.57 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.8 p -144.5 156.12 44.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.167 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 107.15 4.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.551 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -112.56 103.74 11.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.15 -131.59 27.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -97.13 39.36 1.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.572 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.498 ' CE1' HG23 ' A' ' 25' ' ' THR . 80.4 m-70 -137.35 138.5 40.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.431 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -110.85 156.33 21.29 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -158.83 93.7 1.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.924 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -110.18 129.89 55.64 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.471 HD12 ' C ' ' A' ' 63' ' ' LEU . 1.9 pp -122.76 -177.25 3.6 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.064 0.935 . . . . 0.0 112.886 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 65' ' ' ARG . 31.5 tp -144.21 116.54 8.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.141 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' NH2' ' O ' ' A' ' 49' ' ' SER . 13.9 ptp180 -64.67 -129.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.917 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -76.4 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 0.0 110.372 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 71' ' ' HIS . . . -64.68 142.2 58.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 0.0 110.846 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' HIS . 18.9 mm100 -132.97 145.5 57.32 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.778 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.92 85.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.422 1.414 . . . . 0.0 111.303 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' GLN . 67.9 t60 175.98 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.216 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.509 ' CD2' ' HB1' ' A' ' 67' ' ' ALA . 5.8 p80 -76.99 -7.05 54.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.99 145.39 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.003 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.08 36.41 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -88.46 152.03 22.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.413 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 89.7 t -120.93 121.18 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -131.83 132.19 43.5 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.308 0.575 . . . . 0.0 112.218 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 2.2 t80 -138.92 140.55 38.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.137 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.59 152.81 41.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -156.53 -151.64 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.112 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.66 87.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.285 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' CYS . 96.0 m-20 54.0 17.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.663 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.77 68.27 0.92 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.102 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.25 132.72 31.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.136 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.68 130.37 8.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.27 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 1.5 t -92.98 -170.88 2.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 178.48 169.24 0.83 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.979 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -138.59 136.87 36.44 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.702 0.287 . . . . 0.0 110.782 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.03 128.04 50.95 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -142.96 146.92 34.39 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.805 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.5 p -110.98 124.53 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.829 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -91.45 130.95 37.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.72 168.77 32.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 93' ' ' LEU . 10.1 mp -101.26 108.16 53.72 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.47 -26.92 40.17 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.909 1.073 . . . . 0.0 110.999 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 95' ' ' ASP . 24.5 p30 -77.13 153.16 34.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.362 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.92 -103.25 0.27 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.7 147.61 43.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -132.19 27.53 4.48 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.54 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 59.0 t-80 -123.89 51.52 1.53 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.031 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -151.79 137.22 17.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 110.376 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -159.02 150.15 20.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.008 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -85.7 129.43 34.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.77 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -69.13 134.27 49.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 110.889 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.517 ' OXT' ' CG ' ' A' ' 104' ' ' HIS . 16.4 p80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.442 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 5' ' ' ILE . 2.7 pt -80.65 119.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 6' ' ' LEU . 5.5 mp -77.03 -67.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.445 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -146.64 142.01 27.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.825 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.31 137.47 52.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.002 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 9' ' ' LEU . 10.1 mp -96.95 108.41 21.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -116.82 175.85 5.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.348 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.19 108.38 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.252 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.64 134.18 13.6 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.67 0.748 . . . . 0.0 112.778 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.47 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.42 114.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -76.94 171.06 15.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.181 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.59 129.78 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.143 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.8 89.11 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.219 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.72 -171.15 3.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 20' ' ' ALA . 5.4 tm0? -141.48 157.13 45.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 19' ' ' GLN . . . -117.74 138.95 51.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.784 0.326 . . . . 0.0 110.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 27.0 p -125.38 104.55 8.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.324 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -124.4 117.55 24.69 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.429 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -144.54 150.03 36.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.578 ' SG ' HD21 ' A' ' 26' ' ' LEU . 33.3 t -132.75 98.86 4.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.964 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.415 HG23 ' NE2' ' A' ' 59' ' ' HIS . 57.3 m -79.92 114.72 19.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.578 HD21 ' SG ' ' A' ' 24' ' ' CYS . 84.6 mt -105.64 -167.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.838 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -112.87 -2.27 14.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.66 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -145.09 143.31 30.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.277 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.0 137.0 33.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.909 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 20.5 t -114.01 133.92 22.25 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.611 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.5 Cg_exo -61.51 -142.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.816 1.011 . . . . 0.0 109.978 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.0 t -121.45 110.13 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.43 -45.0 0.71 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.84 -12.89 59.73 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.31 132.67 52.08 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -127.52 118.95 24.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.623 ' CE2' ' CD1' ' A' ' 77' ' ' PHE . 75.4 m95 -118.52 106.32 12.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -151.05 149.2 29.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.594 0.711 . . . . 0.0 111.749 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 74' ' ' GLU . 4.1 mp -117.12 122.85 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -61.02 126.68 28.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.596 1.089 . . . . 0.0 110.341 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 -4.93 24.44 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.18 94.2 0.24 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.307 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.63 132.56 45.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 44' ' ' VAL . 35.3 m -85.25 106.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.245 0.545 . . . . 0.0 111.193 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -80.78 156.4 72.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -47.99 -26.72 7.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.264 1.31 . . . . 0.0 110.54 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -107.22 27.25 9.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -57.66 132.06 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.09 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.3 p -90.66 -43.28 10.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.057 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.85 -40.1 63.51 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.443 ' NE1' HD13 ' A' ' 64' ' ' LEU . 28.7 m-90 -106.68 152.79 23.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.188 0.518 . . . . 0.0 110.699 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.8 m -132.12 132.59 43.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.89 138.1 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 110.301 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -146.1 158.81 43.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.135 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.96 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.368 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -129.57 102.95 6.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.973 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.84 -134.22 23.54 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -91.73 20.04 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.456 0.169 . . . . 0.0 111.445 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.415 ' NE2' HG23 ' A' ' 25' ' ' THR . 75.4 m80 -123.61 124.32 42.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.62 0.248 . . . . 0.0 111.166 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -112.21 119.36 38.08 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.71 131.03 56.33 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.416 0.626 . . . . 0.0 111.339 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.35 131.85 28.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.943 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.65 -174.61 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.301 1.048 . . . . 0.0 111.643 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 65' ' ' ARG . 8.0 tp -142.21 119.64 11.63 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 113.007 -1.906 . . . . 0.0 107.351 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.9 mtt180 -61.65 -138.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 p -69.57 112.93 6.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.97 137.89 57.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 70' ' ' HIS . 83.6 mm-40 -129.54 143.14 47.75 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.622 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.44 83.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.09 1.193 . . . . 0.0 111.145 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 68' ' ' GLN . 86.1 t60 174.85 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.887 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -76.38 -1.75 28.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.67 144.27 43.89 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.993 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.94 179.66 40.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 39' ' ' ILE . 94.9 mt-10 -87.29 157.6 19.26 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.687 -0.302 . . . . 0.0 110.351 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.635 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 44.6 t -120.31 116.81 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.675 0.274 . . . . 0.0 110.558 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -131.38 133.96 45.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 12.5 t80 -141.23 142.47 33.95 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.527 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.28 145.52 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -156.67 -153.09 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.379 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.413 ' HE ' HG22 ' A' ' 30' ' ' VAL . 96.0 mtt-85 -55.08 87.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.846 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 55.11 13.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.03 90.36 6.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.404 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -87.91 136.58 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 164.17 35.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.155 0.503 . . . . 0.0 111.212 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 88.3 p -159.95 178.64 9.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.646 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.635 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 175.49 179.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.259 0.552 . . . . 0.0 111.364 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -133.42 110.34 9.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.396 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -102.29 128.69 48.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 147.28 33.15 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.7 132.46 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.986 0.422 . . . . 0.0 110.811 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.631 0.253 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.56 119.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.19 -68.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.753 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.29 140.93 30.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.425 0.631 . . . . 0.0 112.164 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.812 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.4 pt? -130.1 134.12 47.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.623 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.0 tp -101.7 116.99 33.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.12 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -129.75 -170.25 2.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.5 t30 61.4 108.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.496 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.62 133.86 13.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.018 0.913 . . . . 0.0 113.216 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.34 133.89 54.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.2 m -134.2 112.39 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.754 0.788 . . . . 0.0 112.163 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ALA . 56.2 ttm-85 -84.68 147.22 27.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.937 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ARG . . . -34.75 121.83 0.52 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.377 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 14.1 61.34 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.0 150.74 28.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.749 0.309 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -101.69 172.19 7.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.096 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -131.95 138.39 48.31 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.845 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -128.48 112.28 14.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.345 0.593 . . . . 0.0 111.843 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CE2' ' HB1' ' A' ' 20' ' ' ALA . 82.4 m-85 -124.22 116.73 23.17 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -138.49 141.37 39.4 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.793 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -127.01 96.2 4.54 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.516 HG23 ' ND1' ' A' ' 59' ' ' HIS . 16.9 m -73.78 107.23 5.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.528 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -100.24 -171.85 2.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 t -112.12 -11.2 13.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.664 ' H ' HH21 ' A' ' 80' ' ' ARG . 47.7 tp10 -138.75 145.58 40.39 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.161 0.505 . . . . 0.0 110.952 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.21 139.27 39.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.942 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 31' ' ' PRO . 8.7 t -112.9 128.53 25.49 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.78 -145.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 120.074 1.062 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.56 110.67 27.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.26 -29.5 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.52 -17.82 29.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.79 141.98 43.4 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -130.81 132.53 45.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.651 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.563 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 94.9 m95 -130.27 110.42 11.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 85.7 m-85 -158.98 154.35 25.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.201 0.524 . . . . 0.0 111.476 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.33 122.77 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.04 124.41 20.73 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.682 1.128 . . . . 0.0 110.346 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.43 2.39 31.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 100.17 0.79 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.91 136.09 50.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.89 100.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASP . 43.7 mt-30 -87.42 151.17 50.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.73 -22.42 13.36 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.335 1.357 . . . . 0.0 110.644 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.91 14.75 12.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.929 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' GLN . 25.9 p30 -42.8 112.22 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.207 0.527 . . . . 0.0 111.435 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 t -84.7 -46.58 11.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.917 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -85.14 -25.44 27.46 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -113.44 147.56 37.58 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.5 m -126.65 130.04 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.4 130.46 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 p -144.6 153.99 42.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.904 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.21 103.72 6.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.432 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.43 110.78 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.176 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.91 -133.71 52.61 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.54 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 24.4 m -95.41 38.87 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 110.42 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.54 ' ND1' ' O ' ' A' ' 58' ' ' SER . 12.9 m-70 -141.04 141.28 34.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.07 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -129.29 137.27 50.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.74 131.03 47.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.231 0.539 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -124.02 131.6 53.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.399 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.67 165.66 12.79 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.507 1.146 . . . . 0.0 113.711 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 24.9 tp -141.68 113.67 7.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 111.835 -2.439 . . . . 0.0 106.152 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' LEU . 61.8 ttt180 -64.08 -126.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -80.87 109.59 15.58 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.662 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.93 136.05 55.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -133.81 144.57 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.928 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -51.49 94.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.366 1.377 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER 160.82 -21.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.462 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.71 -6.75 55.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.485 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 150.21 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.48 39.21 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.255 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -98.41 151.57 20.42 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.46 115.04 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.6 m -122.36 132.94 54.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 111.568 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 4.2 t80 -144.66 135.38 24.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.977 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ASP . 28.6 p -153.76 -134.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.805 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.664 HH21 ' H ' ' A' ' 28' ' ' GLU . 47.0 mtm180 -52.56 82.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' CYS . 97.3 m-20 45.12 10.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.826 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -97.62 91.38 5.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.6 p -81.2 126.4 39.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.35 133.19 13.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -152.26 133.0 14.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.24 -159.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.769 0.795 . . . . 0.0 111.458 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -142.7 117.25 9.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.852 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.9 tp -107.64 133.02 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 t -136.51 148.66 47.76 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.6 t -111.91 125.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 mp . . . . . 0 N--CA 1.462 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.091 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.61 97.79 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.639 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.82 -54.2 42.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.051 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -138.4 132.38 31.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.775 0.322 . . . . 0.0 110.258 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -118.55 147.3 43.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 8' ' ' LEU . 10.9 mp -121.48 123.0 41.0 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.478 ' H ' ' HE3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.23 -165.64 2.27 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.56 108.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 144.67 3.8 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.89 0.852 . . . . 0.0 113.033 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.09 135.91 51.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.796 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.1 113.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -76.39 170.02 17.15 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.42 109.72 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.168 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.36 -1.23 50.14 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.45 152.12 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.091 0.445 . . . . 0.0 110.136 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.94 154.22 21.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.863 0.363 . . . . 0.0 111.809 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.74 142.11 51.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.711 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -130.67 123.54 29.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 0.0 111.529 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -133.12 123.25 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.55 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.0 t -147.62 154.22 40.37 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.326 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HG ' ' HZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -140.01 99.93 3.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 109.968 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -81.05 120.68 25.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.084 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.2 -174.79 2.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.44 1.99 14.53 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -138.9 143.93 38.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.135 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -75.84 138.99 41.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.402 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.44 136.81 19.88 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.56 -148.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.319 1.15 . . . . 0.0 110.501 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -121.99 124.66 71.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.1 -35.59 4.3 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -70.93 -42.06 70.37 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 140.67 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -148.06 116.25 6.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.866 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.595 ' HZ2' ' HG ' ' A' ' 24' ' ' CYS . 48.6 m95 -109.68 125.14 52.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.442 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 91.3 m-85 -156.86 152.26 26.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 111.517 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.09 119.52 60.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -58.69 116.84 3.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.05 -3.11 9.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.9 107.05 0.13 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.39 132.21 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.072 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.78 104.61 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.197 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -89.14 154.65 49.46 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.44 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -53.07 -25.79 30.17 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.462 1.441 . . . . 0.0 110.057 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -91.31 11.96 21.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.149 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 39.3 p-10 -37.69 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -73.11 -45.8 54.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.484 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.0 -29.08 17.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -102.34 147.06 27.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.187 0.518 . . . . 0.0 111.015 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.1 m -122.15 126.12 47.63 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.91 128.18 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.1 p -142.82 151.76 41.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.056 0.455 . . . . 0.0 111.151 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.14 103.84 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.867 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -104.91 109.12 20.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.715 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.85 -119.17 16.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -105.31 47.43 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.662 0.267 . . . . 0.0 110.449 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.55 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 9.3 t-160 -145.82 138.88 25.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 78.3 m80 -127.05 138.49 53.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.67 109.1 4.33 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.581 HD23 ' C ' ' A' ' 62' ' ' LEU . 8.0 tt -112.67 127.13 56.03 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.396 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 62' ' ' LEU . 2.1 pp -138.38 143.24 39.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 tp -101.83 128.4 48.21 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -71.59 -108.58 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.209 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.9 p -79.91 96.21 6.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 111.234 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.39 142.29 55.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.739 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 70' ' ' HIS . 17.0 mm100 -130.97 144.15 52.36 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.63 84.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.402 1.401 . . . . 0.0 111.378 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' GLN . 78.6 t60 176.25 -28.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -81.77 -6.14 58.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 148.49 9.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.88 -164.91 38.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -104.06 153.71 20.56 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 60.8 t -121.64 115.9 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.106 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -133.01 133.24 42.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.013 0.435 . . . . 0.0 110.965 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.549 ' CE1' ' NE1' ' A' ' 37' ' ' TRP . 56.0 t80 -127.66 133.99 49.62 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 142.89 50.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.878 0.371 . . . . 0.0 110.678 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.823 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 17.7 p -154.36 -156.83 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.363 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.4 ptp180 -50.7 84.67 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.096 0.474 . . . . 0.0 111.6 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' CYS . 99.1 m-20 51.93 0.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -92.82 94.14 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.91 146.99 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.73 165.19 27.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.0 p -151.67 169.85 21.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 177.96 172.1 0.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.836 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -137.55 136.08 37.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -118.55 126.2 51.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.881 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.9 t -144.09 154.18 42.94 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.722 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -115.0 122.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.368 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.787 -179.474 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 6' ' ' LEU . 80.2 mm-40 . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 HD22 ' A' ' 26' ' ' LEU . 1.1 pt -41.78 70.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' GLU . 42.2 mt -81.54 -28.99 33.66 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -107.28 118.83 37.75 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.82 2.1 . . . . 0.0 112.625 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.42 127.96 32.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -90.4 114.93 27.16 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 11' ' ' ASN . 3.2 mmpt? -121.68 -168.1 1.64 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 10' ' ' LYS . 27.1 m120 53.79 103.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.61 121.2 35.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.698 0.761 . . . . 0.0 113.002 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.37 126.16 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.6 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 28.1 m -137.74 121.23 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -76.35 -166.72 0.66 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.71 124.42 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.22 65.96 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.231 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.71 143.91 44.71 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -92.79 163.34 13.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 148.01 27.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -130.49 123.99 30.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.12 116.53 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.69 150.36 38.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -122.08 94.12 4.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.663 0.268 . . . . 0.0 110.712 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 59' ' ' HIS . 19.7 m -71.51 109.9 5.76 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.238 0.542 . . . . 0.0 110.206 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 5' ' ' ILE . 8.2 mt -99.48 -178.57 3.94 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.24 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.86 -3.84 13.39 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 1.1 pm0 -137.45 146.38 44.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.094 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.27 139.24 37.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.421 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' PRO . 21.8 t -107.11 133.24 20.39 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -58.23 -154.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 120.809 1.006 . . . . 0.0 110.187 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -115.53 102.54 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.71 -46.35 0.65 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.76 -43.31 89.29 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.155 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.0 139.97 38.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -140.97 144.37 35.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.714 0.292 . . . . 0.0 110.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 82.9 m95 -140.42 121.79 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.615 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -156.54 152.18 26.99 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.613 0.72 . . . . 0.0 112.127 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -110.36 114.12 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.01 112.06 3.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.013 1.279 . . . . 0.0 107.616 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.5 -15.67 9.85 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.65 89.38 1.17 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.386 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.33 140.48 57.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.728 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.518 HG12 ' HE1' ' A' ' 51' ' ' TRP . 1.8 m -78.65 103.76 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.794 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -102.04 158.25 32.13 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.07 -17.89 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.57 1.513 . . . . 0.0 110.99 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 65.8 m-20 -89.74 -4.95 57.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' ASP . 97.1 m-20 -35.43 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.255 0.55 . . . . 0.0 110.84 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -87.82 -43.07 12.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.096 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.97 -39.32 61.35 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.518 ' HE1' HG12 ' A' ' 44' ' ' VAL . 15.2 p90 -126.32 166.16 17.66 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.271 0.558 . . . . 0.0 111.304 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.3 p -129.62 156.87 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -132.72 120.84 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.3 p -147.89 157.73 43.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.73 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.02 111.53 5.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.63 107.82 18.83 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.08 -123.88 34.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.2 p -93.55 43.1 1.11 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.521 0.2 . . . . 0.0 111.082 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.509 ' CD2' HG23 ' A' ' 25' ' ' THR . 63.5 m80 -147.78 138.86 23.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.901 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -120.22 134.91 55.15 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.02 132.83 34.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.517 0.675 . . . . 0.0 111.28 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tp -126.3 128.94 47.91 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.815 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' TRP . 72.7 mt -105.81 162.91 13.14 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.995 0.903 . . . . 0.0 112.145 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 67' ' ' ALA . 32.9 tp -141.69 108.3 5.34 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -68.01 -121.98 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -83.84 104.75 14.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.524 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB1' ' NE2' ' A' ' 71' ' ' HIS . . . -66.38 108.0 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.5 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 70' ' ' HIS . 51.4 mt-30 -108.13 145.95 32.52 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -48.85 88.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.758 1.639 . . . . 0.0 111.164 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 9.5 m-70 176.83 -28.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.827 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 22.8 p80 -76.99 -8.02 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.663 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.8 147.4 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 110.909 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.3 -131.26 2.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -141.53 146.69 36.68 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.655 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.58 115.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -118.7 126.55 52.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.358 0.599 . . . . 0.0 111.447 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 28.9 t80 -130.08 124.28 32.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.003 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.97 157.01 24.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.4 t -151.18 -155.04 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -55.19 82.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.007 0.432 . . . . 0.0 110.389 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 79' ' ' CYS . 95.1 m-20 57.47 -2.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.681 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -88.75 100.23 12.98 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 83' ' ' VAL . 11.3 p -86.48 124.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.278 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.03 32.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.025 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.5 p -171.07 155.21 4.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.2 156.08 43.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.086 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -82.17 138.66 34.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.68 131.65 50.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -142.97 151.94 41.44 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.229 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.53 ' C ' HD12 ' A' ' 91' ' ' LEU . 14.7 p -111.99 123.44 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.44 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.586 0.231 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 5' ' ' ILE . 18.4 tt -89.84 119.06 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 6' ' ' LEU . 9.5 mp -91.07 -71.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.494 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.26 138.31 29.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.72 HD22 ' C ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.44 158.69 44.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.258 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.8 mt -108.89 131.9 54.57 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 111.508 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -142.55 -171.37 3.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.707 ' H ' ' CB ' ' A' ' 86' ' ' ALA . 66.3 t30 56.05 109.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -159.2 142.15 14.33 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.38 132.96 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.285 -1.779 . . . . 0.0 107.346 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 90' ' ' VAL . 4.2 m -122.31 124.26 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.656 0.741 . . . . 0.0 112.74 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -87.9 165.97 14.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.479 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.35 114.7 2.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.752 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.11 29.71 27.53 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.47 149.83 38.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 110.128 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -113.34 148.35 35.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.71 145.48 51.15 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.215 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 p -124.81 134.34 52.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -133.32 126.22 30.93 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.172 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 t -142.14 142.74 32.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 m -129.28 95.67 4.1 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -77.07 110.13 11.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.12 -174.23 2.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.416 0.627 . . . . 0.0 111.617 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 t -98.7 -20.54 16.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.597 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -142.0 151.16 42.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.008 0.433 . . . . 0.0 111.218 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.6 128.45 35.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.043 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.52 134.77 19.66 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.71 -151.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.028 1.152 . . . . 0.0 110.616 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.93 103.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.84 -37.77 0.66 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.83 -13.09 52.11 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.8 139.84 48.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.376 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -122.97 126.01 46.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.625 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 99.2 m95 -124.66 100.04 6.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.949 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 90.8 m-85 -152.91 149.02 27.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 110.559 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.94 125.09 69.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -48.43 132.76 16.71 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.584 -0.698 . . . . 0.0 111.257 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.63 8.1 56.21 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.205 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.626 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -167.16 125.91 1.35 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.376 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB3' HE22 ' A' ' 45' ' ' GLN . . . -97.28 112.83 24.47 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 44' ' ' VAL . 1.0 OUTLIER -74.88 104.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 112.487 -177.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.475 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.6 mp0 -92.21 157.46 40.72 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -53.29 -23.4 23.35 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.613 1.542 . . . . 0.0 111.495 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -98.35 17.23 19.28 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 45' ' ' GLN . 87.3 m-20 -49.18 128.83 17.24 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.4 p -91.96 -37.25 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.755 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 66.2 t0 -96.48 -32.45 12.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.659 0.266 . . . . 0.0 111.694 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -102.83 139.86 37.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.477 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 m -132.3 130.46 40.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.5 133.21 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -143.34 154.57 43.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.634 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.47 106.0 4.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.327 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.01 105.67 15.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.951 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.32 -126.34 41.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 23.0 t -95.44 37.56 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.633 0.254 . . . . 0.0 110.938 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 58' ' ' SER . 22.1 m-70 -142.81 153.85 43.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.844 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.27 161.8 28.52 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.92 94.2 1.11 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.755 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.05 128.18 54.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.503 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.572 ' C ' HD12 ' A' ' 63' ' ' LEU . 1.9 pp -121.73 -178.29 3.78 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.162 0.982 . . . . 0.0 112.357 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.2 tp -145.01 120.74 10.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.01 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' LEU . 82.8 mmt-85 -64.1 -130.23 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.307 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 m -82.84 108.28 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.95 142.46 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.672 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' HIS . 80.9 mt-30 -134.42 144.8 52.58 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.42 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.29 83.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.296 1.331 . . . . 0.0 111.153 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.3 t60 178.39 -26.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -87.09 -1.16 57.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.837 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.08 145.96 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.18 -123.04 1.0 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -142.47 154.2 44.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.508 0.194 . . . . 0.0 110.531 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -121.22 117.99 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -128.95 129.16 45.09 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.13 0.49 . . . . 0.0 112.145 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.625 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 16.4 t80 -136.65 141.16 43.17 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.35 154.8 39.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' ASP . 3.0 t -157.33 -147.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.703 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 82' ' ' ALA . 24.6 mmm180 -53.79 89.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' CYS . 53.2 t0 50.58 10.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.469 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.14 93.99 8.58 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.1 p -92.23 125.69 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.838 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.24 123.24 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.472 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.8 p -158.53 138.21 11.93 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.692 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.707 ' CB ' ' H ' ' A' ' 11' ' ' ASN . . . -139.62 151.31 45.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -81.21 144.27 31.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.344 0.593 . . . . 0.0 112.35 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 12' ' ' ALA . 49.2 tp -111.95 133.12 54.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.386 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -137.86 139.08 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.104 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 14' ' ' VAL . 97.1 t -104.8 126.67 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.239 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.3 tp . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 121.033 0.444 . . . . 0.0 111.043 -179.752 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 5' ' ' ILE . 18.1 tt -89.67 119.46 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.091 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.58 -63.79 1.17 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.928 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -154.12 146.95 24.35 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.946 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -137.07 145.54 44.07 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.806 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.38 115.54 30.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -131.78 -169.99 2.31 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.071 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' LYS . 60.1 t-20 53.42 107.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.409 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.26 147.93 3.83 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.76 148.62 45.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.111 -1.859 . . . . 0.0 106.631 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.0 m -132.87 110.05 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.288 0.566 . . . . 0.0 111.155 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 53.9 ttt85 -76.31 155.77 33.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.24 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.91 136.12 47.51 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.823 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.35 28.27 68.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 15' ' ' ARG . . . -119.12 143.85 46.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.286 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -98.51 159.24 15.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.846 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.0 148.39 31.65 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.58 124.55 41.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.141 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.43 117.27 21.07 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -143.81 153.99 42.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.11 98.43 3.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.314 0.578 . . . . 0.0 111.05 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -71.13 110.44 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.11 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.04 -177.17 4.06 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 110.781 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 100.0 p -108.3 -12.56 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.116 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -134.29 145.97 49.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.949 0.405 . . . . 0.0 110.902 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.79 129.83 35.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.64 141.57 24.31 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.94 -145.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 120.642 1.265 . . . . 0.0 111.086 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 32' ' ' VAL . 14.0 p -123.15 123.6 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.43 -26.4 6.34 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.39 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.4 -21.21 23.17 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.162 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 143.69 30.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -120.88 126.86 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.572 ' CE2' ' CD2' ' A' ' 77' ' ' PHE . 37.2 m95 -134.45 115.04 13.52 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.657 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -170.37 166.1 8.63 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.287 0.565 . . . . 0.0 112.213 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.78 127.66 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -66.8 132.15 47.43 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 120.772 -1.205 . . . . 0.0 109.713 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.1 -3.92 33.57 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -146.32 -27.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.339 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' ALA . . . 48.3 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' VAL . 1.3 p -60.05 118.93 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.491 0.662 . . . . 0.0 112.52 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -110.98 152.19 43.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.513 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.38 -20.31 47.69 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.911 1.074 . . . . 0.0 111.855 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.82 4.63 49.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.01 137.96 57.97 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.194 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 p -89.31 -33.51 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 51' ' ' TRP . 38.6 p-10 -92.48 -29.34 16.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.662 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.478 ' CE2' HD13 ' A' ' 64' ' ' LEU . 97.4 m95 -110.6 139.14 46.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 111.245 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 93.9 m -127.16 130.28 49.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -125.39 132.91 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 p -144.64 155.82 43.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.501 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.36 105.76 4.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.66 113.78 21.73 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.008 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.26 -133.52 42.48 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -98.26 38.61 1.31 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.815 0.341 . . . . 0.0 110.555 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -139.96 137.92 35.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.125 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -122.08 134.25 54.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 129.36 36.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.36 0.6 . . . . 0.0 111.835 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.44 151.56 41.15 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.245 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 5.0 mp -133.68 165.07 25.78 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.399 1.095 . . . . 0.0 113.156 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' A' ' 51' ' ' TRP . 34.4 tp -143.6 108.39 4.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.643 -2.071 . . . . 0.0 106.365 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.6 mtt-85 -64.58 -121.26 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.2 m -81.87 109.63 16.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 71' ' ' HIS . . . -65.27 134.6 53.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.579 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 0.8 OUTLIER -136.02 147.19 59.76 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.067 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.3 Cg_endo -48.22 90.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.668 1.578 . . . . 0.0 111.693 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.6 m-70 170.63 -29.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.199 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.62 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 49.1 p-80 -83.25 -15.0 52.01 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.27 146.83 27.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.311 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.26 -137.48 4.61 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.527 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 53.6 mp0 -126.87 147.79 50.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.38 111.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -123.45 123.16 40.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.274 0.559 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -145.64 145.94 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.736 179.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.3 151.61 28.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.319 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 81' ' ' ASP . 4.8 t -156.73 -140.96 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.939 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ALA . 19.0 mmm180 -54.23 89.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.979 0.419 . . . . 0.0 110.135 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 44.54 16.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -103.41 69.94 1.02 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 135.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.88 132.51 7.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -141.62 119.36 11.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.141 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.77 -160.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.49 0.662 . . . . 0.0 111.67 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -146.04 121.19 10.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.586 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.7 tp -110.07 130.51 55.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.923 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 t -136.17 146.51 46.94 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.613 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 14' ' ' VAL . 9.6 p -113.29 125.53 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 3.0 mm? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.354 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 121.324 0.583 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -77.51 121.69 30.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.767 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.21 -68.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' C ' HD12 ' A' ' 8' ' ' LEU . 97.2 mt-10 -135.0 124.86 25.49 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 8' ' ' LEU . 7.9 mp -110.73 152.68 26.29 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.037 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 23' ' ' THR . 48.1 tp -124.02 108.79 12.75 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' CE ' ' N ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -130.19 -168.53 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.506 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 m120 54.78 105.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.782 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.93 134.86 6.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.984 0.897 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.73 130.09 54.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.838 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' ARG . 5.1 m -129.91 103.28 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.214 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 14' ' ' VAL . 93.7 mtt180 -47.54 175.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.48 128.91 38.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.099 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.29 42.41 10.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.58 160.91 36.06 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.495 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -95.24 154.63 17.09 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . . . -130.25 133.66 46.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 p -119.62 122.62 41.96 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -132.6 117.85 18.45 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 59.0 p -144.52 151.69 39.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.261 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.99 95.74 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.991 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 p -67.83 123.52 20.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -123.63 143.23 50.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.906 0.384 . . . . 0.0 111.288 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 m -76.77 -13.28 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.921 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -116.94 132.89 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 0.0 111.805 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.97 149.56 30.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.8 t -124.74 122.58 25.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.48 -147.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.229 1.118 . . . . 0.0 110.998 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 32' ' ' VAL . 12.9 p -120.97 118.84 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.742 0.782 . . . . 0.0 109.102 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.28 -25.28 9.36 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -91.78 -19.21 22.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.144 0.497 . . . . 0.0 109.678 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.08 166.59 19.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.408 ' HB2' ' H ' ' A' ' 78' ' ' ALA . 16.3 m -146.52 116.75 7.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.462 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.09 97.79 3.06 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -155.07 156.31 35.65 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.854 HD11 ' CE2' ' A' ' 51' ' ' TRP . 4.9 mm -73.42 101.06 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -47.72 97.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 128.42 -36.28 2.5 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . -125.04 98.28 5.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.07 139.73 51.43 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.824 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.52 113.8 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -104.67 152.39 39.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.37 -19.82 18.33 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.286 1.324 . . . . 0.0 109.989 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.54 31.3 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.51 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 42.4 p-10 -97.48 104.94 17.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.508 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -87.44 -52.78 5.17 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.469 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 64' ' ' LEU . 46.2 m-20 -67.39 -37.53 83.26 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 110.112 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.854 ' CE2' HD11 ' A' ' 39' ' ' ILE . 59.7 t-105 -105.17 148.01 27.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.028 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -146.26 143.74 29.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.644 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -124.79 138.0 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -142.83 158.65 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 111.235 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.01 100.83 3.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -108.86 105.15 14.57 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 -131.22 30.22 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -100.43 37.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.064 0.459 . . . . 0.0 110.595 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -135.75 132.34 36.68 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -115.24 123.23 48.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.73 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.27 122.88 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.5 pt? -141.15 131.43 25.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.32 -169.98 2.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.208 1.004 . . . . 0.0 113.7 -175.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 36.7 tp -146.4 119.9 9.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 113.366 -1.743 . . . . 0.0 106.954 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -68.51 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.8 p -71.46 103.54 2.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.167 0.508 . . . . 0.0 110.225 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.4 135.92 53.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 70' ' ' HIS . 73.8 mt-30 -130.87 144.1 52.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -48.57 92.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.515 1.476 . . . . 0.0 111.599 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 3.7 m-70 166.9 -27.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.891 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -86.36 -0.79 56.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.389 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 145.27 56.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.213 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.05 -150.3 15.36 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -118.66 166.7 12.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.626 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 69.8 t -132.2 133.7 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.7 m -132.6 129.16 38.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.382 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -132.78 140.34 47.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.284 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -161.69 144.36 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.645 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' ASP . 25.4 p -157.6 -135.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -51.81 81.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 44.1 t0 51.28 6.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -96.29 91.38 5.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.91 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.315 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . . . -160.01 -179.49 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.326 0.584 . . . . 0.0 110.992 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 m -158.0 178.9 9.7 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.466 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . -169.47 160.97 9.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.212 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -119.27 132.8 55.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.911 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 tp -121.76 127.04 50.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.535 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 t -146.79 153.85 40.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.284 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.3 p -128.4 110.94 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.992 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.923 -179.599 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.413 ' OE2' ' O ' ' A' ' 80' ' ' ARG . 34.2 tp10 . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.456 HD11 ' HB1' ' A' ' 82' ' ' ALA . 81.8 mt -99.3 121.12 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.554 0.342 . . . . 0.0 110.739 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.8 -71.15 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -126.5 118.38 24.81 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.7 pt? -122.18 144.64 48.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.23 115.69 31.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.662 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -132.26 179.56 6.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.683 -178.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 10' ' ' LYS . 86.4 m-20 51.88 108.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.292 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.36 140.74 7.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.95 0.881 . . . . 0.0 112.76 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 127.81 53.45 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 14' ' ' VAL . 33.1 m -113.06 111.38 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -63.64 166.65 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.186 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 133.83 48.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.998 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.53 43.11 98.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.26 151.73 48.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.345 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -92.83 157.68 16.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.976 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.81 153.82 36.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.42 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.1 t -142.09 148.23 38.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.435 0.636 . . . . 0.0 111.391 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.65 128.92 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.722 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -148.13 152.04 36.62 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.974 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.4 p -142.01 98.06 3.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.402 0.62 . . . . 0.0 111.756 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 m -71.81 120.32 17.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.138 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.16 139.56 47.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.051 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 t -70.79 -13.21 61.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.19 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -131.66 139.96 49.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.129 0.49 . . . . 0.0 111.367 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.74 146.44 33.88 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.915 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -125.24 134.92 26.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.5 -148.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.318 1.149 . . . . 0.0 110.232 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.88 115.01 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.6 -47.44 0.9 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -68.03 -36.79 80.5 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' ' SG ' ' A' ' 79' ' ' CYS . . . -84.08 127.76 34.12 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.909 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.5 t -135.56 138.04 42.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.556 ' CZ2' ' CG ' ' A' ' 77' ' ' PHE . 90.5 m95 -137.76 112.99 9.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.0 p90 -157.91 155.62 29.9 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.202 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.598 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.7 94.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' ILE . 23.8 t-20 -37.61 106.03 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.242 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.77 -9.82 8.55 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.83 102.74 3.44 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 110.496 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 106.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.55 128.37 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.913 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.38 150.1 42.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.18 -25.64 65.34 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.674 1.583 . . . . 0.0 111.78 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -82.29 11.46 5.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 35.8 p-10 -62.28 133.27 54.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.727 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -90.93 -50.07 6.08 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -64.61 -38.68 91.85 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.015 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -104.72 151.38 23.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.432 ' OG1' HD11 ' A' ' 63' ' ' LEU . 10.4 m -135.07 136.69 42.22 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.34 135.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 p -144.21 157.47 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.269 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.92 113.0 3.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.086 0.47 . . . . 0.0 110.757 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 65.8 t0 -130.33 123.68 30.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 -124.84 11.68 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.4 m -115.55 43.02 2.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.739 0.304 . . . . 0.0 110.801 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 56' ' ' ASP . 34.9 p80 -154.26 146.62 23.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.742 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.64 168.1 9.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.97 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.12 100.91 1.4 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.647 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tt -109.93 129.19 55.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.055 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 63' ' ' LEU . 2.0 pp -118.18 173.66 6.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.957 0.885 . . . . 0.0 112.382 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 64' ' ' LEU . 47.2 tp -140.42 115.2 9.58 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 113.54 -1.664 . . . . 0.0 106.602 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.535 ' NH2' ' OG ' ' A' ' 66' ' ' SER . 61.7 ttp85 -68.17 -128.04 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.552 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 82.5 p -75.55 108.61 8.49 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.369 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.26 56.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 66' ' ' SER . 2.8 mp0 -124.91 141.79 39.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.553 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -53.13 86.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.282 1.321 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.1 m-70 174.2 -33.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.708 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -70.64 -5.09 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.795 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.02 145.8 15.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.681 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.88 -167.43 35.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 40' ' ' ASN . 93.2 mt-10 -100.55 165.44 11.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.516 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 37.9 t -128.12 129.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.784 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.2 m -133.42 137.87 45.98 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.462 0.649 . . . . 0.0 110.783 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.556 ' CG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -131.98 134.07 45.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.071 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.462 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -134.59 137.59 43.85 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -151.36 -155.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.468 ' C ' ' N ' ' A' ' 82' ' ' ALA . 79.8 mtp85 -57.77 90.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.8 t0 49.35 14.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -89.73 95.31 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.602 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.48 134.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.395 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.53 154.7 41.85 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.225 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 36.8 p -156.98 173.69 16.64 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.789 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . . . 178.21 175.41 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.193 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -136.98 109.06 7.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.095 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.7 tp -93.47 129.79 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.773 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -137.13 135.08 37.08 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.054 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.18 118.04 41.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' N ' ' HG ' ' A' ' 27' ' ' SER . 10.3 pt-20 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.8 mt -83.8 118.52 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.08 -67.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.269 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -139.81 131.32 27.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.513 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 119.72 36.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.606 ' N ' HD12 ' A' ' 9' ' ' LEU . 9.4 mp -93.84 104.91 16.96 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.677 ' HD3' ' HB2' ' A' ' 86' ' ' ALA . 7.3 mmpt? -132.91 -169.16 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' LYS . 15.6 t-20 59.17 109.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.56 145.84 2.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.832 0.825 . . . . 0.0 111.963 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.09 130.85 53.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.283 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 20' ' ' ALA . 32.8 m -119.92 122.75 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 122.226 1.013 . . . . 0.0 113.397 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.86 167.81 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.048 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.83 55.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.723 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.38 50.76 59.96 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.12 25.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.536 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -100.82 147.36 26.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.141 0.496 . . . . 0.0 110.305 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.697 ' HB2' HG11 ' A' ' 14' ' ' VAL . . . -128.2 140.15 52.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.195 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.01 137.0 47.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.386 0.612 . . . . 0.0 111.83 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -145.67 130.07 17.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.353 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -144.58 148.76 34.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -133.36 95.21 3.47 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.197 0.522 . . . . 0.0 111.666 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.4 m -75.16 113.51 12.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.694 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -107.14 -163.18 0.89 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.481 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.425 ' HG ' ' N ' ' A' ' 4' ' ' GLU . 22.4 p -114.03 -7.28 13.11 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.332 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -146.22 154.79 42.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.121 0.486 . . . . 0.0 111.28 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.46 129.31 35.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.748 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.23 133.58 22.83 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.559 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -63.0 -146.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.255 1.127 . . . . 0.0 111.283 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.5 t -120.5 120.85 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.14 -28.67 5.77 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 53.5 mp0 -85.2 -18.02 35.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.748 0.308 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.0 134.75 51.8 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 m -113.6 140.1 48.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.619 0.247 . . . . 0.0 110.554 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.571 ' CZ2' ' CD1' ' A' ' 77' ' ' PHE . 91.7 m95 -147.27 102.41 3.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.61 153.89 32.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 39' ' ' ILE . 5.2 mp -80.81 145.18 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.819 0.819 . . . . 0.0 111.634 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -78.82 106.17 10.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.517 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.24 -9.18 7.02 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.86 120.71 1.22 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.56 0.219 . . . . 0.0 111.065 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.48 53.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.946 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.0 t -98.54 116.25 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 157.92 45.21 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.51 -34.83 90.9 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.675 1.583 . . . . 0.0 112.12 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -82.22 20.23 1.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.584 0.231 . . . . 0.0 111.593 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 28.8 p-10 -55.05 122.83 11.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.087 0.47 . . . . 0.0 112.118 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -88.93 -51.31 5.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.574 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' OD2' ' CE1' ' A' ' 71' ' ' HIS . 97.5 m-20 -66.17 -38.11 87.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.229 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.479 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 8.7 m-90 -105.94 155.29 19.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.412 0.625 . . . . 0.0 112.128 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -132.55 132.53 42.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -125.0 134.1 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 p -145.87 156.04 43.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.12 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.77 109.7 4.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 59' ' ' HIS . 33.1 p-10 -119.32 102.44 8.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.06 -133.67 31.38 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.4 m -89.94 21.47 3.63 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 122.607 -0.349 . . . . 0.0 111.115 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 77.9 m80 -123.11 124.05 42.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.63 153.07 21.03 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.97 98.0 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.497 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.32 132.66 53.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -130.05 -177.25 4.22 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.483 1.135 . . . . 0.0 112.295 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 51' ' ' TRP . 9.2 tp -145.99 115.24 7.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.532 -2.122 . . . . 0.0 107.362 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 49.7 ttp180 -64.65 -128.45 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -69.01 106.03 2.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.945 0.402 . . . . 0.0 109.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.29 143.13 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.887 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -133.59 139.68 34.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -53.8 89.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.318 1.345 . . . . 0.0 112.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.566 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER 168.18 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.808 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 50' ' ' ASP . 7.2 m-70 -85.71 0.64 52.2 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.96 146.21 33.17 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.707 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.42 -149.5 18.85 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 57.7 mp0 -145.03 119.2 9.47 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 2.8 t -70.63 144.35 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.635 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -124.84 128.0 48.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.662 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CD1' ' CZ2' ' A' ' 37' ' ' TRP . 3.4 t80 -132.47 138.05 47.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -160.24 144.18 14.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 29.9 p -155.91 -132.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.508 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 95.6 mtt-85 -54.53 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.434 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 79' ' ' CYS . 27.9 t70 46.85 14.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.08 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -101.35 88.73 3.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 84' ' ' ALA . 10.4 p -83.78 153.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.426 ' N ' HG22 ' A' ' 83' ' ' VAL . . . -179.64 115.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.79 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.2 t -93.21 -173.91 3.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.987 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.677 ' HB2' ' HD3' ' A' ' 10' ' ' LYS . . . -161.03 154.68 22.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.024 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -114.94 113.76 24.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.445 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 73' ' ' GLY . 38.6 tp -115.11 124.92 52.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -140.49 123.52 16.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.107 0.48 . . . . 0.0 110.715 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.84 119.94 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.181 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.183 0.516 . . . . 0.0 110.086 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tp -82.85 120.5 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.14 -70.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.7 135.58 29.98 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 112.42 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.26 135.05 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.675 HD12 HG22 ' A' ' 23' ' ' THR . 89.7 mt -95.67 112.17 23.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.572 ' NZ ' ' O ' ' A' ' 85' ' ' SER . 1.8 mmpt? -127.78 -176.17 3.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.037 0.446 . . . . 0.0 111.295 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 10' ' ' LYS . 93.2 m-20 55.92 108.63 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.341 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.74 138.81 9.73 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.91 147.93 44.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.421 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 90' ' ' VAL . 1.7 m -133.18 114.98 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.423 0.63 . . . . 0.0 111.189 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -85.25 147.58 26.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.379 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.53 124.98 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.586 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.74 27.13 51.93 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.47 147.0 41.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -103.58 156.3 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.333 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.43 144.35 31.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.91 0.386 . . . . 0.0 110.567 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -127.69 136.26 51.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.472 0.653 . . . . 0.0 111.13 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -137.51 122.01 18.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.675 HG22 HD12 ' A' ' 9' ' ' LEU . 1.7 t -144.3 152.71 41.15 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.536 -0.466 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 26' ' ' LEU . 14.1 t -127.51 92.45 3.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.171 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 m -73.07 114.86 11.71 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 24' ' ' CYS . 84.2 mt -103.81 -169.41 1.63 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.31 0.576 . . . . 0.0 111.362 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.8 t -113.85 -5.13 13.25 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.234 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -140.85 146.11 37.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.64 133.45 35.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.968 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 10.9 t -108.25 134.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.364 -0.35 . . . . 0.0 110.507 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -61.7 -143.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 119.975 1.027 . . . . 0.0 110.047 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.52 111.56 29.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.566 0.698 . . . . 0.0 109.421 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.79 -47.37 0.7 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -67.53 -45.62 75.18 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.069 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.25 138.35 38.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -142.61 112.71 7.06 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.663 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.638 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 98.5 m95 -106.78 107.13 17.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 68.0 m-85 -150.13 150.22 31.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.535 0.683 . . . . 0.0 110.563 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.875 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -125.35 129.27 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -61.07 110.53 1.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.101 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.85 -4.35 6.48 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.811 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.702 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -160.29 76.92 0.62 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.761 0.78 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.92 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 42' ' ' ALA . 6.2 p -67.97 101.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.506 0.669 . . . . 0.0 110.739 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -92.07 155.94 42.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.37 -30.51 15.56 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.667 1.578 . . . . 0.0 111.616 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.63 10.01 19.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 11.0 p-10 -51.0 128.81 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.7 p -92.44 -47.34 7.21 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.071 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 46.2 t0 -72.11 -39.36 68.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.641 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.537 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 3.7 m-90 -106.84 151.07 25.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.316 0.579 . . . . 0.0 111.341 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -128.56 130.28 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.878 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.99 133.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.011 0.434 . . . . 0.0 109.833 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -142.01 153.39 44.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.43 98.58 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.086 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -113.19 105.76 13.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.27 -132.45 48.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -93.34 35.49 1.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.285 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.552 ' CE1' ' OG1' ' A' ' 23' ' ' THR . 63.7 t-80 -139.65 131.77 28.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -118.52 137.02 53.49 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.77 137.94 51.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.301 0.572 . . . . 0.0 111.472 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 tp -132.63 138.16 47.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.32 162.16 25.36 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.265 1.031 . . . . 0.0 112.864 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 65' ' ' ARG . 17.9 tp -140.88 110.9 6.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 112.774 -2.012 . . . . 0.0 106.323 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.7 mtt-85 -62.87 -128.96 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.105 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.6 p -77.61 107.15 9.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.08 0.467 . . . . 0.0 110.285 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 137.55 57.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.35 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 84.2 mt-30 -133.94 135.06 23.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.02 88.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.002 1.135 . . . . 0.0 111.658 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 2.0 t60 -173.48 -39.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 68' ' ' GLN . 22.8 p-80 -82.12 -7.65 59.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.883 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.21 152.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.34 -162.03 34.01 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.16 149.11 21.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.777 0.322 . . . . 0.0 110.581 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 63.0 t -117.51 119.71 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.886 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 137.31 49.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.638 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 2.3 t80 -137.95 134.98 35.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.466 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -133.06 144.25 49.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.8 t -156.88 -151.2 0.31 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.32 0.581 . . . . 0.0 111.502 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -55.84 84.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.122 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' CYS . 90.5 m-20 51.27 8.62 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.4 94.21 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 83' ' ' VAL . 7.5 p -81.74 129.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.935 0.398 . . . . 0.0 110.471 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -134.76 165.39 25.38 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.438 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.572 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 96.9 p -161.68 -179.69 7.46 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 174.59 178.64 0.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 128.86 24.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.274 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.3 tp -113.99 130.07 56.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 t -142.34 155.97 45.21 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.665 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 14' ' ' VAL . 65.9 t -121.0 123.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.394 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.269 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.69 119.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.688 ' N ' HD12 ' A' ' 6' ' ' LEU . 7.6 mp -86.79 -71.44 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.651 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -132.14 128.17 37.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.057 0.456 . . . . 0.0 111.183 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.809 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.8 pt? -129.66 136.69 50.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.79 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.5 tt -104.55 108.99 20.7 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.483 ' N ' HD23 ' A' ' 9' ' ' LEU . 12.4 mmmt -118.39 -171.22 2.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.3 m120 57.04 108.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.91 130.34 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.91 128.45 46.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -131.31 123.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 95.8 mtt180 -80.51 172.6 13.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.433 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 133.18 54.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.114 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.73 23.8 74.07 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ARG . . . -112.8 152.87 28.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.9 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.67 152.48 20.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG11 ' A' ' 14' ' ' VAL . . . -119.5 144.74 46.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -142.48 120.61 12.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 112.193 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -123.6 116.35 22.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.4 t -144.95 150.84 37.66 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.472 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.7 100.75 4.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.573 ' HG1' ' CE1' ' A' ' 59' ' ' HIS . 23.6 m -72.69 112.05 8.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.374 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.04 -166.45 1.23 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.341 0.591 . . . . 0.0 111.245 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.1 p -114.72 -4.83 12.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.915 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -138.37 141.58 39.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.423 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.86 130.59 36.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.515 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 31' ' ' PRO . 26.3 t -104.16 134.9 19.46 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.268 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.15 -147.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 120.022 1.044 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.22 109.52 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.56 -42.2 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.46 -43.58 80.74 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.074 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.34 150.2 33.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.64 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -126.8 126.25 43.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 111.036 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -131.48 112.13 12.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -155.42 153.76 30.87 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.505 0.669 . . . . 0.0 111.508 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 74' ' ' GLU . 4.4 mp -120.99 121.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.32 125.65 24.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.174 0.897 . . . . 0.0 109.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.47 -3.9 31.06 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.4 96.55 0.4 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.271 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.32 139.41 54.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.868 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.43 103.18 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -90.48 153.74 46.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.12 -29.11 27.35 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.767 1.644 . . . . 0.0 111.352 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -97.21 14.21 26.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -46.45 124.73 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -88.09 -44.21 11.11 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.25 -26.19 19.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.444 ' NE1' HD13 ' A' ' 64' ' ' LEU . 8.2 m-90 -110.18 139.92 44.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.493 ' OG1' HD11 ' A' ' 63' ' ' LEU . 23.4 p -136.94 152.72 50.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.56 137.0 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 p -142.43 153.45 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.93 102.39 5.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.027 0.441 . . . . 0.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -109.33 107.65 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.943 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.89 -131.42 45.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.5 p -97.03 47.16 1.04 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.729 0.299 . . . . 0.0 111.008 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.573 ' CE1' ' HG1' ' A' ' 25' ' ' THR . 63.6 t60 -152.44 137.06 16.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.672 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -117.01 135.75 53.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.05 126.51 26.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 111.008 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 tt -131.22 133.86 45.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.322 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.493 HD11 ' OG1' ' A' ' 52' ' ' THR . 1.5 pp -119.56 -176.63 3.2 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.254 1.026 . . . . 0.0 112.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 44.5 tp -146.12 122.22 10.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.144 -1.844 . . . . 0.0 106.302 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' LEU . 93.2 mtt-85 -63.51 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.611 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -78.28 108.1 11.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.73 134.89 50.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.898 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 70' ' ' HIS . 74.0 mt-30 -132.4 145.1 55.84 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.64 84.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.416 1.41 . . . . 0.0 111.246 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 68' ' ' GLN . 81.4 t60 176.97 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.087 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.03 -8.97 59.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.61 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.11 148.71 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.593 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.9 -171.31 42.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 39' ' ' ILE . 84.5 tt0 -97.68 151.68 19.87 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -119.39 118.14 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 117.757 0.253 . . . . 0.0 110.915 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 m -127.97 129.81 47.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.116 0.484 . . . . 0.0 111.115 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.37 139.34 37.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.293 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.91 153.13 31.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.165 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.9 t -157.32 -140.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 82' ' ' ALA . 77.9 mtp85 -55.97 86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.079 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 79' ' ' CYS . 26.9 t0 52.18 10.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -92.59 87.43 5.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.6 p -89.78 125.85 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HB1' ' NZ ' ' A' ' 10' ' ' LYS . . . -155.62 122.59 5.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.165 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 40.8 m -95.43 -174.2 3.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.888 0.375 . . . . 0.0 111.26 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 176.04 173.02 0.35 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -149.0 136.23 20.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 tp -112.74 130.91 55.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -138.57 132.22 30.74 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.701 0.286 . . . . 0.0 111.52 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.81 124.23 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.541 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.466 0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.097 179.4 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 55.1 mp0 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.06 107.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 6' ' ' LEU . 11.2 mp -97.05 -64.06 1.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -120.4 110.46 16.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.0 tp -114.07 129.57 56.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -113.25 125.94 54.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.735 0.303 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.381 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.01 128.64 11.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.49 0.662 . . . . 0.0 111.893 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.82 53.76 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.1 108.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -66.86 174.94 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.31 120.77 8.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.532 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.93 49.67 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.718 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.76 43.3 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.11 152.66 19.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 112.337 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.71 141.11 49.7 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.746 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 p -123.96 110.65 15.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.298 0.57 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -117.19 103.97 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -133.66 139.71 46.62 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.405 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.6 p -137.96 96.94 3.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 m -69.19 117.77 11.25 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.119 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 58' ' ' SER . 46.9 mt -101.65 -174.77 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 t -114.09 3.15 15.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.864 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -126.18 127.76 46.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.512 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.38 75.23 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.92 132.46 74.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.915 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.1 -143.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.925 1.084 . . . . 0.0 110.935 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 32' ' ' VAL . 19.9 m -118.94 109.96 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.629 0.728 . . . . 0.0 109.301 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.36 -56.38 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 80' ' ' ARG . 96.5 mt-10 -69.46 -40.93 76.84 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 149.75 31.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -137.67 137.98 38.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.013 0.435 . . . . 0.0 110.594 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.466 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 63.7 m95 -136.59 105.1 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.87 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 76.8 m-85 -149.54 150.2 31.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.666 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.847 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.2 130.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -62.65 132.79 53.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.269 -0.894 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.76 40.57 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.563 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -164.14 138.57 5.66 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.967 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.18 130.67 47.31 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.87 111.04 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.633 0.254 . . . . 0.0 110.579 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' ASP . 37.0 mt-30 -126.73 153.11 75.75 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.68 -10.26 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.091 1.861 . . . . 0.0 111.488 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' GLN . 45.7 p-10 -108.64 29.42 7.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' ASP . 44.4 p-10 -34.25 161.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.77 0.795 . . . . 0.0 112.378 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -95.79 -62.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.707 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -124.79 -36.02 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -86.98 159.21 19.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.573 0.702 . . . . 0.0 111.312 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.6 m -130.53 144.69 51.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.773 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.43 130.1 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.9 p -143.81 154.91 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.37 100.85 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.351 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -103.21 108.29 19.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.073 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 -132.24 41.11 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 26' ' ' LEU . 10.2 m -97.17 50.87 1.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.391 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -153.67 145.72 23.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -127.36 142.36 51.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.89 12.1 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.287 0.565 . . . . 0.0 111.141 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 63' ' ' LEU . 6.3 tt -122.78 125.2 45.01 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.926 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 62' ' ' LEU . 3.1 pp -139.73 135.65 33.35 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 71' ' ' HIS . 12.4 tp -107.59 111.02 23.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -63.39 -95.59 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.469 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -83.47 103.4 12.79 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 122.09 -0.381 . . . . 0.0 111.729 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.51 55.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.685 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.693 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 40.6 mt-30 -134.22 140.62 36.56 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.74 85.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.059 1.172 . . . . 0.0 111.625 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' GLN . 55.7 t-80 -177.24 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.693 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 35.0 p80 -82.58 -11.24 58.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.366 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.41 146.06 3.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 110.99 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.93 -154.85 25.19 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.38 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.4 mp0 -106.38 154.45 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 72.0 t -116.37 119.56 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.903 0.382 . . . . 0.0 110.688 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.6 m -127.01 130.09 49.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.432 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.64 138.59 36.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.28 153.86 38.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' ' 81' ' ' ASP . 15.1 t -157.07 -132.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.531 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.454 ' C ' ' N ' ' A' ' 82' ' ' ALA . 30.6 mmt180 -57.22 86.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.809 0.338 . . . . 0.0 110.406 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.7 t0 45.41 18.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.454 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -102.77 91.22 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.164 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.9 p -91.76 129.98 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.333 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.56 124.22 10.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.154 0.502 . . . . 0.0 110.802 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 10.3 p -92.14 -173.58 3.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 176.4 174.7 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.117 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -137.43 137.69 39.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.449 . . . . 0.0 111.056 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.2 121.64 31.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 t -142.35 152.06 42.53 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.68 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 90' ' ' VAL . 5.8 p -108.88 108.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.833 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -178.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' CD1' ' A' ' 6' ' ' LEU . 95.2 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.0 mt -86.63 108.59 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.707 ' N ' HD12 ' A' ' 6' ' ' LEU . 6.9 mp -78.98 -64.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.332 -177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.13 113.83 18.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.964 0.411 . . . . 0.0 111.423 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.1 tp -106.73 123.58 48.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.766 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.8 tp -112.07 123.41 50.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.645 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 5.3 mmmm -138.67 -165.44 1.82 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.351 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 10' ' ' LYS . 65.7 t30 57.6 107.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.808 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.18 140.2 8.78 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.292 1.044 . . . . 0.0 113.402 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.23 144.37 51.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.617 -1.629 . . . . 0.0 107.454 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.2 m -123.62 128.95 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.713 0.768 . . . . 0.0 112.704 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ALA . 89.7 mtt180 -96.19 158.0 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.505 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 113.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.574 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.85 62.06 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . -104.54 153.13 21.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.503 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.436 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 9.9 mp0 -106.21 156.4 18.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.204 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . . . -124.88 138.11 54.26 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 t -120.83 109.69 15.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.27 0.557 . . . . 0.0 112.272 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -114.08 108.43 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -144.98 152.12 39.67 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.482 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.9 p -139.28 102.98 4.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 p -74.38 112.25 10.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.302 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.1 mt -101.22 -173.36 2.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.272 0.558 . . . . 0.0 111.359 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.46 -2.71 17.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.54 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -135.19 139.12 44.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.483 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.19 133.92 33.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.264 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' PRO . 61.1 t -108.31 131.34 21.82 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -60.77 -144.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.949 1.018 . . . . 0.0 110.188 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -119.91 122.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.29 -29.25 6.24 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.709 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.98 -12.61 52.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.86 0.362 . . . . 0.0 110.435 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.94 140.91 37.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 m -118.49 125.97 51.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 66.6 m95 -138.72 118.93 13.55 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.856 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -158.28 153.21 25.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.001 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.71 119.85 57.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -56.88 112.8 1.42 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.425 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.62 9.95 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.32 107.01 0.68 Allowed 'General case' 0 C--O 1.23 0.067 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.75 139.94 53.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.02 98.22 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 0.0 111.171 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.463 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.2 pt20 -102.77 151.43 38.32 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.51 -20.03 8.12 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.309 1.34 . . . . 0.0 110.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -98.05 8.31 44.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 45' ' ' GLN . 64.7 m-20 -42.78 113.31 0.45 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.888 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 t -69.64 -44.26 70.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.048 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.24 -35.76 10.25 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.65 138.83 31.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.082 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -124.52 131.74 53.48 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.4 130.01 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 p -146.07 154.29 41.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.86 98.33 5.49 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -100.68 110.82 22.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.464 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.17 -129.2 31.87 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.404 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 61.0 m -93.29 46.84 1.22 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.757 0.313 . . . . 0.0 110.721 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.404 ' CG ' ' C ' ' A' ' 58' ' ' SER . 39.6 m-70 -149.31 143.81 26.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -124.49 132.03 53.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.69 130.6 49.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.109 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 62' ' ' LEU . 2.3 tm? -140.59 114.17 8.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -142.35 153.14 43.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.5 tp -106.53 128.89 54.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.316 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -67.14 -107.75 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.62 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 p -83.59 108.81 16.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.127 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.967 ' HB1' ' CE1' ' A' ' 71' ' ' HIS . . . -69.72 139.05 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.667 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 94.5 mt-30 -130.43 140.46 38.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.554 ' O ' ' ND1' ' A' ' 70' ' ' HIS . 2.6 Cg_endo -46.42 89.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.152 1.235 . . . . 0.0 111.742 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' A' ' 69' ' ' PRO . 1.3 m80 163.81 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.843 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.967 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 28.5 p-80 -78.49 -13.29 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.645 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.544 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.91 -178.07 40.76 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.446 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.37 149.95 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.22 110.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.666 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.0 m -126.04 125.68 43.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.39 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.67 154.46 28.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.4 t -156.33 -132.8 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -57.86 88.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 79' ' ' CYS . 98.8 m-20 46.24 12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -96.6 66.24 2.3 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.1 t -79.81 129.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.865 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.645 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -161.81 144.85 12.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.13 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -153.84 132.11 11.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.91 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.92 -158.68 0.68 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.396 0.617 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -144.56 129.27 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.753 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.6 tp -117.46 126.3 52.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.586 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 t -139.47 148.4 42.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.132 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 14' ' ' VAL . 9.8 p -115.51 128.15 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.008 0.432 . . . . 0.0 111.599 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 N--CA 1.463 0.187 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.012 179.592 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.46 0.062 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.6 HD11 ' HA ' ' A' ' 82' ' ' ALA . 28.7 mt -86.67 119.03 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.74 -69.5 0.58 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' C ' HD13 ' A' ' 8' ' ' LEU . 99.0 mt-10 -134.65 130.39 36.31 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.126 0.489 . . . . 0.0 111.774 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.895 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -126.08 146.58 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.457 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.412 HD12 ' H ' ' A' ' 23' ' ' THR . 88.3 mt -104.61 113.61 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.764 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 3.0 mmpt? -127.39 173.32 9.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.218 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 63.3 108.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 136.43 13.43 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.11 130.92 48.91 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.18 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 6.6 m -126.14 124.25 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.914 0.864 . . . . 0.0 113.319 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -78.04 170.19 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.766 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.68 130.68 45.24 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.49 34.35 54.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.04 147.9 40.75 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.935 0.397 . . . . 0.0 110.919 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -95.54 149.12 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . . . -127.12 144.35 51.05 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.7 p -139.8 133.35 30.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.128 0.489 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -139.12 126.31 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.412 ' H ' HD12 ' A' ' 9' ' ' LEU . 33.5 p -140.03 144.86 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 26' ' ' LEU . 41.9 t -133.53 92.38 2.98 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 110.971 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -74.13 115.42 13.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.622 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 24' ' ' CYS . 91.9 mt -105.37 -177.35 3.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.871 0.843 . . . . 0.0 112.501 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 m -105.31 -15.45 15.04 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.578 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -129.42 129.23 44.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.54 119.64 32.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.578 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -109.81 148.11 37.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.616 -178.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.8 Cg_endo -57.89 -140.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.776 1.651 . . . . 0.0 110.362 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 m -119.21 103.76 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.34 -44.45 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -64.36 -45.59 87.12 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.858 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.47 141.75 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.6 m -135.54 98.58 3.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.562 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 94.3 m95 -102.13 113.89 27.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 88.3 m-85 -150.84 148.03 27.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.183 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 74' ' ' GLU . 1.9 mp -118.99 122.03 68.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -54.44 122.1 9.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.043 0.838 . . . . 0.0 110.008 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.71 -5.71 14.2 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 124.113 0.883 . . . . 0.0 110.974 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' CZ3' ' A' ' 51' ' ' TRP . . . -165.26 111.06 0.92 Allowed 'General case' 0 C--O 1.231 0.085 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.04 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.26 139.59 48.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.916 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -86.36 99.54 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.385 0.612 . . . . 0.0 110.506 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.645 ' C ' ' H ' ' A' ' 47' ' ' ASP . 31.1 mt-30 -124.74 163.69 35.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.8 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.89 20.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.312 1.341 . . . . 0.0 111.677 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.645 ' H ' ' C ' ' A' ' 45' ' ' GLN . 39.0 m-20 -112.22 -19.7 12.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 45' ' ' GLN . 49.2 m-20 -46.12 105.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.226 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 47.9 t -93.12 -39.21 11.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' OD1' ' CZ ' ' A' ' 65' ' ' ARG . 95.3 m-20 -87.14 -25.12 24.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.322 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.441 ' CZ3' ' CB ' ' A' ' 42' ' ' ALA . 5.6 m-90 -112.91 142.99 44.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.074 0.464 . . . . 0.0 111.11 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 m -132.16 136.29 46.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.86 134.68 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -141.94 154.29 44.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.62 107.97 5.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 111.56 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -119.28 105.27 11.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.14 -133.58 45.86 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.9 m -92.29 30.06 1.55 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.641 0.258 . . . . 0.0 111.103 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -134.43 130.13 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.27 137.03 54.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.94 119.21 15.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.255 0.55 . . . . 0.0 111.523 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.0 135.34 55.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.537 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' C ' HD12 ' A' ' 63' ' ' LEU . 2.2 pp -125.23 179.36 5.11 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.068 0.937 . . . . 0.0 113.141 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 39.1 tp -145.68 118.52 8.7 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.56 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' CZ ' ' OD1' ' A' ' 50' ' ' ASP . 28.2 ptt180 -63.94 -127.93 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.436 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.0 p -73.06 110.62 7.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.64 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB1' ' CD2' ' A' ' 71' ' ' HIS . . . -63.62 112.38 2.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.979 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' HIS . 2.8 pt20 -112.48 145.69 33.42 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.92 83.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.623 1.549 . . . . 0.0 111.763 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 175.95 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.635 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 12.3 p80 -73.98 -13.63 60.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.732 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.82 147.6 8.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 110.869 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.84 -170.41 40.6 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 39' ' ' ILE . 80.7 tt0 -99.51 149.63 23.03 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 75.7 t -117.53 115.35 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.7 m -129.3 130.94 46.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.25 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 9.5 t80 -136.79 138.38 40.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.98 147.82 27.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.107 0.479 . . . . 0.0 111.479 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.22 -148.57 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.99 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' A' ' 82' ' ' ALA . 45.1 mmm-85 -60.66 90.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.069 0.461 . . . . 0.0 110.454 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 t0 48.18 14.8 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.193 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.6 ' HA ' HD11 ' A' ' 5' ' ' ILE . . . -104.37 73.63 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.8 t -80.39 151.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.906 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.764 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -157.17 170.38 22.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.286 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 37.1 m -159.1 178.87 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 174.77 179.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 111.179 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 87' ' ' ARG . 83.1 mtt85 -142.07 128.03 19.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.5 tp -113.58 129.46 56.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 t -144.29 153.07 41.64 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.019 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 90' ' ' VAL . 13.9 p -117.65 126.58 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.4 tp . . . . . 0 C--N 1.333 -0.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.08 -179.736 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.554 HG12 HD22 ' A' ' 8' ' ' LEU . 20.2 tt -92.94 114.83 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.2 mp -92.06 -72.46 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.12 121.58 35.55 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.193 0.452 . . . . 0.0 111.966 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.16 126.86 49.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.343 179.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.65 111.77 23.51 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -126.47 -179.88 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.906 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t30 60.37 108.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.72 15.05 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.664 0.986 . . . . 0.0 113.664 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.04 129.65 50.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.15 126.41 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.898 0.856 . . . . 0.0 112.994 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.56 163.88 25.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.618 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 130.44 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.58 40.1 67.29 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.3 46.01 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.962 0.411 . . . . 0.0 110.962 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -101.99 159.78 15.07 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.744 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 151.68 37.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -133.65 135.76 44.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.327 0.584 . . . . 0.0 111.925 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.88 123.56 26.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -135.71 134.57 39.24 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.096 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.56 89.57 3.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 p -71.78 112.42 7.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' O ' ' OG ' ' A' ' 58' ' ' SER . 95.5 mt -112.0 144.2 41.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.76 0.791 . . . . 0.0 112.415 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -63.26 -27.84 69.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.605 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -125.14 143.79 50.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.122 0.487 . . . . 0.0 111.719 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.58 143.82 29.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.342 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' PRO . 38.7 t -117.89 138.0 24.93 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.202 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -62.32 -143.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.229 1.118 . . . . 0.0 110.649 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -125.76 115.64 43.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.45 -29.37 3.16 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.89 -16.07 28.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.967 0.413 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.39 140.35 38.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -128.64 139.47 52.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.115 0.483 . . . . 0.0 111.553 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 96.6 m95 -140.23 106.78 5.32 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.438 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 84.0 m-85 -158.88 157.84 32.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.671 0.748 . . . . 0.0 111.714 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.927 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.49 129.8 75.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -66.17 120.64 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.264 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.43 -2.35 18.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.572 ' O ' HD11 ' A' ' 39' ' ' ILE . . . -165.06 62.16 0.12 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.639 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.49 110.95 0.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 44' ' ' VAL . 4.1 m -79.03 116.75 23.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.616 0.722 . . . . 0.0 112.17 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -82.91 155.12 67.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.043 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -49.28 -24.46 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.486 1.458 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -106.58 27.26 9.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 49' ' ' SER . 41.8 t0 -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.189 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 42.8 p -88.33 -37.69 15.75 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -86.45 -32.9 20.59 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.444 ' NE1' HD13 ' A' ' 64' ' ' LEU . 19.0 m-90 -110.81 145.79 37.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.774 0.321 . . . . 0.0 110.823 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.421 ' HB ' HD23 ' A' ' 63' ' ' LEU . 88.5 m -132.07 127.57 36.39 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.34 135.13 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 p -144.55 156.9 44.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.417 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.6 100.57 4.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.45 112.0 24.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.674 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.23 -123.92 34.67 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 26' ' ' LEU . 6.0 t -106.62 48.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -144.13 139.6 28.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -117.8 118.05 30.98 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.26 106.1 14.97 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.272 0.558 . . . . 0.0 111.659 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.798 ' C ' HD13 ' A' ' 63' ' ' LEU . 10.6 tp -114.24 126.88 55.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.503 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.913 ' H ' HD22 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -125.35 -177.41 3.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.302 1.048 . . . . 0.0 111.032 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 65' ' ' ARG . 40.8 tp -144.16 117.72 9.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.792 -2.004 . . . . 0.0 106.931 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 64' ' ' LEU . 24.5 mmt85 -64.14 -129.07 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.521 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.6 p -78.23 108.9 11.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.94 141.32 56.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 27.1 mt-30 -129.55 142.08 44.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.876 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.73 84.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.296 1.33 . . . . 0.0 111.473 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' GLN . 45.4 t-80 174.15 -23.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.084 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.4 -7.42 59.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.819 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.47 145.62 22.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.611 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.11 -165.38 38.53 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.42 150.47 20.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 85.8 t -117.4 115.33 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.508 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 m -131.55 130.89 42.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -142.23 146.99 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.3 155.1 30.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.164 0.507 . . . . 0.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' ASP . 8.4 t -156.12 -138.59 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.109 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' ALA . 24.3 mmm180 -55.57 89.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.0 p-10 39.52 22.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.767 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -105.84 75.21 1.1 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.98 137.46 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.438 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -151.74 117.43 5.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 41.9 m -92.38 -173.88 3.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.342 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 176.1 172.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.203 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -140.88 135.62 31.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.229 0.538 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.0 tp -120.03 128.34 53.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -142.84 146.51 34.22 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.8 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.1 p -109.85 126.73 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 110.919 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 3.1 mm? . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.1 mt -91.85 119.1 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.717 ' N ' HD12 ' A' ' 6' ' ' LEU . 7.1 mp -82.94 -70.83 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -141.83 136.63 30.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.303 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.881 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.73 143.71 50.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.594 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 117.82 29.93 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 1.2 mmpt? -130.36 178.02 6.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.867 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' LYS . 13.0 m120 52.22 108.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.412 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.86 137.04 9.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.57 0.7 . . . . 0.0 112.028 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.53 125.42 48.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.816 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.65 103.88 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.351 0.596 . . . . 0.0 111.675 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -61.77 141.01 58.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.947 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.85 114.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.58 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.78 7.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.56 155.41 46.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -100.8 153.99 19.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.044 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.26 143.77 34.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 p -121.57 135.62 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.324 0.583 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.97 122.84 27.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -137.08 136.37 38.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 m -127.07 92.88 3.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.916 0.388 . . . . 0.0 111.822 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.572 HG23 ' NE2' ' A' ' 59' ' ' HIS . 72.8 m -74.71 110.16 8.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.575 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.87 -167.05 1.32 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.105 0.478 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 t -107.93 -11.64 15.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.261 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.4 pm0 -140.68 149.11 41.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.703 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.65 146.38 23.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 31' ' ' PRO . 59.4 t -102.02 125.97 35.12 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.611 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.81 -141.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.181 1.254 . . . . 0.0 110.411 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.94 124.52 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.01 31.69 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.687 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.14 -11.58 49.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.309 0.554 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -143.16 53.29 1.36 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -90.37 110.53 21.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.402 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -157.96 152.69 25.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.583 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.483 ' N ' HD13 ' A' ' 39' ' ' ILE . 3.5 mm -74.73 117.07 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.78 95.04 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 133.57 -24.6 3.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 106.01 4.76 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.49 58.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.7 m -82.46 124.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.359 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.02 153.85 60.29 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.29 -33.38 45.22 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.334 1.356 . . . . 0.0 111.072 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 49' ' ' SER . 87.5 m-20 -88.44 14.73 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.881 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' ASP . 48.8 p-10 -32.97 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.507 . . . . 0.0 111.719 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 47' ' ' ASP . 16.1 t -68.01 -40.13 83.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.236 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.06 -27.55 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.447 ' CE3' HD13 ' A' ' 64' ' ' LEU . 4.5 m95 -115.24 152.15 33.21 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.39 -0.194 . . . . 0.0 110.699 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -144.87 152.24 39.95 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 111.228 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.44 139.25 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.855 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 61' ' ' ALA . 2.2 p -140.75 156.05 46.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.544 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.15 107.53 4.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -108.72 104.02 13.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.735 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.38 -134.61 45.15 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.1 m -89.48 38.55 0.91 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.68 0.276 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.572 ' NE2' HG23 ' A' ' 25' ' ' THR . 57.4 m80 -137.59 142.42 41.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.839 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.55 159.88 20.68 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -152.57 82.98 1.23 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.669 0.747 . . . . 0.0 110.749 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -92.15 144.59 25.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.249 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 63' ' ' LEU . 2.8 pp -141.02 174.07 10.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.281 1.039 . . . . 0.0 112.654 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.447 HD13 ' CE3' ' A' ' 51' ' ' TRP . 48.7 tp -142.24 118.16 10.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 113.057 -1.883 . . . . 0.0 106.895 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LEU . 69.5 mtt180 -66.04 -131.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.477 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.1 m -81.57 106.58 13.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.91 0.386 . . . . 0.0 110.815 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.53 54.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.727 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.665 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 55.0 mt-30 -124.66 148.02 57.77 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -44.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.704 1.603 . . . . 0.0 111.451 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . 13.7 t-80 164.15 -21.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.665 ' HD1' ' H ' ' A' ' 68' ' ' GLN . 76.1 m80 -79.87 -8.91 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.17 145.45 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.96 -141.82 7.64 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 39' ' ' ILE . 91.3 mt-10 -134.47 169.99 16.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.547 0.339 . . . . 0.0 110.171 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 44.8 t -128.87 129.15 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.318 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -133.69 130.01 37.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.974 0.416 . . . . 0.0 111.222 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -132.27 141.83 49.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.13 143.8 15.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 10.6 t -158.86 -136.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.286 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 43.8 mtm180 -59.87 85.52 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.186 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' CYS . 94.3 m-20 51.65 14.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.21 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.03 91.36 8.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 110.194 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -81.27 138.72 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.013 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.461 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -164.94 160.46 19.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 16.8 p -160.38 -178.49 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.764 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.65 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 179.84 170.88 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.201 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -129.68 121.38 26.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.195 0.521 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' GLY . 41.6 tp -104.34 128.64 52.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.922 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 t -143.58 125.03 14.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.695 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.51 113.47 28.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.631 -178.692 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.587 0.232 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -92.85 94.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.327 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 mp -61.65 -46.78 88.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.118 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.51 114.62 18.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.907 0.384 . . . . 0.0 110.226 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 116.85 33.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.689 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HB3' ' H ' ' A' ' 23' ' ' THR . 34.6 tp -101.4 120.52 40.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.371 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.725 ' H ' ' CE ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.64 -163.88 1.85 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.295 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.84 108.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.76 139.07 9.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.825 0.821 . . . . 0.0 113.014 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.06 130.95 53.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.688 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 90' ' ' VAL . 9.1 m -136.14 108.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -77.48 169.85 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.146 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.33 107.01 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.34 -7.68 40.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 65' ' ' ARG . . . -76.39 -178.35 4.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.411 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -136.86 149.76 47.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.52 133.47 55.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.216 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.2 t -121.22 106.7 11.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.131 0.491 . . . . 0.0 111.45 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -118.57 106.83 13.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 3.7 p -138.23 147.34 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 31.1 p -134.56 99.45 4.35 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.818 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 m -69.98 110.72 5.21 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.373 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -94.05 175.62 6.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.704 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 t -114.92 -5.57 12.56 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -127.06 137.82 53.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.3 136.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.018 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.3 133.71 24.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.519 -0.277 . . . . 0.0 110.68 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.96 -154.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 119.844 0.98 . . . . 0.0 109.938 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.97 104.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.74 -50.9 0.4 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -69.58 -43.64 72.44 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.8 143.89 37.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.591 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -142.25 127.9 19.15 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 121.011 0.434 . . . . 0.0 111.075 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 33.6 m95 -122.96 111.97 17.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.145 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 87.0 m-85 -157.54 157.73 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 111.336 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.846 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.78 128.57 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.335 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -61.85 118.66 7.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.576 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.7 -0.99 20.1 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.523 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -164.43 68.8 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.821 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.34 131.07 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.69 110.67 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.857 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -92.94 154.42 41.85 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.582 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.65 -25.78 43.29 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 120.999 1.133 . . . . 0.0 110.633 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.89 11.47 29.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.708 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 51' ' ' TRP . 44.4 p-10 -42.77 115.96 0.8 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.5 p -87.87 -39.68 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.665 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -88.97 -26.03 21.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 10.6 m-90 -110.5 145.31 37.94 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HD12 ' A' ' 62' ' ' LEU . 96.7 m -124.54 126.11 45.29 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 p -125.03 129.92 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -143.99 153.16 41.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.43 98.54 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.995 0.426 . . . . 0.0 110.107 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.67 96.83 7.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.04 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.27 -128.17 41.27 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 m -92.79 42.68 1.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -149.41 135.53 18.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -121.74 140.52 52.23 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 130.55 37.83 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 111.548 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 52' ' ' THR . 40.4 tp -135.28 122.7 21.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.865 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' HD12 ' A' ' 63' ' ' LEU . 2.5 pp -141.02 139.76 34.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.1 tp -106.34 119.61 39.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mtt-85 -63.91 -101.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.902 -177.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.6 p -82.81 99.19 9.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.917 0.389 . . . . 0.0 111.312 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.68 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.423 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.686 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 83.6 mt-30 -130.62 139.34 35.3 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.012 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -55.36 85.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.072 1.181 . . . . 0.0 110.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.1 t60 -175.06 -48.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 25.5 p80 -76.96 -0.37 24.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.635 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.05 146.88 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.0 -148.57 12.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.0 mp0 -115.32 156.36 25.63 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.76 0.314 . . . . 0.0 110.399 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.7 t -117.93 116.56 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.489 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.3 m -123.73 131.78 53.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.192 0.52 . . . . 0.0 110.774 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -136.13 130.96 34.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.231 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.46 150.73 51.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.447 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.5 t -153.33 -144.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.649 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' ALA . 21.1 mmm180 -52.77 88.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.953 0.406 . . . . 0.0 109.966 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.8 p30 42.71 17.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -101.7 86.23 2.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 83' ' ' VAL . 10.5 p -82.31 127.33 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.09 129.32 21.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.535 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 11.1 p -92.83 -175.26 3.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.479 0.657 . . . . 0.0 111.631 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 175.68 171.97 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.81 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -146.52 138.57 24.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.985 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.2 tp -117.95 128.85 55.2 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.548 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 t -141.31 153.33 45.1 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.525 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.0 p -106.6 116.11 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.283 -179.265 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.0 mt -82.52 123.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 mp -95.39 -38.84 10.31 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.69 146.32 25.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.207 0.527 . . . . 0.0 110.909 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 8' ' ' LEU . 3.1 pp -161.28 121.67 2.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -125.92 116.18 21.11 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 45.2 mtpt -146.95 -164.22 1.94 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.434 0.635 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.554 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 33.0 t-20 56.02 97.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.789 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -167.27 140.67 3.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.403 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.87 140.33 36.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.65 130.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.922 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -58.76 -172.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . . . -76.44 150.04 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.476 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 -3.18 81.88 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.3 144.97 25.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.127 0.489 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.29 145.94 25.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.67 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.69 52.35 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.2 p -152.95 123.36 7.17 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.341 0.591 . . . . 0.0 112.009 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -125.94 143.96 50.88 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.95 143.76 31.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.076 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 26' ' ' LEU . 5.0 t -127.57 88.28 2.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.787 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.634 HG23 ' NE2' ' A' ' 59' ' ' HIS . 44.1 m -75.07 94.06 2.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.853 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.571 HD21 ' SG ' ' A' ' 24' ' ' CYS . 66.1 mt -82.58 -160.9 0.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.956 0.884 . . . . 0.0 112.949 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.3 t -117.39 -19.08 9.68 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.77 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -121.24 150.0 42.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.189 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.32 141.04 30.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 31' ' ' PRO . 22.6 t -117.04 128.19 26.2 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.623 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.2 Cg_exo -60.17 -146.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.913 1.076 . . . . 0.0 111.217 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.01 120.4 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.67 -26.57 8.4 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.955 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 75.8 tt0 -87.1 -12.12 48.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.918 0.359 . . . . 0.0 110.392 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.53 122.69 47.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -92.79 141.13 28.78 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 95.9 m95 -153.21 101.32 2.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.117 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -160.86 167.09 27.4 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.196 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' ASN . 2.0 mp -118.24 94.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ILE . 22.3 t-20 -32.46 123.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 -2.29 29.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.65 79.1 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.133 -0.533 . . . . 0.0 109.683 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.23 58.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.91 131.78 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.991 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -96.42 151.15 37.87 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.91 -29.69 91.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.051 1.167 . . . . 0.0 112.752 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -94.83 0.56 54.95 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -69.01 130.47 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.5 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -97.69 -2.56 41.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -80.2 -29.25 38.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.949 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -112.52 140.52 47.19 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.4 m -131.82 125.95 33.11 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.27 131.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.3 p -143.82 147.39 34.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.534 0.683 . . . . 0.0 112.291 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.97 112.37 24.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.578 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -120.81 101.44 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.78 -122.11 25.33 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' ND1' ' A' ' 59' ' ' HIS . 47.9 t -110.81 44.77 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.634 ' NE2' HG23 ' A' ' 25' ' ' THR . 32.7 m80 -141.93 135.62 29.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.998 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -117.69 126.74 53.03 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.44 119.06 29.86 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 62' ' ' LEU . 6.5 tt -130.51 123.8 30.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.496 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 62' ' ' LEU . 2.8 pp -121.55 162.65 20.21 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 0.0 110.535 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 65' ' ' ARG . 28.5 tp -124.44 117.71 25.03 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 64' ' ' LEU . 56.4 ttp180 -57.39 -109.19 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.001 -177.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.1 p -87.38 121.24 29.56 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 16' ' ' ALA . . . -64.48 138.6 58.5 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' HIS . 23.3 pt20 -133.21 137.23 28.85 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 119.681 -0.199 . . . . 0.0 110.476 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.71 84.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 120.795 0.996 . . . . 0.0 110.722 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 -177.74 -39.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.735 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' A' ' 72' ' ' ALA . 2.7 p-80 -71.99 -33.69 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.78 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' N ' ' CD2' ' A' ' 71' ' ' HIS . . . -35.54 143.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.88 -132.42 3.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.82 129.86 53.73 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.535 0.207 . . . . 0.0 110.634 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.99 130.86 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 m -132.7 123.77 26.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -139.14 128.16 23.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.183 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.441 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -156.99 154.7 30.05 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.549 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 18.1 p -154.67 -132.78 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.623 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 30.8 mmt180 -54.3 84.24 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.109 0.48 . . . . 0.0 109.796 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' CYS . 87.9 m-20 46.16 13.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.56 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.612 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -94.47 70.18 3.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.2 t -81.27 132.52 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.242 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.01 117.95 5.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.971 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.4 p -127.43 147.17 50.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.549 0.69 . . . . 0.0 111.537 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 11' ' ' ASN . . . -157.9 151.93 24.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.939 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -97.62 131.66 43.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 12' ' ' ALA . 46.3 tp -106.48 134.78 49.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -136.13 162.17 33.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.334 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.54 132.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.151 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 91' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.745 0.307 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG13 ' HB1' ' A' ' 82' ' ' ALA . 91.3 mt -100.18 120.9 50.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.049 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.603 HD21 ' OG ' ' A' ' 27' ' ' SER . 86.8 mt -80.97 -69.35 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.93 124.13 34.34 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -110.8 146.56 36.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.388 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.574 ' C ' HD23 ' A' ' 9' ' ' LEU . 6.4 tt -109.05 114.22 27.78 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.408 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -136.2 174.36 10.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.691 -176.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 60.76 107.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.602 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.23 135.7 11.33 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.853 0.835 . . . . 0.0 112.859 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 158.09 16.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.826 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.84 164.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 111.623 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 18' ' ' ALA . 95.2 mtm-85 -128.32 159.32 35.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.845 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.79 101.66 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.578 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.96 -9.27 54.95 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB3' ' H ' ' A' ' 15' ' ' ARG . . . -78.09 174.93 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 111.015 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -115.22 153.64 30.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.75 149.4 47.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.26 142.8 44.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -148.25 133.35 18.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 3.3 t -149.14 155.53 40.82 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.859 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 t -148.67 96.04 2.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 111.927 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 m -69.92 123.03 20.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.58 150.66 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.5 0.667 . . . . 0.0 112.668 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.603 ' OG ' HD21 ' A' ' 6' ' ' LEU . 17.5 m -74.68 -18.23 60.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.341 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -138.02 140.82 40.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.474 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.0 147.67 42.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.532 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 31' ' ' PRO . 41.3 t -105.53 134.77 19.53 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.2 Cg_exo -61.36 -144.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 CA-C-N 120.218 1.114 . . . . 0.0 110.405 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.78 125.12 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.3 -16.05 57.14 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.617 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -89.89 -19.94 23.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.74 23.8 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.432 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 8.6 t -154.29 129.12 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.738 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.544 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 77.7 m95 -150.37 102.42 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 14.6 p90 -155.57 154.51 31.81 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.777 ' N ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -68.81 97.97 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -48.53 96.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 142.25 -20.08 2.46 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 110.41 4.5 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.34 138.01 58.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.3 t -91.83 128.26 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 111.673 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -84.93 153.24 60.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.652 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 48' ' ' ASP . 2.0 Cg_endo -55.44 -34.08 88.05 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.574 1.516 . . . . 0.0 111.717 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -78.58 21.06 0.4 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.749 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 46' ' ' PRO . 27.5 p-10 -47.53 98.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.7 t -81.41 -49.18 10.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.246 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -64.34 -37.93 89.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.926 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -110.18 161.73 15.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.284 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -138.16 141.02 40.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.94 134.58 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 p -141.75 153.75 44.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.477 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 120.6 3.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.63 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -138.03 116.47 12.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.396 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.26 -108.72 2.61 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -130.67 31.83 4.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.75 0.31 . . . . 0.0 110.476 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.499 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 8.7 t-80 -130.75 132.09 45.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.268 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.42 159.98 16.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.51 97.73 1.35 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.996 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.02 130.91 53.86 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.541 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -178.71 4.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.954 0.883 . . . . 0.0 112.016 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -144.67 120.12 10.32 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.049 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -69.0 -130.54 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.278 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.9 p -58.73 100.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 0.0 111.897 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 139.51 58.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.958 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.26 144.63 52.08 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.571 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -52.5 91.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.337 1.358 . . . . 0.0 111.262 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 8.2 m-70 165.11 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -83.3 -7.42 59.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 148.66 43.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.791 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.75 -160.62 31.65 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.3 167.02 11.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.828 0.347 . . . . 0.0 110.39 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 50.8 t -133.28 133.27 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.75 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 m -131.98 128.23 37.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.311 0.577 . . . . 0.0 111.52 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 0.3 OUTLIER -131.05 137.93 49.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.759 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -164.35 152.43 12.49 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 21.2 p -156.48 -133.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.816 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 49.3 mmm-85 -59.14 92.08 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 42.54 18.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.773 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -107.3 73.7 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.12 153.79 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.798 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.22 178.67 8.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.602 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 p -154.69 -179.14 7.72 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.537 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . -178.16 166.55 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.282 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -126.47 135.98 52.04 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.04 0.447 . . . . 0.0 110.353 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 130.53 54.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -152.88 149.66 28.49 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.619 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.3 p -110.66 120.51 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.46 0.475 . . . . 0.0 109.905 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' C ' HD13 ' A' ' 91' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -73.66 121.48 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.524 ' H ' HD12 ' A' ' 6' ' ' LEU . 5.0 mp -82.02 -70.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -127.85 119.72 26.24 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.895 0.378 . . . . 0.0 111.08 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 tp -114.58 130.58 56.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 23' ' ' THR . 10.8 mp -99.92 123.01 43.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.259 0.552 . . . . 0.0 110.61 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ASN . 4.5 mmpt? -138.75 -178.34 5.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.282 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 10' ' ' LYS . 58.8 t-20 55.14 109.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.553 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.38 136.62 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.964 0.888 . . . . 0.0 113.217 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.84 135.9 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.434 ' CG2' ' NE2' ' A' ' 71' ' ' HIS . 15.6 m -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.018 0.913 . . . . 0.0 112.895 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -81.74 151.99 27.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.493 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.94 128.28 32.67 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.95 39.85 53.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.88 149.69 47.28 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.809 0.338 . . . . 0.0 111.434 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -102.66 151.06 22.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.96 28.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.397 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.55 147.32 48.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.411 0.624 . . . . 0.0 111.993 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -140.55 127.04 20.09 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.607 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.503 HG22 HD22 ' A' ' 9' ' ' LEU . 2.9 t -144.53 147.29 33.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.287 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.464 ' SG ' HD21 ' A' ' 26' ' ' LEU . 30.7 t -130.86 93.1 3.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 111.258 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 59' ' ' HIS . 32.2 m -72.56 113.87 10.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.464 HD21 ' SG ' ' A' ' 24' ' ' CYS . 96.2 mt -113.98 145.32 41.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.09 0.472 . . . . 0.0 111.899 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -71.46 -10.45 59.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.982 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -133.53 137.24 45.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.15 143.33 32.46 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.555 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 31' ' ' PRO . 31.2 t -124.03 128.75 24.99 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.06 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.9 Cg_endo -58.41 -150.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.944 1.096 . . . . 0.0 111.056 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -114.37 102.99 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.34 -49.39 0.48 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.73 -40.46 76.2 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.664 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.63 37.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -124.52 131.1 53.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.039 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.509 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 93.5 m95 -133.37 100.29 4.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.085 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 78.4 m-85 -152.63 153.84 34.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.114 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.16 129.32 74.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.788 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.07 123.55 19.79 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.569 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.2 3.96 20.86 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.471 ' HB1' ' CH2' ' A' ' 51' ' ' TRP . . . -171.56 96.44 0.18 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.977 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 135.83 50.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.86 104.99 14.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.426 0.632 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.63 153.13 47.79 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.363 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.46 -27.87 26.06 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.299 1.333 . . . . 0.0 110.903 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -96.67 12.41 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.508 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 22.9 p30 -39.21 110.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.292 0.568 . . . . 0.0 110.756 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.43 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 2.9 t -76.79 -52.51 9.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.341 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.41 -31.9 37.56 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.471 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 21.5 m-90 -107.47 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.403 ' OG1' HD11 ' A' ' 63' ' ' LEU . 15.8 m -130.2 138.98 50.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.3 131.57 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.8 p -144.5 156.12 44.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.167 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 107.15 4.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.551 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -112.56 103.74 11.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.15 -131.59 27.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -97.13 39.36 1.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.572 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.498 ' CE1' HG23 ' A' ' 25' ' ' THR . 80.4 m-70 -137.35 138.5 40.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.431 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -110.85 156.33 21.29 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -158.83 93.7 1.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.924 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -110.18 129.89 55.64 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 63' ' ' LEU . 1.9 pp -122.76 -177.25 3.6 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.064 0.935 . . . . 0.0 112.886 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 65' ' ' ARG . 31.5 tp -144.21 116.54 8.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.141 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' NH2' ' O ' ' A' ' 49' ' ' SER . 13.9 ptp180 -64.67 -129.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.917 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -76.4 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 0.0 110.372 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 71' ' ' HIS . . . -64.68 142.2 58.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 0.0 110.846 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' HIS . 18.9 mm100 -132.97 145.5 57.32 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.778 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.92 85.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.422 1.414 . . . . 0.0 111.303 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' GLN . 67.9 t60 175.98 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.216 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.509 ' CD2' ' HB1' ' A' ' 67' ' ' ALA . 5.8 p80 -76.99 -7.05 54.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.99 145.39 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.003 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.08 36.41 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -88.46 152.03 22.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.413 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 89.7 t -120.93 121.18 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -131.83 132.19 43.5 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.308 0.575 . . . . 0.0 112.218 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 2.2 t80 -138.92 140.55 38.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.137 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.59 152.81 41.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -156.53 -151.64 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.112 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.66 87.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.285 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' CYS . 96.0 m-20 54.0 17.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.663 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.77 68.27 0.92 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.102 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.25 132.72 31.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.136 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.68 130.37 8.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.27 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 1.5 t -92.98 -170.88 2.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 178.48 169.24 0.83 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.979 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -138.59 136.87 36.44 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.702 0.287 . . . . 0.0 110.782 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.03 128.04 50.95 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -142.96 146.92 34.39 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.805 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.5 p -110.98 124.53 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.829 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 -178.882 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.0 m95 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.54 -172.09 3.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.764 HD23 ' N ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER -126.45 45.76 2.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.315 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -75.58 136.44 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 5' ' ' ILE . 2.7 pt -80.65 119.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 6' ' ' LEU . 5.5 mp -77.03 -67.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.445 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -146.64 142.01 27.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.825 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.31 137.47 52.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.002 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 9' ' ' LEU . 10.1 mp -96.95 108.41 21.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -116.82 175.85 5.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.348 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.19 108.38 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.252 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.64 134.18 13.6 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.67 0.748 . . . . 0.0 112.778 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.47 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.42 114.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -76.94 171.06 15.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.181 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.59 129.78 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.143 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.8 89.11 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.219 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.72 -171.15 3.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 20' ' ' ALA . 5.4 tm0? -141.48 157.13 45.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 19' ' ' GLN . . . -117.74 138.95 51.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.784 0.326 . . . . 0.0 110.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 27.0 p -125.38 104.55 8.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.324 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -124.4 117.55 24.69 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.429 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -144.54 150.03 36.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.578 ' SG ' HD21 ' A' ' 26' ' ' LEU . 33.3 t -132.75 98.86 4.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.964 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.415 HG23 ' NE2' ' A' ' 59' ' ' HIS . 57.3 m -79.92 114.72 19.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.578 HD21 ' SG ' ' A' ' 24' ' ' CYS . 84.6 mt -105.64 -167.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.838 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -112.87 -2.27 14.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.66 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -145.09 143.31 30.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.277 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.0 137.0 33.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.909 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 20.5 t -114.01 133.92 22.25 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.611 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.5 Cg_exo -61.51 -142.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.816 1.011 . . . . 0.0 109.978 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.0 t -121.45 110.13 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.43 -45.0 0.71 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.84 -12.89 59.73 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.31 132.67 52.08 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -127.52 118.95 24.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.623 ' CE2' ' CD1' ' A' ' 77' ' ' PHE . 75.4 m95 -118.52 106.32 12.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -151.05 149.2 29.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.594 0.711 . . . . 0.0 111.749 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 74' ' ' GLU . 4.1 mp -117.12 122.85 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -61.02 126.68 28.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.596 1.089 . . . . 0.0 110.341 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 -4.93 24.44 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.18 94.2 0.24 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.307 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.63 132.56 45.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 44' ' ' VAL . 35.3 m -85.25 106.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.245 0.545 . . . . 0.0 111.193 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -80.78 156.4 72.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -47.99 -26.72 7.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.264 1.31 . . . . 0.0 110.54 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -107.22 27.25 9.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -57.66 132.06 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.09 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.3 p -90.66 -43.28 10.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.057 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.85 -40.1 63.51 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.443 ' NE1' HD13 ' A' ' 64' ' ' LEU . 28.7 m-90 -106.68 152.79 23.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.188 0.518 . . . . 0.0 110.699 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.8 m -132.12 132.59 43.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.89 138.1 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 110.301 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -146.1 158.81 43.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.135 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.96 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.368 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -129.57 102.95 6.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.973 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.84 -134.22 23.54 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -91.73 20.04 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.456 0.169 . . . . 0.0 111.445 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.415 ' NE2' HG23 ' A' ' 25' ' ' THR . 75.4 m80 -123.61 124.32 42.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.62 0.248 . . . . 0.0 111.166 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -112.21 119.36 38.08 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.71 131.03 56.33 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.416 0.626 . . . . 0.0 111.339 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.35 131.85 28.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.943 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.65 -174.61 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.301 1.048 . . . . 0.0 111.643 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 65' ' ' ARG . 8.0 tp -142.21 119.64 11.63 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 113.007 -1.906 . . . . 0.0 107.351 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.9 mtt180 -61.65 -138.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 p -69.57 112.93 6.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.97 137.89 57.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 70' ' ' HIS . 83.6 mm-40 -129.54 143.14 47.75 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.622 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.44 83.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.09 1.193 . . . . 0.0 111.145 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 68' ' ' GLN . 86.1 t60 174.85 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.887 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -76.38 -1.75 28.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.67 144.27 43.89 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.993 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.94 179.66 40.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 39' ' ' ILE . 94.9 mt-10 -87.29 157.6 19.26 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.687 -0.302 . . . . 0.0 110.351 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.635 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 44.6 t -120.31 116.81 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.675 0.274 . . . . 0.0 110.558 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.8 m -131.38 133.96 45.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 12.5 t80 -141.23 142.47 33.95 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.527 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.28 145.52 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -156.67 -153.09 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.379 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' HE ' HG22 ' A' ' 30' ' ' VAL . 96.0 mtt-85 -55.08 87.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.846 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 55.11 13.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.03 90.36 6.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.404 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -87.91 136.58 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 164.17 35.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.155 0.503 . . . . 0.0 111.212 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 88.3 p -159.95 178.64 9.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.646 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.635 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 175.49 179.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.259 0.552 . . . . 0.0 111.364 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -133.42 110.34 9.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.396 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -102.29 128.69 48.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 147.28 33.15 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.7 132.46 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.986 0.422 . . . . 0.0 110.811 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 2.9 mm? -86.98 132.24 33.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.99 14.44 11.21 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 95' ' ' ASP . 28.7 mt -103.05 108.05 57.33 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.497 -0.287 . . . . 0.0 110.65 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -69.97 21.42 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.169 1.246 . . . . 0.0 111.348 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 93' ' ' LEU . 95.1 m-20 -84.03 -1.35 54.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.86 103.45 2.22 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.6 mp -87.72 142.14 28.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.794 0.331 . . . . 0.0 110.457 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -133.8 149.7 51.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.239 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -83.61 117.1 22.94 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -86.14 -9.21 57.05 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -97.85 110.72 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.633 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -66.83 -43.34 83.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.542 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 84.3 t60 -150.39 167.45 27.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.764 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.542 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 98.0 m-70 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.436 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 4' ' ' GLU . 88.9 mtm180 -97.06 173.67 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 mp -75.43 37.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 2' ' ' ARG . 9.6 pt-20 -79.18 149.27 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.659 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.56 119.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.19 -68.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.753 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.29 140.93 30.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.425 0.631 . . . . 0.0 112.164 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.812 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.4 pt? -130.1 134.12 47.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.623 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.0 tp -101.7 116.99 33.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.12 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -129.75 -170.25 2.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.5 t30 61.4 108.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.496 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.62 133.86 13.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.018 0.913 . . . . 0.0 113.216 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.34 133.89 54.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.2 m -134.2 112.39 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.754 0.788 . . . . 0.0 112.163 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ALA . 56.2 ttm-85 -84.68 147.22 27.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.937 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ARG . . . -34.75 121.83 0.52 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.377 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 14.1 61.34 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.0 150.74 28.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.749 0.309 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -101.69 172.19 7.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.096 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -131.95 138.39 48.31 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.845 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -128.48 112.28 14.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.345 0.593 . . . . 0.0 111.843 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CE2' ' HB1' ' A' ' 20' ' ' ALA . 82.4 m-85 -124.22 116.73 23.17 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -138.49 141.37 39.4 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.793 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -127.01 96.2 4.54 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.397 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.516 HG23 ' ND1' ' A' ' 59' ' ' HIS . 16.9 m -73.78 107.23 5.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.528 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -100.24 -171.85 2.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 t -112.12 -11.2 13.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.664 ' H ' HH21 ' A' ' 80' ' ' ARG . 47.7 tp10 -138.75 145.58 40.39 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.161 0.505 . . . . 0.0 110.952 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.21 139.27 39.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.942 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 31' ' ' PRO . 8.7 t -112.9 128.53 25.49 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.78 -145.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 120.074 1.062 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.56 110.67 27.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.26 -29.5 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.52 -17.82 29.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.79 141.98 43.4 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -130.81 132.53 45.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.651 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.563 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 94.9 m95 -130.27 110.42 11.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 85.7 m-85 -158.98 154.35 25.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.201 0.524 . . . . 0.0 111.476 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.33 122.77 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.04 124.41 20.73 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.682 1.128 . . . . 0.0 110.346 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.43 2.39 31.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 100.17 0.79 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.91 136.09 50.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.89 100.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASP . 43.7 mt-30 -87.42 151.17 50.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.73 -22.42 13.36 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.335 1.357 . . . . 0.0 110.644 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.91 14.75 12.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.929 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' GLN . 25.9 p30 -42.8 112.22 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.207 0.527 . . . . 0.0 111.435 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.3 t -84.7 -46.58 11.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.917 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -85.14 -25.44 27.46 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -113.44 147.56 37.58 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.5 m -126.65 130.04 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.4 130.46 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 p -144.6 153.99 42.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.904 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.21 103.72 6.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.432 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.43 110.78 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.176 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.91 -133.71 52.61 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.54 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 24.4 m -95.41 38.87 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.962 0.41 . . . . 0.0 110.42 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.54 ' ND1' ' O ' ' A' ' 58' ' ' SER . 12.9 m-70 -141.04 141.28 34.33 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.07 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -129.29 137.27 50.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.74 131.03 47.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.231 0.539 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -124.02 131.6 53.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.399 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.67 165.66 12.79 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.507 1.146 . . . . 0.0 113.711 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 24.9 tp -141.68 113.67 7.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 111.835 -2.439 . . . . 0.0 106.152 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' LEU . 61.8 ttt180 -64.08 -126.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -80.87 109.59 15.58 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.662 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.93 136.05 55.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -133.81 144.57 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.928 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.588 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -51.49 94.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.366 1.377 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER 160.82 -21.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.462 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.71 -6.75 55.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.485 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 150.21 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.48 39.21 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.255 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -98.41 151.57 20.42 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.46 115.04 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.6 m -122.36 132.94 54.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 111.568 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 4.2 t80 -144.66 135.38 24.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.977 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ASP . 28.6 p -153.76 -134.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.805 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.664 HH21 ' H ' ' A' ' 28' ' ' GLU . 47.0 mtm180 -52.56 82.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' CYS . 97.3 m-20 45.12 10.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.826 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -97.62 91.38 5.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.6 p -81.2 126.4 39.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.35 133.19 13.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -152.26 133.0 14.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.24 -159.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.769 0.795 . . . . 0.0 111.458 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -142.7 117.25 9.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.852 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.9 tp -107.64 133.02 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 t -136.51 148.66 47.76 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.6 t -111.91 125.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 mp -92.93 135.63 33.98 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.091 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.55 -117.92 0.51 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -102.96 107.15 54.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.79 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.202 1.268 . . . . 0.0 111.423 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.34 -79.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.371 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.61 -15.14 2.24 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.26 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.9 pt? -75.38 134.81 40.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.411 0.606 . . . . 0.0 110.388 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -100.22 -13.2 19.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.065 0.459 . . . . 0.0 109.984 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.435 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 4.0 p80 -126.34 137.01 53.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.009 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 100' ' ' HIS . 14.2 p80 -90.73 127.95 36.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 101' ' ' HIS . 86.0 t60 -130.6 -3.24 4.23 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.398 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.53 162.02 41.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.471 . . . . 0.0 111.002 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -46.89 170.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.827 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.3 m0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -97.17 150.25 21.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.1 mt -102.15 7.16 41.05 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.298 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -96.1 -134.72 0.22 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.793 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.61 97.79 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.639 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.82 -54.2 42.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.051 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -138.4 132.38 31.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.775 0.322 . . . . 0.0 110.258 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -118.55 147.3 43.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 8' ' ' LEU . 10.9 mp -121.48 123.0 41.0 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' H ' ' HE3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.23 -165.64 2.27 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.56 108.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 144.67 3.8 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.89 0.852 . . . . 0.0 113.033 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.09 135.91 51.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.796 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.1 113.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -76.39 170.02 17.15 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.42 109.72 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.168 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.36 -1.23 50.14 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.45 152.12 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.091 0.445 . . . . 0.0 110.136 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.94 154.22 21.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.863 0.363 . . . . 0.0 111.809 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.74 142.11 51.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.711 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -130.67 123.54 29.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 0.0 111.529 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -133.12 123.25 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.55 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.0 t -147.62 154.22 40.37 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.326 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HG ' ' HZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -140.01 99.93 3.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 109.968 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -81.05 120.68 25.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.084 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.2 -174.79 2.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.44 1.99 14.53 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -138.9 143.93 38.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.135 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -75.84 138.99 41.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.402 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.44 136.81 19.88 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.56 -148.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.319 1.15 . . . . 0.0 110.501 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -121.99 124.66 71.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.1 -35.59 4.3 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -70.93 -42.06 70.37 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 140.67 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -148.06 116.25 6.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.866 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.595 ' HZ2' ' HG ' ' A' ' 24' ' ' CYS . 48.6 m95 -109.68 125.14 52.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.442 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 91.3 m-85 -156.86 152.26 26.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 111.517 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.09 119.52 60.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -58.69 116.84 3.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.05 -3.11 9.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.9 107.05 0.13 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.39 132.21 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.072 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.78 104.61 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.197 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -89.14 154.65 49.46 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.44 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -53.07 -25.79 30.17 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.462 1.441 . . . . 0.0 110.057 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -91.31 11.96 21.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.149 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 39.3 p-10 -37.69 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -73.11 -45.8 54.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.484 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.0 -29.08 17.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -102.34 147.06 27.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.187 0.518 . . . . 0.0 111.015 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.1 m -122.15 126.12 47.63 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.91 128.18 68.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.1 p -142.82 151.76 41.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.056 0.455 . . . . 0.0 111.151 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.14 103.84 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.867 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -104.91 109.12 20.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.715 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.85 -119.17 16.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -105.31 47.43 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.662 0.267 . . . . 0.0 110.449 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.55 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 9.3 t-160 -145.82 138.88 25.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 78.3 m80 -127.05 138.49 53.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.67 109.1 4.33 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.581 HD23 ' C ' ' A' ' 62' ' ' LEU . 8.0 tt -112.67 127.13 56.03 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.396 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 62' ' ' LEU . 2.1 pp -138.38 143.24 39.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 tp -101.83 128.4 48.21 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -71.59 -108.58 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.209 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.9 p -79.91 96.21 6.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 111.234 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.39 142.29 55.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.739 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 70' ' ' HIS . 17.0 mm100 -130.97 144.15 52.36 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.63 84.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.402 1.401 . . . . 0.0 111.378 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' GLN . 78.6 t60 176.25 -28.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -81.77 -6.14 58.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 148.49 9.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.88 -164.91 38.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -104.06 153.71 20.56 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 60.8 t -121.64 115.9 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.106 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -133.01 133.24 42.86 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.013 0.435 . . . . 0.0 110.965 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.549 ' CE1' ' NE1' ' A' ' 37' ' ' TRP . 56.0 t80 -127.66 133.99 49.62 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 142.89 50.61 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.878 0.371 . . . . 0.0 110.678 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.823 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 17.7 p -154.36 -156.83 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.363 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.4 ptp180 -50.7 84.67 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.096 0.474 . . . . 0.0 111.6 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' CYS . 99.1 m-20 51.93 0.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -92.82 94.14 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.91 146.99 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.73 165.19 27.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.0 p -151.67 169.85 21.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 177.96 172.1 0.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.836 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -137.55 136.08 37.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -118.55 126.2 51.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.881 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.9 t -144.09 154.18 42.94 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.722 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -115.0 122.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.368 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.5 tp -78.6 127.83 32.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.787 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.483 ' C ' HD22 ' A' ' 93' ' ' LEU . . . 150.17 43.44 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 93' ' ' LEU . 1.8 mm? -106.45 168.71 7.76 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 29.12 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.105 1.204 . . . . 0.0 111.738 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -62.66 138.75 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.853 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.12 59.12 4.97 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' CD1' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -79.58 166.12 22.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.6 127.7 33.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.27 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -105.25 127.59 53.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.295 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.0 p-80 -114.47 99.15 7.35 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -103.63 130.07 51.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.308 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -94.56 92.95 7.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.938 0.399 . . . . 0.0 110.584 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -98.21 -19.26 17.97 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.998 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.378 179.81 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -100.32 139.11 36.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 110.878 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -164.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.059 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 6' ' ' LEU . 80.2 mm-40 -64.35 -13.04 48.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 HD22 ' A' ' 26' ' ' LEU . 1.1 pt -41.78 70.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' GLU . 42.2 mt -81.54 -28.99 33.66 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -107.28 118.83 37.75 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.82 2.1 . . . . 0.0 112.625 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.42 127.96 32.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -90.4 114.93 27.16 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 11' ' ' ASN . 3.2 mmpt? -121.68 -168.1 1.64 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 10' ' ' LYS . 27.1 m120 53.79 103.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.61 121.2 35.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.698 0.761 . . . . 0.0 113.002 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.37 126.16 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.6 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 28.1 m -137.74 121.23 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -76.35 -166.72 0.66 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.71 124.42 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.22 65.96 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.231 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.71 143.91 44.71 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -92.79 163.34 13.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 148.01 27.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -130.49 123.99 30.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.12 116.53 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.69 150.36 38.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -122.08 94.12 4.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.663 0.268 . . . . 0.0 110.712 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 59' ' ' HIS . 19.7 m -71.51 109.9 5.76 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.238 0.542 . . . . 0.0 110.206 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 5' ' ' ILE . 8.2 mt -99.48 -178.57 3.94 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.24 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.86 -3.84 13.39 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 1.1 pm0 -137.45 146.38 44.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.094 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.27 139.24 37.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.421 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' PRO . 21.8 t -107.11 133.24 20.39 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -58.23 -154.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 120.809 1.006 . . . . 0.0 110.187 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -115.53 102.54 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.71 -46.35 0.65 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.76 -43.31 89.29 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.155 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.0 139.97 38.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -140.97 144.37 35.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.714 0.292 . . . . 0.0 110.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 82.9 m95 -140.42 121.79 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.615 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -156.54 152.18 26.99 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.613 0.72 . . . . 0.0 112.127 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -110.36 114.12 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.01 112.06 3.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.013 1.279 . . . . 0.0 107.616 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.5 -15.67 9.85 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.65 89.38 1.17 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.386 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.33 140.48 57.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.728 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.518 HG12 ' HE1' ' A' ' 51' ' ' TRP . 1.8 m -78.65 103.76 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.794 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -102.04 158.25 32.13 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.07 -17.89 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.57 1.513 . . . . 0.0 110.99 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 65.8 m-20 -89.74 -4.95 57.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' ASP . 97.1 m-20 -35.43 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.255 0.55 . . . . 0.0 110.84 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -87.82 -43.07 12.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.096 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.97 -39.32 61.35 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.518 ' HE1' HG12 ' A' ' 44' ' ' VAL . 15.2 p90 -126.32 166.16 17.66 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.271 0.558 . . . . 0.0 111.304 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.3 p -129.62 156.87 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -132.72 120.84 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.3 p -147.89 157.73 43.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.73 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.02 111.53 5.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.63 107.82 18.83 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.08 -123.88 34.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.2 p -93.55 43.1 1.11 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.521 0.2 . . . . 0.0 111.082 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.509 ' CD2' HG23 ' A' ' 25' ' ' THR . 63.5 m80 -147.78 138.86 23.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.901 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -120.22 134.91 55.15 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.02 132.83 34.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.517 0.675 . . . . 0.0 111.28 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tp -126.3 128.94 47.91 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.815 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' TRP . 72.7 mt -105.81 162.91 13.14 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.995 0.903 . . . . 0.0 112.145 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 67' ' ' ALA . 32.9 tp -141.69 108.3 5.34 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -68.01 -121.98 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -83.84 104.75 14.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.524 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB1' ' NE2' ' A' ' 71' ' ' HIS . . . -66.38 108.0 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.5 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 70' ' ' HIS . 51.4 mt-30 -108.13 145.95 32.52 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -48.85 88.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.758 1.639 . . . . 0.0 111.164 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 9.5 m-70 176.83 -28.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.827 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 22.8 p80 -76.99 -8.02 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.663 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.8 147.4 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 110.909 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.3 -131.26 2.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -141.53 146.69 36.68 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.655 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.58 115.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -118.7 126.55 52.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.358 0.599 . . . . 0.0 111.447 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 28.9 t80 -130.08 124.28 32.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.003 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.97 157.01 24.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.4 t -151.18 -155.04 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -55.19 82.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.007 0.432 . . . . 0.0 110.389 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 79' ' ' CYS . 95.1 m-20 57.47 -2.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.681 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -88.75 100.23 12.98 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 83' ' ' VAL . 11.3 p -86.48 124.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.278 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.03 32.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.025 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.5 p -171.07 155.21 4.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.2 156.08 43.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.086 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -82.17 138.66 34.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.68 131.65 50.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 t -142.97 151.94 41.44 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.229 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.53 ' C ' HD12 ' A' ' 91' ' ' LEU . 14.7 p -111.99 123.44 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.44 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.7 mp -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.395 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.61 -171.07 41.48 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.956 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 93' ' ' LEU . 2.2 mm? -101.33 152.95 38.07 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -50.1 138.97 35.5 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 121.122 1.215 . . . . 0.0 110.889 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -55.6 168.32 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.599 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.91 -69.58 0.1 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.76 91.54 4.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.807 0.336 . . . . 0.0 110.192 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.74 156.93 45.58 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -75.35 139.72 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -73.82 137.56 43.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.742 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -69.51 -160.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -66.9 -41.41 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -76.39 130.9 38.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.786 -179.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 90.9 m95 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' LEU . 99.7 mtt180 -92.98 159.23 15.41 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 3' ' ' LEU . 7.9 tt 39.43 96.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -78.12 135.3 37.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.664 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 5' ' ' ILE . 18.4 tt -89.84 119.06 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 6' ' ' LEU . 9.5 mp -91.07 -71.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.494 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.26 138.31 29.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.72 HD22 ' C ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.44 158.69 44.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.258 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.8 mt -108.89 131.9 54.57 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 111.508 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -142.55 -171.37 3.4 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.707 ' H ' ' CB ' ' A' ' 86' ' ' ALA . 66.3 t30 56.05 109.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -159.2 142.15 14.33 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.38 132.96 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.285 -1.779 . . . . 0.0 107.346 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 90' ' ' VAL . 4.2 m -122.31 124.26 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.656 0.741 . . . . 0.0 112.74 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -87.9 165.97 14.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.479 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.35 114.7 2.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.752 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.11 29.71 27.53 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.47 149.83 38.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.819 0.343 . . . . 0.0 110.128 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -113.34 148.35 35.89 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.71 145.48 51.15 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.215 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 p -124.81 134.34 52.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -133.32 126.22 30.93 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.172 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 t -142.14 142.74 32.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 m -129.28 95.67 4.1 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -77.07 110.13 11.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.12 -174.23 2.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.416 0.627 . . . . 0.0 111.617 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 t -98.7 -20.54 16.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.597 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -142.0 151.16 42.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.008 0.433 . . . . 0.0 111.218 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.6 128.45 35.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.043 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.52 134.77 19.66 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.71 -151.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.028 1.152 . . . . 0.0 110.616 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.93 103.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.84 -37.77 0.66 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.83 -13.09 52.11 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.8 139.84 48.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.376 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -122.97 126.01 46.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.625 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 99.2 m95 -124.66 100.04 6.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.949 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 90.8 m-85 -152.91 149.02 27.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 110.559 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.94 125.09 69.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -48.43 132.76 16.71 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.584 -0.698 . . . . 0.0 111.257 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.63 8.1 56.21 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.205 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.626 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -167.16 125.91 1.35 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.376 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB3' HE22 ' A' ' 45' ' ' GLN . . . -97.28 112.83 24.47 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 44' ' ' VAL . 1.0 OUTLIER -74.88 104.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 112.487 -177.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.475 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.6 mp0 -92.21 157.46 40.72 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -53.29 -23.4 23.35 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.613 1.542 . . . . 0.0 111.495 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -98.35 17.23 19.28 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 45' ' ' GLN . 87.3 m-20 -49.18 128.83 17.24 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.4 p -91.96 -37.25 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.755 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 66.2 t0 -96.48 -32.45 12.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.659 0.266 . . . . 0.0 111.694 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -102.83 139.86 37.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.477 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 m -132.3 130.46 40.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.5 133.21 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -143.34 154.57 43.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.634 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.47 106.0 4.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.327 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.01 105.67 15.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.951 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.32 -126.34 41.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.46 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 23.0 t -95.44 37.56 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.633 0.254 . . . . 0.0 110.938 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 58' ' ' SER . 22.1 m-70 -142.81 153.85 43.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.844 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.27 161.8 28.52 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.92 94.2 1.11 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.755 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.05 128.18 54.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.503 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.572 ' C ' HD12 ' A' ' 63' ' ' LEU . 1.9 pp -121.73 -178.29 3.78 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.162 0.982 . . . . 0.0 112.357 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.2 tp -145.01 120.74 10.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.01 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' LEU . 82.8 mmt-85 -64.1 -130.23 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.307 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 m -82.84 108.28 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.95 142.46 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.672 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' HIS . 80.9 mt-30 -134.42 144.8 52.58 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.42 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.29 83.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.296 1.331 . . . . 0.0 111.153 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.3 t60 178.39 -26.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -87.09 -1.16 57.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.837 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.08 145.96 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.18 -123.04 1.0 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -142.47 154.2 44.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.508 0.194 . . . . 0.0 110.531 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -121.22 117.99 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.1 m -128.95 129.16 45.09 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.13 0.49 . . . . 0.0 112.145 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.625 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 16.4 t80 -136.65 141.16 43.17 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.35 154.8 39.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' ASP . 3.0 t -157.33 -147.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.703 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 82' ' ' ALA . 24.6 mmm180 -53.79 89.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.225 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' CYS . 53.2 t0 50.58 10.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.14 93.99 8.58 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.1 p -92.23 125.69 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.838 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -157.24 123.24 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.472 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.8 p -158.53 138.21 11.93 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.692 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.707 ' CB ' ' H ' ' A' ' 11' ' ' ASN . . . -139.62 151.31 45.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.777 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -81.21 144.27 31.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.344 0.593 . . . . 0.0 112.35 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 12' ' ' ALA . 49.2 tp -111.95 133.12 54.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.386 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -137.86 139.08 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.104 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 14' ' ' VAL . 97.1 t -104.8 126.67 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.239 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.3 tp -117.29 131.56 56.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.033 0.444 . . . . 0.0 111.043 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.443 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -160.18 159.89 31.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 8.3 mp -98.6 108.38 47.87 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.61 -18.4 42.79 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.05 1.166 . . . . 0.0 111.941 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.79 143.09 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.92 0.391 . . . . 0.0 111.467 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.39 98.59 2.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 97' ' ' LEU . 8.9 mp -81.29 145.37 30.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.842 0.353 . . . . 0.0 110.531 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.64 -37.65 79.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.654 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -151.54 143.0 23.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.654 ' CG ' ' H ' ' A' ' 101' ' ' HIS . 28.4 t60 -102.01 -167.89 1.47 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.654 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 97.1 m-70 -67.72 142.75 56.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.445 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.529 ' N ' ' ND1' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -69.2 130.3 42.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.419 ' CG ' ' C ' ' A' ' 102' ' ' HIS . 8.0 p80 35.3 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.525 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.3 m95 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -91.75 163.85 13.92 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.671 ' N ' HD22 ' A' ' 3' ' ' LEU . 2.8 mm? -69.17 126.54 30.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -82.91 143.13 30.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.745 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 5' ' ' ILE . 18.1 tt -89.67 119.46 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.091 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.58 -63.79 1.17 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.928 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -154.12 146.95 24.35 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.946 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -137.07 145.54 44.07 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.806 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.38 115.54 30.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -131.78 -169.99 2.31 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.071 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' LYS . 60.1 t-20 53.42 107.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.409 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.26 147.93 3.83 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.76 148.62 45.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.111 -1.859 . . . . 0.0 106.631 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.0 m -132.87 110.05 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.288 0.566 . . . . 0.0 111.155 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 53.9 ttt85 -76.31 155.77 33.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.24 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.91 136.12 47.51 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.823 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.35 28.27 68.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 15' ' ' ARG . . . -119.12 143.85 46.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.286 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -98.51 159.24 15.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.846 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.0 148.39 31.65 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.58 124.55 41.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.141 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.43 117.27 21.07 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -143.81 153.99 42.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.11 98.43 3.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.314 0.578 . . . . 0.0 111.05 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -71.13 110.44 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.11 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.04 -177.17 4.06 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 110.781 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 100.0 p -108.3 -12.56 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.116 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HB2' HD12 ' A' ' 3' ' ' LEU . 50.6 tp10 -134.29 145.97 49.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.949 0.405 . . . . 0.0 110.902 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.79 129.83 35.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.64 141.57 24.31 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.94 -145.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 120.642 1.265 . . . . 0.0 111.086 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 32' ' ' VAL . 14.0 p -123.15 123.6 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.43 -26.4 6.34 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.39 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.4 -21.21 23.17 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.162 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 143.69 30.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -120.88 126.86 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.572 ' CE2' ' CD2' ' A' ' 77' ' ' PHE . 37.2 m95 -134.45 115.04 13.52 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.657 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -170.37 166.1 8.63 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.287 0.565 . . . . 0.0 112.213 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.78 127.66 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -66.8 132.15 47.43 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 120.772 -1.205 . . . . 0.0 109.713 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.1 -3.92 33.57 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -146.32 -27.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.339 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' ALA . . . 48.3 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' VAL . 1.3 p -60.05 118.93 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.491 0.662 . . . . 0.0 112.52 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -110.98 152.19 43.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.513 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.38 -20.31 47.69 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.911 1.074 . . . . 0.0 111.855 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.82 4.63 49.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.01 137.96 57.97 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.194 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 p -89.31 -33.51 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 51' ' ' TRP . 38.6 p-10 -92.48 -29.34 16.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.662 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.478 ' CE2' HD13 ' A' ' 64' ' ' LEU . 97.4 m95 -110.6 139.14 46.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 111.245 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 93.9 m -127.16 130.28 49.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -125.39 132.91 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 p -144.64 155.82 43.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.501 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.36 105.76 4.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.66 113.78 21.73 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.008 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.26 -133.52 42.48 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -98.26 38.61 1.31 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.815 0.341 . . . . 0.0 110.555 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -139.96 137.92 35.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.125 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -122.08 134.25 54.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 129.36 36.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.36 0.6 . . . . 0.0 111.835 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.44 151.56 41.15 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.245 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 5.0 mp -133.68 165.07 25.78 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.399 1.095 . . . . 0.0 113.156 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' A' ' 51' ' ' TRP . 34.4 tp -143.6 108.39 4.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.643 -2.071 . . . . 0.0 106.365 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.6 mtt-85 -64.58 -121.26 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.2 m -81.87 109.63 16.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 71' ' ' HIS . . . -65.27 134.6 53.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.579 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 0.8 OUTLIER -136.02 147.19 59.76 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.067 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.557 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.3 Cg_endo -48.22 90.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.668 1.578 . . . . 0.0 111.693 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.6 m-70 170.63 -29.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.199 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.62 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 49.1 p-80 -83.25 -15.0 52.01 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.27 146.83 27.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.311 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.26 -137.48 4.61 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.527 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 53.6 mp0 -126.87 147.79 50.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.38 111.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -123.45 123.16 40.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.274 0.559 . . . . 0.0 111.079 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -145.64 145.94 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.736 179.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.3 151.61 28.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.319 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 81' ' ' ASP . 4.8 t -156.73 -140.96 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.939 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ALA . 19.0 mmm180 -54.23 89.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.979 0.419 . . . . 0.0 110.135 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' CYS . 34.7 t70 44.54 16.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -103.41 69.94 1.02 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 135.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.88 132.51 7.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -141.62 119.36 11.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.141 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.77 -160.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.49 0.662 . . . . 0.0 111.67 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -146.04 121.19 10.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.586 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.7 tp -110.07 130.51 55.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.923 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 t -136.17 146.51 46.94 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.613 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 14' ' ' VAL . 9.6 p -113.29 125.53 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 3.0 mm? -95.49 130.21 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.354 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -105.58 -91.44 2.22 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mp -106.65 170.92 5.19 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.54 50.34 3.48 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.373 1.382 . . . . 0.0 111.824 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -87.45 91.83 8.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 110.668 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.11 -13.19 50.14 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -108.27 125.85 52.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.773 0.32 . . . . 0.0 111.62 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.71 134.35 53.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.391 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' HIS . 36.2 p-80 -67.77 -43.97 78.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.51 ' N ' ' CG ' ' A' ' 100' ' ' HIS . 52.8 t60 -106.62 117.55 34.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.551 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.485 ' O ' ' CG ' ' A' ' 102' ' ' HIS . 47.7 p-80 -103.47 110.6 22.69 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.774 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -61.2 -47.07 87.83 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.242 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.08 -179.522 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.41 ' C ' HD12 ' A' ' 3' ' ' LEU . 96.8 mtt180 -99.81 136.07 40.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.05 0.452 . . . . 0.0 110.699 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 3' ' ' LEU . 6.1 mp -93.55 81.18 4.32 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.961 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.12 167.5 19.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.714 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -77.51 121.69 30.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.767 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.21 -68.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' C ' HD12 ' A' ' 8' ' ' LEU . 97.2 mt-10 -135.0 124.86 25.49 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 8' ' ' LEU . 7.9 mp -110.73 152.68 26.29 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.037 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 23' ' ' THR . 48.1 tp -124.02 108.79 12.75 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' CE ' ' N ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -130.19 -168.53 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.506 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 m120 54.78 105.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.782 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.93 134.86 6.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.984 0.897 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.73 130.09 54.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.838 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' ARG . 5.1 m -129.91 103.28 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.214 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 14' ' ' VAL . 93.7 mtt180 -47.54 175.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.48 128.91 38.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.099 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.29 42.41 10.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.58 160.91 36.06 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.495 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -95.24 154.63 17.09 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.744 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . . . -130.25 133.66 46.68 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 p -119.62 122.62 41.96 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -132.6 117.85 18.45 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 59.0 p -144.52 151.69 39.5 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.261 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.99 95.74 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.991 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 p -67.83 123.52 20.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -123.63 143.23 50.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.906 0.384 . . . . 0.0 111.288 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.425 ' O ' HD23 ' A' ' 3' ' ' LEU . 28.5 m -76.77 -13.28 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.921 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' OE1' HD22 ' A' ' 3' ' ' LEU . 49.4 tp10 -116.94 132.89 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 0.0 111.805 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.97 149.56 30.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.8 t -124.74 122.58 25.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.48 -147.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.229 1.118 . . . . 0.0 110.998 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 32' ' ' VAL . 12.9 p -120.97 118.84 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.742 0.782 . . . . 0.0 109.102 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.28 -25.28 9.36 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -91.78 -19.21 22.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.144 0.497 . . . . 0.0 109.678 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.08 166.59 19.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.408 ' HB2' ' H ' ' A' ' 78' ' ' ALA . 16.3 m -146.52 116.75 7.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.462 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.09 97.79 3.06 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -155.07 156.31 35.65 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.854 HD11 ' CE2' ' A' ' 51' ' ' TRP . 4.9 mm -73.42 101.06 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -47.72 97.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 128.42 -36.28 2.5 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . -125.04 98.28 5.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.07 139.73 51.43 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.824 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.52 113.8 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -104.67 152.39 39.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.37 -19.82 18.33 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.286 1.324 . . . . 0.0 109.989 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.54 31.3 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.51 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 42.4 p-10 -97.48 104.94 17.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.508 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -87.44 -52.78 5.17 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.469 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 64' ' ' LEU . 46.2 m-20 -67.39 -37.53 83.26 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 110.112 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.854 ' CE2' HD11 ' A' ' 39' ' ' ILE . 59.7 t-105 -105.17 148.01 27.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.028 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -146.26 143.74 29.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.644 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -124.79 138.0 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -142.83 158.65 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 111.235 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.01 100.83 3.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -108.86 105.15 14.57 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 -131.22 30.22 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -100.43 37.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.064 0.459 . . . . 0.0 110.595 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -135.75 132.34 36.68 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -115.24 123.23 48.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.73 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.27 122.88 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.97 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.5 pt? -141.15 131.43 25.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -129.32 -169.98 2.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.208 1.004 . . . . 0.0 113.7 -175.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 36.7 tp -146.4 119.9 9.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 113.366 -1.743 . . . . 0.0 106.954 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -68.51 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.8 p -71.46 103.54 2.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.167 0.508 . . . . 0.0 110.225 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.4 135.92 53.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 70' ' ' HIS . 73.8 mt-30 -130.87 144.1 52.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.4 Cg_endo -48.57 92.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.515 1.476 . . . . 0.0 111.599 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 3.7 m-70 166.9 -27.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.891 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -86.36 -0.79 56.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.389 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 145.27 56.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.213 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.05 -150.3 15.36 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -118.66 166.7 12.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.626 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 69.8 t -132.2 133.7 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.7 m -132.6 129.16 38.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.382 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -132.78 140.34 47.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.284 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -161.69 144.36 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.645 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' ASP . 25.4 p -157.6 -135.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 82' ' ' ALA . 21.0 mmm180 -51.81 81.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 44.1 t0 51.28 6.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -96.29 91.38 5.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.91 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.315 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . . . -160.01 -179.49 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.326 0.584 . . . . 0.0 110.992 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 m -158.0 178.9 9.7 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.466 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . -169.47 160.97 9.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.212 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -119.27 132.8 55.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.911 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 tp -121.76 127.04 50.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.535 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 t -146.79 153.85 40.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.284 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.3 p -128.4 110.94 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.992 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.9 mt -82.38 133.24 35.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.923 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.02 116.8 3.28 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.5 mt -114.58 147.03 37.21 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -53.35 125.75 19.45 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 120.794 0.996 . . . . 0.0 110.68 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -88.71 138.42 31.43 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.753 0.311 . . . . 0.0 111.073 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.27 -118.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.2 mt -99.19 -2.26 37.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.527 0.203 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -77.02 124.93 28.5 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.931 0.396 . . . . 0.0 111.313 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -155.97 139.8 16.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -129.1 135.99 49.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.685 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.09 166.48 14.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.199 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -102.85 123.6 46.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.459 . . . . 0.0 110.735 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -66.75 -38.26 86.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.572 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -92.69 140.44 29.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.226 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.794 HD12 ' N ' ' A' ' 3' ' ' LEU . 2.9 mp -100.37 116.26 31.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' OE2' ' O ' ' A' ' 80' ' ' ARG . 34.2 tp10 -139.11 -119.76 0.13 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.208 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.456 HD11 ' HB1' ' A' ' 82' ' ' ALA . 81.8 mt -99.3 121.12 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.554 0.342 . . . . 0.0 110.739 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.8 -71.15 0.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -126.5 118.38 24.81 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.7 pt? -122.18 144.64 48.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.573 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -102.23 115.69 31.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.662 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -132.26 179.56 6.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.683 -178.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 10' ' ' LYS . 86.4 m-20 51.88 108.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.292 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.36 140.74 7.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.95 0.881 . . . . 0.0 112.76 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 127.81 53.45 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 14' ' ' VAL . 33.1 m -113.06 111.38 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -63.64 166.65 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.186 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 133.83 48.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.998 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.53 43.11 98.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.26 151.73 48.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.345 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -92.83 157.68 16.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.976 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.81 153.82 36.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.42 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.1 t -142.09 148.23 38.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.435 0.636 . . . . 0.0 111.391 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.65 128.92 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.722 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -148.13 152.04 36.62 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.974 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.4 p -142.01 98.06 3.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.402 0.62 . . . . 0.0 111.756 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 m -71.81 120.32 17.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.138 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.16 139.56 47.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.051 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 t -70.79 -13.21 61.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.19 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -131.66 139.96 49.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.129 0.49 . . . . 0.0 111.367 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.74 146.44 33.88 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.915 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -125.24 134.92 26.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.5 -148.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.318 1.149 . . . . 0.0 110.232 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.88 115.01 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.6 -47.44 0.9 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -68.03 -36.79 80.5 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' ' SG ' ' A' ' 79' ' ' CYS . . . -84.08 127.76 34.12 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.909 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.5 t -135.56 138.04 42.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.556 ' CZ2' ' CG ' ' A' ' 77' ' ' PHE . 90.5 m95 -137.76 112.99 9.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.853 0.359 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.0 p90 -157.91 155.62 29.9 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.202 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.598 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.7 94.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' ILE . 23.8 t-20 -37.61 106.03 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.242 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.77 -9.82 8.55 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.83 102.74 3.44 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 110.496 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 106.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.55 128.37 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.913 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.38 150.1 42.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.5 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.18 -25.64 65.34 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.674 1.583 . . . . 0.0 111.78 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -82.29 11.46 5.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 35.8 p-10 -62.28 133.27 54.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.727 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -90.93 -50.07 6.08 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -64.61 -38.68 91.85 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.015 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -104.72 151.38 23.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.432 ' OG1' HD11 ' A' ' 63' ' ' LEU . 10.4 m -135.07 136.69 42.22 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.34 135.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 p -144.21 157.47 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.269 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.92 113.0 3.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.086 0.47 . . . . 0.0 110.757 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 65.8 t0 -130.33 123.68 30.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 -124.84 11.68 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.4 m -115.55 43.02 2.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.739 0.304 . . . . 0.0 110.801 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 56' ' ' ASP . 34.9 p80 -154.26 146.62 23.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.742 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.64 168.1 9.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.97 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.12 100.91 1.4 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.647 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tt -109.93 129.19 55.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.055 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 63' ' ' LEU . 2.0 pp -118.18 173.66 6.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.957 0.885 . . . . 0.0 112.382 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 64' ' ' LEU . 47.2 tp -140.42 115.2 9.58 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 113.54 -1.664 . . . . 0.0 106.602 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.535 ' NH2' ' OG ' ' A' ' 66' ' ' SER . 61.7 ttp85 -68.17 -128.04 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.552 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 82.5 p -75.55 108.61 8.49 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.369 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.26 56.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 66' ' ' SER . 2.8 mp0 -124.91 141.79 39.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.553 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.2 Cg_endo -53.13 86.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.282 1.321 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 2.1 m-70 174.2 -33.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.708 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -70.64 -5.09 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.795 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.02 145.8 15.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.681 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.88 -167.43 35.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 40' ' ' ASN . 93.2 mt-10 -100.55 165.44 11.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.516 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 37.9 t -128.12 129.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.784 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.2 m -133.42 137.87 45.98 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.462 0.649 . . . . 0.0 110.783 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.556 ' CG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -131.98 134.07 45.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.071 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.462 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -134.59 137.59 43.85 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -151.36 -155.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.468 ' C ' ' N ' ' A' ' 82' ' ' ALA . 79.8 mtp85 -57.77 90.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.8 t0 49.35 14.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -89.73 95.31 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.602 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.48 134.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.395 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.53 154.7 41.85 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.225 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 36.8 p -156.98 173.69 16.64 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.789 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . . . 178.21 175.41 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.193 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -136.98 109.06 7.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.095 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.7 tp -93.47 129.79 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.773 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -137.13 135.08 37.08 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.054 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.18 118.04 41.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.582 HD13 ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -62.19 120.31 10.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' N ' HD13 ' A' ' 91' ' ' LEU . . . 166.05 95.57 0.1 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.19 109.11 62.0 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.39 -158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.896 1.064 . . . . 0.0 111.121 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.17 114.44 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.74 1.38 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 97' ' ' LEU . 10.3 mp -88.32 2.97 51.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.204 0.526 . . . . 0.0 110.275 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -68.96 -34.39 75.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.669 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.96 -175.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -115.8 176.89 4.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.1 m170 54.42 84.63 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -59.75 -42.99 94.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -136.58 -40.53 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.701 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.597 -179.718 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 99.3 m95 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.724 ' C ' HD23 ' A' ' 3' ' ' LEU . 84.0 mtp180 -97.76 -174.13 2.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.394 0.14 . . . . 0.0 111.321 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 2' ' ' ARG . 1.2 pt? 33.5 30.18 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.379 0.609 . . . . 0.0 110.557 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 2' ' ' ARG . 10.3 pt-20 -77.02 143.49 39.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.157 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.8 mt -83.8 118.52 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.08 -67.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.269 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -139.81 131.32 27.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.513 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 119.72 36.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' N ' HD12 ' A' ' 9' ' ' LEU . 9.4 mp -93.84 104.91 16.96 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.677 ' HD3' ' HB2' ' A' ' 86' ' ' ALA . 7.3 mmpt? -132.91 -169.16 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' LYS . 15.6 t-20 59.17 109.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.56 145.84 2.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.832 0.825 . . . . 0.0 111.963 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.09 130.85 53.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.283 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 20' ' ' ALA . 32.8 m -119.92 122.75 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 122.226 1.013 . . . . 0.0 113.397 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.86 167.81 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.048 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.83 55.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.723 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.38 50.76 59.96 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.12 25.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.536 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -100.82 147.36 26.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.141 0.496 . . . . 0.0 110.305 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.697 ' HB2' HG11 ' A' ' 14' ' ' VAL . . . -128.2 140.15 52.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.195 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.01 137.0 47.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.386 0.612 . . . . 0.0 111.83 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -145.67 130.07 17.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.353 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -144.58 148.76 34.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -133.36 95.21 3.47 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.197 0.522 . . . . 0.0 111.666 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.4 m -75.16 113.51 12.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.694 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -107.14 -163.18 0.89 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.481 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 22.4 p -114.03 -7.28 13.11 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.332 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -146.22 154.79 42.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.121 0.486 . . . . 0.0 111.28 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.46 129.31 35.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.748 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.23 133.58 22.83 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.559 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -63.0 -146.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.255 1.127 . . . . 0.0 111.283 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.5 t -120.5 120.85 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.14 -28.67 5.77 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 53.5 mp0 -85.2 -18.02 35.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.748 0.308 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.0 134.75 51.8 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 m -113.6 140.1 48.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.619 0.247 . . . . 0.0 110.554 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.571 ' CZ2' ' CD1' ' A' ' 77' ' ' PHE . 91.7 m95 -147.27 102.41 3.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.61 153.89 32.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 39' ' ' ILE . 5.2 mp -80.81 145.18 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.819 0.819 . . . . 0.0 111.634 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -78.82 106.17 10.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.517 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.24 -9.18 7.02 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.86 120.71 1.22 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.56 0.219 . . . . 0.0 111.065 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.48 53.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.946 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.0 t -98.54 116.25 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 157.92 45.21 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.51 -34.83 90.9 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.675 1.583 . . . . 0.0 112.12 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -82.22 20.23 1.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.584 0.231 . . . . 0.0 111.593 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 28.8 p-10 -55.05 122.83 11.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.087 0.47 . . . . 0.0 112.118 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -88.93 -51.31 5.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.574 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' OD2' ' CE1' ' A' ' 71' ' ' HIS . 97.5 m-20 -66.17 -38.11 87.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.229 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.479 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 8.7 m-90 -105.94 155.29 19.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.412 0.625 . . . . 0.0 112.128 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -132.55 132.53 42.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -125.0 134.1 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 p -145.87 156.04 43.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.12 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.77 109.7 4.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 59' ' ' HIS . 33.1 p-10 -119.32 102.44 8.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.06 -133.67 31.38 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.4 m -89.94 21.47 3.63 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 122.607 -0.349 . . . . 0.0 111.115 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 77.9 m80 -123.11 124.05 42.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.63 153.07 21.03 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.97 98.0 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.497 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.32 132.66 53.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -130.05 -177.25 4.22 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.483 1.135 . . . . 0.0 112.295 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 51' ' ' TRP . 9.2 tp -145.99 115.24 7.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.532 -2.122 . . . . 0.0 107.362 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 49.7 ttp180 -64.65 -128.45 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -69.01 106.03 2.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.945 0.402 . . . . 0.0 109.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.29 143.13 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.887 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -133.59 139.68 34.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -53.8 89.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.318 1.345 . . . . 0.0 112.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.566 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER 168.18 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.808 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 50' ' ' ASP . 7.2 m-70 -85.71 0.64 52.2 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.96 146.21 33.17 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.707 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.42 -149.5 18.85 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 57.7 mp0 -145.03 119.2 9.47 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 2.8 t -70.63 144.35 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.635 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -124.84 128.0 48.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.662 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' CD1' ' CZ2' ' A' ' 37' ' ' TRP . 3.4 t80 -132.47 138.05 47.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.42 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -160.24 144.18 14.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 29.9 p -155.91 -132.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.508 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 95.6 mtt-85 -54.53 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.434 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 79' ' ' CYS . 27.9 t70 46.85 14.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.08 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -101.35 88.73 3.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 84' ' ' ALA . 10.4 p -83.78 153.43 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.426 ' N ' HG22 ' A' ' 83' ' ' VAL . . . -179.64 115.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.79 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.2 t -93.21 -173.91 3.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.987 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.677 ' HB2' ' HD3' ' A' ' 10' ' ' LYS . . . -161.03 154.68 22.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.024 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -114.94 113.76 24.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.445 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 73' ' ' GLY . 38.6 tp -115.11 124.92 52.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -140.49 123.52 16.56 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.107 0.48 . . . . 0.0 110.715 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.84 119.94 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.181 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.0 tp -92.52 111.55 23.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.183 0.516 . . . . 0.0 110.086 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.57 -24.44 0.92 Allowed Glycine 0 N--CA 1.466 0.665 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.036 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 93' ' ' LEU . 7.4 mp -105.9 108.3 61.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.95 139.69 89.21 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 CA-C-N 119.793 0.962 . . . . 0.0 111.244 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 46.1 p-10 -89.71 109.26 20.25 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.564 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 94.39 0.15 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.71 143.76 26.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.004 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -81.23 161.59 23.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.229 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.681 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 30.6 t60 67.87 -152.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.311 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.681 ' H ' ' CD2' ' A' ' 99' ' ' HIS . 7.0 t-80 46.16 82.79 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.61 ' N ' ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -61.55 112.45 2.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.148 0.499 . . . . 0.0 110.189 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.426 ' NE2' ' C ' ' A' ' 104' ' ' HIS . 80.9 t60 -149.04 103.53 3.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.792 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.92 -46.13 90.67 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.752 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.426 ' C ' ' NE2' ' A' ' 102' ' ' HIS . 50.6 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.014 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.4 m0 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -90.0 147.08 23.9 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.247 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.806 ' H ' HD22 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -88.3 94.14 9.74 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 121.268 0.556 . . . . 0.0 110.089 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.18 151.36 29.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.008 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tp -82.85 120.5 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.14 -70.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.7 135.58 29.98 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 112.42 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.26 135.05 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.431 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.675 HD12 HG22 ' A' ' 23' ' ' THR . 89.7 mt -95.67 112.17 23.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.572 ' NZ ' ' O ' ' A' ' 85' ' ' SER . 1.8 mmpt? -127.78 -176.17 3.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.037 0.446 . . . . 0.0 111.295 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 10' ' ' LYS . 93.2 m-20 55.92 108.63 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.341 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.74 138.81 9.73 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.91 147.93 44.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.421 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 90' ' ' VAL . 1.7 m -133.18 114.98 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.423 0.63 . . . . 0.0 111.189 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -85.25 147.58 26.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.379 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.53 124.98 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.586 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.74 27.13 51.93 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.47 147.0 41.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -103.58 156.3 17.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.333 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.43 144.35 31.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.91 0.386 . . . . 0.0 110.567 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -127.69 136.26 51.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.472 0.653 . . . . 0.0 111.13 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -137.51 122.01 18.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.675 HG22 HD12 ' A' ' 9' ' ' LEU . 1.7 t -144.3 152.71 41.15 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.536 -0.466 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 26' ' ' LEU . 14.1 t -127.51 92.45 3.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.171 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 m -73.07 114.86 11.71 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 24' ' ' CYS . 84.2 mt -103.81 -169.41 1.63 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.31 0.576 . . . . 0.0 111.362 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.8 t -113.85 -5.13 13.25 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.234 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -140.85 146.11 37.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.64 133.45 35.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.968 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 31' ' ' PRO . 10.9 t -108.25 134.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.364 -0.35 . . . . 0.0 110.507 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -61.7 -143.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 119.975 1.027 . . . . 0.0 110.047 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.52 111.56 29.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.566 0.698 . . . . 0.0 109.421 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.79 -47.37 0.7 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -67.53 -45.62 75.18 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.069 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.25 138.35 38.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -142.61 112.71 7.06 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.663 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.638 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 98.5 m95 -106.78 107.13 17.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 68.0 m-85 -150.13 150.22 31.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.535 0.683 . . . . 0.0 110.563 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.875 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -125.35 129.27 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -61.07 110.53 1.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.101 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.85 -4.35 6.48 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.811 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.702 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -160.29 76.92 0.62 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.761 0.78 . . . . 0.0 111.316 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.92 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 42' ' ' ALA . 6.2 p -67.97 101.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.506 0.669 . . . . 0.0 110.739 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -92.07 155.94 42.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.37 -30.51 15.56 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.667 1.578 . . . . 0.0 111.616 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.63 10.01 19.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.204 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 11.0 p-10 -51.0 128.81 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.7 p -92.44 -47.34 7.21 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.071 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 46.2 t0 -72.11 -39.36 68.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.641 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.537 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 3.7 m-90 -106.84 151.07 25.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.316 0.579 . . . . 0.0 111.341 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -128.56 130.28 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.878 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.99 133.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.011 0.434 . . . . 0.0 109.833 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -142.01 153.39 44.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.43 98.58 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.086 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -113.19 105.76 13.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.27 -132.45 48.24 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -93.34 35.49 1.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.285 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.552 ' CE1' ' OG1' ' A' ' 23' ' ' THR . 63.7 t-80 -139.65 131.77 28.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -118.52 137.02 53.49 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.77 137.94 51.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.301 0.572 . . . . 0.0 111.472 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 tp -132.63 138.16 47.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.32 162.16 25.36 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.265 1.031 . . . . 0.0 112.864 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 65' ' ' ARG . 17.9 tp -140.88 110.9 6.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 112.774 -2.012 . . . . 0.0 106.323 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 64' ' ' LEU . 95.7 mtt-85 -62.87 -128.96 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.105 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.6 p -77.61 107.15 9.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.08 0.467 . . . . 0.0 110.285 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 137.55 57.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.35 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 84.2 mt-30 -133.94 135.06 23.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.02 88.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.002 1.135 . . . . 0.0 111.658 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 2.0 t60 -173.48 -39.75 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 68' ' ' GLN . 22.8 p-80 -82.12 -7.65 59.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.883 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.21 152.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.34 -162.03 34.01 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.16 149.11 21.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.777 0.322 . . . . 0.0 110.581 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 63.0 t -117.51 119.71 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.886 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 137.31 49.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.638 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 2.3 t80 -137.95 134.98 35.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.466 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -133.06 144.25 49.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.8 t -156.88 -151.2 0.31 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.32 0.581 . . . . 0.0 111.502 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -55.84 84.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.122 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' CYS . 90.5 m-20 51.27 8.62 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -93.4 94.21 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 83' ' ' VAL . 7.5 p -81.74 129.98 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.935 0.398 . . . . 0.0 110.471 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -134.76 165.39 25.38 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.438 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.572 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 96.9 p -161.68 -179.69 7.46 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 174.59 178.64 0.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 128.86 24.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.274 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.3 tp -113.99 130.07 56.56 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 t -142.34 155.97 45.21 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.665 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 14' ' ' VAL . 65.9 t -121.0 123.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.394 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.3 mt -79.44 138.46 37.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.35 -37.72 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.31 108.85 62.39 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -61.43 142.81 96.67 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 119.671 0.918 . . . . 0.0 111.0 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -106.57 -29.21 9.79 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.4 -124.24 4.01 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.7 128.61 55.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.68 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -148.01 -98.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.245 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 101' ' ' HIS . 56.3 t-80 -105.15 58.62 0.68 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.23 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -62.29 -41.53 98.58 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.603 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.528 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 11.6 t60 -63.52 121.6 14.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.153 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -67.36 -45.31 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.626 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -72.66 141.47 48.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.4 m80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.761 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.97 143.6 26.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 111.111 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.707 ' N ' HD22 ' A' ' 3' ' ' LEU . 1.3 mm? -90.97 111.01 22.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.027 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -82.86 151.99 25.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.202 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.69 119.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.688 ' N ' HD12 ' A' ' 6' ' ' LEU . 7.6 mp -86.79 -71.44 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.651 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -132.14 128.17 37.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.057 0.456 . . . . 0.0 111.183 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.809 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.8 pt? -129.66 136.69 50.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.79 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.5 tt -104.55 108.99 20.7 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.483 ' N ' HD23 ' A' ' 9' ' ' LEU . 12.4 mmmt -118.39 -171.22 2.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.3 m120 57.04 108.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.91 130.34 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.91 128.45 46.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -131.31 123.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 95.8 mtt180 -80.51 172.6 13.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.433 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 133.18 54.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.114 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.73 23.8 74.07 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ARG . . . -112.8 152.87 28.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.9 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.67 152.48 20.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG11 ' A' ' 14' ' ' VAL . . . -119.5 144.74 46.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -142.48 120.61 12.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 112.193 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -123.6 116.35 22.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 2.4 t -144.95 150.84 37.66 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.472 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.7 100.75 4.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.573 ' HG1' ' CE1' ' A' ' 59' ' ' HIS . 23.6 m -72.69 112.05 8.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.374 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.04 -166.45 1.23 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.341 0.591 . . . . 0.0 111.245 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.1 p -114.72 -4.83 12.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.915 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -138.37 141.58 39.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.423 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.86 130.59 36.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.515 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 31' ' ' PRO . 26.3 t -104.16 134.9 19.46 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.268 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.0 Cg_exo -60.15 -147.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 120.022 1.044 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.22 109.52 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.56 -42.2 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.46 -43.58 80.74 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.074 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.34 150.2 33.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.64 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -126.8 126.25 43.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 111.036 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -131.48 112.13 12.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -155.42 153.76 30.87 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.505 0.669 . . . . 0.0 111.508 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 74' ' ' GLU . 4.4 mp -120.99 121.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.32 125.65 24.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 119.174 0.897 . . . . 0.0 109.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.47 -3.9 31.06 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.4 96.55 0.4 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.271 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.32 139.41 54.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.868 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.43 103.18 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -90.48 153.74 46.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.12 -29.11 27.35 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.767 1.644 . . . . 0.0 111.352 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -97.21 14.21 26.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -46.45 124.73 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -88.09 -44.21 11.11 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.25 -26.19 19.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.444 ' NE1' HD13 ' A' ' 64' ' ' LEU . 8.2 m-90 -110.18 139.92 44.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.493 ' OG1' HD11 ' A' ' 63' ' ' LEU . 23.4 p -136.94 152.72 50.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.56 137.0 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 p -142.43 153.45 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.93 102.39 5.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.027 0.441 . . . . 0.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -109.33 107.65 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.943 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.89 -131.42 45.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.5 p -97.03 47.16 1.04 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.729 0.299 . . . . 0.0 111.008 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.573 ' CE1' ' HG1' ' A' ' 25' ' ' THR . 63.6 t60 -152.44 137.06 16.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.672 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -117.01 135.75 53.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.05 126.51 26.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 111.008 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 tt -131.22 133.86 45.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.322 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.493 HD11 ' OG1' ' A' ' 52' ' ' THR . 1.5 pp -119.56 -176.63 3.2 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.254 1.026 . . . . 0.0 112.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 44.5 tp -146.12 122.22 10.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 113.144 -1.844 . . . . 0.0 106.302 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' LEU . 93.2 mtt-85 -63.51 -130.77 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.611 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -78.28 108.1 11.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.73 134.89 50.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.898 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 70' ' ' HIS . 74.0 mt-30 -132.4 145.1 55.84 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -50.64 84.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.416 1.41 . . . . 0.0 111.246 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 68' ' ' GLN . 81.4 t60 176.97 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.087 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.03 -8.97 59.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.61 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.11 148.71 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.593 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.9 -171.31 42.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 39' ' ' ILE . 84.5 tt0 -97.68 151.68 19.87 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -119.39 118.14 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 117.757 0.253 . . . . 0.0 110.915 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 m -127.97 129.81 47.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.116 0.484 . . . . 0.0 111.115 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.37 139.34 37.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.293 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.91 153.13 31.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.165 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.9 t -157.32 -140.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 82' ' ' ALA . 77.9 mtp85 -55.97 86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.079 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 79' ' ' CYS . 26.9 t0 52.18 10.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 80' ' ' ARG . . . -92.59 87.43 5.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.6 p -89.78 125.85 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HB1' ' NZ ' ' A' ' 10' ' ' LYS . . . -155.62 122.59 5.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.165 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 40.8 m -95.43 -174.2 3.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.888 0.375 . . . . 0.0 111.26 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 176.04 173.02 0.35 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -149.0 136.23 20.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 tp -112.74 130.91 55.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -138.57 132.22 30.74 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.701 0.286 . . . . 0.0 111.52 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.81 124.23 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.541 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.8 tp -136.73 116.31 12.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.097 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.41 -166.03 36.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.729 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 94' ' ' PRO . 2.5 mm? -96.5 157.34 35.56 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 93' ' ' LEU . 2.5 Cg_endo -45.36 -174.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.953 1.769 . . . . 0.0 111.622 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -60.44 -43.4 96.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.236 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.94 -107.0 0.31 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.71 135.33 38.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -86.62 122.11 30.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.575 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.615 ' CD2' ' H ' ' A' ' 99' ' ' HIS . 7.1 p80 -79.36 -16.7 55.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.563 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -99.94 178.67 4.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 110.799 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -136.34 136.97 40.14 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.219 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -155.67 159.23 39.39 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.561 ' N ' ' ND1' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -156.5 148.68 23.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.389 179.798 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 2' ' ' ARG . 75.8 t-105 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 85.3 mtt85 -75.73 150.85 37.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.488 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.71 85.51 1.63 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 110.052 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 55.1 mp0 -138.09 -73.34 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.647 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.06 107.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 6' ' ' LEU . 11.2 mp -97.05 -64.06 1.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -120.4 110.46 16.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.0 tp -114.07 129.57 56.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -113.25 125.94 54.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.735 0.303 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.381 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.01 128.64 11.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.49 0.662 . . . . 0.0 111.893 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.82 53.76 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.1 108.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -66.86 174.94 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.31 120.77 8.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.532 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.93 49.67 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.718 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.76 43.3 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.11 152.66 19.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 112.337 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.71 141.11 49.7 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.746 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 p -123.96 110.65 15.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.298 0.57 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -117.19 103.97 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -133.66 139.71 46.62 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.405 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.6 p -137.96 96.94 3.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 m -69.19 117.77 11.25 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.119 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 58' ' ' SER . 46.9 mt -101.65 -174.77 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 t -114.09 3.15 15.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.864 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -126.18 127.76 46.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.512 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.38 75.23 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.92 132.46 74.25 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.915 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.1 -143.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.925 1.084 . . . . 0.0 110.935 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 32' ' ' VAL . 19.9 m -118.94 109.96 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.629 0.728 . . . . 0.0 109.301 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.36 -56.38 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 80' ' ' ARG . 96.5 mt-10 -69.46 -40.93 76.84 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 149.75 31.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -137.67 137.98 38.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.013 0.435 . . . . 0.0 110.594 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.466 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 63.7 m95 -136.59 105.1 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.87 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 76.8 m-85 -149.54 150.2 31.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.666 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.847 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.2 130.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -62.65 132.79 53.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.269 -0.894 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.76 40.57 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.563 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -164.14 138.57 5.66 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.967 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.18 130.67 47.31 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.87 111.04 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.633 0.254 . . . . 0.0 110.579 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' ASP . 37.0 mt-30 -126.73 153.11 75.75 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -48.68 -10.26 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.091 1.861 . . . . 0.0 111.488 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' GLN . 45.7 p-10 -108.64 29.42 7.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' ASP . 44.4 p-10 -34.25 161.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.77 0.795 . . . . 0.0 112.378 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -95.79 -62.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.707 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -124.79 -36.02 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -86.98 159.21 19.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.573 0.702 . . . . 0.0 111.312 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.6 m -130.53 144.69 51.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.773 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.43 130.1 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.9 p -143.81 154.91 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.37 100.85 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.351 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -103.21 108.29 19.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.073 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 -132.24 41.11 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 26' ' ' LEU . 10.2 m -97.17 50.87 1.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.391 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -153.67 145.72 23.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -127.36 142.36 51.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.89 12.1 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.287 0.565 . . . . 0.0 111.141 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 63' ' ' LEU . 6.3 tt -122.78 125.2 45.01 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.926 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 62' ' ' LEU . 3.1 pp -139.73 135.65 33.35 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 71' ' ' HIS . 12.4 tp -107.59 111.02 23.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -63.39 -95.59 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.469 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -83.47 103.4 12.79 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 122.09 -0.381 . . . . 0.0 111.729 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.51 55.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.685 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.693 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 40.6 mt-30 -134.22 140.62 36.56 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.74 85.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.059 1.172 . . . . 0.0 111.625 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' GLN . 55.7 t-80 -177.24 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.693 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 35.0 p80 -82.58 -11.24 58.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.366 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.41 146.06 3.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 110.99 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.93 -154.85 25.19 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.38 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.4 mp0 -106.38 154.45 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 72.0 t -116.37 119.56 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.903 0.382 . . . . 0.0 110.688 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.6 m -127.01 130.09 49.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.432 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.64 138.59 36.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.28 153.86 38.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' ' 81' ' ' ASP . 15.1 t -157.07 -132.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.531 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.454 ' C ' ' N ' ' A' ' 82' ' ' ALA . 30.6 mmt180 -57.22 86.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.809 0.338 . . . . 0.0 110.406 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 79' ' ' CYS . 47.7 t0 45.41 18.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.454 ' N ' ' C ' ' A' ' 80' ' ' ARG . . . -102.77 91.22 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.164 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.9 p -91.76 129.98 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.333 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.56 124.22 10.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.154 0.502 . . . . 0.0 110.802 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 10.3 p -92.14 -173.58 3.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 176.4 174.7 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.117 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -137.43 137.69 39.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.449 . . . . 0.0 111.056 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.2 121.64 31.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 t -142.35 152.06 42.53 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.68 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 90' ' ' VAL . 5.8 p -108.88 108.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.833 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 tp -73.69 128.45 35.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.5 -78.1 1.34 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 93' ' ' LEU . 6.6 mp -105.28 146.94 33.71 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.01 140.89 48.66 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 121.12 1.213 . . . . 0.0 110.958 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -64.21 162.11 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.943 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.11 98.48 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.09 127.5 32.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.83 120.66 34.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.725 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.61 -36.44 84.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -138.47 147.5 43.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.21 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -120.65 -1.02 10.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -65.64 -43.4 89.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.206 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -62.01 -47.84 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m80 . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.376 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -100.73 126.4 47.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.195 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -144.78 40.89 1.29 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.684 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' CD1' ' A' ' 6' ' ' LEU . 95.2 mt-10 -75.73 149.77 37.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.859 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.0 mt -86.63 108.59 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.707 ' N ' HD12 ' A' ' 6' ' ' LEU . 6.9 mp -78.98 -64.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.332 -177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.13 113.83 18.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.964 0.411 . . . . 0.0 111.423 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.1 tp -106.73 123.58 48.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.766 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.8 tp -112.07 123.41 50.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.953 0.406 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.645 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 5.3 mmmm -138.67 -165.44 1.82 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.351 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 10' ' ' LYS . 65.7 t30 57.6 107.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.808 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.18 140.2 8.78 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.292 1.044 . . . . 0.0 113.402 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.23 144.37 51.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.617 -1.629 . . . . 0.0 107.454 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.2 m -123.62 128.95 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.713 0.768 . . . . 0.0 112.704 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ALA . 89.7 mtt180 -96.19 158.0 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.505 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 113.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.574 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.85 62.06 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . -104.54 153.13 21.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.503 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.436 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 9.9 mp0 -106.21 156.4 18.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.204 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . . . -124.88 138.11 54.26 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 t -120.83 109.69 15.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.27 0.557 . . . . 0.0 112.272 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -114.08 108.43 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -144.98 152.12 39.67 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.482 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 27.9 p -139.28 102.98 4.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 p -74.38 112.25 10.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.302 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.1 mt -101.22 -173.36 2.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.272 0.558 . . . . 0.0 111.359 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.46 -2.71 17.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.54 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -135.19 139.12 44.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.483 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.19 133.92 33.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.264 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' PRO . 61.1 t -108.31 131.34 21.82 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.1 Cg_exo -60.77 -144.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.949 1.018 . . . . 0.0 110.188 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -119.91 122.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.29 -29.25 6.24 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.709 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.98 -12.61 52.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.86 0.362 . . . . 0.0 110.435 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.94 140.91 37.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 m -118.49 125.97 51.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 66.6 m95 -138.72 118.93 13.55 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.856 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 95.5 m-85 -158.28 153.21 25.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.001 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.71 119.85 57.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -56.88 112.8 1.42 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.425 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.62 9.95 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.32 107.01 0.68 Allowed 'General case' 0 C--O 1.23 0.067 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.75 139.94 53.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.02 98.22 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 0.0 111.171 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.463 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.2 pt20 -102.77 151.43 38.32 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.51 -20.03 8.12 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.309 1.34 . . . . 0.0 110.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -98.05 8.31 44.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 45' ' ' GLN . 64.7 m-20 -42.78 113.31 0.45 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.888 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 t -69.64 -44.26 70.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.048 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.24 -35.76 10.25 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.65 138.83 31.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.082 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -124.52 131.74 53.48 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.4 130.01 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 p -146.07 154.29 41.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.86 98.33 5.49 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -100.68 110.82 22.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.464 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.17 -129.2 31.87 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.404 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 61.0 m -93.29 46.84 1.22 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.757 0.313 . . . . 0.0 110.721 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.404 ' CG ' ' C ' ' A' ' 58' ' ' SER . 39.6 m-70 -149.31 143.81 26.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.807 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -124.49 132.03 53.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.69 130.6 49.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.109 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 62' ' ' LEU . 2.3 tm? -140.59 114.17 8.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -142.35 153.14 43.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.5 tp -106.53 128.89 54.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.316 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -67.14 -107.75 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.62 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 p -83.59 108.81 16.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.127 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.967 ' HB1' ' CE1' ' A' ' 71' ' ' HIS . . . -69.72 139.05 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.667 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 94.5 mt-30 -130.43 140.46 38.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.554 ' O ' ' ND1' ' A' ' 70' ' ' HIS . 2.6 Cg_endo -46.42 89.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.152 1.235 . . . . 0.0 111.742 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' A' ' 69' ' ' PRO . 1.3 m80 163.81 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.843 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.967 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 28.5 p-80 -78.49 -13.29 59.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.645 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.544 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.91 -178.07 40.76 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.446 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.37 149.95 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.22 110.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.666 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.0 m -126.04 125.68 43.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.39 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.67 154.46 28.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.4 t -156.33 -132.8 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -57.86 88.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 79' ' ' CYS . 98.8 m-20 46.24 12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -96.6 66.24 2.3 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.1 t -79.81 129.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.865 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.645 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -161.81 144.85 12.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.13 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -153.84 132.11 11.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.91 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.92 -158.68 0.68 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.396 0.617 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -144.56 129.27 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.753 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.6 tp -117.46 126.3 52.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.586 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 t -139.47 148.4 42.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.132 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 14' ' ' VAL . 9.8 p -115.51 128.15 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.008 0.432 . . . . 0.0 111.599 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.6 tp -92.41 124.51 36.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.012 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.25 -68.9 0.42 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -109.03 157.42 37.04 Favored Pre-proline 0 CA--C 1.527 0.058 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -44.95 161.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.777 1.652 . . . . 0.0 111.477 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.59 -9.43 2.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.734 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.99 44.91 22.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.23 136.89 55.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -70.67 126.65 30.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.58 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 86.0 t60 -171.88 31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.532 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -67.5 -45.25 76.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -74.62 119.86 19.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 110.84 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -74.25 -19.45 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -48.47 -79.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.457 ' OXT' ' CG ' ' A' ' 104' ' ' HIS . 55.4 p-80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.601 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.53 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 31.8 t90 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 4' ' ' GLU . 97.5 mtt180 -101.09 95.67 6.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 2' ' ' ARG . 4.8 mp 35.93 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.53 ' OE2' ' N ' ' A' ' 1' ' ' TRP . 17.2 pt-20 -84.66 144.95 28.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.237 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.6 HD11 ' HA ' ' A' ' 82' ' ' ALA . 28.7 mt -86.67 119.03 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.74 -69.5 0.58 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' C ' HD13 ' A' ' 8' ' ' LEU . 99.0 mt-10 -134.65 130.39 36.31 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.126 0.489 . . . . 0.0 111.774 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.895 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -126.08 146.58 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.457 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.412 HD12 ' H ' ' A' ' 23' ' ' THR . 88.3 mt -104.61 113.61 27.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.764 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 3.0 mmpt? -127.39 173.32 9.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.218 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 63.3 108.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 136.43 13.43 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.11 130.92 48.91 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.18 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 71' ' ' HIS . 6.6 m -126.14 124.25 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.914 0.864 . . . . 0.0 113.319 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -78.04 170.19 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.766 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.68 130.68 45.24 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.49 34.35 54.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.04 147.9 40.75 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.935 0.397 . . . . 0.0 110.919 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -95.54 149.12 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . . . -127.12 144.35 51.05 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.7 p -139.8 133.35 30.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.128 0.489 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -139.12 126.31 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.412 ' H ' HD12 ' A' ' 9' ' ' LEU . 33.5 p -140.03 144.86 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 26' ' ' LEU . 41.9 t -133.53 92.38 2.98 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 110.971 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -74.13 115.42 13.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.622 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 24' ' ' CYS . 91.9 mt -105.37 -177.35 3.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.871 0.843 . . . . 0.0 112.501 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 m -105.31 -15.45 15.04 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.578 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -129.42 129.23 44.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.54 119.64 32.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.578 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -109.81 148.11 37.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.616 -178.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.8 Cg_endo -57.89 -140.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.776 1.651 . . . . 0.0 110.362 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 m -119.21 103.76 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.34 -44.45 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -64.36 -45.59 87.12 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.858 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.47 141.75 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.6 m -135.54 98.58 3.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.562 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 94.3 m95 -102.13 113.89 27.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 88.3 m-85 -150.84 148.03 27.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.183 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 74' ' ' GLU . 1.9 mp -118.99 122.03 68.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -54.44 122.1 9.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 119.043 0.838 . . . . 0.0 110.008 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.71 -5.71 14.2 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 124.113 0.883 . . . . 0.0 110.974 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' CZ3' ' A' ' 51' ' ' TRP . . . -165.26 111.06 0.92 Allowed 'General case' 0 C--O 1.231 0.085 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.04 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.26 139.59 48.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.916 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -86.36 99.54 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.385 0.612 . . . . 0.0 110.506 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.645 ' C ' ' H ' ' A' ' 47' ' ' ASP . 31.1 mt-30 -124.74 163.69 35.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.8 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.89 20.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.312 1.341 . . . . 0.0 111.677 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.645 ' H ' ' C ' ' A' ' 45' ' ' GLN . 39.0 m-20 -112.22 -19.7 12.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 45' ' ' GLN . 49.2 m-20 -46.12 105.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.226 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 47.9 t -93.12 -39.21 11.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' OD1' ' CZ ' ' A' ' 65' ' ' ARG . 95.3 m-20 -87.14 -25.12 24.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.322 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.441 ' CZ3' ' CB ' ' A' ' 42' ' ' ALA . 5.6 m-90 -112.91 142.99 44.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.074 0.464 . . . . 0.0 111.11 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 m -132.16 136.29 46.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.86 134.68 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -141.94 154.29 44.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.62 107.97 5.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 111.56 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -119.28 105.27 11.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.14 -133.58 45.86 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.9 m -92.29 30.06 1.55 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.641 0.258 . . . . 0.0 111.103 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -134.43 130.13 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.27 137.03 54.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.94 119.21 15.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.255 0.55 . . . . 0.0 111.523 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.0 135.34 55.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.537 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' C ' HD12 ' A' ' 63' ' ' LEU . 2.2 pp -125.23 179.36 5.11 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.068 0.937 . . . . 0.0 113.141 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 39.1 tp -145.68 118.52 8.7 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.56 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' CZ ' ' OD1' ' A' ' 50' ' ' ASP . 28.2 ptt180 -63.94 -127.93 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.436 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.0 p -73.06 110.62 7.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.64 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB1' ' CD2' ' A' ' 71' ' ' HIS . . . -63.62 112.38 2.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.979 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' HIS . 2.8 pt20 -112.48 145.69 33.42 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.92 83.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.623 1.549 . . . . 0.0 111.763 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 175.95 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.635 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' CG2' ' A' ' 14' ' ' VAL . 12.3 p80 -73.98 -13.63 60.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.732 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.82 147.6 8.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 110.869 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.84 -170.41 40.6 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 39' ' ' ILE . 80.7 tt0 -99.51 149.63 23.03 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 75.7 t -117.53 115.35 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.7 m -129.3 130.94 46.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.25 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 9.5 t80 -136.79 138.38 40.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.98 147.82 27.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.107 0.479 . . . . 0.0 111.479 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.22 -148.57 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.99 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' A' ' 82' ' ' ALA . 45.1 mmm-85 -60.66 90.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.069 0.461 . . . . 0.0 110.454 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 t0 48.18 14.8 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.193 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.6 ' HA ' HD11 ' A' ' 5' ' ' ILE . . . -104.37 73.63 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.8 t -80.39 151.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.906 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.764 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -157.17 170.38 22.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.286 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 37.1 m -159.1 178.87 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 174.77 179.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 111.179 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 87' ' ' ARG . 83.1 mtt85 -142.07 128.03 19.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.5 tp -113.58 129.46 56.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 t -144.29 153.07 41.64 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.019 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 90' ' ' VAL . 13.9 p -117.65 126.58 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.4 tp -62.55 134.33 56.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.08 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.92 59.73 0.48 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 19.7 mt -99.2 108.52 50.25 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.72 136.48 66.87 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.819 0.971 . . . . 0.0 112.17 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -78.84 175.71 10.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.279 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.05 17.84 33.59 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 97' ' ' LEU . 10.6 mp -73.13 145.05 46.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.151 0.501 . . . . 0.0 111.051 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -102.24 116.3 32.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.142 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -84.02 146.22 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.695 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.516 ' O ' ' CD2' ' A' ' 100' ' ' HIS . 0.4 OUTLIER -61.54 131.47 50.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 0.0 110.609 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 41.63 80.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.499 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 103' ' ' HIS . 60.1 t-80 -67.44 148.43 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.331 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.414 ' N ' ' ND1' ' A' ' 103' ' ' HIS . 2.8 m80 -85.26 132.89 34.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.227 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.665 -179.332 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 95.3 m95 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -98.84 149.31 23.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.251 0.548 . . . . 0.0 111.369 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.632 HD21 HD22 ' A' ' 26' ' ' LEU . 10.1 tt -84.24 93.87 8.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.088 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -72.86 131.44 42.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.222 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.554 HG12 HD22 ' A' ' 8' ' ' LEU . 20.2 tt -92.94 114.83 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.2 mp -92.06 -72.46 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.12 121.58 35.55 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.193 0.452 . . . . 0.0 111.966 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.16 126.86 49.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.343 179.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.65 111.77 23.51 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -126.47 -179.88 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.906 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t30 60.37 108.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.72 15.05 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.664 0.986 . . . . 0.0 113.664 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.04 129.65 50.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.15 126.41 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.898 0.856 . . . . 0.0 112.994 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.56 163.88 25.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.618 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 130.44 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.58 40.1 67.29 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.3 46.01 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.962 0.411 . . . . 0.0 110.962 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -101.99 159.78 15.07 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.744 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 151.68 37.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -133.65 135.76 44.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.327 0.584 . . . . 0.0 111.925 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.88 123.56 26.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -135.71 134.57 39.24 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.096 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.56 89.57 3.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 p -71.78 112.42 7.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.632 HD22 HD21 ' A' ' 3' ' ' LEU . 95.5 mt -112.0 144.2 41.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.76 0.791 . . . . 0.0 112.415 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -63.26 -27.84 69.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.605 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -125.14 143.79 50.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.122 0.487 . . . . 0.0 111.719 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.58 143.82 29.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.342 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' PRO . 38.7 t -117.89 138.0 24.93 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.202 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.0 Cg_exo -62.32 -143.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.229 1.118 . . . . 0.0 110.649 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -125.76 115.64 43.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.45 -29.37 3.16 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.89 -16.07 28.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.967 0.413 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.39 140.35 38.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -128.64 139.47 52.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.115 0.483 . . . . 0.0 111.553 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 38' ' ' TYR . 96.6 m95 -140.23 106.78 5.32 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.438 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 84.0 m-85 -158.88 157.84 32.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.671 0.748 . . . . 0.0 111.714 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.927 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -121.49 129.8 75.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -66.17 120.64 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.264 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.43 -2.35 18.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.572 ' O ' HD11 ' A' ' 39' ' ' ILE . . . -165.06 62.16 0.12 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.639 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.49 110.95 0.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 44' ' ' VAL . 4.1 m -79.03 116.75 23.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.616 0.722 . . . . 0.0 112.17 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -82.91 155.12 67.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.043 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -49.28 -24.46 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.486 1.458 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -106.58 27.26 9.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 49' ' ' SER . 41.8 t0 -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.189 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 42.8 p -88.33 -37.69 15.75 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -86.45 -32.9 20.59 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.444 ' NE1' HD13 ' A' ' 64' ' ' LEU . 19.0 m-90 -110.81 145.79 37.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.774 0.321 . . . . 0.0 110.823 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.421 ' HB ' HD23 ' A' ' 63' ' ' LEU . 88.5 m -132.07 127.57 36.39 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.34 135.13 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 p -144.55 156.9 44.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.417 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.6 100.57 4.68 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.45 112.0 24.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.674 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.23 -123.92 34.67 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 26' ' ' LEU . 6.0 t -106.62 48.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -144.13 139.6 28.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -117.8 118.05 30.98 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.26 106.1 14.97 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.272 0.558 . . . . 0.0 111.659 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.798 ' C ' HD13 ' A' ' 63' ' ' LEU . 10.6 tp -114.24 126.88 55.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.503 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.913 ' H ' HD22 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -125.35 -177.41 3.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.302 1.048 . . . . 0.0 111.032 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 65' ' ' ARG . 40.8 tp -144.16 117.72 9.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.792 -2.004 . . . . 0.0 106.931 176.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 64' ' ' LEU . 24.5 mmt85 -64.14 -129.07 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.521 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.6 p -78.23 108.9 11.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.94 141.32 56.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 27.1 mt-30 -129.55 142.08 44.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.876 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.73 84.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.296 1.33 . . . . 0.0 111.473 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' GLN . 45.4 t-80 174.15 -23.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.084 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.4 -7.42 59.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.819 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.47 145.62 22.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.211 -0.595 . . . . 0.0 109.611 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.11 -165.38 38.53 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.42 150.47 20.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 85.8 t -117.4 115.33 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.508 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.3 m -131.55 130.89 42.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -142.23 146.99 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -157.3 155.1 30.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.164 0.507 . . . . 0.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' ASP . 8.4 t -156.12 -138.59 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.109 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' ALA . 24.3 mmm180 -55.57 89.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.0 p-10 39.52 22.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.767 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -105.84 75.21 1.1 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.98 137.46 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.438 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -151.74 117.43 5.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 41.9 m -92.38 -173.88 3.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.342 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 176.1 172.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.203 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -140.88 135.62 31.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.229 0.538 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.0 tp -120.03 128.34 53.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -142.84 146.51 34.22 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.8 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.1 p -109.85 126.73 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 110.919 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 3.1 mm? -101.28 128.13 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.07 -33.06 0.07 OUTLIER Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -111.59 127.53 26.74 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.6 144.82 99.34 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 CA-C-N 120.013 1.04 . . . . 0.0 111.799 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -70.45 140.62 52.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.072 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.17 -37.45 0.8 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.01 -86.16 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.98 155.09 20.01 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.39 115.26 27.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.572 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -157.74 -17.49 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.295 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.77 111.28 21.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.315 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -83.18 -57.5 3.25 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.718 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -153.02 172.04 17.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.595 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.396 179.596 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.2 mtm-85 -59.89 -113.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 3' ' ' LEU . 9.5 mp -89.65 74.48 7.56 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -77.43 136.75 38.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.425 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.1 mt -91.85 119.1 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.717 ' N ' HD12 ' A' ' 6' ' ' LEU . 7.1 mp -82.94 -70.83 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -141.83 136.63 30.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.303 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.881 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.73 143.71 50.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.594 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 117.82 29.93 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 1.2 mmpt? -130.36 178.02 6.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.867 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 10' ' ' LYS . 13.0 m120 52.22 108.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.412 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.86 137.04 9.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.57 0.7 . . . . 0.0 112.028 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.53 125.42 48.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.816 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.65 103.88 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.351 0.596 . . . . 0.0 111.675 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -61.77 141.01 58.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.947 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.85 114.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.58 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.78 7.47 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.56 155.41 46.55 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -100.8 153.99 19.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.044 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.26 143.77 34.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 p -121.57 135.62 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.324 0.583 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.97 122.84 27.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.0 p -137.08 136.37 38.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 m -127.07 92.88 3.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.916 0.388 . . . . 0.0 111.822 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.572 HG23 ' NE2' ' A' ' 59' ' ' HIS . 72.8 m -74.71 110.16 8.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.575 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.87 -167.05 1.32 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.105 0.478 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 t -107.93 -11.64 15.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.261 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.4 pm0 -140.68 149.11 41.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.703 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.65 146.38 23.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 31' ' ' PRO . 59.4 t -102.02 125.97 35.12 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.611 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.7 Cg_exo -59.81 -141.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.181 1.254 . . . . 0.0 110.411 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.94 124.52 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.01 31.69 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.687 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.14 -11.58 49.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.309 0.554 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -143.16 53.29 1.36 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.539 ' O ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -90.37 110.53 21.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.402 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -157.96 152.69 25.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.583 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.483 ' N ' HD13 ' A' ' 39' ' ' ILE . 3.5 mm -74.73 117.07 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.78 95.04 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 133.57 -24.6 3.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 106.01 4.76 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.49 58.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.7 m -82.46 124.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.359 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.02 153.85 60.29 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.29 -33.38 45.22 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.334 1.356 . . . . 0.0 111.072 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 49' ' ' SER . 87.5 m-20 -88.44 14.73 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.881 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' ASP . 48.8 p-10 -32.97 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.507 . . . . 0.0 111.719 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 47' ' ' ASP . 16.1 t -68.01 -40.13 83.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.236 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -88.06 -27.55 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.447 ' CE3' HD13 ' A' ' 64' ' ' LEU . 4.5 m95 -115.24 152.15 33.21 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.39 -0.194 . . . . 0.0 110.699 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -144.87 152.24 39.95 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.751 0.31 . . . . 0.0 111.228 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.44 139.25 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.855 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 61' ' ' ALA . 2.2 p -140.75 156.05 46.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.544 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.15 107.53 4.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -108.72 104.02 13.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.735 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.38 -134.61 45.15 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.1 m -89.48 38.55 0.91 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.68 0.276 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.572 ' NE2' HG23 ' A' ' 25' ' ' THR . 57.4 m80 -137.59 142.42 41.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.839 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.55 159.88 20.68 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -152.57 82.98 1.23 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.669 0.747 . . . . 0.0 110.749 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -92.15 144.59 25.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.249 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 63' ' ' LEU . 2.8 pp -141.02 174.07 10.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 122.281 1.039 . . . . 0.0 112.654 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.447 HD13 ' CE3' ' A' ' 51' ' ' TRP . 48.7 tp -142.24 118.16 10.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 113.057 -1.883 . . . . 0.0 106.895 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LEU . 69.5 mtt180 -66.04 -131.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.477 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.1 m -81.57 106.58 13.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.91 0.386 . . . . 0.0 110.815 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.53 54.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.727 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.665 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 55.0 mt-30 -124.66 148.02 57.77 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -44.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.704 1.603 . . . . 0.0 111.451 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . 13.7 t-80 164.15 -21.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.665 ' HD1' ' H ' ' A' ' 68' ' ' GLN . 76.1 m80 -79.87 -8.91 59.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.17 145.45 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 88' ' ' LEU . . . 160.96 -141.82 7.64 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 39' ' ' ILE . 91.3 mt-10 -134.47 169.99 16.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.547 0.339 . . . . 0.0 110.171 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 44.8 t -128.87 129.15 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.318 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -133.69 130.01 37.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.974 0.416 . . . . 0.0 111.222 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -132.27 141.83 49.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.13 143.8 15.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 10.6 t -158.86 -136.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.286 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 43.8 mtm180 -59.87 85.52 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.186 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' CYS . 94.3 m-20 51.65 14.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.21 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.03 91.36 8.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 110.194 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -81.27 138.72 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.013 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.461 ' HB1' ' HZ2' ' A' ' 10' ' ' LYS . . . -164.94 160.46 19.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 16.8 p -160.38 -178.49 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.764 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.65 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . 179.84 170.88 1.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.201 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -129.68 121.38 26.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.195 0.521 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' GLY . 41.6 tp -104.34 128.64 52.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.922 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 t -143.58 125.03 14.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.695 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.51 113.47 28.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.64 156.24 23.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.631 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.2 -174.81 14.42 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.3 mt -107.62 170.53 5.49 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.13 -2.91 11.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.828 1.685 . . . . 0.0 111.376 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.98 107.9 12.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.043 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.05 97.75 2.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 2.4 pp -89.95 147.55 23.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 111.098 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -144.46 -80.58 0.18 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.946 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.403 ' H ' ' H ' ' A' ' 100' ' ' HIS . 67.6 t60 -154.89 -11.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.829 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.403 ' H ' ' H ' ' A' ' 99' ' ' HIS . 97.6 m-70 -70.92 -78.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.39 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 102' ' ' HIS . 83.7 t60 -134.21 136.2 43.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.574 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.427 ' O ' ' CD2' ' A' ' 101' ' ' HIS . 92.7 m-70 -104.67 -170.88 1.83 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.119 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -61.82 -6.16 2.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.679 179.913 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -100.5 91.79 4.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.943 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.495 HD13 ' OG ' ' A' ' 27' ' ' SER . 97.0 mt -76.93 146.69 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -140.62 -141.36 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -92.85 94.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.327 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 mp -61.65 -46.78 88.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.118 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.51 114.62 18.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.907 0.384 . . . . 0.0 110.226 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 116.85 33.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.689 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HB3' ' H ' ' A' ' 23' ' ' THR . 34.6 tp -101.4 120.52 40.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.371 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.725 ' H ' ' CE ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -146.64 -163.88 1.85 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.295 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.84 108.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.76 139.07 9.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.825 0.821 . . . . 0.0 113.014 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.06 130.95 53.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.688 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 90' ' ' VAL . 9.1 m -136.14 108.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -77.48 169.85 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.146 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.33 107.01 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.34 -7.68 40.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 65' ' ' ARG . . . -76.39 -178.35 4.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.411 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -136.86 149.76 47.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.52 133.47 55.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.216 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.2 t -121.22 106.7 11.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.131 0.491 . . . . 0.0 111.45 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -118.57 106.83 13.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 9' ' ' LEU . 3.7 p -138.23 147.34 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 31.1 p -134.56 99.45 4.35 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.818 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 m -69.98 110.72 5.21 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.373 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -94.05 175.62 6.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.704 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.495 ' OG ' HD13 ' A' ' 3' ' ' LEU . 9.4 t -114.92 -5.57 12.56 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -127.06 137.82 53.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.3 136.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.018 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.3 133.71 24.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.519 -0.277 . . . . 0.0 110.68 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.96 -154.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 119.844 0.98 . . . . 0.0 109.938 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.97 104.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.74 -50.9 0.4 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -69.58 -43.64 72.44 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.8 143.89 37.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.591 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -142.25 127.9 19.15 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 121.011 0.434 . . . . 0.0 111.075 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 33.6 m95 -122.96 111.97 17.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.145 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 87.0 m-85 -157.54 157.73 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 111.336 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.846 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.78 128.57 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.335 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -61.85 118.66 7.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.576 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.7 -0.99 20.1 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.523 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -164.43 68.8 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.821 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.34 131.07 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.69 110.67 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.857 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -92.94 154.42 41.85 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.582 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.65 -25.78 43.29 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 120.999 1.133 . . . . 0.0 110.633 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.89 11.47 29.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.708 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 51' ' ' TRP . 44.4 p-10 -42.77 115.96 0.8 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.5 p -87.87 -39.68 14.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.665 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -88.97 -26.03 21.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 10.6 m-90 -110.5 145.31 37.94 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HD12 ' A' ' 62' ' ' LEU . 96.7 m -124.54 126.11 45.29 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 p -125.03 129.92 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -143.99 153.16 41.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.43 98.54 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.995 0.426 . . . . 0.0 110.107 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.67 96.83 7.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.04 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.27 -128.17 41.27 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 m -92.79 42.68 1.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -149.41 135.53 18.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -121.74 140.52 52.23 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.96 130.55 37.83 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 111.548 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 52' ' ' THR . 40.4 tp -135.28 122.7 21.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.865 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.466 ' O ' HD12 ' A' ' 63' ' ' LEU . 2.5 pp -141.02 139.76 34.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.1 tp -106.34 119.61 39.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mtt-85 -63.91 -101.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.902 -177.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.6 p -82.81 99.19 9.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.917 0.389 . . . . 0.0 111.312 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.68 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.423 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.686 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 83.6 mt-30 -130.62 139.34 35.3 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.012 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -55.36 85.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.072 1.181 . . . . 0.0 110.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.1 t60 -175.06 -48.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' H ' ' A' ' 68' ' ' GLN . 25.5 p80 -76.96 -0.37 24.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.635 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.05 146.88 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.0 -148.57 12.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.0 mp0 -115.32 156.36 25.63 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.76 0.314 . . . . 0.0 110.399 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.7 t -117.93 116.56 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.489 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.3 m -123.73 131.78 53.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.192 0.52 . . . . 0.0 110.774 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -136.13 130.96 34.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.231 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.46 150.73 51.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.447 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 81' ' ' ASP . 7.5 t -153.33 -144.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.649 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' ALA . 21.1 mmm180 -52.77 88.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.953 0.406 . . . . 0.0 109.966 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 79' ' ' CYS . 3.8 p30 42.71 17.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -101.7 86.23 2.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 83' ' ' VAL . 10.5 p -82.31 127.33 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.09 129.32 21.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.535 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 11.1 p -92.83 -175.26 3.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.479 0.657 . . . . 0.0 111.631 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 175.68 171.97 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.81 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -146.52 138.57 24.85 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.985 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.2 tp -117.95 128.85 55.2 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.548 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.3 t -141.31 153.33 45.1 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.525 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.0 p -106.6 116.11 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 tp -78.92 126.3 30.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.283 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.77 3.94 4.64 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.18 107.54 55.83 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.3 -13.27 35.54 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 120.934 1.089 . . . . 0.0 111.305 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.28 122.44 18.87 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.625 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 100' ' ' HIS . . . -156.82 84.56 0.14 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.3 1.08 46.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.46 -35.61 75.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.28 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.511 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 81.1 m-70 -130.46 103.71 6.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.047 0.451 . . . . 0.0 111.394 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 99' ' ' HIS . 12.4 m80 -156.34 168.96 25.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 86.6 t60 56.02 2.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 100' ' ' HIS . 3.2 m-70 -62.04 -92.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -66.7 -44.15 82.45 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.985 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.531 ' CD2' ' H ' ' A' ' 104' ' ' HIS . 9.6 p80 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.701 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.4 m0 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 4' ' ' GLU . 99.6 mtt180 -96.24 133.29 40.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.793 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -70.07 21.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.597 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 2' ' ' ARG . 15.8 pt-20 -57.03 143.42 38.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.326 0.584 . . . . 0.0 111.732 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.0 mt -82.52 123.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 mp -95.39 -38.84 10.31 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.69 146.32 25.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.207 0.527 . . . . 0.0 110.909 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 8' ' ' LEU . 3.1 pp -161.28 121.67 2.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -125.92 116.18 21.11 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 45.2 mtpt -146.95 -164.22 1.94 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.434 0.635 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.554 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 33.0 t-20 56.02 97.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.789 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -167.27 140.67 3.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.403 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.87 140.33 36.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.65 130.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.922 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -58.76 -172.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . . . -76.44 150.04 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.476 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 -3.18 81.88 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.3 144.97 25.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.127 0.489 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.29 145.94 25.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.67 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.69 52.35 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.2 p -152.95 123.36 7.17 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.341 0.591 . . . . 0.0 112.009 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -125.94 143.96 50.88 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.95 143.76 31.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.076 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 26' ' ' LEU . 5.0 t -127.57 88.28 2.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.787 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.634 HG23 ' NE2' ' A' ' 59' ' ' HIS . 44.1 m -75.07 94.06 2.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.853 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.571 HD21 ' SG ' ' A' ' 24' ' ' CYS . 66.1 mt -82.58 -160.9 0.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.956 0.884 . . . . 0.0 112.949 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.3 t -117.39 -19.08 9.68 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.77 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -121.24 150.0 42.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.189 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.32 141.04 30.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 31' ' ' PRO . 22.6 t -117.04 128.19 26.2 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.623 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 30' ' ' VAL . 4.2 Cg_exo -60.17 -146.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.913 1.076 . . . . 0.0 111.217 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.01 120.4 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.67 -26.57 8.4 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.955 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 80' ' ' ARG . 75.8 tt0 -87.1 -12.12 48.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.918 0.359 . . . . 0.0 110.392 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.53 122.69 47.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -92.79 141.13 28.78 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 77' ' ' PHE . 95.9 m95 -153.21 101.32 2.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.117 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -160.86 167.09 27.4 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.196 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' ASN . 2.0 mp -118.24 94.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ILE . 22.3 t-20 -32.46 123.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.23 -2.29 29.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.65 79.1 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.133 -0.533 . . . . 0.0 109.683 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.23 58.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.91 131.78 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.991 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -96.42 151.15 37.87 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.91 -29.69 91.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.051 1.167 . . . . 0.0 112.752 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -94.83 0.56 54.95 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -69.01 130.47 42.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.5 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -97.69 -2.56 41.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -80.2 -29.25 38.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.949 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -112.52 140.52 47.19 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.4 m -131.82 125.95 33.11 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.27 131.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.3 p -143.82 147.39 34.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.534 0.683 . . . . 0.0 112.291 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.97 112.37 24.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.578 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -120.81 101.44 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.78 -122.11 25.33 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' ND1' ' A' ' 59' ' ' HIS . 47.9 t -110.81 44.77 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.634 ' NE2' HG23 ' A' ' 25' ' ' THR . 32.7 m80 -141.93 135.62 29.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.998 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -117.69 126.74 53.03 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.44 119.06 29.86 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 62' ' ' LEU . 6.5 tt -130.51 123.8 30.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.496 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 62' ' ' LEU . 2.8 pp -121.55 162.65 20.21 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.992 0.425 . . . . 0.0 110.535 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 65' ' ' ARG . 28.5 tp -124.44 117.71 25.03 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 64' ' ' LEU . 56.4 ttp180 -57.39 -109.19 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.001 -177.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.1 p -87.38 121.24 29.56 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 16' ' ' ALA . . . -64.48 138.6 58.5 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' HIS . 23.3 pt20 -133.21 137.23 28.85 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 119.681 -0.199 . . . . 0.0 110.476 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.71 84.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 120.795 0.996 . . . . 0.0 110.722 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' GLN . 85.9 t60 -177.74 -39.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.735 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' A' ' 72' ' ' ALA . 2.7 p-80 -71.99 -33.69 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.78 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' N ' ' CD2' ' A' ' 71' ' ' HIS . . . -35.54 143.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.88 -132.42 3.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.82 129.86 53.73 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.535 0.207 . . . . 0.0 110.634 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.99 130.86 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 m -132.7 123.77 26.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD2' ' CH2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -139.14 128.16 23.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.183 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.441 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -156.99 154.7 30.05 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.549 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 80' ' ' ARG . 18.1 p -154.67 -132.78 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.623 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 30.8 mmt180 -54.3 84.24 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.109 0.48 . . . . 0.0 109.796 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' CYS . 87.9 m-20 46.16 13.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.56 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.612 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -94.47 70.18 3.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.2 t -81.27 132.52 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.242 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.01 117.95 5.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.971 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.4 p -127.43 147.17 50.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.549 0.69 . . . . 0.0 111.537 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 11' ' ' ASN . . . -157.9 151.93 24.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.939 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -97.62 131.66 43.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 12' ' ' ALA . 46.3 tp -106.48 134.78 49.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -136.13 162.17 33.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.334 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.54 132.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.151 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 92' ' ' GLY . 1.9 tm? -98.78 124.01 43.37 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.679 ' N ' HD13 ' A' ' 91' ' ' LEU . . . 171.27 105.32 0.18 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.221 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -109.59 106.52 58.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.44 135.21 41.65 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.912 1.004 . . . . 0.0 111.296 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -89.16 95.62 10.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -98.17 -16.76 31.63 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.9 pp -86.7 128.47 35.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 110.793 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.64 149.22 31.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.537 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -87.62 132.44 34.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 81.5 t60 -148.64 9.58 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.94 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -139.31 151.08 46.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -86.93 139.39 30.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.942 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -142.11 137.77 31.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.18 179.703 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.6 m95 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.436 ' C ' HD12 ' A' ' 3' ' ' LEU . 96.9 mtt-85 -100.7 133.73 44.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.625 0.25 . . . . 0.0 110.471 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 3' ' ' LEU . 9.4 mp -96.89 129.12 44.38 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -137.83 -115.43 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG13 ' HB1' ' A' ' 82' ' ' ALA . 91.3 mt -100.18 120.9 50.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.049 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.603 HD21 ' OG ' ' A' ' 27' ' ' SER . 86.8 mt -80.97 -69.35 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.93 124.13 34.34 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -110.8 146.56 36.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.388 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.574 ' C ' HD23 ' A' ' 9' ' ' LEU . 6.4 tt -109.05 114.22 27.78 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -136.2 174.36 10.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.691 -176.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 60.76 107.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.602 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.23 135.7 11.33 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.853 0.835 . . . . 0.0 112.859 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 158.09 16.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.826 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.84 164.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 111.623 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 18' ' ' ALA . 95.2 mtm-85 -128.32 159.32 35.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.845 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.79 101.66 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.578 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.96 -9.27 54.95 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB3' ' H ' ' A' ' 15' ' ' ARG . . . -78.09 174.93 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 111.015 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -115.22 153.64 30.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.75 149.4 47.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.26 142.8 44.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -148.25 133.35 18.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 59' ' ' HIS . 3.3 t -149.14 155.53 40.82 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.859 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 t -148.67 96.04 2.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 111.927 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 m -69.92 123.03 20.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.58 150.66 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.5 0.667 . . . . 0.0 112.668 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.603 ' OG ' HD21 ' A' ' 6' ' ' LEU . 17.5 m -74.68 -18.23 60.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.341 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -138.02 140.82 40.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.474 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.0 147.67 42.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.532 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 31' ' ' PRO . 41.3 t -105.53 134.77 19.53 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 30' ' ' VAL . 3.2 Cg_exo -61.36 -144.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 CA-C-N 120.218 1.114 . . . . 0.0 110.405 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.78 125.12 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.3 -16.05 57.14 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.617 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -89.89 -19.94 23.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.74 23.8 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.432 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 8.6 t -154.29 129.12 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.738 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.544 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 77.7 m95 -150.37 102.42 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 14.6 p90 -155.57 154.51 31.81 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.777 ' N ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -68.81 97.97 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -48.53 96.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 142.25 -20.08 2.46 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 110.41 4.5 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.34 138.01 58.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.329 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.3 t -91.83 128.26 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 111.673 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -84.93 153.24 60.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.652 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 48' ' ' ASP . 2.0 Cg_endo -55.44 -34.08 88.05 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.574 1.516 . . . . 0.0 111.717 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -78.58 21.06 0.4 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.749 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 46' ' ' PRO . 27.5 p-10 -47.53 98.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.7 t -81.41 -49.18 10.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.246 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -64.34 -37.93 89.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.926 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -110.18 161.73 15.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.284 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -138.16 141.02 40.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.94 134.58 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 p -141.75 153.75 44.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.477 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 120.6 3.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.63 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -138.03 116.47 12.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.396 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.26 -108.72 2.61 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -130.67 31.83 4.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.75 0.31 . . . . 0.0 110.476 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.499 ' NE2' ' OG1' ' A' ' 23' ' ' THR . 8.7 t-80 -130.75 132.09 45.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.268 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.42 159.98 16.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.51 97.73 1.35 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.996 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.02 130.91 53.86 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.541 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -178.71 4.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.954 0.883 . . . . 0.0 112.016 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -144.67 120.12 10.32 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.049 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -69.0 -130.54 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.278 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.9 p -58.73 100.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 0.0 111.897 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 139.51 58.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.958 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.26 144.63 52.08 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.571 ' O ' ' CG ' ' A' ' 70' ' ' HIS . 2.5 Cg_endo -52.5 91.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.337 1.358 . . . . 0.0 111.262 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' PRO . 8.2 m-70 165.11 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -83.3 -7.42 59.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 148.66 43.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.791 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.75 -160.62 31.65 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.3 167.02 11.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.828 0.347 . . . . 0.0 110.39 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 50.8 t -133.28 133.27 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.75 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 m -131.98 128.23 37.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.311 0.577 . . . . 0.0 111.52 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.544 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 0.3 OUTLIER -131.05 137.93 49.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.759 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -164.35 152.43 12.49 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 21.2 p -156.48 -133.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.816 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' SG ' ' A' ' 79' ' ' CYS . 49.3 mmm-85 -59.14 92.08 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 42.54 18.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.773 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -107.3 73.7 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.12 153.79 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.798 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.22 178.67 8.53 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.602 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 p -154.69 -179.14 7.72 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.537 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . . . -178.16 166.55 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.282 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -126.47 135.98 52.04 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.04 0.447 . . . . 0.0 110.353 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 130.53 54.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -152.88 149.66 28.49 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.619 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.3 p -110.66 120.51 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.46 0.475 . . . . 0.0 109.905 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.61 HD13 ' N ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -108.03 118.99 38.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.61 ' N ' HD13 ' A' ' 91' ' ' LEU . . . -169.49 -175.02 38.35 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.6 mt -107.03 150.46 39.87 Favored Pre-proline 0 CA--C 1.521 -0.172 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.39 -27.2 23.32 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 CA-C-N 119.497 0.856 . . . . 0.0 110.68 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -65.76 136.64 56.49 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.5 -5.61 66.87 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.31 134.06 43.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.164 0.507 . . . . 0.0 111.34 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -126.92 -88.87 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.051 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -168.86 126.98 1.03 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.617 ' N ' ' ND1' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -179.37 65.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.212 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.24 -47.01 84.26 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.909 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -165.0 -56.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.36 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -91.19 105.33 17.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.881 -1.057 . . . . 0.0 110.823 -179.54 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -94.53 174.33 7.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -144.66 23.98 1.56 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.04 135.23 44.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -73.66 121.48 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.524 ' H ' HD12 ' A' ' 6' ' ' LEU . 5.0 mp -82.02 -70.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -127.85 119.72 26.24 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.895 0.378 . . . . 0.0 111.08 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 tp -114.58 130.58 56.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 23' ' ' THR . 10.8 mp -99.92 123.01 43.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.259 0.552 . . . . 0.0 110.61 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ASN . 4.5 mmpt? -138.75 -178.34 5.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.282 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 10' ' ' LYS . 58.8 t-20 55.14 109.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.553 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.38 136.62 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.964 0.888 . . . . 0.0 113.217 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.84 135.9 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.434 ' CG2' ' NE2' ' A' ' 71' ' ' HIS . 15.6 m -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.018 0.913 . . . . 0.0 112.895 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -81.74 151.99 27.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.493 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.94 128.28 32.67 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.95 39.85 53.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.88 149.69 47.28 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.809 0.338 . . . . 0.0 111.434 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -102.66 151.06 22.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.96 28.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.397 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.55 147.32 48.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.411 0.624 . . . . 0.0 111.993 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -140.55 127.04 20.09 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.607 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.503 HG22 HD22 ' A' ' 9' ' ' LEU . 2.9 t -144.53 147.29 33.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.287 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.464 ' SG ' HD21 ' A' ' 26' ' ' LEU . 30.7 t -130.86 93.1 3.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 111.258 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 59' ' ' HIS . 32.2 m -72.56 113.87 10.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.464 HD21 ' SG ' ' A' ' 24' ' ' CYS . 96.2 mt -113.98 145.32 41.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.09 0.472 . . . . 0.0 111.899 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -71.46 -10.45 59.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.982 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -133.53 137.24 45.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.15 143.33 32.46 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.555 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 31' ' ' PRO . 31.2 t -124.03 128.75 24.99 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.06 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 30' ' ' VAL . 2.9 Cg_endo -58.41 -150.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.944 1.096 . . . . 0.0 111.056 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -114.37 102.99 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.34 -49.39 0.48 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.73 -40.46 76.2 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.664 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.63 37.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -124.52 131.1 53.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.039 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.509 ' CZ2' ' CE1' ' A' ' 77' ' ' PHE . 93.5 m95 -133.37 100.29 4.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.085 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 78.4 m-85 -152.63 153.84 34.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.114 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -124.16 129.32 74.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.788 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.07 123.55 19.79 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.569 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.2 3.96 20.86 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' HB1' ' CH2' ' A' ' 51' ' ' TRP . . . -171.56 96.44 0.18 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.977 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 135.83 50.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.86 104.99 14.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.426 0.632 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.63 153.13 47.79 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.363 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.46 -27.87 26.06 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.299 1.333 . . . . 0.0 110.903 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -96.67 12.41 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.508 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 22.9 p30 -39.21 110.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.292 0.568 . . . . 0.0 110.756 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.43 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 2.9 t -76.79 -52.51 9.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.341 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.41 -31.9 37.56 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' CH2' ' HB1' ' A' ' 42' ' ' ALA . 21.5 m-90 -107.47 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.403 ' OG1' HD11 ' A' ' 63' ' ' LEU . 15.8 m -130.2 138.98 50.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.3 131.57 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.8 p -144.5 156.12 44.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.167 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 107.15 4.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.551 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -112.56 103.74 11.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.15 -131.59 27.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -97.13 39.36 1.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.572 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.498 ' CE1' HG23 ' A' ' 25' ' ' THR . 80.4 m-70 -137.35 138.5 40.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.431 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -110.85 156.33 21.29 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -158.83 93.7 1.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.924 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -110.18 129.89 55.64 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 63' ' ' LEU . 1.9 pp -122.76 -177.25 3.6 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.064 0.935 . . . . 0.0 112.886 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 65' ' ' ARG . 31.5 tp -144.21 116.54 8.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.141 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' NH2' ' O ' ' A' ' 49' ' ' SER . 13.9 ptp180 -64.67 -129.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.917 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -76.4 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 0.0 110.372 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 71' ' ' HIS . . . -64.68 142.2 58.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 0.0 110.846 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' HIS . 18.9 mm100 -132.97 145.5 57.32 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.778 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.92 85.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.422 1.414 . . . . 0.0 111.303 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' GLN . 67.9 t60 175.98 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.216 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.509 ' CD2' ' HB1' ' A' ' 67' ' ' ALA . 5.8 p80 -76.99 -7.05 54.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.99 145.39 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.003 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.08 36.41 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -88.46 152.03 22.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.413 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 89.7 t -120.93 121.18 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -131.83 132.19 43.5 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.308 0.575 . . . . 0.0 112.218 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CE1' ' CZ2' ' A' ' 37' ' ' TRP . 2.2 t80 -138.92 140.55 38.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.137 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -144.59 152.81 41.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -156.53 -151.64 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.112 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -55.66 87.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.285 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' CYS . 96.0 m-20 54.0 17.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.663 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.77 68.27 0.92 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.102 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.25 132.72 31.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.136 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.68 130.37 8.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.27 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 1.5 t -92.98 -170.88 2.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 178.48 169.24 0.83 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.979 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -138.59 136.87 36.44 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.702 0.287 . . . . 0.0 110.782 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.03 128.04 50.95 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.4 t -142.96 146.92 34.39 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.805 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.5 p -110.98 124.53 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.829 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -91.45 130.95 37.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.72 168.77 32.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 93' ' ' LEU . 10.1 mp -101.26 108.16 53.72 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.47 -26.92 40.17 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.909 1.073 . . . . 0.0 110.999 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 24.5 p30 -77.13 153.16 34.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.362 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.92 -103.25 0.27 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.7 147.61 43.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -132.19 27.53 4.48 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.54 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 59.0 t-80 -123.89 51.52 1.53 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.031 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -151.79 137.22 17.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 110.376 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -159.02 150.15 20.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.008 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -85.7 129.43 34.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.77 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -69.13 134.27 49.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 110.889 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.517 ' OXT' ' CG ' ' A' ' 104' ' ' HIS . 16.4 p80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.442 -179.901 . . . . . . . . 1 1 . 1 stop_ save_